{
  "meta": {
    "title": "Aiims_May_2018_2018_05_06",
    "url": "https://brainandscalpel.vercel.app/aiims-may-2018-2018-05-06-d280b9a3.html",
    "scrapedAt": "2025-11-29T18:15:41.499Z"
  },
  "questions": [
    {
      "id": 50000,
      "choices": [
        {
          "id": 200000,
          "text": "<p><span style=\"font-size:12.0pt;\">External carotid artery</span></p>"
        },
        {
          "id": 200001,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal carotid artery</span></p>"
        },
        {
          "id": 200002,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyrocervical trunk</span></p>"
        },
        {
          "id": 200003,
          "text": "<p><span style=\"font-size:12.0pt;\">Lingual artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Inferior thyroid artery is the branch of which of the following? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q2276709",
      "question_audio": null,
      "question_video": null,
      "map_id": 34656549,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Thyrocervical trunk</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The inferior thyroid artery is a branch of the thyrocervical trunk, which is a branch of the subclavian artery's first part. The inferior thyroid artery ascends anterior to the medial border of the scalenus anterior, then turns medially just below the sixth cervical transverse process and descends on longus colli to the thyroid gland's lower border.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/17_0SR9MRp.jpg\" width=\"1070\" height=\"1154\"></p><p> </p><p><span style=\"font-size:12.0pt;\">The relationships between the terminal branches and the recurrent laryngeal nerve are highly variable and have significant surgical implications.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. External Carotid Artery</strong>: The external carotid artery supplies most of the structures in the neck, face, scalp, and the upper part of the skull. This artery has several branches, including the superior thyroid, lingual, facial, maxillary, and superficial temporal arteries, among others. While it does supply areas around the thyroid, especially through its superior thyroid branch, it is not the origin of the inferior thyroid artery.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Internal Carotid Artery</strong>: The internal carotid artery has no branches in the neck. Instead, it moves upward to supply the brain and eyes. It's essential for cerebral circulation and plays a crucial role in supplying blood to the brain.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Lingual Artery</strong>: The lingual artery is a branch of the external carotid artery. It supplies the muscles and mucosa of the tongue. Given its role and location, it is not involved in supplying the thyroid gland or associated structures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The thyrocervical trunk is a short branch of the subclavian artery, and it supplies numerous structures in the neck. The branches of the thyrocervical trunk are the inferior thyroid artery, the ascending cervical artery, and the transverse cervical artery (which can further divide into superficial and deep branches). The <strong>inferior thyroid artery</strong>, which arises from the thyrocervical trunk, mainly supplies the thyroid and parathyroid glands.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/17_0SR9MRp.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200002,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50001,
      "choices": [
        {
          "id": 200004,
          "text": "<p><span style=\"font-size:12pt;\">A and B</span></p>"
        },
        {
          "id": 200005,
          "text": "<p><span style=\"font-size:12pt;\">B and C</span></p>"
        },
        {
          "id": 200006,
          "text": "<p><span style=\"font-size:12pt;\">A, B and C</span></p>"
        },
        {
          "id": 200007,
          "text": "<p><span style=\"font-size:12pt;\">Only C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements is true regarding the instrument shown below? </span>(INICET MAY 2018)</p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12pt;\">﻿﻿﻿It is used in women not on thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿It is used in women on thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿It is removed once the patient starts ambulating.</span></li></ol><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xyXdk3I.jpg\" alt=\"\" width=\"300\" height=\"258\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xyXdk3I.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9996197",
      "question_audio": null,
      "question_video": null,
      "map_id": 34354735,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) A, B and C</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The image shows a pneumatic compression hose. It is used in women who are not on any thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\"><strong>It is also used along with pharmacotherapy in women at risk of thromboembolism undergoing a cesarean section</strong></span></li><li><span style=\"font-size:12pt;\">It is discontinued once the patient starts ambulating post-surgery.</span></li><li><span style=\"font-size:12pt;\">It is used because pregnancy and surgery increase the risk of thromboembolism.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">Different guidelines are there for different societies (Both ACOG and SMFM) recommend pneumatic compression devices for all patients undergoing cesarean section. This table is from Williams and shows the different guidelines:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-153951.jpg\" alt=\"\" width=\"1000\" height=\"672\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Pneumatic compression devices are used for thromboembolism prevention in women undergoing cesarean sections, whether or not they are on thromboprophylaxis, and are discontinued once the patient starts ambulating post-surgery.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 2575, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-153951.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50002,
      "choices": [
        {
          "id": 200008,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">3 >2>1</span></p>"
        },
        {
          "id": 200009,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">3>1>2</span></p>"
        },
        {
          "id": 200010,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1>2>3</span></p>"
        },
        {
          "id": 200011,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1=2=3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">As a medical student, you're learning about the margin of error and its relationship with sample size. With three studies of different sizes (Sample 1: 1000, Sample 2: 800, Sample 3: 600), how would you order the expected margins of error from largest to smallest? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip8.jpg\" alt=\"\" width=\"572\" height=\"333\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip8.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6763392",
      "question_audio": null,
      "question_video": null,
      "map_id": 34526543,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 3>2>1</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Curve 1 exhibits the smallest margin of error, followed by Curve 2, and then Curve 3. Thus, the ranking is as follows: 3>2>1.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The depicted image showcases three normal distribution curves with varying sample sizes, all sharing the same mean but differing in standard deviation.</span></li><li><span style=\"color:black;font-size:12.0pt;\">When the sample size decreases, the peak diminishes, and the curve adopts a flatter shape.</span></li><li><span style=\"color:black;font-size:12.0pt;\">This signifies a broader confidence interval for the specified mean.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The width of the curve's base is directly linked to the margin of error.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The margin of error in a study is inversely related to the square root of the sample size.</span></li><li><span style=\"font-size:12.0pt;\">This relationship implies that a larger sample size will generally lead to a smaller margin of error, assuming other variables like variance remain constant.</span></li></ul>",
      "correct_choice_id": 200008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50003,
      "choices": [
        {
          "id": 200012,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 200013,
          "text": "<p><span style=\"font-size:12.0pt;\">30</span></p>"
        },
        {
          "id": 200014,
          "text": "<p><span style=\"font-size:12.0pt;\">50</span></p>"
        },
        {
          "id": 200015,
          "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the angle subtended by the largest alphabet on the Snellen's chart at 60m distance?(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2685266",
      "question_audio": null,
      "question_video": null,
      "map_id": 34191899,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 5</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The angle subtended by the largest alphabet on the Snellen’s chart at 60m distance is 5 minutes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_05UM3WC.jpg\" alt=\"\" width=\"700\" height=\"434\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The largest letter on a Snellen chart subtends an angle of 5 minutes of arc at any standard testing distance is essential for interpreting visual acuity results correctly. This standardization is fundamental in diagnosing and measuring visual acuity across different settings and distances</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_05UM3WC.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50004,
      "choices": [
        {
          "id": 200016,
          "text": "<p><span style=\"font-size:12.0pt;\">Selenium</span></p>"
        },
        {
          "id": 200017,
          "text": "<p><span style=\"font-size:12.0pt;\">Manganese</span></p>"
        },
        {
          "id": 200018,
          "text": "<p><span style=\"font-size:12.0pt;\">Molybdenum</span></p>"
        },
        {
          "id": 200019,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Alkali disease of livestock is caused by an excess of which of the following minerals? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q6897507",
      "question_audio": null,
      "question_video": null,
      "map_id": 34177824,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Selenium</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Animals that consume grains containing 5 to 40 mg selenium/kg over a period of several weeks or months suffer from <strong>chronic selenosis, known as alkali disease</strong>. Signs include liver cirrhosis, lameness, hoof malformations, loss of hair, and emaciation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"> It is associated with <strong>loss of hair on the mane and tail, hoof deformities, and decreased reproductive performance</strong>1. It is caused by <strong>toxicity from eating plants or grain with protein-bound, insoluble selenium</strong>2. This disease normally occurs in cattle and sheep feeding on seleniferous plants</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Selenium intoxication can also be acute and subacute (<strong>blind staggers type</strong>).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Manganese:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Manganese deficiency can lead to skeletal abnormalities, reproductive issues, and poor growth in livestock.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Excess:</strong> Excess manganese is rare and typically does not cause a condition similar to alkali disease.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Molybdenum:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Molybdenum deficiency can impair the function of molybdoenzymes, leading to metabolic disturbances.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Excess:</strong> Excess molybdenum can interfere with copper metabolism, leading to copper deficiency (known as molybdenosis) in livestock, characterized by symptoms such as diarrhea, poor growth, and anemia.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Iron:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Iron deficiency can lead to anemia, weakness, and poor growth in livestock.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Excess:</strong> Excess iron can cause toxicity, but it does not cause the specific symptoms of alkali disease. Iron toxicity is more likely to result in gastrointestinal disturbances and liver damage.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Alkali disease in livestock is caused by chronic selenium toxicity, leading to liver cirrhosis, hoof malformations, loss of hair, and emaciation. This condition is distinct from the effects of other mineral toxicities or deficiencies.</span></p>",
      "correct_choice_id": 200016,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50005,
      "choices": [
        {
          "id": 200020,
          "text": "<p><span style=\"font-size:12.0pt;\">Localizing the tumor</span></p>"
        },
        {
          "id": 200021,
          "text": "<p><span style=\"font-size:12.0pt;\">Identifying the margins</span></p>"
        },
        {
          "id": 200022,
          "text": "<p><span style=\"font-size:12.0pt;\">Sentinel Lymph node biopsy</span></p>"
        },
        {
          "id": 200023,
          "text": "<p><span style=\"font-size:12.0pt;\">Identifying metastasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The procedure in the image shows methylene blue dye being injected in the peritumoral region. What is this procedure used for? (AIIMS MAY 2018)</span></p><p> </p><p><span style=\"color:black;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-88_fHf9HEh.jpg\" alt=\"\" width=\"300\" height=\"227\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-88_fHf9HEh.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3276982",
      "question_audio": null,
      "question_video": null,
      "map_id": 34751737,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Sentinel lymph node biopsy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The utility of <strong>injection of methylene blue</strong> in the region around the tumor is for sentinel lymph node biopsy (SLNB).</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Methylene blue dye, along with other tracers, is commonly employed in sentinel lymph node biopsy procedures. Sentinel lymph nodes are the first lymph nodes that cancer is likely to spread to from a primary tumor. By injecting the dye around the tumor, these sentinel lymph nodes can be identified and biopsied to determine if cancer has spread to them. This helps in staging and planning further treatment.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SLN biopsy rationale:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Afferent lymphatics from a primary tumor first drain into the sentinel node, before draining into the other nodes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">So, if sentinel lymph node is positive, it is possible that the other axillary nodes are also involved. Hence, axillary dissection would be necessary.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">If the sentinel node is tumor free, then regional nodal metastasis is unlikely.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The nodes can be identified using:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Fluorescein dye</span></li><li><span style=\"font-size:12.0pt;\">Methylene blue</span></li><li><span style=\"font-size:12.0pt;\">Radioactive sulfur colloid-labeled albumin</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The recommended site of injection is in the <strong>subdermal plexus surrounding the nipple.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is used in patients with clinically node-negative disease.</span></p>",
      "correct_choice_id": 200022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50006,
      "choices": [
        {
          "id": 200024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Infective cardiomyopathy</span></span></span></span></p>"
        },
        {
          "id": 200025,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Takotsubo cardiomyopathy</span></span></span></span></p>"
        },
        {
          "id": 200026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Acute myocardial infarction</span></span></span></span></p>"
        },
        {
          "id": 200027,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypertrophic cardiomyopathy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">60-year-old lady presented with chest pain and exertional dyspnea. Her family says she was previously healthy and there was no similar disease in the family members. ECG on arrival is suggestive of Anterior wall MI. Her son succumbed to Severe COVID-19 pneumonia. CAG showed normal epicardial coronaries. What is the likely diagnosis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q4528650",
      "question_audio": null,
      "question_video": null,
      "map_id": 34283531,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Takotsubo cardiomyopathy</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Stress cardiomyopathy <strong>commonly affects Women (post-menopausal) > men predominantly</strong> due to emotional > physical stress.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Neurogenic myocardial stunning</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <strong>occurs leading to heart failure</strong>. Beta2 (Gs stimulation) at base and Beta2 (Gi) activation leads to hypercontractility at the base & <em>apical ballooning</em> giving a typical <strong><em>Takotsubo appearance</em></strong><em>.</em></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">ECG mimic ACS</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, RWMA not corresponding to single artery territory, normal CAG with <em>Mild troponin elevation are clues to takotsubo.</em></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">T<strong>reatment with beta-blockers, ACE inhibitors if non-responsive</strong>. Carries good prognosis.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">No signs of infection/Inflammation are given in the history. In presence of stress and temporal association, infection less likely.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Normal CAG rules out significant macrovascular CAD.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> </span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>HCM shows dagger like q waves</strong>, SAM, Asymmetrical septal hypertrophy on ECHO.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Takotsubo cardiomyopathy can present with symptoms and ECG changes similar to those of an acute myocardial infarction, but it is distinguished by normal coronary arteries on angiography and is often precipitated by severe emotional stress, fitting the patient's recent personal history.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reference - Harrison/Cardiology/Cardiomyopathies/Chap 259. </span></span></strong></span></span></p>",
      "correct_choice_id": 200025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50007,
      "choices": [
        {
          "id": 200028,
          "text": "<p><span style=\"font-size:12.0pt;\">PAS</span></p>"
        },
        {
          "id": 200029,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcian blue</span></p>"
        },
        {
          "id": 200030,
          "text": "<p><span style=\"font-size:12.0pt;\">Masson trichrome</span></p>"
        },
        {
          "id": 200031,
          "text": "<p><span style=\"font-size:12.0pt;\">PTAH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Acid mucin is stained by _______? </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q5224838",
      "question_audio": null,
      "question_video": null,
      "map_id": 34233495,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Alcian blue</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>MUCIN STAINS:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Alcian blue: </strong>Stains acid-simple non-sulfated and acid-simple mesenchymal mucins, acid-complex sulfated mucins and acid-complex connective tissue mucins. Does NOT stain neutral mucins</span></li><li><span style=\"font-size:12.0pt;\"><strong>Colloidal iron: </strong>Stains acid-simple non-sulfated, acid-simple mesenchymal, acid-complex sulfated mucins. Does NOT stain neutral mucins or acid-complex connective tissue mucins</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mucicarmine: </strong>Very specific for epithelial mucins, including adenocarcinomas</span></li><li><span style=\"font-size:12.0pt;\"><strong>PAS (periodic acid-Schiff): </strong>Stains glycogen as well as mucins, but tissue can be pre-digested with diastase to remove glycogen. Stains neutral and acid-simple non-sulfated and acid-complex sulfated mucins. Does NOT stain acid-simple mesenchymal mucins and acid-complex connective tissue mucins</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. PAS</strong>: Stains both glycogen and mucins, but is not as specific as Alcian blue for acid mucins.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Masson trichrome</strong>: Primarily used for staining connective tissue (collagen) and is not specific for mucins.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. PTAH (Phosphotungstic acid hematoxylin)</strong>: Typically used for staining muscle striations, fibrin, and glial fibers, not for mucins.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Alcian blue</strong> is the preferred stain for identifying acid mucins in tissue samples, distinguishing it from other stains that target different types of mucins or tissue components.</span></p>",
      "correct_choice_id": 200029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50008,
      "choices": [
        {
          "id": 200032,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Leflunomide</span></span></span></span></p>"
        },
        {
          "id": 200033,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Febuxostat</span></span></span></span></p>"
        },
        {
          "id": 200034,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Methotrexate</span></span></span></span></p>"
        },
        {
          "id": 200035,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Etanercept</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following drugs is not used in rheumatoid arthritis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q8922305",
      "question_audio": null,
      "question_video": null,
      "map_id": 34817377,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Febuxostat</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Febuxostat is not used in the treatment of rheumatoid arthritis. It is a xanthine oxidase inhibitor primarily used as a hypouricemic agent for managing gout by reducing uric acid production. Its primary function is to alleviate the symptoms and prevent the recurrence of gout, not to treat inflammatory or autoimmune conditions like rheumatoid arthritis.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <strong>A. Leflunomide:</strong> Incorrect choice for the given answer as Leflunomide is indeed used in the treatment of rheumatoid arthritis. It is a disease-modifying antirheumatic drug (DMARD) that works by suppressing the immune system to reduce inflammation.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong> </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>C. Methotrexate:</strong> Incorrect because Methotrexate is a cornerstone treatment for rheumatoid arthritis. It is another DMARD that helps reduce joint damage and decrease the pain and swelling associated with RA.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong> </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>D. Etanercept:</strong> Incorrect as it is also used in rheumatoid arthritis treatment. Etanercept is a TNF (tumor necrosis factor) inhibitor, which is a type of biologic therapy that helps to decrease inflammation and slow disease progression in RA.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Febuxostat is specifically used to manage gout by lowering uric acid levels and does not have a role in the treatment regimen for rheumatoid arthritis, which typically involves DMARDs and biologic agents aimed at controlling systemic inflammation and preventing joint damage.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reference - Harrison/Rheumatology/RA/Chap 358</span></span></strong></span></span></p>",
      "correct_choice_id": 200033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50009,
      "choices": [
        {
          "id": 200036,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mean > Median > Mode</span></p>"
        },
        {
          "id": 200037,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mode > Median > Mean</span></p>"
        },
        {
          "id": 200038,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mode = Mean = Median</span></p>"
        },
        {
          "id": 200039,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Peaked symmetrical distribution</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Given the particular appearance and characteristics of the box-whisker plot as shown below, which of the following statements most accurately describes the relationships between the mean, median, and mode? (AIIMS MAY 2018) </span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip9.jpg\" alt=\"\" width=\"200\" height=\"336\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8916179",
      "question_audio": null,
      "question_video": null,
      "map_id": 34298384,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Mean > Median > Mode </strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">The provided box-whisker plot illustrates a distribution that is positively skewed (right skewed).</span></li><li><span style=\"color:black;font-size:12.0pt;\">In a positively skewed distribution, the mean > median > mode.</span></li><li><span style=\"color:black;font-size:12.0pt;\">To further understand and correlate the fact, have a look at the following images:</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture8222.jpg\" alt=\"\" width=\"900\" height=\"337\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In Right skew curve: Mean > Median > Mode</span></li><li><span style=\"font-size:12.0pt;\">In Left skew curve: Mean < Median < Mode</span></li><li><span style=\"font-size:12.0pt;\">In Normal distribution: Mean = Median = Mode.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture8222.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50010,
      "choices": [
        {
          "id": 200040,
          "text": "<p><span style=\"font-size:12.0pt;\">Tattooing</span></p>"
        },
        {
          "id": 200041,
          "text": "<p><span style=\"font-size:12.0pt;\">Suggillation</span></p>"
        },
        {
          "id": 200042,
          "text": "<p><span style=\"font-size:12.0pt;\">Putrefaction</span></p>"
        },
        {
          "id": 200043,
          "text": "<p><span style=\"font-size:12.0pt;\">Decomposition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the following post-mortem change. (</span>AIIMS May 2018)</p><p> </p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/04/112.jpg\" alt=\"\" width=\"300\" height=\"180\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/04/112.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7258580",
      "question_audio": null,
      "question_video": null,
      "map_id": 34704470,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Suggillation</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows post mortem staining on the back, also called suggillation. Post-mortem staining (PMS) is the settling of the blood in the dependent portions of the body after death due to loss of circulation, causing a purplish-red discoloration of the skin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tattooing: </strong>Tattoos appear as distinct, well-defined patterns or designs, often in various colors. Tattoos can be located anywhere on the body and are not necessarily confined to dependent areas. They are typically intentional markings made by injecting ink into the skin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Putrefaction: </strong>The body becomes greenish in colour in putrefaction. Later it becomes blackish.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decomposition:</strong> Same explanation as that of putrefaction</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Post Mortem Staining (PMS)</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"> It is the settling of the blood in the dependent, portion of the body after death due to loss of circulation, causing a purplish red discoloration of the skin.</span></li><li><span style=\"font-size:12.0pt;\">Other names of PMS are:</span><ul><li><span style=\"font-size:12.0pt;\">Hypostasis</span></li><li><span style=\"font-size:12.0pt;\">livor mortis</span></li><li><span style=\"font-size:12.0pt;\">Vibices</span></li><li><span style=\"font-size:12.0pt;\">Suggillation</span></li><li><span style=\"font-size:12.0pt;\">Postmortem Lividity</span></li><li><span style=\"font-size:12.0pt;\">Cadaveric lividity</span></li><li><span style=\"font-size:12.0pt;\">Darkening of death</span></li></ul></li><li><span style=\"font-size:12.0pt;\"> It is present on dependent areas, but absent on pressure areas as the blood vessels get compressed. In a supine body the pressure areas are back of chest, buttocks etc as these are in the direct contact with ground.</span></li></ul>",
      "correct_choice_id": 200041,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50011,
      "choices": [
        {
          "id": 200044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cystoscopy</span></span></span></p>"
        },
        {
          "id": 200045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3 swab test</span></span></span></p>"
        },
        {
          "id": 200046,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">MRI</span></span></span></p>"
        },
        {
          "id": 200047,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cystometry</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the most useful test in vesicovaginal fistula? </span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q1503612",
      "question_audio": null,
      "question_video": null,
      "map_id": 34667506,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Cystoscopy</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cystoscopy is the most useful test for diagnosing vesicovaginal fistula (VVF). It allows direct visualization of the bladder and can help identify the exact location, size, and number of fistulas. Additionally, cystoscopy can be used to assess the bladder for any associated injuries or other abnormalities.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 3 swab test:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This test is used to identify the type of genitourinary fistula (vesicovaginal or ureterovaginal) but is not as specific as cystoscopy for visualizing the fistula directly.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. MRI:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> While MRI can provide detailed images of the pelvic structures and help in the diagnosis of fistulas, it is not the first-line investigation. It is more useful in complex cases or when additional information is needed.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Cystometry:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This test evaluates bladder filling and voiding problems and is not specific for diagnosing vesicovaginal fistula.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cystoscopy is the most useful test for directly visualizing vesicovaginal fistulas, determining their size, location, and number, and assessing the bladder for any associated injuries.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 417, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 200044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50012,
      "choices": [
        {
          "id": 200048,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure more than 130/85mmHg</span></p>"
        },
        {
          "id": 200049,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnea</span></p>"
        },
        {
          "id": 200050,
          "text": "<p><span style=\"font-size:12.0pt;\">LDL more than 100 mg/dl</span></p>"
        },
        {
          "id": 200051,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasting triglyceride >150 mg/dl</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a component of Syndrome Z? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q6628442",
      "question_audio": null,
      "question_video": null,
      "map_id": 34858662,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) LDL more than 100 mg/dl</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Syndrome Z also known as Metabolic Syndrome, is characterized by a cluster of conditions that increase the risk of heart disease, stroke, and diabetes. Syndrome involve the pressence of any three of the following five traits: </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Any 3/5 for diagnosis:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Central Obesity:</strong> > 102cm (M),> 88 cm (F); [90(M), 80 cm (F) <i>in Indians</i>]: Only if questions specifically mention <i>Indian population.</i></span></li><li><span style=\"font-size:12.0pt;\">BP > 130/85 mmHg</span></li><li><span style=\"font-size:12.0pt;\">FBS > 100 mg/dL<s>/A1c</s></span></li><li><span style=\"font-size:12.0pt;\">Low HDL (in mg/dL): < 40 (F), < 50 <s>cm</s>(M)</span></li><li><span style=\"font-size:12.0pt;\">High TGL: > 150 mg/dL</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">While LDL cholesterol management is crucial in cardiovascular risk reduction, it is not one of the criteria for diagnosing Metabolic Syndrome, which focuses on abdominal obesity, blood pressure, fasting blood sugar, HDL cholesterol, and triglycerides.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Gastro/Fatty liver/Chap408</strong></span></p>",
      "correct_choice_id": 200050,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50013,
      "choices": [
        {
          "id": 200052,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">BCG, OPV 1st dose, Pentavalent 1st dose, Rota virus 1st dose</span></p>"
        },
        {
          "id": 200053,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">OPV 1st dose, Pentavalent 1st dose, Measles 1st dose</span></p>"
        },
        {
          "id": 200054,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">BCG, OPV 1st dose, Measles 1st dose</span></p>"
        },
        {
          "id": 200055,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">OPV 1st dose, DPT 1st dose, Measles 1st dose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">As a Medical Officer at a Community Health Center (CHC), you're consulted by a mother about starting immunizations for her 13-month-old son who hasn't received any vaccines since birth. Based on the national immunization schedule, which combination of vaccines would you recommend for this child's initial immunization? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9298028",
      "question_audio": null,
      "question_video": null,
      "map_id": 34253964,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) OPV 1st dose, DPT 1st dose, Measles 1st dose</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">DPT-1, OPV-1 and Measles 1st dose will be given to this child.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Age Limits for Delayed Immunization in NIS, India</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture62222.jpg\" alt=\"\" width=\"800\" height=\"535\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture62222.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200055,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50014,
      "choices": [
        {
          "id": 200056,
          "text": "<p><span style=\"font-size:12.0pt;\">Hormone-sensitive lipase</span></p>"
        },
        {
          "id": 200057,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycogen phosphorylase</span></p>"
        },
        {
          "id": 200058,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate carboxylase</span></p>"
        },
        {
          "id": 200059,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphofructokinase 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following enzyme activity decreases in fasting? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4667521",
      "question_audio": null,
      "question_video": null,
      "map_id": 34437744,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Phosphofructokinase 1</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Phosphofructokinase 1 (PFK-1) is a key regulatory enzyme in glycolysis that catalyzes the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate. Its activity is increased in the fed state and decreased during fasting. During fasting, the body's metabolic state shifts to prioritize gluconeogenesis and fatty acid oxidation, leading to a decrease in glycolytic enzyme activities, including PFK-1.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hormone-sensitive lipase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Activity:</strong> Increases during fasting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Mobilizes fatty acids from adipose tissue by breaking down triglycerides.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glycogen phosphorylase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Activity:</strong> Increases during fasting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Breaks down glycogen to glucose-1-phosphate in the liver and muscles, providing glucose during fasting.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pyruvate carboxylase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Activity:</strong> Increases during fasting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Catalyzes the conversion of pyruvate to oxaloacetate, a key step in gluconeogenesis.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-122001_pKklJhK.jpg\" alt=\"\" width=\"1000\" height=\"663\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-122001_pKklJhK.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200059,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50015,
      "choices": [
        {
          "id": 200060,
          "text": "<p><span style=\"font-size:12.0pt;\">Type II</span></p>"
        },
        {
          "id": 200061,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III</span></p>"
        },
        {
          "id": 200062,
          "text": "<p><span style=\"font-size:12.0pt;\">Type IV</span></p>"
        },
        {
          "id": 200063,
          "text": "<p><span style=\"font-size:12.0pt;\">Type V</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following types of collagens is involved in wound healing? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q3360954",
      "question_audio": null,
      "question_video": null,
      "map_id": 34004399,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Type III</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Collagen III is the first to be synthesized in the early stages of wound healing </strong>and is replaced by collagen I, the dominant skin collagen. Initially there is random deposition of collagen during the granulation tissue formation which is further enhanced by enzyme-induced covalent cross-linking. This process matures the collagen into complex structures that are reoriented for tensile strength restoration. Collagen remodeling continues for months after wound closure and the <strong>tensile strength of the repaired tissue increases to about 80–85% of normal tissue</strong> if all processes proceed without any perturbations.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note –</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Collagen is a major structural protein found in connective tissue.</span></li></ul><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Type I is the most abundant form.</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Type II:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Location:</strong> Found primarily in cartilage and the vitreous humor of the eye.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Provides structural support to cartilage and vitreous body.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Disease:</strong> Deficiency leads to severe chondrodysplasias and osteoarthritis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Type IV:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Location:</strong> Found in basement membranes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Provides structural integrity to the basement membrane.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Disease:</strong> Deficiency causes Alport syndrome.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Type V:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Location:</strong> Found as a minor component in tissues containing collagen I.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Contributes to the regulation of collagen fibril assembly.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Disease:</strong> Deficiency causes Ehlers-Danlos syndrome type I (EDS-I).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Properties of Different types of Collagen:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-121900_zInpYlJ.jpg\" alt=\"\" width=\"1000\" height=\"1038\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-121900_zInpYlJ.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50016,
      "choices": [
        {
          "id": 200064,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">L3-L4</span></p>"
        },
        {
          "id": 200065,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">L1-L2</span></p>"
        },
        {
          "id": 200066,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">T12-L1</span></p>"
        },
        {
          "id": 200067,
          "text": "<p><span style=\"font-size:12.0pt;\">L2-L3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">At what level does the spinal cord end in adults? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q6011926",
      "question_audio": null,
      "question_video": null,
      "map_id": 34188815,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Ans. B) L1-L2</strong></span></p><p> </p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Termination of the Spinal Cord:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Anatomy: </strong>The spinal cord terminates at a region called the conus medullaris.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Details: </strong>Below the conus medullaris, a bundle of spinal nerve roots continues downward, which is called the cauda equina (meaning \"horse's tail\" in Latin) due to its appearance.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Adult Spinal Cord End: </strong>The lower end of the spinal cord in adults is at the lower border of L1.</span></li></ul><p> </p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. L3-L4: </strong></span><span style=\"font-size:12.0pt;\">This is incorrect as the spinal cord in adults does not extend to this level. This level is generally where lumbar punctures are performed to avoid the spinal cord.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. T12-L1:</strong></span><span style=\"font-size:12.0pt;\"><strong> </strong>This is slightly higher than the actual end of the spinal cord in adults. The spinal cord terminates at L1-L2, not T12-L1.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. L2-L3:</strong></span><span style=\"font-size:12.0pt;\"><strong> </strong>This is incorrect as well because the spinal cord ends at L1-L2 in adults, not extending to L2-L3.</span></p><p> </p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The spinal cord in adults terminates at the lower border of L1, at the region called the conus medullaris, with the cauda equina continuing downward from this point.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong></span><span style=\"font-size:12.0pt;\"> <strong>1414</strong></span></p>",
      "correct_choice_id": 200065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50017,
      "choices": [
        {
          "id": 200068,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Response- Mitigation- Reconstruction- Rehabilitation- Preparedness</span></span></span></span></p>"
        },
        {
          "id": 200069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Mitigation- Rehabilitation- Reconstruction- Preparedness- response</span></span></span></span></p>"
        },
        {
          "id": 200070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Response- Rehabilitation- Reconstruction- Mitigation- Preparedness</span></span></span></span></p>"
        },
        {
          "id": 200071,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Mitigation- Preparedness- Reconstruction- Rehabilitation- Response</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">As a physician on a disaster preparedness committee in a region prone to natural disasters, you are discussing the appropriate sequence of actions following a disaster. </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:black\">Which of the following sequences correctly represents the appropriate steps in disaster management after the event has taken place? (AIIMS MAY 2018)</span></span></span></p>",
      "unique_key": "Q4347675",
      "question_audio": null,
      "question_video": null,
      "map_id": 34719651,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"> <strong>Ans. C) Response – Rehabilitation – Reconstruction – Mitigation – Preparedness</strong></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct sequence after a disaster as per the general disaster management principles is:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Response:</span></strong><span style=\"font-size:12.0pt\"> Immediate actions taken to ensure safety, provide emergency services, and stabilize the situation. This involves – </span></span></span></li>\r\n</ol>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Search, rescue and first aid</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Field care</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Triage</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tagging</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identification of dead</span></span></span></li>\r\n</ul>\r\n\r\n<ol start=\"2\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rehabilitation:</span></strong><span style=\"font-size:12.0pt\"> Short-term recovery and normalization of operations to restore basic services and functions in the affected area.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reconstruction:</span></strong><span style=\"font-size:12.0pt\"> Long-term rebuilding of infrastructure and restoration of a fully functional community.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mitigation:</span></strong><span style=\"font-size:12.0pt\"> Efforts to reduce the risk and lessen the impact of future disasters.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Preparedness:</span></strong><span style=\"font-size:12.0pt\"> Planning and preparation to improve response activities for future disasters.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Disaster Cycle</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/whatsapp-image-2023-10-20-at-173957.jpeg\" style=\"height:534px; width:500px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/whatsapp-image-2023-10-20-at-173957.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200070,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50018,
      "choices": [
        {
          "id": 200072,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hysterectomy</span></span></span></p>"
        },
        {
          "id": 200073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Trachelectomy</span></span></span></p>"
        },
        {
          "id": 200074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Conization</span></span></span></p>"
        },
        {
          "id": 200075,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Colposcopy with LEEP</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 40-year-old woman has cervical intraepithelial neoplasia III. What would be the management? </span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q7327790",
      "question_audio": null,
      "question_video": null,
      "map_id": 34520156,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Colposcopy with LEEP</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cervical intraepithelial neoplasia III (CIN 3) is a severe form of cervical dysplasia that is diagnosed by cervical biopsy. The standard treatment for CIN 2 or CIN 3 is an excisional procedure, which aims to remove the affected tissue to prevent progression to invasive cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">LEEP (Loop Electrosurgical Excision Procedure):</span></strong></span></span></li>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">LEEP is the excisional procedure of choice for treating CIN 3.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">It involves using a thin wire loop that is heated by electric current to excise the transformation zone of the cervix where abnormal cells are located.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">LEEP is also known as LLETZ (Large Loop Excision of the Transformation Zone).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Hysterectomy:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is a more radical procedure that involves the removal of the uterus. It is generally not the first-line treatment for CIN 3 unless there are other indications, such as concurrent invasive cancer or other gynecological conditions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Trachelectomy:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This procedure involves removing the cervix while preserving the uterus. It is more commonly used for early-stage cervical cancer in women who wish to preserve fertility.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Conization:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> While conization (removal of a cone-shaped piece of tissue from the cervix) is a valid treatment for CIN 3, LEEP is often preferred due to its effectiveness and lower morbidity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CIN 3 is best treated with an excisional procedure, with the Loop Electrosurgical Excision Procedure (LEEP) being the procedure of choice.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 328, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 200075,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50019,
      "choices": [
        {
          "id": 200076,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoglycemia</span></span></span></p>"
        },
        {
          "id": 200077,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypokalemia</span></span></span></p>"
        },
        {
          "id": 200078,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tremors</span></span></span></p>"
        },
        {
          "id": 200079,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tachycardia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is NOT a side effect of salbutamol?(AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q6995113",
      "question_audio": null,
      "question_video": null,
      "map_id": 34706832,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Hypoglycemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Salbutamol is a β2 receptor agonist that is used as a Short Acting Bronchodilator in the relief of acute exacerbations from asthma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It can lead to tachycardia (due to stimulation of the β1 receptors at large doses), Hypokalemia and development of tolerance on long term use due to desensitization of its receptors and in large doses can lead to hyperglycemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypokalemia</span></strong><span style=\"font-size:12.0pt\">: This is a known side effect of salbutamol due to its action on β2 receptors, which increase potassium uptake into cells, resulting in lower serum potassium levels.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tremors</span></strong><span style=\"font-size:12.0pt\">: These are a common side effect of salbutamol due to β2 receptor stimulation in skeletal muscles, leading to muscle tremors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tachycardia</span></strong><span style=\"font-size:12.0pt\">: Salbutamol, especially at higher doses, can stimulate β1 receptors in the heart, leading to an increased heart rate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Salbutamol can cause hypokalemia, tremors, and tachycardia, but it does not cause hypoglycemia. Instead, it can lead to hyperglycemia due to its effect on glycogenolysis and gluconeogenesis.</span></span></span></p>",
      "correct_choice_id": 200076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50020,
      "choices": [
        {
          "id": 200080,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural effusion</span></p>"
        },
        {
          "id": 200081,
          "text": "<p><span style=\"font-size:12.0pt;\">Hilar lymphadenopathy</span></p>"
        },
        {
          "id": 200082,
          "text": "<p><span style=\"font-size:12.0pt;\">Consolidation</span></p>"
        },
        {
          "id": 200083,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchiectasis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 39-year-old male patient presented with complaints of fever and cough. His chest radiograph shows air bronchogram sign. The probable diagnosis is:(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2417060",
      "question_audio": null,
      "question_video": null,
      "map_id": 34377145,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Consolidation</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patient complaining of fever and cough with positive air bronchogram sign on chest x-ray suggests lobar consolidation which is most commonly due to Pneumococcal pneumonia.</span></p><p> </p><p><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Air bronchogram</strong> refers to the phenomenon of air-filled bronchi (dark) being made visible by the opacification of surrounding alveoli (grey/white). It is almost always caused by a pathologic airspace/alveolar process, in which something other than air fills the alveoli. </span></p><p> </p><p><span style=\"font-size:12.0pt;\">The causes of air bronchogram are as follows:</span></p><ul><li><a href=\"https://radiopaedia.org/articles/air-space-opacification-1?lang=us\"><span style=\"background-color:white;color:black;font-size:12pt;\"><u>Pulmonary consolidation</u></span></a></li><li><a href=\"https://radiopaedia.org/articles/pulmonary-oedema?lang=us\"><span style=\"background-color:white;color:black;font-size:12pt;\"><u>Pulmonary Edema</u></span></a><span style=\"background-color:white;color:black;font-size:12pt;\">: especially with </span><a href=\"https://radiopaedia.org/articles/pulmonary-alveolaroedema?lang=us\"><span style=\"background-color:white;color:black;font-size:12pt;\"><u>alveolar edema</u></span></a><span style=\"background-color:white;color:black;font-size:12pt;\"> </span></li><li><span style=\"background-color:white;color:black;font-size:12pt;\">Neoplasms: </span><a href=\"https://radiopaedia.org/articles/broncholoalveolar-carcinoma?lang=us\"><span style=\"background-color:white;color:black;font-size:12pt;\"><u>bronchioloalveolar carcinoma</u></span></a><span style=\"background-color:white;color:black;font-size:12pt;\">; </span><a href=\"https://radiopaedia.org/articles/pulmonary-lymphoma?lang=us\"><span style=\"background-color:white;color:black;font-size:12pt;\"><u>pulmonary lymphoma</u></span></a></li></ul><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pleural effusion:</strong> Would typically show blunting of the costophrenic angles and a fluid level on the chest X-ray, not associated with air bronchograms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hilar lymphadenopathy:</strong> Presents as enlarged hilar shadows on X-ray, which do not include the air bronchogram sign.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bronchiectasis:</strong> Characterized by permanent dilation of parts of the airways of the lung; air bronchograms can be present but are more commonly associated with acute infections or consolidations.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br> </p><p><span style=\"font-size:12.0pt;\">The air bronchogram sign on a chest X-ray, indicative of the presence of air within the bronchi surrounded by opacified alveoli, is a classic feature of pulmonary consolidation, most commonly seen in pneumococcal pneumonia.</span></p>",
      "correct_choice_id": 200082,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50021,
      "choices": [
        {
          "id": 200084,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral infection</span></p>"
        },
        {
          "id": 200085,
          "text": "<p><span style=\"font-size:12.0pt;\">Drugs</span></p>"
        },
        {
          "id": 200086,
          "text": "<p><span style=\"font-size:12.0pt;\">Fungal infection</span></p>"
        },
        {
          "id": 200087,
          "text": "<p><span style=\"font-size:12.0pt;\">Auto-immunity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the likely cause of a disease that is characterized by the occurrence of blistering and peeling affecting over 30% of the body surface area? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2934953",
      "question_audio": null,
      "question_video": null,
      "map_id": 34171950,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Drugs</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Adverse drug reactions can lead to a condition known as <strong>Stevens-Johnson Syndrome (SJS) </strong>or its more severe form, <strong>Toxic Epidermal Necrolysis (TEN</strong>), where there is extensive detachment of the <strong>epidermis </strong>and <strong>mucous membrane </strong>involvement. This severe reaction typically involves <strong>over 30% </strong>of the <strong>body surface area </strong>in TEN. It is a medical <strong>emergency </strong>and can be <strong>life-threatening. </strong>The implicated drugs often include <strong>allopurinol</strong>, certain <strong>anticonvulsants, sulphonamide </strong>antibiotics, and <strong>NSAIDs</strong>, among others.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">As <strong>more than 30%</strong> of the body surface is involved, the diagnosis is <strong>toxic epidermal necrolysis (TEN). Clinical picture will be as shown in the image below.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/whatsapp-image-2023-11-20-at-191405.jpeg\" alt=\"\" width=\"300\" height=\"400\"></strong></i></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SJS Toxic Epidermal Necrolysis classification based on BSA involvement:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Based on <strong>body surface area (BSA):  </strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-095458.png\" alt=\"\" width=\"1000\" height=\"247\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SJS/TEN </strong>is primarily a <strong>drug‐induced</strong> phenomenon, with a culprit drug being demonstrated in approximately <strong>85%</strong> of cases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Common drugs that can cause SJS/TEN are:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Allopurinol</span></li><li><span style=\"font-size:12.0pt;\">Carbamazepine</span></li><li><span style=\"font-size:12.0pt;\">Lamotrigine</span></li><li><span style=\"font-size:12.0pt;\">Nevirapine</span></li><li><span style=\"font-size:12.0pt;\">Oxicam (Non‐steroidal anti‐inflammatory drugs)</span></li><li><span style=\"font-size:12.0pt;\">Phenobarbital</span></li><li><span style=\"font-size:12.0pt;\">Phenytoin</span></li><li><span style=\"font-size:12.0pt;\">Sulfamethoxazole and other sulfa antibiotics</span></li><li><span style=\"font-size:12.0pt;\">Sulfasalazine</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Viral Infection: </strong>Viral infections can indeed cause <strong>skin rashes</strong> and even <strong>blistering</strong> in some cases, such as with <strong>herpe</strong>s viruses, including <strong>Varicella-zoster </strong>virus and <strong>Herpes simplex virus</strong>. However, they rarely lead to a condition with widespread blistering affecting over 30% of the body surface area.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fungal Infection: </strong>Fungal infections typically cause localized skin changes such as rashes, <strong>scaling,</strong> and sometimes blistering, but these are usually limited in scope and do not affect such a large proportion of the skin surface as described in the scenario.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Auto-immunity: </strong>Autoimmune diseases like <strong>pemphigus vulgaris </strong>can cause blistering, but they do <strong>not</strong> usually result in acute widespread <strong>skin peeling over 30% </strong>of the body surface area. The blisters in pemphigus vulgaris are more <strong>superficial</strong> and often <strong>rupture </strong>easily, <strong>not</strong> typically resulting in <strong>extensive peeling</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In conclusion, when presented with <strong>widespread</strong> <strong>blistering</strong> and <strong>peeling</strong> of such a significant portion of the skin, <strong>drug reactions</strong> should be the <strong>first consideration</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The occurrence of <strong>blistering</strong> and <strong>peeling</strong> affecting <strong>over 30%</strong> of the body surface area is most commonly associated with <strong>severe drug reactions</strong>, such as <strong>Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN).</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition, Chapter 119, Page no 119.13</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/whatsapp-image-2023-11-20-at-191405.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200085,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50022,
      "choices": [
        {
          "id": 200088,
          "text": "<p><span style=\"font-size:12.0pt;\">Clostridium</span></p>"
        },
        {
          "id": 200089,
          "text": "<p><span style=\"font-size:12.0pt;\">Klebsiella</span></p>"
        },
        {
          "id": 200090,
          "text": "<p><span style=\"font-size:12.0pt;\">Acinetobacter</span></p>"
        },
        {
          "id": 200091,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemophilus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely causative organism of ventilator-associated pneumonia among the following? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4129051",
      "question_audio": null,
      "question_video": null,
      "map_id": 34191137,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Acinetobacter.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Acinetobacter species are particularly prevalent in hospital settings and are a common cause of ventilator-associated pneumonia (VAP). These organisms are known for their ability to survive on surfaces for extended periods and their resistance to multiple antibiotics, making them a significant concern in intensive care units where patients are often intubated. Acinetobacter, along with Pseudomonas and Stenotrophomonas, is known for colonizing the respiratory tract of ventilated patients, leading to VAP, which typically occurs after 48 hours of mechanical ventilation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clostridium: </strong>This genus, including species like Clostridium difficile, is more commonly associated with gastrointestinal infections, particularly antibiotic-associated diarrhea, rather than pneumonia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Klebsiella: </strong>While Klebsiella pneumoniae can cause ventilator-associated pneumonia, it is generally less common than Acinetobacter in this specific infection context. Klebsiella tends to be more associated with community-acquired pneumonia and hospital-acquired infections outside of the ventilator context.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haemophilus: </strong>Haemophilus influenzae can cause respiratory tract infections but is more commonly linked to community-acquired pneumonia and exacerbations of chronic obstructive pulmonary disease rather than VAP.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Acinetobacter, pseudomonas, stenotrophomonas, Burkholderia cepacia are common organisms causing VAP. VAP occurs due to colonization by organisms in < 48 hours.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Pulmonology/Pneumonia/Chap 142</strong></span></p>",
      "correct_choice_id": 200090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50023,
      "choices": [
        {
          "id": 200092,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 200093,
          "text": "<p><span style=\"font-size:12.0pt;\">Heberden's nodes on pre-existing osteoarthritis</span></p>"
        },
        {
          "id": 200094,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenosynovitis of extensor tendon of MCP joints</span></p>"
        },
        {
          "id": 200095,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-traumatic dystrophy with complex regional pain syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A woman presents with pain, swelling and redness of knee joint and hand. There were associated complaints of morning stiffness with problem in squatting. The swelling spared the DIP joints. The image of the patient’s hands is shown below. What is the most likely diagnosis?(AIIMS MAY 2018)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-618.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-618.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9072115",
      "question_audio": null,
      "question_video": null,
      "map_id": 34178395,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Rheumatoid arthritis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>RHEUMATOID ARTHRITIS</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Rheumatoid arthritis is a chronic non-suppurative inflammation of the synovial joints.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">It occurs between the age of 20 and 50 years.</span></li><li><span style=\"font-size:12.0pt;\">Women are affected about 3 times more commonly than men.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Older women (> 60 year) are 6 times more commonly involved than younger one.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>It may present as:</strong></span><ul><li><span style=\"font-size:12.0pt;\">An acute, symmetrical polyarthritis: Pain and stiffness in multiple joints (at least four), particularly in the morning, mark the beginning of the disease.</span></li><li><span style=\"font-size:12.0pt;\">This may be followed by frank symptoms of articular inflammation.</span></li><li><span style=\"font-size:12.0pt;\">The joints affected most commonly are the metacarpophalangeal joints, particularly that of the index finger.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Joints affected in Rheumatoid arthritis</strong>:</span></li></ul></li></ul><ol><li><span style=\"font-size:12.0pt;\"><strong>Common: </strong>MCP joints of hand, PIP joints of fingers, wrists, knees, elbows, ankles, MTP joint</span></li><li><span style=\"font-size:12.0pt;\"><strong>Less common: </strong>Hip joint, temporo mandibular joint, upper cervical spine</span></li><li><span style=\"font-size:12.0pt;\"><strong>Uncommon: </strong>Atlanto-axial joint, facet joints of cervical spine</span><ul><li><span style=\"font-size:12.0pt;\">Usually, DIP is not involved. <strong>It</strong> <strong>is involved when swan neck and boutonniere deformity develops.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Lumbar spine is spared.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Others:</strong> The onset may be with fever, the cause of which cannot be established (PUO), especially in children. Sometimes, visceral manifestations of the disease such as pneumonitis, rheumatoid nodules etc. may antedate the joint complaints.</span></li></ul></li></ol></li><li><span style=\"font-size:12.0pt;\"><strong>Inflammatory markers like ESR and CRP are elevated</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Some studies have shown that HLA DR4 positivity affects the prognosis in patients of rheumatoid arthritis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deformities in Rheumatoid Arthritis:</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-192708.jpg\" alt=\"\" width=\"1000\" height=\"624\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Radiological Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Reduced joint space</span></li><li><span style=\"font-size:12.0pt;\">Erosion of articular margins</span></li><li><span style=\"font-size:12.0pt;\">Subchondral cysts</span></li><li><span style=\"font-size:12.0pt;\">Juxta-articular rarefaction</span></li><li><span style=\"font-size:12.0pt;\">Soft tissue shadow at the level of the joint because of joint effusion or synovial hypertrophy</span></li><li><span style=\"font-size:12.0pt;\">Deformities of the hand and fingers</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Heberden's nodes on pre-existing osteoarthritis</strong>. Heberden’s nad Bouchard’s nodes are firm swellings over the superolateral and dorsal aspects of DIP and PIP joints respectively. Lateral view of the x-ray of the hand reveals large exostoses arising from the proximal ends of the distal phalanges in the attachment of extensor and flexor tendons. They may begin as small, round, fluctuant, tender mass, a little to one side of the dorsum of the joint.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture37_cozqfUH.jpg\" alt=\"\" width=\"300\" height=\"199\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture38.jpg\" alt=\"\" width=\"250\" height=\"216\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tenosynovitis of extensor tendon of MCP joints</strong>. Tenosynovitis is quite common, but it is generally not a striking or isolated clinical complaint. The most common sites are the extensor tendon sheaths on the dorsum of the hand, the extensor sheaths over the dorsum of the foot, and those of the posterior tibial tendon and the peroneus longus and brevis tendons. If tenosynovitis is very prominent, Blau syndrome should be considered. Triggering or loss of extension of the fingers may result from a stenosing synovitis of the flexor tendon sheaths.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture39_SzzvaGq.jpg\" alt=\"\" width=\"300\" height=\"208\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Post-traumatic dystrophy with complex regional pain syndrome</strong>. CRPS is characterized by a chronic neurological disorder involving upper or lower limbs after any type of injury or surgery. In some cases, it occurs spontaneously. Sensory and autonomic disturbances are the main features of this syndrome (allodynia or hyperalgesia, edema, changes in skin blood flow or abnormal sudomotor activity) and are disproportionate to the starting event. The underlying mechanism is still unknown. Multiple mechanisms considered to play a role in the generation and maintenance of CRPS includes biofeedback from autonomic nervous system, alterations of central nervous system, neurogenic inflammation and immunological mechanisms. There is no specific diagnostic test for CRPS. History, clinical examination, symptoms and signs of the patient are the main aspects to be considered for a correct diagnosis. CRPS does not have a pathognomonic sign. The key symptom is prolonged pain that may be constant and disproportionate to the initial injury. The characteristics of the pain are continuous, spontaneous or episodic. Patients frequently described this symptom as burning. The distal part of the limb is the most common area and the typical clinical manifestations are red skin, pain, and swelling. Symptoms may change over time and vary from patient to patient. Over time the injured limb can became pale, cold and in addition muscle spasm and tightening can appear. This condition is often irreversible.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image and the symptoms in a female of pain, swelling and redness of knee joint and hand, morning stiffness with problem in squatting is clinical for Rheumatoid Arthritis.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-192708.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50024,
      "choices": [
        {
          "id": 200096,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystoisospora</span></p>"
        },
        {
          "id": 200097,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclospora</span></p>"
        },
        {
          "id": 200098,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptosporidium</span></p>"
        },
        {
          "id": 200099,
          "text": "<p><span style=\"font-size:12.0pt;\">Microspora</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A kinyoun positive oocyst (25 m) was isolated from an HIV patient with diarrhea. Identify the organism?</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-172804.png\" alt=\"\" width=\"400\" height=\"304\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-172804.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q9723372",
      "question_audio": null,
      "question_video": null,
      "map_id": 34682353,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cystoisospora</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Diarrhea in an HIV patient is suggestive of a coccidean parasitic infestation. Kinyoun stain positive oocysts in the image are identified as Cystoisospora.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Points in favor:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">HIV patient with diarrhea</span></li><li><span style=\"font-size:12.0pt;\">Oocysts are long and oval-shaped, which stain pink to red with Kinyoun staining.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cyclospora:</strong> Cyclospora oocysts are smaller (8-12 µm) and round, with variable acid-fast staining. They sporulate in soil and contain two sporocysts with two sporozoites each.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cryptosporidium:</strong> Cryptosporidium oocysts are even smaller (4-6 µm) and round. They are uniformly acid-fast and contain four sporozoites. Sporulation occurs inside the host cell.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Microspora:</strong> Microspora are obligate intracellular parasites that do not have the same oocyst structure as coccidian parasites. They are detected by different staining methods and appear as small spores rather than larger oocysts.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Comparison of coccidian parasites causing diarrhea in an immunocompromised host:</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-114024.png\" alt=\"\" width=\"1000\" height=\"369\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-114024.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50025,
      "choices": [
        {
          "id": 200100,
          "text": "<p><span style=\"font-size:12.0pt;\">Valproate</span></p>"
        },
        {
          "id": 200101,
          "text": "<p><span style=\"font-size:12.0pt;\">Olanzapine</span></p>"
        },
        {
          "id": 200102,
          "text": "<p><span style=\"font-size:12.0pt;\">Imipramine</span></p>"
        },
        {
          "id": 200103,
          "text": "<p><span style=\"font-size:12.0pt;\">Venlafaxine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Abrupt stoppage of which of the following drugs causes agitation, anxiety and insomnia? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q8047478",
      "question_audio": null,
      "question_video": null,
      "map_id": 34947225,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Venlafaxine</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Abrupt discontinuation or dose reduction of venlafaxine has been known to result in a discontinuation syndrome characterized by agitation, anxiety, and insomnia. This is particularly noted with venlafaxine because of its short half-life. While all the drugs listed can have withdrawal symptoms if stopped suddenly, venlafaxine is particularly associated with these symptoms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Valproate:</strong> Abrupt discontinuation can lead to seizure recurrence in those using it as an antiepileptic and can cause relapse of mood symptoms in those using it as mood stabilizer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Olanzapine: </strong>Stopping it can result in a return of psychotic symptoms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Imipramine:</strong> It can cause withdrawal symptoms, but they are typically more varied and might include headache, nausea, and malaise.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The key features of antidepressant discontinuation syndrome, often abbreviated as FINISH:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>F</strong>lu-like symptoms</span></li><li><span style=\"font-size:12.0pt;\"><strong>I</strong>nsomnia</span></li><li><span style=\"font-size:12.0pt;\"><strong>N</strong>ausea</span></li><li><span style=\"font-size:12.0pt;\"><strong>I</strong>mbalance</span></li><li><span style=\"font-size:12.0pt;\"><strong>S</strong>ensory disturbances (e.g., electric shock sensations)</span></li><li><span style=\"font-size:12.0pt;\"><strong>H</strong>yperarousal (e.g., anxiety, agitation).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">It is particularly common with SSRIs and SNRIs with shorter half-lives, such as <strong>venlafaxine (most common)</strong>. Short acting SSRIs such as paroxetine and fluvoxamine are also commonly associated with discontinuation syndrome. Gradual tapering and patient education are essential to prevent and manage this syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 3150.</strong></span></p>",
      "correct_choice_id": 200103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50026,
      "choices": [
        {
          "id": 200104,
          "text": "<p><span style=\"font-size:12.0pt;\">Lecithin-sphingomyelin ratio > 2.0</span></p>"
        },
        {
          "id": 200105,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive shake test</span></p>"
        },
        {
          "id": 200106,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased phosphatidyl glycerol</span></p>"
        },
        {
          "id": 200107,
          "text": "<p><span style=\"font-size:12.0pt;\">Nile blue test showing >50% of blue cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an indicator of fetal lung maturity?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9845592",
      "question_audio": null,
      "question_video": null,
      "map_id": 34664705,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Nile blue test showing >50% of blue cells</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The <strong>Nile blue test</strong> is a laboratory test used to assess fetal lung maturity by staining desquamated fetal cells obtained from amniotic fluid. The correct interpretation of this test is that if more than <strong>50% of the cells stain orange</strong>, it indicates pulmonary maturity. Therefore, the presence of more than 50% <strong>blue</strong> cells, as mentioned in Option D, suggests <strong>immature lungs</strong> rather than maturity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lecithin-sphingomyelin ratio > 2.0: </strong>The Lecithin-sphingomyelin (L/S) ratio is a well-established method for assessing fetal lung maturity. A ratio greater than 2.0 typically indicates mature fetal lungs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Positive shake test: </strong>The shake test, also known as the foam stability test, assesses the presence of surfactant in amniotic fluid. A positive shake test, indicated by the formation of stable bubbles, suggests fetal lung maturity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased phosphatidyl glycerol: </strong>The presence of phosphatidylglycerol in amniotic fluid is another indicator of lung maturity, particularly in pregnancies complicated by diabetes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The presence of more than 50% orange cells in the Nile blue test indicates fetal lung maturity, whereas more than 50% blue cells suggest immaturity.</span></p>",
      "correct_choice_id": 200107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50027,
      "choices": [
        {
          "id": 200108,
          "text": "<p><span style=\"font-size:12.0pt;\">Only the roots of this plant are poisonous</span></p>"
        },
        {
          "id": 200109,
          "text": "<p><span style=\"font-size:12.0pt;\">Causes AV block</span></p>"
        },
        {
          "id": 200110,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug of choice for poisoning is Atropine</span></p>"
        },
        {
          "id": 200111,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitha zeher is one of the varieties of this plant</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Identify the incorrect statement regarding the picture given below? (</span>AIIMS May 2018,)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/image-4.jpg\" alt=\"\" width=\"300\" height=\"403\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/image-4.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1846446",
      "question_audio": null,
      "question_video": null,
      "map_id": 34906643,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Only the roots of this plant are poisonous</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows aconite, a highly toxic plant. All parts of the aconite plant are poisonous, not just the roots.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Causes AV block: </strong>Correct statement. Aconite poisoning causes AV block due to its effects on the heart.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Drug of choice for poisoning is Atropine: </strong>Correct statement. Atropine is used to counteract the bradycardia and AV block caused by aconite poisoning.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mitha zeher is one of the varieties of this plant: </strong>Correct statement. \"Mitha zeher\" is a common name for aconite.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Aconite:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">All parts of the plant are poisonous.</span></li><li><span style=\"font-size:12.0pt;\">Aconite is also called as - monkhood, mitha zeher, bish, and bikh.</span></li><li><span style=\"font-size:12.0pt;\">Method of poisoning - It is a cardiac poison and causes AV block, bradycardia.</span></li><li><span style=\"font-size:12.0pt;\">Treatment of choice - Atropine</span></li></ul>",
      "correct_choice_id": 200108,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50028,
      "choices": [
        {
          "id": 200112,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">At the onset of labor</span></span></span></p>"
        },
        {
          "id": 200113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">34 weeks</span></span></span></p>"
        },
        {
          "id": 200114,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">36 weeks</span></span></span></p>"
        },
        {
          "id": 200115,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">40 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A pregnant woman with cardiac disease is on warfarin therapy. When will the final switch to heparin be advised? </span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q5996476",
      "question_audio": null,
      "question_video": null,
      "map_id": 34585149,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) 36 weeks</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The management of anticoagulation in pregnant women with cardiac disease involves switching from warfarin to heparin at specific times to minimize the risk of complications to the fetus and to prepare for delivery.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Switch to Heparin at 36 Weeks:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> According to guidelines from the American College of Chest Physicians, pregnant women on warfarin therapy should switch to heparin at 36 weeks of gestation. This is done to reduce the risk of bleeding complications during labor and delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Guidelines Summary:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Early Pregnancy (up to 12 weeks):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Discontinue warfarin as soon as pregnancy is diagnosed, especially if the warfarin dose is >5mg/day, due to the risk of warfarin embryopathy.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Replace with heparin (5,000 units twice daily subcutaneously) or low molecular weight heparin (LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">After 12 Weeks to 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Warfarin can be resumed after the 12th week and continued up to 36 weeks.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">At 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Switch from warfarin to heparin (either unfractionated or LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Just Before Delivery:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Discontinue heparin just before delivery.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Postpartum:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Restart heparin (unfractionated or LMWH) 6 hours after vaginal delivery and 24 hours after cesarean section.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Warfarin therapy can also be safely resumed during breastfeeding.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The final switch from warfarin to heparin in pregnant women with cardiac disease is advised at 36 weeks of gestation to minimize the risk of bleeding complications during labor and delivery.</span></span></span></p>",
      "correct_choice_id": 200114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50029,
      "choices": [
        {
          "id": 200116,
          "text": "<p><span style=\"font-size:12.0pt;\">Paranoid personality disorder</span></p>"
        },
        {
          "id": 200117,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizoid personality disorder</span></p>"
        },
        {
          "id": 200118,
          "text": "<p><span style=\"font-size:12.0pt;\">Antisocial personality disorder</span></p>"
        },
        {
          "id": 200119,
          "text": "<p><span style=\"font-size:12.0pt;\">Emotionally unstable personality disorder</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A bashful young man who prefers social solitude appears emotionally frigid and lives alone. There is no history of delusions or hallucinations. The most likely explanation is? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q5443276",
      "question_audio": null,
      "question_video": null,
      "map_id": 34656644,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Schizoid personality disorder</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Schizoid personality disorder is marked by <strong>detachment from social relationships</strong> and a restricted range of emotional expression. Individuals prefer <strong>solitude</strong> and appear <strong>emotionally cold.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Paranoid personality disorder: </strong>It is characterized by <strong>excessive suspiciousness</strong> and distrust of others. They may be <strong>excessively sensitive </strong>and give <strong>excessive importance to themselves</strong>. The vignette described above does not mention suspiciousness, infact mentions there is no history of delusions. Hence the answer is not paranoid personality disorder.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Antisocial personality disorder: </strong>These patients disregard others' rights and frequently violates them. They frequently get involved in unlawful behaviours such as theft, conning etc. </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Emotionally unstable personality disorder: </strong>Otherwise known as Borderline personality disorder. They are almost always in the state of crisis. They have a history of <strong>unstable relationships and emotions</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Schizoid personality disorder is characterized by <strong>detachment</strong> from social relationships and prefer <strong>solitary activities</strong>. They are <strong>emotionally cold</strong> and are indifferent to praise or criticism. There is also an <strong>absence of close relationships</strong>. It is classified as a Cluster A personality disorder.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 2152</strong></span></p>",
      "correct_choice_id": 200117,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50030,
      "choices": [
        {
          "id": 200120,
          "text": "<p><span style=\"font-size:18px;\">Dense regular</span></p>"
        },
        {
          "id": 200121,
          "text": "<p><span style=\"font-size:18px;\">Dense irregular</span></p>"
        },
        {
          "id": 200122,
          "text": "<p><span style=\"font-size:18px;\">Loose regular</span></p>"
        },
        {
          "id": 200123,
          "text": "<p><span style=\"font-size:18px;\">Loose irregular</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">What type of connective tissue is found in the region indicated by the black arrow in the provided image? (AIIMS May 2018)</span></p><p> </p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13495.jpg\" alt=\"\" width=\"300\" height=\"382\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13495.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7184649",
      "question_audio": null,
      "question_video": null,
      "map_id": 34242977,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Dense irregular</strong></span></p><p> </p><p><span style=\"font-size:18px;\">In<strong> </strong>the provided image, the black arrow points to a region with a <strong>meshwork of collagen fibers</strong>. This pattern is characteristic of <strong>dense irregular connective tissue, </strong>which is identified by its densely packed<strong> collagen </strong>fibers that are arranged in an <strong>irregular, haphazard </strong>fashion. This type of connective tissue provides <strong>strength and support </strong>and allows the skin to <strong>resist multidirectional </strong>forces. It is typically found in areas that require <strong>strength and rigidity</strong>, such as the <strong>dermis</strong> of the skin, which is what is likely being shown in this histological slide.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Dermis (precisely Reticular dermis) </strong>is made up of <strong>dense irregular connective tissue.</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Irregular connective tissue, </strong>is characterized by <strong>collagen fibers</strong> that are <strong>randomly oriented</strong> in multiple directions.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Irregular connective tissue </strong>is of three types: <strong>Loose, Dense & Adipose</strong>.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Dense </strong>connective tissue can be found in areas where <strong>unsheathed organs </strong>are protected and where there is significant <strong>mechanical stress.</strong></span></p><p> </p><ul><li><span style=\"font-size:18px;\">This arrangement of fibers provides <strong>strength and elasticity </strong>in multiple directions, allowing the skin to <strong>resist tearing.</strong></span></li></ul><p> </p><p><span style=\"font-size:18px;\">Function: Provides <strong>structural integrity </strong>and <strong>support</strong> for the skin.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Dense connective tissue:</strong></span></p><p> </p><ul><li><span style=\"font-size:18px;\">It typically exists in the <strong>reticular dermis</strong>.</span></li><li><span style=\"font-size:18px;\"><strong>Muscle and nerve sheaths </strong>made of the <strong>superficial</strong> connective tissue</span></li><li><span style=\"font-size:18px;\">Adventitia of <strong>large vessels</strong></span></li><li><span style=\"font-size:18px;\"><strong>Capsules</strong> of various organs & glands (e.g.: testis sclera, periosteum, perichondrium)</span></li></ul><p> </p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Option A.</strong> <strong>Dense regular connective tissue</strong> features <strong>collagen fibers</strong> that are <strong>parallel</strong> to each other, conferring <strong>tensile strength</strong> in one particular direction. It is typically found in <strong>tendons and ligaments</strong>, where the force is exerted in a <strong>single direction as shown in the image below</strong>.</span></p><p> </p><p><span style=\"color:#374151;font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture72221.jpg\" alt=\"\" width=\"700\" height=\"306\"></span></p><p> </p><p><span style=\"font-size:18px;\">This is not what we see in the image, where the fibers are not arranged in parallel.</span></p><p> </p><p><span style=\"font-size:18px;\">Irregular and Regular connective tissue</span></p><p> </p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/screenshot-2023-11-20-195526.png\" alt=\"\" width=\"1000\" height=\"559\"></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Option C</strong>. <strong>Loose regular connective tissue</strong> is not a recognized classification.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Option D. Loose irregular connective tissue </strong>is also not a recognized classification. What is commonly known is <strong>loose connective </strong>tissue (also termed <strong>areolar connective tissue</strong>), which has a much <strong>looser fiber </strong>arrangement and a lot of <strong>ground substance</strong>, often found <strong>beneath epithelial layers</strong>, surrounding <strong>blood vessels</strong>, and <strong>nerves</strong>. It has a different appearance from what is indicated by the arrow in the image.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:18px;\">The image shows <strong>dense irregular</strong> connective tissue, which is characterized by a dense network of <strong>collagen fibers</strong> arranged in an <strong>irregular</strong> pattern, commonly found in the d<strong>ermis</strong> of the skin, providing <strong>strength</strong> and the ability to resist <strong>multi-directional forces</strong>.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition: Volume 1 Chapter 2, Page no 2.34</strong></span></p><p><span style=\"font-size:18px;\"><strong>Grays Anatomy: The anatomical basis of clinical practice- 42<sup>nd</sup> edition- page no 40, 41</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture72221.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50031,
      "choices": [
        {
          "id": 200124,
          "text": "<p><span style=\"font-size:12.0pt;\">Struvite</span></p>"
        },
        {
          "id": 200125,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystine</span></p>"
        },
        {
          "id": 200126,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium oxalate dihydrate</span></p>"
        },
        {
          "id": 200127,
          "text": "<p><span style=\"font-size:12.0pt;\">Uric Acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which type of renal calculi is resistant to Extracorporal Shock-Wave Lithotripsy (ESWL)? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3812580",
      "question_audio": null,
      "question_video": null,
      "map_id": 34340722,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cystine</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cystine stones are resistant to extracorporal shock wave lithotripsy (ESWL) due to their hardness. Cystine, brushite, and calcium oxalate monohydrate stones are the most refractory to SWL fragmentation, with cystine and brushite being the most resistant.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cystine stones are known to be resistant to ESWL. These stones are composed of cystine, an amino acid, and they have a dense and crystalline structure that makes them less responsive to shock wave treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Struvite</strong>: Struvite stones are generally responsive to ESWL. They often contain magnesium and ammonia and can be fragmented successfully with shock waves. However, when they attain large size and form staghorn shape, ESWL is not performed.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C.</strong> <strong>Calcium oxalate dihydrate</strong>: ESWL is often effective for calcium oxalate dihydrate stones. These stones are one of the most common types, and their composition typically allows for successful fragmentation with shock waves.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Uric Acid</strong>: Uric acid stones are also responsive to ESWL. These stones are composed of uric acid crystals and can be effectively broken down using shock wave lithotripsy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">ESWL is a non-invasive method that generates shockwaves outside the body, which are focused on the stones. It is the most common method of treating urinary tract stones nowadays. Stones up to approximately 2 cm in size can be treated with this form of treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Complications: </strong>Infection, haematuria, parenchymal hemorrhage, and perirenal hematoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Contraindications: Obese patients, pregnant patients, and patients on oral anticoagulants.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note: </strong>Stone fragments collecting in the distal ureter following ESWL are called steinstrasse.    </span></p>",
      "correct_choice_id": 200125,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50032,
      "choices": [
        {
          "id": 200128,
          "text": "<p><span style=\"font-size:12pt;\">FSH</span></p>"
        },
        {
          "id": 200129,
          "text": "<p><span style=\"font-size:12pt;\">Estrogen</span></p>"
        },
        {
          "id": 200130,
          "text": "<p><span style=\"font-size:12pt;\">LH</span></p>"
        },
        {
          "id": 200131,
          "text": "<p><span style=\"font-size:12pt;\">Progesterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following hormones will be secreted in high amounts by the ovarian granulosa cells during the follicular phase of the menstrual cycle? </span>(INICET MAY 2018)</p>",
      "unique_key": "Q1870924",
      "question_audio": null,
      "question_video": null,
      "map_id": 34601855,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Estrogen</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, the granulosa cells of the developing follicles secrete high amounts of estrogen, specifically estradiol. This phase is characterized by the development of a primordial follicle to the Graafian stage, with atresia of neighboring follicles. The following events occur during this phase:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Estrogen Secretion:</strong> Granulosa cells secrete increasing amounts of estrogen, primarily estradiol, which causes proliferation of the endometrium in preparation for potential implantation.</span></li><li><span style=\"font-size:12pt;\"><strong>Up-regulation of Receptors:</strong> LH and FSH receptors are up-regulated in both theca and granulosa cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Feedback Mechanism:</strong> The rising estradiol levels exert a negative feedback effect on the anterior pituitary, suppressing the secretion of FSH and LH to moderate levels.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. FSH (Follicle Stimulating Hormone):</strong> FSH is secreted by the anterior pituitary gland and stimulates the growth of ovarian follicles but is not secreted by granulosa cells.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. LH (Luteinizing Hormone):</strong> LH is also secreted by the anterior pituitary and plays a role in the later stages of follicle development and ovulation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Progesterone:</strong> Progesterone is primarily secreted by the corpus luteum after ovulation during the luteal phase of the menstrual cycle.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, ovarian granulosa cells secrete high amounts of estrogen, which is crucial for the proliferation of the endometrium and regulation of FSH and LH levels.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 78, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50033,
      "choices": [
        {
          "id": 200132,
          "text": "<p><span style=\"font-size:12.0pt;\">CSOM with Cholesteatoma</span></p>"
        },
        {
          "id": 200133,
          "text": "<p><span style=\"font-size:12.0pt;\">Senile deafness</span></p>"
        },
        {
          "id": 200134,
          "text": "<p><span style=\"font-size:12.0pt;\">Meniere's disease</span></p>"
        },
        {
          "id": 200135,
          "text": "<p><span style=\"font-size:12.0pt;\">Otosclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In what situations does Gelle's test yield a negative result?(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9956471",
      "question_audio": null,
      "question_video": null,
      "map_id": 34405616,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Otosclerosis</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Gelle's test is negative when the ossicular chain is fixed as in case of otosclerosis.</span></li><li><span style=\"font-size:12.0pt;\">Gelle's test –  Increased pressure in the ear canal by Siegel's speculum, pushes the tympanic membrane and ossicles inwards raising the intralabyrinthine pressure and reducing the mobility of the basilar membrane leading to decreased hearing. This is called as Gelle’s positive seen in normal and SNHL patients.</span></li><li><span style=\"font-size:12.0pt;\">No change in hearing on applying pressure is Gelle’s negative, seen in ossicular chain fixation or discontinuity.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CSOM with Cholesteatoma: </strong>In case of CSOM with cholesteatoma, the pressure increased by the seigel’s speculum will directly push the cholesteatoma onto the ossicles (there is no fixation of ossicles here) and then there will be increased intralabyrinthine pressure. Hence Gelle will be positive.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Senile deafness: </strong>In case of senile deafness (presbycusis), there will be sensorineural hearing loss and it is due to natural aging of the hair cells. The ossicles will be mobile normally and hence Gelle will be positive.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Meniere’s disease: </strong>In case of Meniere’s disease also, the ossicles are not involved. On siegelisation, the inward pushed TM and ossicles will raise intralabyrinthine pressure, thereby making Gelle test positive.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Gelle’s test is instrumental in diagnosing conditions involving ossicular chain mobility. A negative Gelle's test, indicating ossicular fixation, is particularly indicative of otosclerosis, which is crucial for determining appropriate management strategies, including potential surgical interventions like stapedectomy for improving hearing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 24, 25</strong></span></p>",
      "correct_choice_id": 200135,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50034,
      "choices": [
        {
          "id": 200136,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle-debranching enzyme</span></p>"
        },
        {
          "id": 200137,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphoructokinase 1</span></p>"
        },
        {
          "id": 200138,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6 phosphatase</span></p>"
        },
        {
          "id": 200139,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle glycogen phosphorylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An adolescent male patient presented with pain in the calf muscles on exercise. On biopsy, an excessive amount of glycogen was found to be present in the muscle. What is the most likely enzyme deficiency? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q2037205",
      "question_audio": null,
      "question_video": null,
      "map_id": 34334371,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Muscle glycogen phosphorylase</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical features described are suggestive of McArdle's disease (glycogen storage disease type V), which is caused by a deficiency of muscle glycogen phosphorylase. This enzyme deficiency leads to an inability to break down glycogen into glucose in the muscle cells, resulting in exercise intolerance, muscle pain, and accumulation of glycogen in muscles.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Muscle-debranching enzyme:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Causes Cori's disease (glycogen storage disease type III).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Highly branched dextrin accumulates in liver and muscle, leading to fasting hypoglycemia, hepatomegaly, and myopathy.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note:</strong> This enzyme is involved in the debranching process of glycogenolysis, but the primary symptoms are different from those described in the question.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Phosphofructokinase 1:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Causes Tarui's disease (glycogen storage disease type VII).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Exercise intolerance, muscle pain, and myoglobinuria, similar to McArdle's, but also includes hemolytic anemia due to the enzyme's role in glycolysis in red blood cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note:</strong> This enzyme is involved in glycolysis, not directly in glycogen metabolism.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glucose 6 phosphatase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Causes Von Gierke's disease (glycogen storage disease type Ia).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Fasting hypoglycemia, hepatomegaly, hyperuricemia, and lactic acidosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note:</strong> This enzyme deficiency affects the liver's ability to release glucose, but not directly linked to muscle symptoms described in the question.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/01.jpg\" alt=\"\" width=\"1000\" height=\"1261\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/01.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200139,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50035,
      "choices": [
        {
          "id": 200140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cytarabine</span></span></span></span></p>"
        },
        {
          "id": 200141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dexamethasone</span></span></span></span></p>"
        },
        {
          "id": 200142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Doxorubicin</span></span></span></span></p>"
        },
        {
          "id": 200143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Methotrexate</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q8884939",
      "question_audio": null,
      "question_video": null,
      "map_id": 34157967,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Dexamethasone</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct choice is B, Dexamethasone, because the symptoms described (fever, tachypnea, and pulmonary infiltrates) suggest the patient may be experiencing differentiation syndrome, which can occur following the treatment of acute promyelocytic leukemia (APML) with agents like Arsenic trioxide and All-Trans retinoic acid. Differentiation syndrome is characterized by such symptoms and can improve with the administration of Dexamethasone. Dexamethasone is also used intrathecally in children for treating Acute Myeloid Leukemia (AML), indicating its relevance in managing severe inflammatory reactions in hematological conditions.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Cytarabine: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This option is incorrect as Cytarabine is primarily used in the treatment of acute myeloid leukemia and not specifically indicated for the management of differentiation syndrome in APML.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Doxorubicin: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incorrect because Doxorubicin is utilized for its efficacy against various cancers including Hodgkin's disease, cancer of the breast, and thyroid but is not suitable for treating differentiation syndrome in APML. It is also known for its cardiotoxic effects.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Methotrexate: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incorrect as it is not recommended in the treatment regimen for APML and does not address the immediate complications of differentiation syndrome.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dexamethasone is used to manage differentiation syndrome in patients with acute promyelocytic leukemia, characterized by symptoms like fever, tachypnea, and pulmonary infiltrates following treatment with specific leukemia drugs</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reference - Harrison/Oncology/Acute leukemia/chap100-743</span></span></strong></span></span></p>",
      "correct_choice_id": 200141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50036,
      "choices": [
        {
          "id": 200144,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastroschisis</span></p>"
        },
        {
          "id": 200145,
          "text": "<p><span style=\"font-size:12.0pt;\">Bladder exstrophy</span></p>"
        },
        {
          "id": 200146,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior vesical fissure</span></p>"
        },
        {
          "id": 200147,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior ectopic anus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newborn female presents with continuous dribbling of urine. The image below shows the pathology from which the patient is suffering. The most likely diagnosis is: (AIIMS MAY 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/15/untitled-419.jpg\" alt=\"\" width=\"300\" height=\"208\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/15/untitled-419.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2024410",
      "question_audio": null,
      "question_video": null,
      "map_id": 34849030,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Bladder exstrophy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Bladder exstrophy is the diagnosis in this case, which is characterized by an open, inside-out bladder on the surface of the lower abdominal wall, and an exposed dorsal urethra. The pathogenesis of this condition is thought to be due to an embryological defect in abdominal wall development. In affected females, there is epispadias with bifid clitoris and small, laterally displaced labia minora, while in affected males, there is epispadias as well.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gastrochisis</strong>: The abdominal contents will be out and not covered in a sac.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture5_Wg8NfXu.jpg\" alt=\"\" width=\"300\" height=\"179\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture6_B3UEphp.jpg\" alt=\"\" width=\"300\" height=\"223\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Superior vesical fissure</strong>: A defect of closure in the infra-umbilical abdominal wall through which vesical mucous membrane protruded. A probe introduced into the urethra appeared externally at the place of the infraumbilical defect. Following the diagnosis of superior vesical fissure, resection of the protruding vesical mucous membrane and closure were carried out.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anterior ectopic anus</strong>: The above features and image doesn’t correlate with the mentioned findings in the question.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Bladder exstrophy presents as an exposed, inside-out bladder on the abdominal wall, often associated with continuous dribbling of urine, especially in female newborns with epispadias and bifid clitoris.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture5_Wg8NfXu.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200145,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50037,
      "choices": [
        {
          "id": 200148,
          "text": "<p><span style=\"font-size:16px;\">Commonly presents in the 20-40 years age group</span></p>"
        },
        {
          "id": 200149,
          "text": "<p><span style=\"font-size:16px;\">Matrix consists of proliferating mononuclear cells</span></p>"
        },
        {
          "id": 200150,
          "text": "<p><span style=\"font-size:16px;\">Osteoclast giant cells constitute the proliferative component of the tumor</span></p>"
        },
        {
          "id": 200151,
          "text": "<p><span style=\"font-size:16px;\">It is a benign tumor which may have lung metastasis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">About giant-cell tumor, all are true except:(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q7348139",
      "question_audio": null,
      "question_video": null,
      "map_id": 34721481,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\"><strong>Ans. C. Osteoclast giant cells constitute the proliferative component of the tumor</strong></span></p><p style=\"margin-left:0cm;\"> </p><p style=\"margin-left:0cm;\"><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\"><strong>GIANT-CELL TUMOR (OSTEOCLASTOMA)</strong></span></p><p style=\"margin-left:0cm;\"> </p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">It is bone lesion of uncertain origin, most commonly seen in distal femur, proximal tibia, proximal humerus and distal radius.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Most commonly seen in 20-40 years of age, after epiphyseal fusion.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\"><strong>Histology:</strong> </span><ul style=\"list-style-type:circle;\"><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Multinucleated giant cells are seen on a background of stromal cells with little or no visible intercellular tissue. </span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">The osteoclast giant cells are the malignant cells, which induce the proliferation of mononuclear macrophage-lineage cells, hence the dividing cell population is the mononuclear cells which form the matrix.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">The proliferative component of a giant cell tumor (GCT) is primarily made up of the mononuclear stromal cells, which are mesenchymal in origin.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">These stromal cells are the neoplastic (tumor-forming) cells of GCT and play a central role in tumor growth and aggressiveness.</span></li></ul></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Although these tumors typically are benign, pulmonary metastases occur in approximately 3% of patients. </span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Malignant giant cell tumors represent less than 5% of total GCT. </span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\"><strong>Clinical Features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Most commonly presents with pain, with or without swelling</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Pathological fracture occurs in 10-15% of cases</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Pulmonary metastasis occurs in 4% of cases, but they usually regress spontaneously.</span></li></ul></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Microscopically, giant cell tumors are composed of multinucleated giant cells (40-60 nuclei per cell) in a sea of mononuclear stromal cells (malignant cells). </span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\"><strong>The nuclei of the mononuclear cells are identical to the nuclei of the giant cells, a feature that helps to distinguish giant cell tumors from other tumors that may contain many giant cells. </strong></span></li></ul><p> </p><p style=\"margin-left:0cm;\"><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\"> </p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Giant cell tumors commonly presents in the 20-40 years of age group. </span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Microscopically, the matrix consists of proliferating mononuclear cells.</span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">Osteoclast giant cells induce the proliferation of the monoculcear macrophage cells, increasing the mononuclear cell population. </span></li><li><span style=\"background-color:hsl(0,0%,100%);font-size:16px;\">It is a benign tumor which may have lung metastasis in about 4% cases.</span></li></ul>",
      "correct_choice_id": 200150,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50038,
      "choices": [
        {
          "id": 200152,
          "text": "<p><span style=\"font-size:12.0pt;\">Check blood sugar level</span></p>"
        },
        {
          "id": 200153,
          "text": "<p><span style=\"font-size:12.0pt;\">Give oral antihypertensive</span></p>"
        },
        {
          "id": 200154,
          "text": "<p><span style=\"font-size:12.0pt;\">IV mannitol</span></p>"
        },
        {
          "id": 200155,
          "text": "<p><span style=\"font-size:12.0pt;\">CT brain</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An elderly diabetic and hypertensive patient was carried to the emergency room in a comatose state. On examination, the blood pressure was 170/100 mmHg and pulse rate were >100/min. Plantar reflex was bilateral extensor. What is the next step to do? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q2621831",
      "question_audio": null,
      "question_video": null,
      "map_id": 34540741,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Check Blood sugar level</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Evaluation of Common reversible emergency causes are targeted in the ER. Altered mental status occurring acutely can be remembered with MIST.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Step 1.</strong> Rx >>> Dx priority (↓ Glucose).</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture52.jpg\" alt=\"\" width=\"1000\" height=\"389\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. </strong>HTN emergency is treated with I.V. antihypertensives.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. </strong>I.V. mannitol is used in the management of cerebral edema.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. </strong>CT brain to be done after ruling out life-threatening reversible common causes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The initial management of any comatose patient, particularly those with diabetes, should include rapid assessment of blood glucose levels to rule out hypo- or hyperglycemia as a reversible cause of the coma. This immediate action can be life-saving and should precede other investigations and treatments.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture52.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50039,
      "choices": [
        {
          "id": 200156,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Transvaginal ultrasound</span></span></span></p>"
        },
        {
          "id": 200157,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Reassure her that it's normal to have delayed period</span></span></span></p>"
        },
        {
          "id": 200158,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Beta HCG estimation</span></span></span></p>"
        },
        {
          "id": 200159,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Serum FSH and LH</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient has been on MALA-N for 6 months. She is compliant, but she complained of missed periods. What is the next step? (INICET MAY 2018)</span></span></p>",
      "unique_key": "Q8586483",
      "question_audio": null,
      "question_video": null,
      "map_id": 34717433,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Beta HCG estimation</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">MALA-N is a combined oral contraceptive pill (OCP). Despite high compliance, all contraceptive methods have a failure rate. The first consideration for a missed period in a woman of reproductive age is pregnancy. Therefore, the next step is to estimate beta HCG levels to rule out pregnancy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Beta HCG Estimation:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is essential to confirm or rule out pregnancy. Serum beta HCG can detect pregnancy as early as five days before the first missed period.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><strong>Other Options:</strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Transvaginal ultrasound:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is not the initial step. It is more appropriate once pregnancy is confirmed or other issues are suspected.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Reassure her that it's normal to have a delayed period:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> While some irregularity can occur with OCPs, pregnancy must be ruled out first.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Serum FSH and LH:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> These tests are used to evaluate ovarian function but are not appropriate for initial evaluation of a missed period in this context.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">When a woman on combined oral contraceptive pills presents with a missed period, the first step is to rule out pregnancy by estimating beta HCG levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 622, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 200158,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50040,
      "choices": [
        {
          "id": 200160,
          "text": "<p><span style=\"font-size:12.0pt;\">E2VTM3</span></p>"
        },
        {
          "id": 200161,
          "text": "<p><span style=\"font-size:12.0pt;\">E2VTM4</span></p>"
        },
        {
          "id": 200162,
          "text": "<p><span style=\"font-size:12.0pt;\">E2V1M3</span></p>"
        },
        {
          "id": 200163,
          "text": "<p><span style=\"font-size:12.0pt;\">E2VNTM3</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Calculate the GCS Score in an intubated patient, with findings of eye movements to pain and abnormal flexion? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q1403354",
      "question_audio": null,
      "question_video": null,
      "map_id": 34166949,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) E2VNTM3</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Glasgow Coma Scale (GCS) score is used to assess the level of consciousness in patients with traumatic brain injury and other conditions. In this scenario, the patient is intubated, which affects the ability to assess the verbal response. The current nomenclature for denoting non-testability due to intubation is \"NT\" (Non-testable) for the verbal component.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Eye Opening (E): </strong>The patient opens eyes in response to painful stimuli, which scores 2.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Verbal Response (V): </strong>The verbal component is non-testable (NT) due to intubation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Motor Response (M): </strong>The patient exhibits abnormal flexion (decorticate response), which scores 3.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">This combination gives a GCS score of E2VNTM3.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture50_HnLdYbm.jpg\" alt=\"\" width=\"1000\" height=\"326\"></p><p> </p><p><span style=\"font-size:12.0pt;\">NT = non-testability of the corresponding component.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Used mainly in <strong>acute TBI </strong>(Traumatic brain injury).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Update:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. GCS-P Score </strong>takes pupillary activity into consideration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>P = </strong>Pupillary non-reactivity</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2 = </strong>Both pupil</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1 = </strong>One pupil</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>0 = </strong>None</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Minimum = 1, Max = 15.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. FOUR score </strong>(Full outline of unresponsiveness) is currently employed having better sensitivity, specificity and PPV.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In intubated patients, the GCS verbal score is marked as \"NT\" for non-testable. The GCS remains a vital tool in assessing the level of consciousness, particularly in emergency and critical care settings, ensuring that changes in the patient’s neurological status are promptly recognized and appropriately managed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Neurology/Basics /Chapter 443-TBI</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture50_HnLdYbm.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50041,
      "choices": [
        {
          "id": 200164,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity and specificity will increase</span></p>"
        },
        {
          "id": 200165,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity will decrease, specificity will increase</span></p>"
        },
        {
          "id": 200166,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity and specificity will decrease</span></p>"
        },
        {
          "id": 200167,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity will increase, specificity will decrease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are assessing the impact of a new series testing protocol on the performance characteristics of diagnostic tests for a specific disease. You need to explain to your team how this method affects the test's sensitivity and specificity. What would be the correct explanation? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q6166281",
      "question_audio": null,
      "question_video": null,
      "map_id": 34071691,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Sensitivity will decrease, specificity will increase</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>SCREENING TESTS USED IN SERIES:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">A population is subjected to one screening test followed by a second screening test; 2nd screening test is applied on those individuals only who test positive on the 1st screening test</span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Combined sensitivity of 2 tests A & B in series: Sensitivity (A) × Sensitivity (B)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Combined specificity of 2 tests A & B in series: [Specificity (A) + Specificity (B)] – [Specificity (A) × Specificity (B)]</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>SCREENING TESTS USED IN PARALLEL:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">A population is subjected to two (or more) screening tests at the same time; each of the individuals is subjected to both (or all) screening tests</span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Combined sensitivity of 2 tests A & B in parallel: [Sensitivity (A) + Sensitivity (B)] – [Sensitivity (A) × Sensitivity (B)]</span></li><li><span style=\"color:black;font-size:12.0pt;\">Combined specificity of 2 tests A & B in parallel: Specificity (A) × Specificity (B)</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/screenshot-2023-10-20-165555.jpg\" alt=\"\" width=\"800\" height=\"341\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/screenshot-2023-10-20-165555.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200165,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50042,
      "choices": [
        {
          "id": 200168,
          "text": "<p><span style=\"font-size:12.0pt;\">Sympathetic overactivity</span></p>"
        },
        {
          "id": 200169,
          "text": "<p><span style=\"font-size:12.0pt;\">Vagal stimulation</span></p>"
        },
        {
          "id": 200170,
          "text": "<p><span style=\"font-size:12.0pt;\">Venous air embolism</span></p>"
        },
        {
          "id": 200171,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid body stimulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient is undergoing modified radical neck dissection (MRND) for laryngeal malignancy. While ligating the internal jugular vein, his ETCO2 dropped from 40 mmHg to 14 mmHg, and the patient developed hypotension along with cardiac arrhythmia. Which of the following is the most likely cause? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4268337",
      "question_audio": null,
      "question_video": null,
      "map_id": 34399343,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Ans. C) Venous air embolism</strong></span></p><p> </p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Venous Air Embolism:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition: </strong>It refers to the entry of air into the venous system, which can then travel to the heart and block the pulmonary circulation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation: </strong>A sudden drop in ETCO2, hypotension, and potential cardiac arrhythmias. A \"mill wheel\" murmur might be heard on auscultation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario: </strong>The sudden drop in ETCO2, combined with hypotension and cardiac arrhythmia following manipulation of the internal jugular vein during surgery in a head-up position, strongly suggests venous air embolism.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>There are four important events here:</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">Bleeding from the internal jugular vein (severed vein which can entrap air)</span></li><li><span style=\"font-size:12.0pt;\">A drastic fall in ETCO2</span></li><li><span style=\"font-size:12.0pt;\">Hypotension</span></li><li><span style=\"font-size:12.0pt;\">Neck surgery – requires head-up position which reduces blood pressure in neck veins</span></li></ol><p> </p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Sympathetic Overactivity:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition: </strong>It refers to excessive stimulation of the sympathetic nervous system.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation: </strong>It typically manifests as hypertension (raised blood pressure) and tachycardia (increased heart rate).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario: </strong>The patient developed hypotension, not hypertension, so this option is less likely.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Vagal Stimulation:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition: </strong>Activation of the vagus nerve, one of the cranial nerves, which plays a role in controlling the heart, lungs, and digestive tract.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation: </strong>Vagal stimulation can cause bradycardia (slowed heart rate) and hypotension.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario: </strong>While vagal stimulation can explain the hypotension and arrhythmia, it does not account for the drastic drop in ETCO2.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Carotid Body Stimulation:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition: </strong>The carotid body is a small cluster of chemoreceptors located at the bifurcation of the carotid artery. It monitors changes in blood oxygen levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation: </strong>Stimulation can cause changes in heart rate and blood pressure, but it typically results in hypertension.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario: </strong>Given that the patient is hypotensive, this option is less likely.</span></li></ul><p> </p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">A sudden drop in ETCO2, hypotension, and cardiac arrhythmias during surgery, especially involving the internal jugular vein and head-up positioning, strongly suggests venous air embolism.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pgs 1878-1880</strong></span></p>",
      "correct_choice_id": 200170,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50043,
      "choices": [
        {
          "id": 200172,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumobilia</span></p>"
        },
        {
          "id": 200173,
          "text": "<p><span style=\"font-size:12.0pt;\">Small bowel obstruction</span></p>"
        },
        {
          "id": 200174,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic gall stone</span></p>"
        },
        {
          "id": 200175,
          "text": "<p><span style=\"font-size:12.0pt;\">Large bowel obstruction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A middle-aged female patient with a history of cholelithiasis, presented with vomiting and abdominal pain. The abdominal radiograph showed Rigler's triad. Which of these is not a component of Rigler's triad? (AIIMS 2018)</span></p>",
      "unique_key": "Q3822744",
      "question_audio": null,
      "question_video": null,
      "map_id": 34617663,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Large bowel obstruction</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Rigler's triad is a radiologic finding associated with gallstone ileus, consisting of three specific signs: pneumobilia (air within the biliary tree), small bowel obstruction, and an ectopic calcified gallstone, typically found in the right iliac fossa. These findings are indicative of a gallstone that has passed into the intestinal tract via a biliary-enteric fistula and is causing an obstruction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumobilia:</strong> Correctly identified as a part of Rigler's triad, indicating the presence of air within the biliary system due to a fistula between the biliary tree and the gastrointestinal tract.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>B. Small Bowel Obstruction:</strong> Also a component of Rigler's triad, typically caused by the ectopic gallstone blocking the small intestine.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ectopic Gall Stone:</strong> Another correct component of Rigler's triad, representing the gallstone that has migrated and is causing obstruction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:10.5pt;\"><strong>Rigler triad consists of three findings seen in gallstone ileus:</strong></span></p><p> </p><ul><li><a href=\"https://radiopaedia.org/articles/pneumobilia?lang=us\"><span style=\"background-color:white;color:black;font-size:12.0pt;\"><u>Pneumobilia</u></span></a></li><li><a href=\"https://radiopaedia.org/articles/small-bowel-obstruction?lang=us\"><span style=\"background-color:white;color:black;font-size:12.0pt;\"><u>Small Bowel Obstruction</u></span></a></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">Ectopic calcified </span><a href=\"https://radiopaedia.org/articles/gallstones-1?lang=us\"><span style=\"background-color:white;color:black;font-size:12.0pt;\"><u>gallstone</u></span></a><span style=\"background-color:white;color:black;font-size:12.0pt;\">, usually in the right iliac fossa</span></li></ul>",
      "correct_choice_id": 200175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50044,
      "choices": [
        {
          "id": 200176,
          "text": "<p><span style=\"font-size:12.0pt;\">Kaposi sarcoma</span></p>"
        },
        {
          "id": 200177,
          "text": "<p><span style=\"font-size:12.0pt;\">Castleman's disease</span></p>"
        },
        {
          "id": 200178,
          "text": "<p><span style=\"font-size:12.0pt;\">Adult T-cell leukemia</span></p>"
        },
        {
          "id": 200179,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary effusion lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Human herpesvirus 8 is associated with all except? (INICET MAY 2018)</span></p>",
      "unique_key": "Q8060779",
      "question_audio": null,
      "question_video": null,
      "map_id": 34710957,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adult T-cell leukemia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Adult T-cell leukemia is caused by HTLV-1 (and not HHV8).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Human Herpesvirus-8 (HHV-8), also called Kaposi sarcoma Herpesvirus (KSHV), belongs to the family of DNA viruses Herpeseviridae. It causes Kaposi sarcoma (a vascular malignancy) and B cell lymphoproliferative diseases such as primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD).</span></p>",
      "correct_choice_id": 200178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50045,
      "choices": [
        {
          "id": 200180,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphylococcus aureus</span></p>"
        },
        {
          "id": 200181,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptococcus pyogenes</span></p>"
        },
        {
          "id": 200182,
          "text": "<p><span style=\"font-size:12.0pt;\">Clostridium botulinum</span></p>"
        },
        {
          "id": 200183,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacillus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The test shown in the image below. Which uses a bacitracin disk, is useful in identifying? (INICET MAY 2018)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-240.jpg\" alt=\"\" width=\"300\" height=\"287\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-240.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3853849",
      "question_audio": null,
      "question_video": null,
      "map_id": 34149933,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Streptococcus pyogenes</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image shows blood agar culture with bacitracin disk with a zone of inhibition around the disk, which means that the organism is sensitive to bacitracin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Among the options given, Streptococcus pyogenes is susceptible to bacitracin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-9.jpg\" alt=\"\" width=\"500\" height=\"672\"></span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Staphylococcus aureus: </strong>Staphylococcus aureus is catalase-positive and does not typically exhibit bacitracin sensitivity. It is identified by coagulase testing and its ability to grow in the presence of high salt concentrations.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clostridium botulinum: </strong>Clostridium botulinum is an anaerobic Gram-positive rod and is not identified using bacitracin sensitivity testing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bacillus: </strong>Bacillus species are Gram-positive rods that form spores and are not typically identified using bacitracin sensitivity testing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The bacitracin disk test is used to identify Streptococcus pyogenes (Group A Streptococcus), which is characterized by its sensitivity to bacitracin and beta-hemolytic activity on blood agar. This test differentiates S. pyogenes from other beta-hemolytic streptococci, which are resistant to bacitracin.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-9.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50046,
      "choices": [
        {
          "id": 200184,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Excessive sweating</span></span></span></p>"
        },
        {
          "id": 200185,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Adrenal Insufficiency</span></span></p>"
        },
        {
          "id": 200186,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Diarrhoea</span></span></p>"
        },
        {
          "id": 200187,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">SIADH</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The following Darrow Yannet diagram is suggestive of which condition? (</span></span>AIIMS May 2018)</p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-151847.png\" style=\"height:145px; width:400px\" /></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note: The solid line is the original fluid compartment the dotted line denotes the change caused by the condition?</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-151847.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q8879189",
      "question_audio": null,
      "question_video": null,
      "map_id": 34838896,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Adrenal Insufficiency</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Darrow Yannet diagrams are graphs that tell you the osmolarity and volume changes of body fluids. X axis represents volume. Y axis represents solute concentration.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-152035.png\" style=\"height:215px; width:300px\" /></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Addison's disease is adrenal insufficiency. Aldosterone makes you retain sodium so in the absence of aldosterone, you will lose sodium.) so osmolarity of ECF will decrease. ECF volume will decrease as fluid will move from ECF to ICF, thus ICF volume will increase.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Excessive sweating: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Generally leads to both sodium and water loss, reducing volume but potentially increasing or maintaining osmolarity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Diarrhoea: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Also causes loss of water and electrolytes but usually does not lead to a significant increase in ICF volume.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. SIADH (Syndrome of Inappropriate Antidiuretic Hormone): </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes hyponatremia and increased ECF volume, opposite to what is seen in the diagram.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adrenal insufficiency leads to a decrease in ECF volume and osmolarity due to loss of sodium and water, prompting a compensatory increase in ICF volume. This is visualized in the Darrow Yannet diagram by the shift from a higher solute concentration and volume to lower levels in the ECF and an increase in the ICF.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-152035.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200185,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50047,
      "choices": [
        {
          "id": 200188,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Epidemic</span></p>"
        },
        {
          "id": 200189,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Endemic</span></p>"
        },
        {
          "id": 200190,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sporadic</span></p>"
        },
        {
          "id": 200191,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Outbreak</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">As the in-charge epidemiologist of an urban CHC, you've been reviewing the weekly infectious disease reports. In a particular community under your jurisdiction, you observe that dengue case counts typically range from 40 to 50 cases every week. During your current weekly review, you note there are 48 reported cases of dengue. Based on this data and your understanding of epidemiological terminology, how would you classify this week's situation with respect to dengue? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q8216033",
      "question_audio": null,
      "question_video": null,
      "map_id": 34988613,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Endemic </strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">The given scenario is an example of an endemic disease.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Endemic</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Endemic: Constant presence of a disease or infectious agent in a defined geographical area. It is the ‘usual or expected frequency’ of a disease in a population</span></li><li><span style=\"color:black;font-size:12.0pt;\">Types of Endemic:</span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">Hyper-endemic: Constant presence of a disease or infectious agent at high incidence/prevalence AND affects all age groups equally</span></li><li><span style=\"color:black;font-size:12.0pt;\">Holo-endemic: A high level of infection beginning early in life AND affecting most of the children population</span></li></ul></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Epidemic:</strong> Incorrect because an epidemic refers to an increase in the number of cases of a disease beyond what is normally expected in that population in that area. The current case count does not exceed the usual range.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sporadic:</strong> Incorrect because sporadic refers to a disease that occurs infrequently and irregularly; here, the cases are neither infrequent nor irregular.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Outbreak:</strong> Similar to an epidemic, an outbreak implies a greater-than-anticipated increase in the number of cases within a small, localized area over a short period. Again, since the case count is within normal expectations, this term does not apply.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Endemic: Is the ‘usual or expected frequency’ of a disease in a population</span></li></ul>",
      "correct_choice_id": 200189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50048,
      "choices": [
        {
          "id": 200192,
          "text": "<p><span style=\"font-size:12.0pt;\">Temperature</span></p>"
        },
        {
          "id": 200193,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain</span></p>"
        },
        {
          "id": 200194,
          "text": "<p><span style=\"font-size:12.0pt;\">Touch</span></p>"
        },
        {
          "id": 200195,
          "text": "<p><span style=\"font-size:12.0pt;\">Proprioception</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following sensations is not perceived by the spinal nucleus of the trigeminal nerve?</span></p>",
      "unique_key": "Q7580012",
      "question_audio": null,
      "question_video": null,
      "map_id": 34042425,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Proprioception</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Proprioception refers to the sense of the relative position of body parts and the strength of effort being employed in movement. It provides the brain with information about limb position, movement, and force. It is perceived by the mesencephalic nucleus of the trigeminal nerve, not the spinal nucleus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Temperature</strong>: Temperature sensation refers to the ability of the body to perceive differences in external and internal temperatures.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Relation to Spinal Nucleus of Trigeminal Nerve</strong>: The spinal nucleus of the trigeminal nerve plays a key role in mediating temperature sensations from the face. It receives input from the descending or spinal tract of the trigeminal nerve for temperature sensation from the face.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Pain</strong>: Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Relation to Spinal Nucleus of Trigeminal Nerve</strong>: The spinal nucleus is responsible for pain sensation from the face. Pain fibers from the face descend along the spinal tract of the trigeminal nerve and synapse in the spinal nucleus of the trigeminal nerve.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Touch</strong>: Touch or tactile sensation refers to the ability of the body to perceive pressure or contact with the skin.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Relation to Spinal Nucleus of Trigeminal Nerve</strong>: Light touch from the face is also processed by the spinal nucleus, but it's worth noting that discriminative touch (ability to recognize specific shapes and textures) from the face is primarily processed by the main or chief sensory nucleus of the trigeminal nerve, not the spinal nucleus.</span></li></ul><p><span style=\"font-size:11pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The trigeminal nerve consists of 4 nuclei: </span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-13.jpg\" alt=\"\" width=\"600\" height=\"233\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-13.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200195,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50049,
      "choices": [
        {
          "id": 200196,
          "text": "<p><span style=\"font-size:12.0pt;\">Trochlear nerve palsy</span></p>"
        },
        {
          "id": 200197,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Lateral rectus palsy</span></p>"
        },
        {
          "id": 200198,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Internuclear ophthalmoplegia</span></p>"
        },
        {
          "id": 200199,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Oculomotor palsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following image indicates: (</span>AIIMS May 2018)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture9_7BaZjsz.jpg\" alt=\"\" width=\"500\" height=\"241\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture9_7BaZjsz.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9218586",
      "question_audio": null,
      "question_video": null,
      "map_id": 34264413,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Oculomotor palsy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image suggests oculomotor nerve palsy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The central image shows the eyes in primary gaze where the patient's left eye has deviated down and out. There is also ptosis of the left eyelid. From the eye movements, it can be seen that adduction, elevation, and depression are absent in the left eye.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">All of these findings indicate oculomotor nerve palsy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Signs observed in a patient with oculomotor nerve palsy include:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Profound ptosis: This is due to the weakness of the levator muscle.</span></li><li><span style=\"font-size:12.0pt;\">Abduction and depression in the primary position (\"down and out\"): This is due to the unopposed action of the lateral rectus and superior oblique muscles.</span></li><li><span style=\"font-size:12.0pt;\">Intorsion of the eye at rest: This is due to the intact superior oblique.</span></li><li><span style=\"font-size:12.0pt;\">Limited adduction: This is due to medial rectus weakness.</span></li><li><span style=\"font-size:12.0pt;\">Limited elevation: This is due to the weakness of the superior rectus and inferior oblique.</span></li><li><span style=\"font-size:12.0pt;\">Limited depression: This is due to the weakness of the inferior rectus.</span></li><li><span style=\"font-size:12.0pt;\">Dilated pupil and defective accommodation: This is due to parasympathetic palsy.</span></li><li><span style=\"font-size:12.0pt;\">Normal abduction: This is due to the intact lateral rectus</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/whatsapp-image-2023-09-27-at-165211_P6uff1N.jpeg\" alt=\"\" width=\"700\" height=\"473\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Trochlear nerve palsy:</strong> Primarily affects the superior oblique muscle, leading to vertical diplopia and head tilt but does not cause ptosis or pupil involvement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lateral rectus palsy:</strong> Would lead to medial deviation of the eye due to unopposed action of the medial rectus muscle, affecting horizontal eye movement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Internuclear ophthalmoplegia:</strong> Characterized by impairment of horizontal eye movements, particularly affecting the adduction of the eye on the side of the lesion, with nystagmus in the abducting eye, typically not involving the eyelid or pupil.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Oculomotor palsy involves multiple dysfunctions including ptosis, \"down and out\" eye position, and possibly a dilated pupil. Recognizing the full range of symptoms is critical for a correct diagnosis, indicating a comprehensive evaluation of cranial nerve III integrity.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/whatsapp-image-2023-09-27-at-165211_P6uff1N.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50050,
      "choices": [
        {
          "id": 200200,
          "text": "<p><span style=\"font-size:12.0pt;\">Allis test</span></p>"
        },
        {
          "id": 200201,
          "text": "<p><span style=\"font-size:12.0pt;\">Thomas test</span></p>"
        },
        {
          "id": 200202,
          "text": "<p><span style=\"font-size:12.0pt;\">Ober test</span></p>"
        },
        {
          "id": 200203,
          "text": "<p><span style=\"font-size:12.0pt;\">Trendelenburg test</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55-year-old female came with hip flexor contracture. What is the most likely test to be done in this case?(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3008742",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578468,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Thomas test</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>THOMAS TEST</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It is used to assess for hip flexion contracture and psoas syndrome.</span></li><li><span style=\"font-size:12.0pt;\">It is especially useful when the fixed flexion deformity is masked by excessive lordosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Steps:</strong></span></li></ul><p> </p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_87.jpg\" alt=\"\" width=\"700\" height=\"658\"></strong></span></p><p> </p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture1.jpg\" alt=\"\" width=\"300\" height=\"222\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Allis test.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">The Galeazzi test, also called Allis test, is used to assess hip dislocation, specifically testing for developmental dysplasia of the hip (DDH) and can also be used to assess significant leg length inequality. The examination is performed with the child lying supine and their hips flexed to 45 degrees with knees flexed to 90 degrees, and feet on examining table. In this position, look for symmetry in the level of the knees. Galeazzi’s test is positive if the height of the knees is asymmetrical, and may be due to hip dislocation, DDH, congenital femoral shortening, fracture, other congenital conditions. It is also helpful in determining whether the leg length inequality is primarily from the femur or the tibia and can be used to assess leg length with knee or hip flexion contracture.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture2.jpg\" alt=\"\" width=\"400\" height=\"184\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ober test</strong>. The Ober's test evaluates a tight, contracted or inflamed Tensor Fasciae Latae (TFL) and Iliotibial band (ITB). The patient should be in side-lying with the affected side up. Bottom knee and hip should be flexed to flatten the lumbar curve. Stand behind the patient and firmly stabilize the pelvis/greater trochanter to prevent movement in any direction. Grasp the distal end of the patient’s affected leg with your other hand and flex the leg to a right angle at the knee. Extend and abduct the hip joint. Slowly lower the leg towards the table, adduct hip until motion is restricted. Ensure that the hip does not internally rotate and flex during the test and the pelvis must be stabilized. As allowing the thigh to drop in flexion and internal rotation would 'give in' to the tight TFL and not accurately test the length. If the ITB is normal, the leg will adduct with the thigh dropping down slightly below the horizontal, the test is called negative. If the ITB is tight, the leg would remain in the abducted position and the patient would experience lateral knee pain, the test is called positive.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture3.jpg\" alt=\"\" width=\"400\" height=\"212\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Trendelenburg test. </strong>The aim of <strong>Trendelenburg’s</strong> <strong>test</strong> is to assess the strength of the hip abductors, specifically the gluteus medius and minimus. It is done when a patient complains of a <strong>limp</strong>, or <strong>hip pain</strong> or as part of a normal physical examination assessing <strong>gait</strong>. If the patient is comfortable to stand alone, stand behind the patient. Alternatively, stand in front of the patient, with their forearms positioned on yours to support them. Ask the patient to lift each foot in turn off the ground. When the patient lifts their <strong>right</strong> foot, the <strong>left</strong> hip abductors are being tested. When the patient lifts their <strong>left</strong> foot, the <strong>right</strong> hip abductors are being tested. Position your hands on the patient’s <strong>iliac crests</strong>. Observe carefully if the hip on the unsupported side <strong>lifts</strong> or <strong>droops</strong>. If the patient is using your arms for support, you will feel them pressing down on one of your arms if their hip abductors are unable to support their weight. A positive Trendelenburg’s sign (pathological) involves <strong>sagging</strong> of the pelvis on the <strong>unsupported side</strong> due to the abductor muscles failing to stabilise the hip towards the weight-bearing femur.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture4.jpg\" alt=\"\" width=\"300\" height=\"332\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Thomas test is used to assess the hip flexor contracture.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_87.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50051,
      "choices": [
        {
          "id": 200204,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ketoconazole: Lanosterol-14-demethylase inhibition</span></span></span></p>"
        },
        {
          "id": 200205,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flucytosine: Inhibits microtubule synthesis and thus hinders mitosis</span></span></span></p>"
        },
        {
          "id": 200206,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Terbinafine: Squalene epoxidase inhibition</span></span></span></p>"
        },
        {
          "id": 200207,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amphotericin B: Sequesters ergosterol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the wrongly matched pair of antifungals with its mechanism of action? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q7327109",
      "question_audio": null,
      "question_video": null,
      "map_id": 34127132,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Flucytosine: Inhibits microtubule synthesis and thus hinders mitosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the above Antifungal agents are correctly matched with their corresponding mechanisms of action except for Flucytosine. Flucytosine acts by inhibiting the synthesis of nucleic acid. Griseofulvin is the antifungal that acts by inhibiting microtubule synthesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Ketoconazole: Lanosterol-14-demethylase inhibition</span></strong></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Ketoconazole is correctly matched. It inhibits lanosterol-14-demethylase, an enzyme involved in the biosynthesis of ergosterol, which is a crucial component of the fungal cell membrane.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Terbinafine: Squalene epoxidase inhibition</span></strong></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Terbinafine is correctly matched. It inhibits squalene epoxidase, an enzyme involved in the biosynthesis of ergosterol, leading to the accumulation of toxic levels of squalene and cell death.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Amphotericin B: Sequesters ergosterol</span></strong></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Amphotericin B is correctly matched. It binds to ergosterol in the fungal cell membrane, creating pores that increase membrane permeability and cause cell contents to leak out, leading to cell death.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flucytosine inhibits nucleic acid synthesis, not microtubule synthesis. The correct antifungal that inhibits microtubule synthesis is griseofulvin.</span></span></span></p>",
      "correct_choice_id": 200205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50052,
      "choices": [
        {
          "id": 200208,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Simple hysterectomy</span></span></span></p>"
        },
        {
          "id": 200209,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Medroxy progesterone acetate</span></span></span></p>"
        },
        {
          "id": 200210,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Levonorgestrel</span></span></span></p>"
        },
        {
          "id": 200211,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Radiotherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which among the following is an ideal treatment for a 55-year-old female with simple hyperplasia of the endometrium with atypia? </span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q1052658",
      "question_audio": null,
      "question_video": null,
      "map_id": 34071408,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Simple hysterectomy</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">For postmenopausal women with atypical hyperplasia of the endometrium, the recommended treatment is a total hysterectomy. This approach is taken due to the increased risk of progression to endometrial carcinoma, especially given the presence of atypia and the patient's postmenopausal status.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Simple Hysterectomy:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This involves the surgical removal of the uterus and is considered the ideal treatment for postmenopausal women with endometrial hyperplasia with atypia to prevent the progression to cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Medroxyprogesterone acetate:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is a progestogen treatment used primarily for managing endometrial hyperplasia without atypia, especially in women who desire to preserve fertility. It is not the ideal treatment for atypical hyperplasia in a postmenopausal woman.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Levonorgestrel:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> The Levonorgestrel intrauterine system (LNG-IUS) is used for managing endometrial hyperplasia without atypia and as a conservative treatment for women wishing to preserve fertility. However, it is not the treatment of choice for atypical hyperplasia in a postmenopausal woman.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Radiotherapy:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is not a standard treatment for endometrial hyperplasia with atypia. It is typically reserved for more advanced or inoperable endometrial cancers.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">For postmenopausal women with endometrial hyperplasia with atypia, the ideal treatment is a total hysterectomy to prevent progression to endometrial carcinoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 330, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 200208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50053,
      "choices": [
        {
          "id": 200212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Benzathine penicillin 2.4 million units weekly for three weeks</span></span></span></span></p>"
        },
        {
          "id": 200213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Benzathine penicillin 2.4 million units as single dose</span></span></span></span></p>"
        },
        {
          "id": 200214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tetracycline 2g daily</span></span></span></span></p>"
        },
        {
          "id": 200215,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Benzathine penicillin 12-24 million units for 21 days</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is used in the treatment of late cardiovascular syphilis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q3043048",
      "question_audio": null,
      "question_video": null,
      "map_id": 34601541,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Benzathine penicillin 2.4 million units weekly for three weeks.</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Late cardiovascular syphilis is a form of tertiary syphilis that typically requires intensive antibiotic treatment to effectively manage the disease. The recommended regimen for treating this condition involves the administration of Benzathine penicillin G at a dose of 2.4 million units administered intramuscularly once a week for a total of three weeks. This regimen is effective because it maintains a therapeutic level of penicillin in the blood over a prolonged period, which is necessary for eradicating the persistent Treponema pallidum bacteria responsible for syphilis.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-155546.png\" style=\"height:717px; width:1000px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-155546.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50054,
      "choices": [
        {
          "id": 200216,
          "text": "<p><span style=\"font-size:12.0pt;\">Western blot</span></p>"
        },
        {
          "id": 200217,
          "text": "<p><span style=\"font-size:12.0pt;\">Tandem mass spectrometry</span></p>"
        },
        {
          "id": 200218,
          "text": "<p><span style=\"font-size:12.0pt;\">PCR</span></p>"
        },
        {
          "id": 200219,
          "text": "<p><span style=\"font-size:12.0pt;\">Gel electrophoresis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the best screening investigation for metabolic disorders?</span></p>",
      "unique_key": "Q3681205",
      "question_audio": null,
      "question_video": null,
      "map_id": 34126055,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tandem mass spectrometry</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Tandem Mass Spectrometry</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Two mass spectrometers (MS) are arranged sequentially.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>first MS separates big peptides, based on their mass</strong>.</span></li><li><span style=\"font-size:12.0pt;\">From this observation, a single peptide can be directed into the second MS (called <strong>parent ion or precursor ion</strong>). The parent ion enters the collision cell of the second MS. Here the <strong>ions collide with argon gas molecules and are broken into smaller ions</strong>. These daughter ions (product ions) are detected and quantified by their mass spectrum in the second instrument.</span></li><li><span style=\"font-size:12.0pt;\">The high selectivity of MS-MS is that the parent ion mass and daughter ion mass are used for characterization.</span></li><li><span style=\"font-size:12.0pt;\"><strong>The applications</strong> of MS-MS include:</span><ul><li><span style=\"font-size:12.0pt;\">Identification and quantification of proteins</span></li><li><span style=\"font-size:12.0pt;\"><strong>Drug screening</strong></span></li><li><span style=\"font-size:12.0pt;\">Pesticides</span></li><li><span style=\"font-size:12.0pt;\">Pollutants</span></li><li><span style=\"font-size:12.0pt;\"><strong>Screening of inborn errors of metabolism, especially organic acidurias.</strong></span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Western blot:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Used for detecting specific proteins in a sample using antibody binding.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Limitation:</strong> Not suitable for broad metabolic disorder screening; used for protein analysis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. PCR (Polymerase Chain Reaction):</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Amplifies DNA sequences for genetic analysis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Limitation:</strong> Highly specific for known genetic mutations; not suitable for comprehensive metabolic screening.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gel electrophoresis:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Separates molecules (DNA, RNA, proteins) based on size and charge.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Limitation:</strong> Not specific or sensitive enough for broad metabolic disorder screening.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Tandem mass spectrometry (MS/MS) is the preferred method for screening metabolic disorders due to its ability to simultaneously analyze multiple metabolites with high sensitivity and specificity.</span></p>",
      "correct_choice_id": 200217,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50055,
      "choices": [
        {
          "id": 200220,
          "text": "<p><span style=\"font-size:12.0pt;\">Growing scalp hematoma</span></p>"
        },
        {
          "id": 200221,
          "text": "<p><span style=\"font-size:12.0pt;\">Growing fracture</span></p>"
        },
        {
          "id": 200222,
          "text": "<p><span style=\"font-size:12.0pt;\">Subdural hygroma</span></p>"
        },
        {
          "id": 200223,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old child with a history of fall 1 year back with parietal bone fracture, has now presented with a painful and growing parietal swelling. What is the likely diagnosis? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9008804",
      "question_audio": null,
      "question_video": null,
      "map_id": 34825237,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Growing fracture</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The likely diagnosis is a <strong>growing fracture</strong>, also known as a traumatic leptomeningeal cyst or encephalocele. This condition occurs when a skull fracture, particularly one associated with a dural tear, fails to heal properly. The enlargement of the fracture site may be due to the herniation of brain tissue, dilated ventricles, or the formation of a leptomeningeal cyst.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Clinical features of a growing fracture:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It typically occurs in children younger than 3 years old.</span></li><li><span style=\"font-size:12.0pt;\">The condition is usually detected within a year of the initial head injury.</span></li><li><span style=\"font-size:12.0pt;\">It presents as a localized swelling or palpable skull defect that tends to increase in size.</span></li><li><span style=\"font-size:12.0pt;\">If not detected early, it can present later with symptoms such as headaches, seizures, or neurological deficits.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Growing scalp hematoma</strong>: This condition would typically be associated with a history of jaundice and falling hemoglobin levels, which are not described in this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Subdural hygroma</strong>: Common presentations include fever, headache, nausea, vomiting, and confusion. These symptoms are not consistent with the presentation described in this question.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic abscess</strong>: A chronic abscess usually presents with a long history of fever and signs of sepsis, which are not mentioned in this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">A growing fracture is a rare but serious condition in young children, often presenting as a growing swelling over a skull fracture site within a year of the initial injury. Early detection and treatment are crucial to prevent long-term complications.</span></p>",
      "correct_choice_id": 200221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50056,
      "choices": [
        {
          "id": 200224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Nothing, since CT was normal</span></span></span></span></p>"
        },
        {
          "id": 200225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Start on aspirin + clopidogrel</span></span></span></span></p>"
        },
        {
          "id": 200226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Intravenous thrombolysis</span></span></span></span></p>"
        },
        {
          "id": 200227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Advice BP control</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient presents with left-sided facial paralysis and weakness for the past 1 hour. Her blood pressure is 160/100 mmHg and CT shows dense MCA sign. What would be your next step? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q1609369",
      "question_audio": null,
      "question_video": null,
      "map_id": 34787059,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Intravenous thrombolysis</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The patient's presentation of acute left-sided facial paralysis and weakness, alongside the finding of a dense MCA (Middle Cerebral Artery) sign on a CT scan, indicates an acute ischemic stroke. The dense MCA sign is a radiologic indicator of a thrombus or embolus in the MCA, which is one of the most common sites for cerebral infarctions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Given that the symptoms began only 1 hour ago and the CT has confirmed the location of the occlusion without showing any signs of hemorrhage or extensive infarction (which would contraindicate thrombolysis), intravenous thrombolysis is the most appropriate intervention. This treatment is aimed at dissolving the clot and restoring blood flow to the affected area of the brain.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture57.jpg\" style=\"height:304px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Nothing, since CT was normal: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incorrect because the CT was not normal; it showed a dense MCA sign, indicating an acute stroke.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Start on aspirin + clopidogrel: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This would generally be considered in secondary prevention after the acute management phase of ischemic stroke, or if the patient was not a candidate for thrombolysis.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Advice BP control: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">While controlling blood pressure is important, it is not the immediate next step in the management of a patient showing signs of acute ischemic stroke with a window for thrombolysis.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In cases of acute ischemic stroke with clear indications, intravenous thrombolysis should be administered as soon as possible within the therapeutic window to improve outcomes. Immediate evaluation and management are critical to maximize recovery and minimize long-term disability.</span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture57.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50057,
      "choices": [
        {
          "id": 200228,
          "text": "<p><span style=\"font-size:12.0pt;\">Praziquantel</span></p>"
        },
        {
          "id": 200229,
          "text": "<p><span style=\"font-size:12.0pt;\">Ivermectin</span></p>"
        },
        {
          "id": 200230,
          "text": "<p><span style=\"font-size:12.0pt;\">Albendazole</span></p>"
        },
        {
          "id": 200231,
          "text": "<p><span style=\"font-size:12.0pt;\">Diethylcarbamazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which medication is used to treat an infection caused by the cestode egg of the given organism? (INICET MAY 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-173512.png\" alt=\"\" width=\"300\" height=\"300\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-173512.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q1046203",
      "question_audio": null,
      "question_video": null,
      "map_id": 34737060,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Praziquantel</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The egg in the image is of Hymenolepis nana (dwarf tapeworm) </strong>and it is treated by praziquantel (5-10 mg/kg once).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">H. nana egg is colorless, almost transparent, oval, non-bile stained, 30–50 µm (micrometers) in diameter, has <strong>polar filaments</strong>. When shed in stool they are immediately infective and survive up to 10 days in the external environment, they are embryonated and have a 6-hooked oncospheres inside the shells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Shell consists of two distinct membranes; inner membrane has two small “knobs” or poles from which 4–8 filaments arise and spread.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-242.jpg\" alt=\"\" width=\"400\" height=\"312\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ivermectin:</strong> Ivermectin is used to treat infections caused by various nematodes and ectoparasites but is not effective against cestodes like Hymenolepis nana.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Albendazole:</strong> Albendazole is an effective treatment for various helminth infections, including some cestodes, but praziquantel is specifically preferred for Hymenolepis nana.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diethylcarbamazine:</strong> Diethylcarbamazine is used primarily for treating filarial infections, not cestode infections like Hymenolepis nana.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Praziquantel is the medication used to treat infections caused by the cestode egg of Hymenolepis nana (dwarf tapeworm). The eggs are colorless, almost transparent, and immediately infective when shed in stool. Praziquantel effectively treats this infection with a single dose of 5-10 mg/kg.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-242.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200228,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50058,
      "choices": [
        {
          "id": 200232,
          "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Conventional karyotyping</span></span></span></p>"
        },
        {
          "id": 200233,
          "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FISH</span></span></span></p>"
        },
        {
          "id": 200234,
          "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone marrow aspiration</span></span></span></p>"
        },
        {
          "id": 200235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Next generation sequencing</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">t(11,22) is best diagnosed by: </span></span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q2125062",
      "question_audio": null,
      "question_video": null,
      "map_id": 34441814,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) FISH</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">t(11,22) can be best detected using fluorescence in situ hybridization (FISH). FISH uses DNA probes that recognize sequences specific to particular chromosomal regions. As part of the Human Genome Project, large libraries of bacterial artificial chromosomes that span the entire human genome were created. The human DNA insert in these clones is on the order of 100,000–200,000 base pairs, which defines the limit of resolution of FISH for identifying chromosomal changes. These DNA clones are labeled with fluorescent dyes and applied to metaphase spreads or interphase nuclei. The probe hybridizes to its homologous genomic sequence and thus labels a specific chromosomal region that can be visualized under a fluorescent microscope. The ability of FISH to circumvent the need for dividing cells is invaluable when a rapid diagnosis is warranted (e.g., when deciding to treat a patient with acute myeloid leukemia with retinoic acid, which is only effective in a particular subtype with a chromosomal translocation involving the retinoic acid receptor gene). </span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FISH can be performed on prenatal samples (e.g., cells obtained by amniocentesis, chorionic villus biopsy, or umbilical cord blood), peripheral blood lymphocytes, touch preparations from cancer biopsies, and even archival tissue sections. FISH has been used for detection of numeric abnormalities of chromosomes (aneuploidy); for the demonstration of subtle microdeletions or complex translocations not detectable by routine karyotyping; for analysis of gene amplification (e.g., HER2/NEU in breast cancer or N-MYC amplification in neuroblastomas); and for mapping newly isolated genes of interest to their chromosomal loci.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/962.jpg\" style=\"height:360px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Conventional karyotyping</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Although conventional karyotyping can detect chromosomal translocations, it is less sensitive and slower than FISH, particularly for small or complex translocations.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Bone marrow aspiration</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This procedure is used to obtain a sample for analysis, but it is not a diagnostic test in itself for specific chromosomal translocations.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Next generation sequencing (NGS)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: NGS is a powerful tool for sequencing entire genomes, but it is not typically the first choice for detecting specific chromosomal translocations like t(11;22).</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FISH </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is the preferred method for detecting the <strong>t(11;22) translocation</strong>, due to its ability to precisely identify specific chromosomal abnormalities in various sample types.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbin and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 340-341</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">​​​​​​</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/962.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50059,
      "choices": [
        {
          "id": 200236,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma vagina</span></p>"
        },
        {
          "id": 200237,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma vulva</span></p>"
        },
        {
          "id": 200238,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma cervix</span></p>"
        },
        {
          "id": 200239,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma endometrium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Sentinel lymph node biopsy is most useful in which of the following gynecological malignancies? </span>(INICET MAY 2018)</p>",
      "unique_key": "Q7417925",
      "question_audio": null,
      "question_video": null,
      "map_id": 34869618,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Carcinoma vulva</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Sentinel lymph node biopsy is particularly useful in the management of vulval carcinomas among gynecological malignancies. The technique helps in determining the extent of lymph node involvement and thereby reduces unnecessary lymph node dissections and their associated complications, such as lymphedema. Sentinel lymph node biopsy can effectively identify the first lymph node (sentinel node) that drains the primary tumor, which is likely to be the first site of metastasis.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Lymphatic Mapping and Sentinel Node Biopsy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Intraoperative Injection:</strong> Intradermal injection of blue dye around the tumor to map lymphatic drainage.</span></li><li><span style=\"font-size:12pt;\"><strong>Radioactive Tracer:</strong> Labeling tissues with a radioactive tracer and localizing with a hand-held detector.</span></li><li><span style=\"font-size:12pt;\"><strong>Lymphoscintigraphy:</strong> This imaging technique has a 100% detection rate for sentinel lymph nodes.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Utility in Other Malignancies:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Breast carcinoma</span></li><li><span style=\"font-size:12pt;\">Penile carcinoma</span></li><li><span style=\"font-size:12pt;\">Malignant melanoma</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Carcinoma vagina:</strong> Sentinel lymph node biopsy is less commonly used in vaginal cancer compared to vulvar cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Carcinoma cervix:</strong> While sentinel lymph node biopsy can be used, it is more established and routinely applied in vulvar cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Carcinoma endometrium:</strong> Sentinel lymph node biopsy is also useful but not as prominently used as in vulvar carcinoma.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Sentinel lymph node biopsy is most useful in vulvar carcinoma among gynecological malignancies to reduce unnecessary lymph node dissection and its complications.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 608, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200237,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50060,
      "choices": [
        {
          "id": 200240,
          "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small-cell lung cancer</span></span></span></p>"
        },
        {
          "id": 200241,
          "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CMV-associated organizing pneumonia</span></span></span></p>"
        },
        {
          "id": 200242,
          "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cryptococcal pneumonia</span></span></span></p>"
        },
        {
          "id": 200243,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 65-year-old HIV-positive man presented with fever and breathlessness for 2 weeks. Imaging shows dense infiltration in the lower lobe and the lung biopsy showed the following finding. What is the diagnosis?</span></span> (AIIMS MAY 2018)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/973.jpg\" style=\"height:199px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/973.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4245002",
      "question_audio": null,
      "question_video": null,
      "map_id": 34842604,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) CMV-associated organizing pneumonia</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given image shows a cytomegalic pneumocyte containing characteristic intranuclear basophilic inclusion surrounded by a clear halo known <strong>as owl's eye appearance</strong>. Along with the given clinical scenario, it is suggestive of cytomegalovirus (<strong>CMV) pneumonia</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CMV is a -group herpesvirus. It causes the following conditions:</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I<strong>mmunocompetent</strong> individuals - asymptomatic or mononucleosis-like infection</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Neonates </strong>- devastating systemic infections</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I<strong>mmunosuppressed</strong> individuals - serious, life-threatening, disseminated CMV infections of the lungs (pneumonitis) and gastrointestinal tract (colitis)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Small-cell lung cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This does not present with the characteristic owl's eye appearance seen in CMV infection.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Cryptococcal pneumonia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Cryptococcosis is a fungal infection that can affect the lungs but typically presents with encapsulated yeast forms, not the cytomegalic cells characteristic of CMV.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Tuberculosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: TB typically presents with granulomas and caseating necrosis rather than the cytomegalic changes seen in CMV pneumonia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of <strong>owl's eye intranuclear inclusions</strong> in pneumocytes on lung biopsy, especially in an immunocompromised patient, is strongly suggestive of <strong>CMV-associated organizing pneumonia</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\"> </p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbin and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 639-640</span></strong></span></span></p>",
      "correct_choice_id": 200241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50061,
      "choices": [
        {
          "id": 200244,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Common witness</span></p>"
        },
        {
          "id": 200245,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hand writing expert</span></p>"
        },
        {
          "id": 200246,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Doctor</span></p>"
        },
        {
          "id": 200247,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hostile witness</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Identify the person to whom the First-hand knowledge rule is applicable? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q6405699",
      "question_audio": null,
      "question_video": null,
      "map_id": 34740881,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Common witness</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The first-hand knowledge rule applies to a common witness who gives evidence about the facts directly observed by them. This rule ensures that the testimony provided is based on direct observation and personal experience rather than hearsay or second-hand information.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Handwriting expert: </strong>An expert witness who provides testimony based on specialized knowledge or expertise, rather than direct personal observation of the facts in question.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Doctor: </strong>A medical professional who may provide expert testimony based on their medical expertise, rather than direct observation of the facts in question.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. A hostile witness</strong> is a witness who appears to be refusing to fully testify in support of the person who called them or testifies in a way that significantly differs from their pre-trial.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note : An expert witness </strong>is a person with extensive experience or knowledge in a specific field or discipline beyond that expected from a layperson. The expert witness's duty is to apply their expertise to give a professional opinion to the tribunal or court on particular matters in dispute. Doctors, handwriting/ fingerprints/ firearms experts come under this category.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The first-hand knowledge rule ensures that the testimony provided by a common witness is based on direct observation and personal experience, thereby maintaining the integrity and reliability of the evidence presented in court.</span></p>",
      "correct_choice_id": 200244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50062,
      "choices": [
        {
          "id": 200248,
          "text": "<p><span style=\"font-size:12.0pt;\">Natural Killer cell lymphoblastic leukemia/lymphoma</span></p>"
        },
        {
          "id": 200249,
          "text": "<p><span style=\"font-size:12.0pt;\">B-lymphoblastic leukemia/lymphoma with hypodiploidy</span></p>"
        },
        {
          "id": 200250,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute myeloid leukemia with RUNX1 mutation</span></p>"
        },
        {
          "id": 200251,
          "text": "<p><span style=\"font-size:12.0pt;\">Splenic B-cell lymphoma/leukemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All leukemias come under provisional entity in WHO 2016 classification of hematolymphoid tumours except: </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q1106053",
      "question_audio": null,
      "question_video": null,
      "map_id": 34865536,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) B-lymphoblastic leukemia/ lymphoma with hypodiploidy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>It is not a provisional entity under WHO 2016 Classification of Hematopoietic and Lymphoid Tumors</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Leukemias that come under provisional entity in WHO 2016 classification of hematolymphoid are:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Myeloid/lymphoid neoplasms with <strong>PCM1-JAK2</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Refractory cytopenia</strong> of childhood</span></li><li><span style=\"font-size:12.0pt;\">AML with <strong>BCR-ABL1</strong></span></li><li><span style=\"font-size:12.0pt;\">AML with mutated <strong>RUNX1 </strong>(Option C)</span></li><li><span style=\"font-size:12.0pt;\">B-lymphoblastic leukemia/lymphoma, <strong>BCR-ABL1–like</strong></span></li><li><span style=\"font-size:12.0pt;\">B-lymphoblastic leukemia/lymphoma with <strong>iAMP21</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Early T-cell precursor</strong> lymphoblastic leukemia</span></li><li><span style=\"font-size:12.0pt;\">Natural killer (<strong>NK) cell</strong> lymphoblastic leukemia/lymphoma (Option A)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Splenic B-cell lymphoma/leukemia</strong>, unclassifiable (Option D)</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The WHO 2016 classification introduced several provisional entities in hematolymphoid neoplasms, which are conditions that are newly recognized or still under study for their clinical significance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>B-lymphoblastic leukemia/lymphoma with hypodiploidy</strong> is <strong>not a provisional entity</strong> under the WHO 2016 Classification of Hematopoietic and Lymphoid Tumors.</span></p>",
      "correct_choice_id": 200249,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50063,
      "choices": [
        {
          "id": 200252,
          "text": "<p><span style=\"font-size:12.0pt;\">Skeletal dysplasia</span></p>"
        },
        {
          "id": 200253,
          "text": "<p><span style=\"font-size:12.0pt;\">Rickets</span></p>"
        },
        {
          "id": 200254,
          "text": "<p><span style=\"font-size:12.0pt;\">Scurvy</span></p>"
        },
        {
          "id": 200255,
          "text": "<p><span style=\"font-size:12.0pt;\">Blount disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old child was brought to the OPD with a painless deformity. A radiograph of the child's legs is shown below. The most common cause of this deformity is? </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:462/731;width:51.59%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150422.jpg\" width=\"462\" height=\"731\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150422.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1195850",
      "question_audio": null,
      "question_video": null,
      "map_id": 34477131,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Rickets</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The X-ray shows <strong>bow legs</strong> or <strong>genu varum</strong>, which is most commonly seen in <strong>rickets</strong>. Rickets is a bone mineralization disorder that primarily affects children with open growth plates, resulting from a deficiency of vitamin D, calcium, or phosphate. This deficiency leads to improper bone mineralization and structural deformities, especially in weight-bearing bones such as the legs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Common radiological features of rickets include:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Loss of the provisional zone of calcification (the earliest sign)</span></li><li><span style=\"font-size:12.0pt;\">Delayed appearance of the epiphysis</span></li><li><span style=\"font-size:12.0pt;\">Widening of the growth plate</span></li><li><span style=\"font-size:12.0pt;\">Cupping and fraying of the metaphysis</span></li><li><span style=\"font-size:12.0pt;\">Bowing of the diaphysis</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">In toddlers, genu varum is one of the most common initial signs of rickets. Other clinical features, such as frontal bossing, rachitic rosary, and delayed closure of fontanelles, may also be present.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Skeletal dysplasia:</strong> Skeletal dysplasia refers to a group of disorders affecting bone growth and development, but it does not typically present with the classical features of rickets.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Scurvy:</strong> Scurvy is caused by a deficiency of vitamin C and primarily affects collagen formation, leading to bleeding gums, poor wound healing, and bone pain, but it is not associated with the characteristic bowing of the legs seen in rickets.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blount disease:</strong> Blount disease is a growth disorder of the tibia (shinbone) causing it to angle inward, but it typically affects older children and adolescents and has a different radiographic appearance than rickets.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Rickets is the most common cause of bone deformities like genu varum in children. It results from a deficiency in vitamin D, calcium, or phosphate, leading to improper bone development, particularly in areas with rapid growth like the knees and wrists.</span></p>",
      "correct_choice_id": 200253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50064,
      "choices": [
        {
          "id": 200256,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">e-VIN</span></p>"
        },
        {
          "id": 200257,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Freeze indicator</span></p>"
        },
        {
          "id": 200258,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitor</span></p>"
        },
        {
          "id": 200259,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Fridge indicator</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are overseeing the arrival of vaccines at a remote clinic. To ensure the vaccines have maintained their potency during transit, which tool would you use? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q1152875",
      "question_audio": null,
      "question_video": null,
      "map_id": 34663850,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Vaccine vial monitor</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain.</span></li><li><span style=\"color:black;font-size:12.0pt;\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></li><li><span style=\"color:black;font-size:12.0pt;\">A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Expiry date can’t be determined by VVM and has no relation to extend the expiry date.</span></li><li><span style=\"color:black;font-size:12.0pt;\">If the square and the circle are the same in colour or square is darker, then the vaccine should be discarded.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture52222.jpg\" alt=\"\" width=\"700\" height=\"370\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. e-VIN: </strong>e-VIN (Electronic Vaccine Intelligence Network) tracks the stock status and temperature of vaccine inventories via the internet, but it does not assess the viability of individual vaccine vials upon arrival.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Freeze indicator:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">Freeze indicator detects exposure to freezing temperatures, which can damage vaccines, but it does not indicate heat exposure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Fridge indicator: </strong>Fridge indicator monitors the temperature inside a refrigerator, ensuring it remains within a safe range but does not provide specific information about the exposure of individual vaccine vials during transport.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture422.jpg\" alt=\"\" width=\"800\" height=\"580\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture52222.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200258,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50065,
      "choices": [
        {
          "id": 200260,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Larger teeth</span></p>"
        },
        {
          "id": 200261,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Frontal and maxillary sinuses are larger</span></p>"
        },
        {
          "id": 200262,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Frontal and parietal eminences are larger</span></p>"
        },
        {
          "id": 200263,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Supratympanic crest is present</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following trait is a feature of the female skull? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q3266567",
      "question_audio": null,
      "question_video": null,
      "map_id": 34706707,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Frontal and parietal eminences are larger</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Remember:</strong> In general, most features are larger and more prominent in males. However, there are three features which are exceptionally larger or more prominent in females. Just remember these:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Frontal Eminence</strong> is more prominent in females </span></li><li><span style=\"font-size:12.0pt;\"><strong>Parietal Eminence</strong> is more prominent in females</span></li><li><span style=\"font-size:12.0pt;\"><strong>Orbits </strong>are larger in females</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Larger teeth: </strong>Incorrect. Male skulls typically have larger teeth compared to females.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Frontal and maxillary sinuses are larger: </strong>Incorrect. These sinuses are generally larger in males.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Supratympanic crest is present: </strong>Incorrect. This feature is more commonly found in male skulls.</span></p><p> </p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>General differences between male and female bones: </strong>There are some general features which help to differentiate male and female bones. These are applicable to most bones, hence no need to remember separately for each bone. These are</span></p><p> </p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Size: </strong>Male bones tend are larger than female bones.</span></p><p> </p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Texture: </strong>The texture of male bones can be rougher and more rugged due to increased muscle attachment areas.</span></p><p> </p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Articular Surface Size: </strong>Male bones may have larger articular surfaces compared to females<strong>.</strong></span></p><p> </p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Bone Markings: </strong>Bony markings where muscles and ligaments attach are more prominent in males.</span></p><p> </p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\">So for individual bones, just remember the specific features, instead of general features</span></p>",
      "correct_choice_id": 200262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50066,
      "choices": [
        {
          "id": 200264,
          "text": "<p><span style=\"font-size:12.0pt;\">Potts spine</span></p>"
        },
        {
          "id": 200265,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 200266,
          "text": "<p><span style=\"font-size:12.0pt;\">Cauda equina syndrome</span></p>"
        },
        {
          "id": 200267,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone metastasis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55-year-old male presents with severe backache for 10 days and urinary incontinence with a history of intervertebral lumbar disc prolapse. There is no H/o fever or weight loss. What is the likely diagnosis?</span></p>",
      "unique_key": "Q6470397",
      "question_audio": null,
      "question_video": null,
      "map_id": 34817002,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Cauda equina syndrome</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>CAUDA EQUINA SYNDROME</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Cauda equina syndrome results from compression (squeezing) of the cauda equina – the sac of nerves and nerve roots at the base and just below the spinal cord in the lumbosacral spinal canal.</span></li><li><span style=\"font-size:12.0pt;\">It is a rare but serious disorder, and a medical emergency.</span></li><li><span style=\"font-size:12.0pt;\">The nerves of the cauda equina provide motor and sensory function to the legs and the bladder.</span></li><li><span style=\"font-size:12.0pt;\">Compression of these nerves can interrupt their function, and the effects can be severe.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Causes:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Lumbar disc herniation (most common)</span></li><li><span style=\"font-size:12.0pt;\">Trauma</span></li><li><span style=\"font-size:12.0pt;\">Spinal tumor</span></li><li><span style=\"font-size:12.0pt;\">Spinal stenosis</span></li><li><span style=\"font-size:12.0pt;\">Infection</span></li><li><span style=\"font-size:12.0pt;\">Vertebral fractures from osteoporosis</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Symptoms:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Severe low back pain</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bladder dysfunction</strong> such as urinary retention or incontinence</span></li><li><span style=\"font-size:12.0pt;\">Bowel incontinence</span></li><li><span style=\"font-size:12.0pt;\">Muscle weakness or sensory loss in both legs</span></li><li><span style=\"font-size:12.0pt;\">Loss of motor function in legs</span></li><li><span style=\"font-size:12.0pt;\">Loss or reduction of reflexes</span></li><li><span style=\"font-size:12.0pt;\"><strong>Saddle anesthesia</strong> (inability to feel anything in the body areas that would sit on a saddle)</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Investigations:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Magnetic resonance (MR) imaging: </strong>The best method of imaging the spinal cord, nerve roots, intervertebral discs, and ligaments. Since these scans can detect damage or disease of soft tissue, <strong>MRIs are valuable in diagnosing the cause of cauda equina syndrome.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Myelogram: </strong>Procedure that involves <strong>injecting a liquid dye into the spinal column</strong>. These X-ray and CT images [usually performed with a computerized tomography (CT) scan] can show pressure on the cauda equina from herniated discs and other conditions.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Cauda equina syndrome is a potential surgical emergency and may require timely decompression surgery to reduce/remove the pressure on the nerve(s).</span></li><li><span style=\"font-size:12.0pt;\">Undergoing early surgery seems to offer the best chance for improvement of sensory and muscle function as well as bowel and bladder function.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pott’s spine. Back pain, </strong>usually minimal, is the <strong>commonest symptom </strong>(1st symptom). <strong>Tenderness </strong>is the <strong>earliest sign</strong>. Twist tenderness for anterior elements is more significant as disease involves the vertebral body (paradiscal) anteriorly. Paravertebral muscle spasm resulting in stiffness in the affected region is a constant early finding. The spine is held rigid. When picking an object up from floor, there is flexion at hips and knees and the spine is in extension (Coin test). Earliest sign in patient with neurological deficit is <strong>increased deep tendon reflexes </strong>or clonus or extensor plantar response (twitching of muscles can be seen even earlier).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Multiple myeloma. Elderly with bone pains, increased ESR and hypercalcemia is multiple myeloma till proved otherwise. </strong>Bone pain is the most common complaint for patients with multiple myeloma. In contrast to most bone tumors, other systemic problems, such as weakness, weight loss, anemia, thrombocytopenia, peripheral neuropathy, hypercalcemia, or renal failure, frequently are present at the time of diagnosis of multiple myeloma. Symptoms usually are of short duration because of the aggressive nature of the disease. Pathological fractures are relatively common. The spine is the most common location followed by the ribs and pelvis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bone metastasis. </strong>The common symptoms include<strong> </strong>bone pain (frequent symptom), gradual in onset and described as a dull, boring pain that is worse at night. Bone metastases causing nerve root compression can present as radicular pain different from mechanical pain. As the vertebra is the most common site of metastasis, a significant complication includes spinal cord compression, which is an oncologic emergency. Metastatic spinal cord compression occurs either through pathological vertebral collapse or direct epidural extension. Patients may present initially with back pain. Limb weakness is the second most common symptom. Sensory symptoms include paresthesia and numbness at and below the level of cord compression. Autonomic dysfunction, including bowel and bladder incontinence and impotence, is typically a late presentation. In malignancy, hypercalcemia can be multifactorial and confers a poor prognosis overall. Osteolytic bone metastases are associated with 10-30% of the cases of hypercalcemia of malignancy due to enhanced osteoclastic bone resorption. Symptoms include nausea, anorexia, abdominal pain, constipation, and mental status changes. Bone metastases cause bone destruction, increasing the risk for atraumatic fracture.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The presenting symptoms and history of the patient are suggestive of cauda equine syndrome caused due to lumbar disc prolapse.</span></p>",
      "correct_choice_id": 200266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50067,
      "choices": [
        {
          "id": 200268,
          "text": "<p><span style=\"font-size:12pt;\">Increased number of theca lutein cysts</span></p>"
        },
        {
          "id": 200269,
          "text": "<p><span style=\"font-size:12pt;\">Persistently enlarged uterus</span></p>"
        },
        {
          "id": 200270,
          "text": "<p><span style=\"font-size:12pt;\">Plateau of high serum hCG</span></p>"
        },
        {
          "id": 200271,
          "text": "<p><span style=\"font-size:12pt;\">Sub-urethral nodule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following can be indicators of choriocarcinoma except: </span>(INICET MAY 2018)</p>",
      "unique_key": "Q7254016",
      "question_audio": null,
      "question_video": null,
      "map_id": 34127542,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Increased number of theca lutein cysts</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Choriocarcinoma is a malignant form of gestational trophoblastic neoplasia (GTN) that arises from trophoblastic tissue following a molar pregnancy, miscarriage, abortion, or normal pregnancy. Indicators of choriocarcinoma include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Persistently enlarged uterus:</strong> Indicates continued trophoblastic proliferation.</span></li><li><span style=\"font-size:12pt;\"><strong>Plateau of high serum hCG:</strong> Persistent high levels of hCG after treatment suggest ongoing trophoblastic disease.</span></li><li><span style=\"font-size:12pt;\"><strong>Sub-urethral nodule:</strong> A rare but specific sign of metastatic choriocarcinoma.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">The presence of theca lutein cysts alone is not a specific indicator of choriocarcinoma, though these cysts can persist in cases of GTN. The increased number of theca lutein cysts is associated with molar pregnancies and persistent GTN but not specifically indicative of choriocarcinoma.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Persistently enlarged uterus:</strong> This is a common finding in choriocarcinoma due to persistent trophoblastic tissue.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Plateau of high serum hCG:</strong> This is a hallmark of choriocarcinoma as it indicates continued activity of the trophoblastic cells.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Sub-urethral nodule:</strong> This can be a sign of metastasis from choriocarcinoma. Indicates metastasis of choriocarcinoma forming a firm palpable mass beneath urethral nodule</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Indicators of choriocarcinoma include persistently enlarged uterus, plateau of high serum hCG, and sub-urethral nodules, but not an increased number of theca lutein cysts alone.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 361, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50068,
      "choices": [
        {
          "id": 200272,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Panchayat Health Committee</span></p>"
        },
        {
          "id": 200273,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Village Health Planning and Management Committee</span></p>"
        },
        {
          "id": 200274,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Rogi Kalyan Samiti</span></p>"
        },
        {
          "id": 200275,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Village Health Sanitation and Nutrition Committee</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">As part of a health development project in rural India, you're asked about the key community group responsible for overseeing local health, sanitation, and nutrition initiatives. Which committee best fits this description? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q6362246",
      "question_audio": null,
      "question_video": null,
      "map_id": 34432451,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Village Health Sanitation and Nutrition Committee</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">One of the key elements of the National Rural Health Mission is the Village Health, Sanitation and Nutrition committee (VHSNC).</span></li><li><span style=\"color:black;font-size:12.0pt;\">The committee has been formed to take collective actions on issues related to health and its social determinants at the village level.</span></li><li><span style=\"color:black;font-size:12.0pt;\">They are particularly envisaged as being central to ‘local level community action’ under NRHM, which would develop to support the process of Decentralized Health Planning.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Thus VHSNC is envisaged to take leadership in providing a platform for improving health awareness and access of community for health services, address specific local needs and serve as a mechanism for community based planning and monitoring.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The committee is formed at the revenue village level and it should act as a sub-committee of the Gram Panchayat.</span></li><li><span style=\"color:black;font-size:12.0pt;\">It should have a minimum of 15 members which should comprise of elected member of the Panchayat who shall lead the committee, all those working for health and health related services should participate, community members/ beneficiaries and representation from all community sub-groups especially the vulnerable sections and hamlets/ habitations. ASHA residing in the village shall be the member secretary and convener of the committee.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"> <strong>ROLES AND RESPONSIBILITIES </strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Create awareness about nutritional issues and significance of nutrition as an important determinant of health.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Carry out survey on nutritional status and nutritional deficiencies in the village especially among women and children.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Identify locally available food stuffs of high nutrient value as well as disseminate and promote best practices (traditional wisdom) congruent with local culture, capabilities and physical environment through a process of community consultation.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Inclusion of Nutritional needs in the Village Health Plan – The committee will do an in-depth analysis of causes of malnutrition at the community and household levels, by involving the ANM, AWW, ASHA and ICDS Supervisors.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Monitoring and Supervision of Village Health and Nutrition Day to ensure that it is organized every month in the village with the active participation of the whole village.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Facilitate early detection of malnourished children in the community; tie up referral to the nearest Nutritional Rehabilitation Centre (NRC) as well as follow up for sustained outcome.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Supervise the functioning of Anganwadi Centre (AWC) in the village and facilitate its working in improving nutritional status of women and children.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Act as a grievances redressal forum on health and nutrition issues.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Panchayat Health Committee </strong>and <strong>Option B. Village Health Planning and Management Committee </strong>generally refer to broader terms, but they do not specifically target the integrated approach of the VHSNC.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C. Rogi Kalyan Samiti (Patient Welfare Committee) / Hospital Management Committee </strong>is a simple yet effective management structure. This committee, a registered society, acts as a group of trustees for the hospitals to manage the affairs of the hospital. It consists of members from local Panchayati Raj Institutions (PRIs), NGOs, local elected representatives and officials from Government sector who are responsible for proper functioning and management of the hospital / Community Health Centre / FRUs. RKS / HMS is free to prescribe, generate and use the funds with it as per its best judgement for smooth functioning and maintaining the quality of services.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The VHSNC plays a crucial role in the grassroots-level health planning and implementation in rural India, ensuring that health initiatives are tailored to the specific needs and conditions of the community.</span></li><li><span style=\"font-size:12pt;\">It is a vital part of the health ecosystem, facilitating a comprehensive approach to public health management in rural settings.</span></li></ul>",
      "correct_choice_id": 200275,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50069,
      "choices": [
        {
          "id": 200276,
          "text": "<p><span style=\"font-size:12.0pt;\">Human Immunodeficiency Virus (HIV)</span></p>"
        },
        {
          "id": 200277,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis A Virus (HAV)</span></p>"
        },
        {
          "id": 200278,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B Virus (HBV)</span></p>"
        },
        {
          "id": 200279,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis C Virus (HCV)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Solvent/Detergent (SD) plasma destroys lipid-enveloped viruses. So, on SD plasma transfusion, which of the following infection is likely to occur? (INICET MAY 2018)</span></p>",
      "unique_key": "Q4488946",
      "question_audio": null,
      "question_video": null,
      "map_id": 34982219,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hepatitis A Virus (HAV)</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The solvent/detergent (SD) process used for plasma can safely inactivate all lipid-enveloped virus. <strong>HAV is a non-enveloped virus,</strong> and hence it's not affected by solvent/detergent (SD) plasma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hepatitis B, C, and HIV are enveloped.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Human Immunodeficiency Virus (HIV):</strong> HIV is an enveloped virus. The SD process effectively inactivates HIV by disrupting its lipid envelope, making it non-infectious.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hepatitis B Virus (HBV):</strong> HBV is also an enveloped virus. The SD process disrupts the lipid envelope of HBV, rendering it non-infectious.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hepatitis C Virus (HCV):</strong> HCV is another enveloped virus. The SD process targets and inactivates HCV by disrupting its lipid envelope.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The solvent/detergent (SD) process inactivates lipid-enveloped viruses such as HIV, HBV, and HCV. However, it does not inactivate non-enveloped viruses like Hepatitis A Virus (HAV), making HAV infections a potential risk during SD plasma transfusion.</span></p>",
      "correct_choice_id": 200277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50070,
      "choices": [
        {
          "id": 200280,
          "text": "<p><span style=\"font-size:12.0pt;\">Asbestosis</span></p>"
        },
        {
          "id": 200281,
          "text": "<p><span style=\"font-size:12.0pt;\">Silicosis</span></p>"
        },
        {
          "id": 200282,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
        },
        {
          "id": 200283,
          "text": "<p><span style=\"font-size:12.0pt;\">Mesothelioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient working in a factory presented with lung fibrosis and thickening of pleura. Biopsy was done. Diagnosis from the histopathology picture is?</span> (AIIMS MAY 2018)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/965.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/965.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5211899",
      "question_audio": null,
      "question_video": null,
      "map_id": 34525777,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Asbestosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This clinical scenario and image showing typical asbestos bodies are suggestive of asbestosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Asbestosis is a type of pneumoconiosis associated with asbestos exposure. The disease-causing capabilities of the different forms of asbestos depend on concentration, size, shape, and solubility. This condition is <strong>marked by diffuse pulmonary interstitial fibrosis.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Grossly</strong>, the affected lungs are small and firm with <strong>cartilage-like thickening of the pleura</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-123503.png\" alt=\"\" width=\"600\" height=\"220\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The sectioned surface shows variable degree of pulmonary fibrosis, especially in the<strong> </strong>advanced cases may show cystic changes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Histologically, the following changes are observed:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Non-specific interstitial fibrosis.</span></li><li><span style=\"font-size:12.0pt;\">Presence of characteristic <strong>asbestos bodies</strong> - asbestos fibres coated with glycoprotein and hemosiderin and appear beaded or dumbbell-shaped. The coating <strong>stains positively for Prussian blue reaction.</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note: Asbestos exposure is associated with malignant mesothelioma, </strong>a rare and aggressive cancer of the pleura.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-123702.png\" alt=\"\" width=\"1000\" height=\"213\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-115000.png\" alt=\"\" width=\"400\" height=\"192\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Microscopic appearance</strong> of asbestos body. An asbestos body is an asbestos fibre coated with glycoprotein and hemosiderin giving it beaded or dumbbell – shaped appearance with bulbous ends.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Silicosis</strong>: Another type of pneumoconiosis caused by inhalation of silica dust, but it does not produce asbestos bodies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tuberculosis</strong>: An infectious disease primarily caused by Mycobacterium tuberculosis, characterized by granulomas and caseating necrosis, not by the presence of asbestos bodies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mesothelioma</strong>: While asbestos exposure is a risk factor for mesothelioma, the histological appearance in this case is more indicative of asbestosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Asbestosis </strong>is identified by the presence of characteristic <strong>asbestos bodies</strong> within the lung tissue, which are asbestos fibers coated with glycoproteins and hemosiderin, and it is commonly associated with <strong>asbestos exposure</strong> in occupational settings.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 1309</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-123503.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50071,
      "choices": [
        {
          "id": 200284,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">50</span></p>"
        },
        {
          "id": 200285,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">100</span></p>"
        },
        {
          "id": 200286,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">150</span></p>"
        },
        {
          "id": 200287,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">200</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">While working at a rural health sub-centre, you and a medical intern are analyzing annual infant registration metrics. The intern inquires about the expected annual infant registration rate when a health worker is actively on duty at the sub center. What is the best representation of this rate? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q7155758",
      "question_audio": null,
      "question_video": null,
      "map_id": 34048103,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) 150</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Each year, a total of 150 infants should be enrolled at a sub-centre.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Annual infant population = Total population × % infants in population or expected birth rate</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">The infant population percentage, or the anticipated birth rate, ought to be derived from local data. In cases where a specific local percentage is not accessible, it is approximated at 3% of the overall population.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Total population in a sub centre = 5000.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Here, annual infant population = 5000 × 3/100 = 150</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Total population catered by a Sub centre = 5000</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Crude birth rate (CBR) India = 19 per 1000 Mid-year population (SRS 2016)</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">So, estimated number of births in a year = 19/1000 ×5000 = 95 births per year</span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Also, current Infant mortality rate (IMR) India = 28 per 1000 Live births</span></li><li><span style=\"color:black;font-size:12.0pt;\">So, Expected number of infant deaths in a year in that population = 28/1000 × 95 = 2.7 deaths</span></li><li><span style=\"color:black;font-size:12.0pt;\">So, total number of expected alive infants = 95 – 2.7 = 92 Infants approximately</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In a rural health sub-centre, the expected annual infant registration rate effectively captures both the births and adjustments for infant mortality.</span></li><li><span style=\"font-size:12.0pt;\">The number 150 serves as a practical target for ensuring all newborns are accounted for within the community health system.</span></li><li><span style=\"font-size:12.0pt;\">This figure supports proactive health planning and resource allocation, emphasizing the importance of accurate and timely health data registration.</span></li></ul>",
      "correct_choice_id": 200286,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50072,
      "choices": [
        {
          "id": 200288,
          "text": "<p><span style=\"font-size:12.0pt;\">Hopping on one leg</span></p>"
        },
        {
          "id": 200289,
          "text": "<p><span style=\"font-size:12.0pt;\">Drawing a square</span></p>"
        },
        {
          "id": 200290,
          "text": "<p><span style=\"font-size:12.0pt;\">Feeding by spoon</span></p>"
        },
        {
          "id": 200291,
          "text": "<p><span style=\"font-size:12.0pt;\">Passing a ball to someone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The absence of which of the following milestones in a 3-year-old child is called as developmental delay? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4927186",
      "question_audio": null,
      "question_video": null,
      "map_id": 34897402,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Feeding by spoon</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Feeding with a spoon is a social milestone that typically develops around 18 months of age. If a child is unable to feed themselves with a spoon by 24 months, it can be considered a developmental delay. By the age of 3 years, most children should have well-established self-feeding skills, including the ability to hold and use a spoon effectively.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hopping on one leg</strong>: This milestone typically develops around 4 years of age. It would not be considered a delay if a 3-year-old is unable to hop on one leg.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Drawing a square</strong>: Drawing a square is a fine motor skill that generally develops around 4 and a half years of age, so its absence at 3 years old is not considered a delay.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Passing a ball to someone</strong>: This social and motor skill usually develops around 4 years of age. Therefore, a 3-year-old not being able to pass a ball would not be considered delayed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The absence of feeding with a spoon by 24 months can indicate a developmental delay in social and motor skills in a child.</span></p>",
      "correct_choice_id": 200290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50073,
      "choices": [
        {
          "id": 200292,
          "text": "<p><span style=\"font-size:12.0pt;\">Horizontal nystagmus towards the same side</span></p>"
        },
        {
          "id": 200293,
          "text": "<p><span style=\"font-size:12.0pt;\">Vertical nystagmus towards the same side</span></p>"
        },
        {
          "id": 200294,
          "text": "<p><span style=\"font-size:12.0pt;\">Horizontal nystagmus towards the opposite side</span></p>"
        },
        {
          "id": 200295,
          "text": "<p><span style=\"font-size:12.0pt;\">Vertical nystagmus towards the opposite side</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During the process of conducting a caloric test, what kind of nystagmus should one anticipate when using cold water irrigation?(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9482653",
      "question_audio": null,
      "question_video": null,
      "map_id": 34659293,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Horizontal nystagmus towards the opposite side</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In caloric testing, cold water irrigation produces horizontal nystagmus towards the opposite side.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Fitzgerald-Hallpike test or bithermal caloric test procedure:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Patient is made to lie supine with the head tilted 30° forward so that the horizontal canal is vertical.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture17.jpg\" alt=\"\" width=\"453\" height=\"684\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Irrigation stimulates the lateral/ horizontal semicircular canal which produces horizontal nystagmus.</span></li><li><span style=\"font-size:12.0pt;\">Cold water induces nystagmus to the opposite side and warm water to the same side (remember mnemonic COWS: cold-opposite, warm-same)</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Horizontal nystagmus towards the same side: </strong>This option is incorrect for cold water irrigation. Cold water causes the fluid in the horizontal semicircular canal to move in a way that induces nystagmus towards the opposite side, not the same side.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B. Vertical nystagmus towards the same side and Option D. Vertical nystagmus towards the opposite side: </strong>Vertical nystagmus does not occur in caloric testing, as this test specifically stimulates the horizontal semicircular canal, inducing horizontal nystagmus. Vertical nystagmus is generally associated with different pathologies and is not a result of standard caloric testing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The caloric test, particularly when using cold water, is designed to stimulate the horizontal semicircular canal, resulting in horizontal nystagmus towards the opposite side. This test is critical for evaluating unilateral weaknesses in the vestibular system and helps in diagnosing conditions affecting balance and spatial orientation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, page No. 45</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture17.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50074,
      "choices": [
        {
          "id": 200296,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Placenta membranacea</span></span></span></p>"
        },
        {
          "id": 200297,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Placenta succenturiata</span></span></span></p>"
        },
        {
          "id": 200298,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Circummarginate placenta</span></span></span></p>"
        },
        {
          "id": 200299,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Circumvallate placenta</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A pregnant woman delivered a baby with the normal expulsion of an intact placenta. After half an hour she started bleeding per vaginal. On examination, she was hypotensive, and a boggy mass was palpated per abdomen. Ultrasound showed retained placental tissues. What is the likely diagnosis? </span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q2285417",
      "question_audio": null,
      "question_video": null,
      "map_id": 34832565,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Placenta succenturiate</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">It is mentioned here that the placenta expelled looked normal and intact</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In such a case, if there is a retained component, it could be a succenturiate lobe </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Placenta succenturiata refers to a placenta with an additional lobe/lobes of placental tissue located a few centimeters away.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The ancillary lobes can be associated with complications such as placenta previa, vasa previa, postpartum hemorrhage or infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture3.jpg\" style=\"height:190px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Placenta membranacea: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Placenta membranacea is a rare placental disorder characterized by the presence of fetal membranes (complete or partially) covered by chorionic villi. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Associated with painless vaginal bleeding in the second and third trimester</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This condition can be associated with other placental abnormalities, such as placenta previa or accreta.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Perinatal outcome may include stillbirth, preterm delivery, or neonatal death.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture4.jpg\" style=\"height:224px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Circummarginate placenta: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Uncommon variation in placental morphology in which a thin fibrous ring is present at the margin of the chorionic plate where the fetal vessels appear to terminate.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The placenta is unduly large and thin. The placenta not only develops from the chorion frondosum but also from the chorion laeve so that the whole of the ovum is practically covered by the placenta</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Associated with Abortion, Hydrorrhea gravidarum (excessive watery vaginal discharge), Antepartum hemorrhage, Growth retardation of the baby, Preterm delivery and Retained placenta or membranes.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture5.jpg\" style=\"height:300px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Circumvallate placenta: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The fetal surface is divided into a central depressed zone surrounded by a thickened white ring which is usually complete. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The ring is situated at varying distances from the margin of the placenta. The ring is composed of a double fold of amnion and chorion with degenerated decidua (vera) and fibrin in between </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Vessels radiate from the cord insertion as far as the ring and then disappear from view </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The peripheral zone outside the ring is thicker and the edge is elevated and rounded.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture6.jpg\" style=\"height:252px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Placenta succenturiata is characterized by an additional lobe of placental tissue separate from the main placenta, which can be retained postpartum, leading to hemorrhage and requiring careful monitoring and management.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page 253, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture3.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200297,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50075,
      "choices": [
        {
          "id": 200300,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">From onset of rash to 3 days after rash</span></p>"
        },
        {
          "id": 200301,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">2 weeks before rash to 1 week after rash</span></p>"
        },
        {
          "id": 200302,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">From onset of rash to 5 days after rash</span></p>"
        },
        {
          "id": 200303,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">From catarrhal stage to 4 days after rash</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">In a busy OPD at a District hospital, you are evaluating a 5-year-old boy who presents with fever, generalized malaise, and a distinctive rash. The child's clinical presentation strongly suggests a diagnosis of measles. The mother, anxious about the contagious nature of the disease and the risk it poses to her other kids and family members, inquires about the recommended period of isolation for her infected child. What would be your most appropriate recommendation for the duration of isolation? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3100770",
      "question_audio": null,
      "question_video": null,
      "map_id": 34978778,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) From catarrhal stage to 4 days after rash</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Patient should be advised to stay in isolation from onset of catarrhal stage to 3rd/4th day of rash.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Isolation is the separation for the period of communicability, of infected persons from others in such places/conditions as to prevent/limit transmission to those susceptible.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/disease.jpg\" alt=\"\" width=\"600\" height=\"764\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/disease.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50076,
      "choices": [
        {
          "id": 200304,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage I</span></p>"
        },
        {
          "id": 200305,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II</span></p>"
        },
        {
          "id": 200306,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III</span></p>"
        },
        {
          "id": 200307,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person presents with a tongue ulcer persisting for 3 months. Upon examination, a lesion measuring 3.5 cm x 2.5 cm is observed, accompanied by an 8 mm area of hardened tissue. No lymph node enlargement is detected. According to the 8th AJCC guidelines, what stage does this lesion correspond to? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q8548603",
      "question_audio": null,
      "question_video": null,
      "map_id": 34470319,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Stage II</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In the given case can be classified as <strong>T2N0M0</strong> as per AJCC 2002 as the size of the lesion is between 2-4 cm (T2) with no nodal (N0) or distant metastasis (M0) and that will come under Stage II disease.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-163941.png\" alt=\"\" width=\"800\" height=\"634\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stage I:</strong> This stage would be applicable for T1 tumors, which are 2 cm or less in greatest dimension, and does not fit the description of the lesion presented.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stage III:</strong> This stage would involve either T3 tumors, which are greater than 4 cm, or any T1-T3 tumors with N1 lymph node involvement, neither of which applies to this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Stage IV:</strong> This stage is reserved for more advanced disease involving T4 tumors, any tumor with N2 or N3 lymph node involvement, or distant metastasis (M1), which are not applicable in this scenario.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/How%20to%20use%20the%20App%20-%20Copy.png\" width=\"844\" height=\"720\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition pg 256</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-163941.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50077,
      "choices": [
        {
          "id": 200308,
          "text": "<p><span style=\"font-size:12.0pt;\">Juvenile myoclonic epilepsy</span></p>"
        },
        {
          "id": 200309,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical absence</span></p>"
        },
        {
          "id": 200310,
          "text": "<p><span style=\"font-size:12.0pt;\">Choreo-athetoid epilepsy</span></p>"
        },
        {
          "id": 200311,
          "text": "<p><span style=\"font-size:12.0pt;\">Centrotemporal spikes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An adolescent girl complains of dropping objects from hands precipitated during morning hours and exams. There is no history of loss of consciousness. One of her cousins has been diagnosed with epilepsy. EEG was suggestive of epileptic spikes. What is the most probable diagnosis? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q8452636",
      "question_audio": null,
      "question_video": null,
      "map_id": 34321280,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Juvenile myoclonic epilepsy</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The clinical presentation described is consistent with <strong>Juvenile Myoclonic Epilepsy (JME)</strong>. JME is characterized by <strong>myoclonic jerks</strong>, which are sudden, brief, involuntary muscle contractions typically involving both arms. These jerks are most frequent in the morning, often leading to the dropping of objects, as described in this case. The patient maintains consciousness during these episodes, which is typical for JME.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Factors supporting the diagnosis:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Myoclonic jerks: </strong>The hallmark seizure type in JME, often occurring shortly after waking up in the morning.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Maintained consciousness: </strong>The patient remains aware during the myoclonic jerks.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Triggers: </strong>Seizures can be triggered by stimuli such as sleep deprivation, stress, and photic stimulation (e.g., flashing lights).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Genetics: </strong>A mutation in the <strong>GABRA1</strong> gene is associated with JME.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment: </strong>Sodium valproate is the drug of choice.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prognosis: </strong>Generally good with appropriate treatment.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atypical absence:</strong> Absence seizures are characterized by brief lapses in consciousness without motor symptoms like dropping objects. Atypical absences last longer than typical ones and have slower onset and resolution.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Choreo-athetoid epilepsy:</strong> This condition involves <strong>involuntary irregular movements</strong> of the face, head, trunk, and extremities, which does not align with the symptoms described in this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Centrotemporal spikes:</strong> Benign Epilepsy with Centrotemporal Spikes (BECTS), also known as Rolandic epilepsy, involves brief stereotypical partial seizures, typically with facial and oropharyngeal involvement, not consistent with the symptomatology in this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Juvenile Myoclonic Epilepsy (JME) is characterized by myoclonic jerks, typically occurring in the morning, with preserved consciousness and a good response to sodium valproate.</span></p>",
      "correct_choice_id": 200308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50078,
      "choices": [
        {
          "id": 200312,
          "text": "<p><span style=\"font-size:12.0pt;\">Cadherin</span></p>"
        },
        {
          "id": 200313,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitronectin</span></p>"
        },
        {
          "id": 200314,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibronectin</span></p>"
        },
        {
          "id": 200315,
          "text": "<p><span style=\"font-size:12.0pt;\">Selectin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#040c28;font-size:12.0pt;\">Which of the following is high-molecular weight glycoprotein of the extracellular matrix that binds to integrins? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q9790339",
      "question_audio": null,
      "question_video": null,
      "map_id": 34888109,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Fibronectin</strong></span></p><p> </p><p><span style=\"color:#040c28;font-size:12.0pt;\">Fibronectin is a high-molecular weight (~500-~600 kDa) glycoprotein of the extracellular matrix that binds to membrane-spanning receptor proteins called integrins</span><span style=\"background-color:white;color:#4d5156;font-size:12.0pt;\">.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Integrins are cell surface receptors that play a crucial role in connecting cells to their extracellular environment, including other cells and the extracellular matrix (ECM). Integrins can connect with several types of molecules and proteins, including:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Extracellular Matrix (ECM) Proteins: </strong>Integrins can bind to various components of the ECM, such as fibronectin, laminin, collagen, and vitronectin. These interactions allow cells to anchor to the ECM and provide structural support.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cell Adhesion Molecules: </strong>Integrins can connect with other cell adhesion molecules on neighbouring cells, promoting cell-cell interactions and the formation of multicellular structures. Examples of cell adhesion molecules include cadherins, selectins, and immunoglobulin superfamily proteins.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Signalling Proteins: </strong>Integrins can also associate with intracellular signalling proteins, such as focal adhesion kinases (FAK), Src family kinases, and various adapter proteins. These interactions transmit signals from the ECM to the cell's interior, influencing cellular processes like cell growth, migration, and differentiation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Blood Clotting Factors: </strong>In platelets, integrins can bind to fibrinogen and von Willebrand factor, contributing to platelet aggregation and blood clot formation.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cadherin: </strong>Involved in calcium-dependent cell-cell adhesion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vitronectin: </strong>Also a part of the extracellular matrix but known for its role in serum spreading factor and in the promotion of cell adhesion and spreading.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Selectin: </strong>Plays a role in cell adhesion during the immune response, particularly in the binding of white blood cells to the endothelium.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fibronectin is a key component of the extracellular matrix that interacts with cell surface integrins to mediate various cellular processes including adhesion, migration, and tissue repair.</span></p>",
      "correct_choice_id": 200314,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50079,
      "choices": [
        {
          "id": 200316,
          "text": "<p><span style=\"font-size:12pt;\">Elevated B-hCG, PAPP-A and lower estriol, AFP</span></p>"
        },
        {
          "id": 200317,
          "text": "<p><span style=\"font-size:12pt;\">Elevated B-hCG, Inhibin and lower estriol, AFP</span></p>"
        },
        {
          "id": 200318,
          "text": "<p><span style=\"font-size:12pt;\">Lower -CG, PAPP-A and elevated estriol, AFP</span></p>"
        },
        {
          "id": 200319,
          "text": "<p><span style=\"font-size:12pt;\">Lower B-hCG, Inhibin and elevated estriol, AFP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following changes can be seen in the quadruple screening for Down syndrome? </span>(INICET MAY 2018)</p>",
      "unique_key": "Q6415728",
      "question_audio": null,
      "question_video": null,
      "map_id": 34771490,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Elevated B-hCG, Inhibin and lower estriol, AFP</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The triple and quadruple test is done between 15 – 21 weeks.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Components of Triple test are: Free β hCG, unconjugated Estriol (uE3) and Maternal Serum α-fetoprotein.</span></li><li><span style=\"font-size:12pt;\">Components of the Quadruple test are: Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein. And Inhibin A.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-152106.jpg\" alt=\"\" width=\"1000\" height=\"198\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Easy to remember</strong>: <strong>B</strong> for <strong>B</strong>ig; so in Down’s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Elevated B-hCG, PAPP-A and lower estriol, AFP:</strong> This combination is not correct as PAPP-A is not part of the quadruple test and it typically decreases in Down syndrome.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Lower B-hCG, PAPP-A and elevated estriol, AFP:</strong> This combination is not correct for Down syndrome. β hCG and Inhibin A are elevated in Down syndrome.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Lower B-hCG, Inhibin and elevated estriol, AFP:</strong> This combination is not correct for Down syndrome. β hCG and Inhibin A are elevated in Down syndrome.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In Down syndrome (Trisomy 21), the quadruple test shows elevated β hCG and Inhibin A, and decreased AFP and uE3.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 863, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-152106.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200317,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50080,
      "choices": [
        {
          "id": 200320,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrogen peroxide</span></p>"
        },
        {
          "id": 200321,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethylene oxide</span></p>"
        },
        {
          "id": 200322,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma rays</span></p>"
        },
        {
          "id": 200323,
          "text": "<p><span style=\"font-size:12.0pt;\">UV rays</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Plasma sterilization makes use of: (INICET MAY 2018)</span></p>",
      "unique_key": "Q9874158",
      "question_audio": null,
      "question_video": null,
      "map_id": 34150156,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hydrogen peroxide</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A variety of hydrogen peroxide gas-based processes that use plasma as part of the sterilization process are known as \"plasma sterilization.\"</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The sterilization chamber is evacuated and hydrogen peroxide solution is injected from a cassette and is vaporized in the sterilization chamber to a concentration of 6 mg/l. The hydrogen peroxide vapor diffuses through the chamber (50 minutes), exposes all surfaces of the load to the sterilant, and initiates the inactivation of microorganisms. An electrical field created by a radio frequency is applied to the chamber to create a gas plasma. Microbicidal free radicals (e.g., hydroxyl and hydroperoxyl) are generated in the plasma. The excess gas is removed and in the final stage (i.e., vent) of the process the sterilization chamber is returned to atmospheric pressure by introduction of high-efficiency filtered air. The by-products of the cycle (e.g., water vapor, oxygen) are nontoxic and eliminate the need for aeration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-183_MZDVDBa.jpg\" alt=\"\" width=\"500\" height=\"313\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span><strong>:</strong></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ethylene oxide:</strong> Ethylene oxide is a gas used for sterilization, particularly for items that cannot withstand high temperatures. It is not used in plasma sterilization.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gamma rays:</strong> Gamma rays are used for radiation sterilization, a different method that utilizes high-energy photons to sterilize equipment. They are not involved in plasma sterilization.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. UV rays:</strong> UV rays are used for surface sterilization and disinfection. They are not part of the plasma sterilization process.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span><strong>:</strong></p><p> </p><p><span style=\"font-size:12.0pt;\">Plasma sterilization makes use of hydrogen peroxide vapor, which is activated into a plasma state by an electrical field, generating microbicidal free radicals that effectively inactivate microorganisms. This method is efficient and leaves nontoxic by-products, making it suitable for sterilizing sensitive medical and laboratory equipment.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-183_MZDVDBa.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200320,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50081,
      "choices": [
        {
          "id": 200324,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Skimmed Milk</span></span></span></span></p>"
        },
        {
          "id": 200325,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Condensed Milk</span></span></span></span></p>"
        },
        {
          "id": 200326,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ice-cream</span></span></span></span></p>"
        },
        {
          "id": 200327,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Yogurt</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 22-year-old man presented with diarrhea and intolerance to dairy products. On investigation, he was found to have a lactase deficiency. Which of the following agents is least likely to cause symptoms of lactose intolerance? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q5664827",
      "question_audio": null,
      "question_video": null,
      "map_id": 34701600,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Yogurt</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Yogurt is the least likely to cause symptoms of lactose intolerance among the options listed. This is because yogurt contains live bacteria, specifically lactobacilli, which help to break down lactose. This fermentation process reduces the lactose content significantly, making yogurt easier to digest for individuals with lactase deficiency. Additionally, these bacteria can contribute to the production of some lactase enzyme, aiding in the digestion of any remaining lactose.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Skimmed Milk: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Contains nearly the same amount of lactose as regular milk, just with less fat. It is likely to cause symptoms in someone with lactose intolerance.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Condensed Milk: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Even higher in lactose because it is milk that has been concentrated by removing water. High lactose content makes it more likely to cause intolerance symptoms.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Ice-cream: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Typically high in lactose because it is made from cream and milk, both of which are high in lactose. Ice cream can also contain mix-ins and flavorings that increase the lactose content.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Yogurt contains lactobacillus, that helps in lactase production and also low lactose levels.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reference - Harrison/Gastroenterology/Diarrhea/chap 471</span></span></strong></span></span></p>",
      "correct_choice_id": 200327,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50082,
      "choices": [
        {
          "id": 200328,
          "text": "<p><span style=\"font-size:12.0pt;\">Vas deferens</span></p>"
        },
        {
          "id": 200329,
          "text": "<p><span style=\"font-size:12.0pt;\">Peritoneal Reflection</span></p>"
        },
        {
          "id": 200330,
          "text": "<p><span style=\"font-size:12.0pt;\">Iliopubic tract</span></p>"
        },
        {
          "id": 200331,
          "text": "<p><span style=\"font-size:12.0pt;\">Spermatic vessels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a boundary of the triangle of doom? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5422712",
      "question_audio": null,
      "question_video": null,
      "map_id": 34701205,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Iliopubic tract</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Iliopubic tract does not form a boundary of the triangle of doom.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Iliopubic tract is <strong>not</strong> a boundary of the Triangle of Doom. It is not directly associated with this anatomical region. It forms the lateral boundary of triangle of pain</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vas deferens</strong>: It runs medially and is considered one of the key landmarks in this anatomical region.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Peritoneal Reflection</strong>: It forms the inferior boundary of this anatomical triangle.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Spermatic vessels</strong>: The spermatic vessels are one of the boundaries of the Triangle of Doom. They are located laterally and are an important landmark in this anatomical triangle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The triangle of doom is bounded-</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Medially by the vas deferens</span></li><li><span style=\"font-size:12.0pt;\">Laterally by the vessels of the spermatic cord</span></li><li><span style=\"font-size:12.0pt;\">Inferiorly by peritoneal reflection</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Apex is oriented superiorly at the internal ring</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The contents of the space are-</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">External iliac vessels</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note: </strong>Staples must be avoided in this region during hernia repair due to the risk of injury to the vessels which might cause severe hemorrhage.</span></p>",
      "correct_choice_id": 200330,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50083,
      "choices": [
        {
          "id": 200332,
          "text": "<p><span style=\"font-size:12.0pt;\">Wernicke's area</span></p>"
        },
        {
          "id": 200333,
          "text": "<p><span style=\"font-size:12.0pt;\">Broca's area</span></p>"
        },
        {
          "id": 200334,
          "text": "<p><span style=\"font-size:12.0pt;\">Heschl's gyrus</span></p>"
        },
        {
          "id": 200335,
          "text": "<p><span style=\"font-size:12.0pt;\">Striate area</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents to you with inability to form words but can make noises. He also knows what he wants to say. What area of the brain has been damaged in this patient? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p>",
      "unique_key": "Q3477941",
      "question_audio": null,
      "question_video": null,
      "map_id": 34052405,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Broca's area</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Broca's area (areas 44, 45) in this patient is damaged. This is located in the posterior part of the frontal lobe, usually in the dominant hemisphere (the left hemisphere in most right-handed individuals).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Broca’s area is critical for speech production and grammar processing. Damage to Broca's area results in expressive or non-fluent aphasia. Patients typically understand spoken language and know what they want to say but struggle to form words or construct sentences. Their speech might be slow, with a struggle to find the right words, and they might omit small connecting words like \"is\" or \"the.\"</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Wernicke's Area</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Location</strong>: This area is located in the posterior part of the superior temporal gyrus in the dominant cerebral hemisphere, which is the left hemisphere in about 95% of right-handed individuals and 70% of left-handed individuals.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Wernicke's area is involved in language comprehension. Damage to this area results in receptive aphasia. Patients can produce speech, but it often lacks meaning, and they have difficulty understanding spoken or written language. Their speech might be fluent, but it's usually nonsensical or includes made-up words.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Heschl's Gyrus</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Location</strong>: Located in the primary auditory cortex within the Sylvian fissure in the temporal lobe.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Heschl's gyrus is responsible for primary auditory processing, meaning it processes incoming auditory information. Damage to this area might impair the ability to perceive sounds.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Striate Area</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Location</strong>: Located in the primary visual cortex in the occipital lobe.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: The striate area (or V1) is the primary processing center for visual information. Damage to this area can lead to blindness or partial visual field deficits depending on the extent and location of the injury.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-8.jpg\" alt=\"\" width=\"600\" height=\"295\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200333,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50084,
      "choices": [
        {
          "id": 200336,
          "text": "<p><span style=\"font-size:12.0pt;\">Dialysis port</span></p>"
        },
        {
          "id": 200337,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemoport</span></p>"
        },
        {
          "id": 200338,
          "text": "<p><span style=\"font-size:12.0pt;\">Electro-convulsive therapy lead</span></p>"
        },
        {
          "id": 200339,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma camera</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the device given below.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150437.jpg\" width=\"732\" height=\"425\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150437.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6182767",
      "question_audio": null,
      "question_video": null,
      "map_id": 34402181,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chemoport</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows a chemoport. Chemoports are implantable venous access devices specifically designed to facilitate the administration of chemotherapy in patients. These devices allow for repeated access to the venous system, making them suitable for long-term use in cancer treatment. They are implanted under the skin, typically in the chest area, with the catheter inserted into large veins, commonly the internal jugular or subclavian veins. The device remains in place for 1 to 2 years or longer, depending on the treatment requirements, and is later explanted once it is no longer needed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dialysis port</strong>: A dialysis port is a device used to provide vascular access for hemodialysis. It has a different design and is intended specifically for dialysis treatments rather than chemotherapy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150449.jpg\" width=\"691\" height=\"292\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Electro-convulsive therapy lead</strong> : This lead is used in electroconvulsive therapy (ECT) to deliver electric currents to the brain for therapeutic purposes in certain psychiatric conditions. It has no use in chemotherapy administration or venous access.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150459.jpg\" width=\"512\" height=\"390\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gamma camera</strong> : A gamma camera is a diagnostic imaging device used in nuclear medicine to visualize the distribution of radioactive tracers in the body. It is not an implantable device and has no function in delivering chemotherapy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150517.jpg\" width=\"699\" height=\"398\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A chemoport is an implantable venous access device used for administering chemotherapy, commonly placed in large veins like the internal jugular or subclavian veins.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150449.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200337,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50085,
      "choices": [
        {
          "id": 200340,
          "text": "<p><span style=\"font-size:12.0pt;\">Deep branch of ulnar nerve</span></p>"
        },
        {
          "id": 200341,
          "text": "<p><span style=\"font-size:12.0pt;\">Median Nerve</span></p>"
        },
        {
          "id": 200342,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior interosseous nerve</span></p>"
        },
        {
          "id": 200343,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior interosseous nerve</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Loss of flexion at the interphalangeal joint of thumb after supracondylar fracture is due to the involvement of? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q2850349",
      "question_audio": null,
      "question_video": null,
      "map_id": 34779201,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Anterior interosseous nerve</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Loss of flexion at the interphalangeal (IP) joint of the thumb, is due to the involvement of the anterior interosseous nerve (AIN). This is a branch of the median nerve. It runs down the forearm along with the anterior interosseous artery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It supplies the deep muscles of the anterior (flexor) compartment of the forearm. Specifically, it provides innervation to the flexor pollicis longus (which flexes the interphalangeal joint of the thumb), the radial half of the flexor digitorum profundus, and the pronator quadratus. Injury to this nerve can lead to the inability to flex the interphalangeal joint of the thumb and the distal phalanges of the index and middle fingers, leading to the characteristic \"pinch sign\" or \"OK sign\" presentation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-11.jpg\" alt=\"\" width=\"300\" height=\"497\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Deep Branch of Ulnar Nerve</strong>: It arises from the ulnar nerve after it passes the flexor retinaculum in the wrist. The deep branch is mainly motor in function.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This nerve supplies the hypothenar muscles (muscles of the little finger), the ulnar two lumbricals, all the interossei (both palmar and dorsal), and adductor pollicis. It does not have any role in the flexion of the interphalangeal joint of the thumb.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Median Nerve</strong>: This nerve originates from both the medial and lateral cords of the brachial plexus. It travels down the arm and forearm and goes through the carpal tunnel at the wrist.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It supplies most of the flexors in the forearm and several muscles in the hand, including the thenar muscles (muscles of the thumb). But the flexion at the interphalangeal joint of the thumb is more specifically due to the anterior interosseous branch of the median nerve, not the main trunk of the median nerve.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Posterior Interosseous Nerve</strong>: It is a continuation of the deep branch of the radial nerve. It travels in the forearm between the superficial and deep layers of muscles.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This nerve supplies the extensor muscles of the wrist and fingers. It's not involved in flexion movements and hence, not responsible for the flexion of the interphalangeal joint of the thumb.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Flexion of thumb occurs at 2 joints:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">IP joint: Flexor pollicis longs (FPL) supplied by the anterior interosseous nerve (a branch of the median nerve, C7 and C8).</span></li><li><span style=\"font-size:12.0pt;\">MCP joint: Flexor pollicis brevis (FPB supplied by the recurrent motor branch of the median nerve.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Most commonly injured nerve in SCH fracture: <strong>AIN > Median > Radial > Ulnar (AMRU)</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Deep branch of ulnar nerve → ulnar claw hand</span></li><li><span style=\"font-size:12.0pt;\">Posterior interosseous nerve → innervates the extensor muscles of the wrist and fingers. Weakness or paralysis of these muscles can cause difficulty in extending the wrist and fingers</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-11.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50086,
      "choices": [
        {
          "id": 200344,
          "text": "<p><span style=\"font-size:12pt;\">Uterotonic within 1 minute of delivery</span></p>"
        },
        {
          "id": 200345,
          "text": "<p><span style=\"font-size:12pt;\">Delayed clamping, cutting and ligation of cord</span></p>"
        },
        {
          "id": 200346,
          "text": "<p><span style=\"font-size:12pt;\">Gentle massage of uterus</span></p>"
        },
        {
          "id": 200347,
          "text": "<p><span style=\"font-size:12pt;\">Controlled cord traction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not included in the active management of the third stage of labor to prevent post-partum hemorrhage? </span>(INICET MAY 2018)</p>",
      "unique_key": "Q5345752",
      "question_audio": null,
      "question_video": null,
      "map_id": 34247628,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Gentle massage of uterus</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>AMTSL</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Purpose</strong>: To prevent <strong>postpartum hemorrhage (PPH)</strong>, a major cause of maternal death.</span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Give a uterotonic drug</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Oxytocin 10 IU IM</strong> immediately after the birth of the baby</span></li><li><span style=\"font-size:16px;\">This helps the uterus contract and reduce bleeding</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Controlled Cord Traction (CCT)</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Gently pull the umbilical cord while supporting the uterus to help deliver the placenta</span></li><li><span style=\"font-size:16px;\">Only if trained and placenta is ready to come</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Intermittent uterine tone assessment</strong></span></li></ol><p> </p><p><span style=\"font-size:16px;\"><strong>Delayed cord clamping</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Wait 1–3 minutes before clamping the umbilical cord</span></li><li><span style=\"font-size:16px;\">Improves baby’s iron stores and reduces anemia</span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Uterotonic within 1 minute of delivery:</strong> This is a critical step in AMTSL to prevent PPH by promoting uterine contractions.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Delayed clamping, cutting and ligation of cord:</strong> Delayed cord clamping (after 1 to 3 minutes) is recommended for all births to enhance neonatal outcomes</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Controlled cord traction:</strong> This is a part of AMTSL to aid in the delivery of the placenta.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The active management of the third stage of labor includes the administration of a uterotonic, controlled cord traction, and assessing uterine tone rather than sustained uterine massage for all women who have received a uterotonic.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Ref: </strong></span><a href=\"https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1\"><span style=\"font-size:16px;\"><strong><u>https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1</u></strong></span></a></p>",
      "correct_choice_id": 200346,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50087,
      "choices": [
        {
          "id": 200348,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pulmonary TB</span></p>"
        },
        {
          "id": 200349,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">CNS and disseminated TB</span></p>"
        },
        {
          "id": 200350,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pulmonary and CNS TB</span></p>"
        },
        {
          "id": 200351,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pulmonary and skeletal TB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are counseling a new mother about the importance of immunization for her newborn. She is particularly interested in understanding the BCG vaccine's benefits, as she has heard conflicting opinions from friends and family. Based on current evidence and guidelines, which of the following best describes the primary protective effects of the BCG vaccine in the context of tuberculosis (TB)? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4065219",
      "question_audio": null,
      "question_video": null,
      "map_id": 34555201,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) CNS and disseminated TB </strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">BCG vaccine provides protection against CNS and disseminated TB.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>BCG Vaccine</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">LIVE, Attenuated, Lyophilised vaccine</span></li><li><span style=\"color:black;font-size:12.0pt;\">Reconstituent – NORMAL SALINE</span></li><li><span style=\"color:black;font-size:12.0pt;\">Strain DANISH–1331 (VIA M. BOVIS, 239 SC FOR 13 YR)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Dose 0.05 (upto 28 days, then 0.1 ml) ID, just above insertion of left deltoid</span></li><li><span style=\"color:black;font-size:12.0pt;\">Efficacy 0-80% (MEDIAN-50%)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Dose at birth, 1 TU in 0.1 ml</span></li><li><span style=\"color:black;font-size:12.0pt;\">20 years protection {No protection against pulmonary TB}</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture9222.jpg\" alt=\"\" width=\"200\" height=\"341\"></span></p><p> </p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The BCG vaccine is primarily recommended for its effectiveness in preventing severe forms of tuberculosis, such as CNS and disseminated TB, in children.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture9222.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50088,
      "choices": [
        {
          "id": 200352,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate nucleus</span></p>"
        },
        {
          "id": 200353,
          "text": "<p><span style=\"font-size:12.0pt;\">Lentiform nucleus</span></p>"
        },
        {
          "id": 200354,
          "text": "<p><span style=\"font-size:12.0pt;\">Dentate nucleus</span></p>"
        },
        {
          "id": 200355,
          "text": "<p><span style=\"font-size:12.0pt;\">Red nucleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Purkinje cells of cerebellum relay into: (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4539861",
      "question_audio": null,
      "question_video": null,
      "map_id": 34040764,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Dentate nucleus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The cerebellum's purkinje cells relay information to the dentate nucleus, one of the deep cerebellar nuclei.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It is the cerebellum's distinguishing cell. It is a large flask-shaped cell. Climbing fibres from the inferior olivary nucleus stimulate it. This cell's main output is inhibitory in nature and is directed at cerebellar nuclei. These are the most important output neurons.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-12.jpg\" alt=\"\" width=\"500\" height=\"280\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Caudate Nucleus</strong>: It's one of the structures that make up the basal ganglia in the brain. The caudate nucleus has a long, C-shaped structure and is located laterally in the brain, near the lateral ventricles. It plays roles in various functions like voluntary movement control, learning, memory, and emotion. Purkinje cells do not primarily relay into the caudate nucleus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Lentiform Nucleus</strong>: Another component of the basal ganglia, the lentiform nucleus is located deep within the brain and is laterally placed in relation to the thalamus. The lentiform nucleus is made up of two structures: the putamen and the globus pallidus. It's involved in movement regulation and other functions. Purkinje cells do not have a direct relay into the lentiform nucleus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Red Nucleus</strong>: Found in the midbrain, the red nucleus has a reddish hue due to its rich blood supply and the presence of iron. It plays a role in motor coordination, particularly in the coordination of limb movements. While the red nucleus does receive input from the cerebellum, the primary relay from Purkinje cells is to the deep cerebellar nuclei, not directly to the red nucleus. The dentate nucleus, in turn, can send projections to the red nucleus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Dentate Nucleus</strong> is one of the deep cerebellar nuclei and is situated within the white matter of the cerebellum. The dentate nucleus is the largest of the deep cerebellar nuclei and plays a role in the planning, initiation, and control of voluntary movements.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Purkinje cells in the cerebellar cortex send inhibitory projections to the deep cerebellar nuclei, including the dentate nucleus. This is the main output pathway for the cerebellar cortex.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-12.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50089,
      "choices": [
        {
          "id": 200356,
          "text": "<p><span style=\"font-size:12.0pt;\">Lipids without MHC proteins</span></p>"
        },
        {
          "id": 200357,
          "text": "<p><span style=\"font-size:12.0pt;\">Peptides with MHC proteins</span></p>"
        },
        {
          "id": 200358,
          "text": "<p><span style=\"font-size:12.0pt;\">CD20</span></p>"
        },
        {
          "id": 200359,
          "text": "<p><span style=\"font-size:12.0pt;\">CD3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Gamma delta T cell receptors (γδ TCRs) recognizes? </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q8435069",
      "question_audio": null,
      "question_video": null,
      "map_id": 34847506,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Lipids without MHC proteins</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">A small population of mature T cells expresses a type of TCR composed of γ and δ polypeptide chains. <strong>The γδ TCR recognizes peptides, lipids, and small molecules, without a requirement for display by MHC proteins</strong>. γδ T cells tend to aggregate at epithelial surfaces, such as the skin and mucosa of the gastrointestinal and urogenital tracts, suggesting that these cells are sentinels that protect against microbes that try to enter through epithelia</span></li><li><span style=\"font-size:12.0pt;\"><strong>The αβ TCR recognizes peptide antigens that are displayed by major histocompatibility complex (MHC. molecules on the surfaces of antigen-presenting cells (APCs).</strong> By limiting the specificity of T cells for peptides displayed by cell surface MHC molecules, <strong>called MHC restriction</strong>, the immune system ensures that T cells see only cell-associated antigens (e.g., those derived from microbes in cells).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Peptides with MHC proteins</strong>: This is characteristic of <strong>αβ TCRs</strong>, not γδ TCRs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CD20</strong>: CD20 is a B cell marker, not a target recognized by T cell receptors.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CD3</strong>: CD3 is a signaling molecule associated with the T cell receptor complex but is not a specific target recognized by the TCR itself.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Gamma delta T cell receptors (γδ TCRs) </strong>are unique in that they can recognize <strong>lipids and other molecules without the need for MHC protein presentation</strong>, distinguishing them from the more common αβ T cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8th edition pg 353</strong></span></p>",
      "correct_choice_id": 200356,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50090,
      "choices": [
        {
          "id": 200360,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿A-Corpus Callosum</span></p>"
        },
        {
          "id": 200361,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿C-Hypothalamus</span></p>"
        },
        {
          "id": 200362,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿B-Pituitary gland</span></p>"
        },
        {
          "id": 200363,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿D-Cerebellum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the wrongly marked structure in the diagram? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture3_1r7skAE.jpg\" alt=\"\" width=\"300\" height=\"228\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture3_1r7skAE.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8725521",
      "question_audio": null,
      "question_video": null,
      "map_id": 34181192,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. C-Hypothalamus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows the midsagittal section of the brain. The wrongly marked structure is C-hypothalamus. The structure marked as C corresponds to the thalamus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-10.jpg\" alt=\"\" width=\"700\" height=\"351\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Corpus Callosum</strong>: It's a large white matter structure found deep within the brain, lying superiorly to the thalamus and under the cortex. It connects the two cerebral hemispheres.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The primary purpose of the corpus callosum is to integrate motor, sensory, and cognitive performances between the cerebral cortex on one side of the brain to the same region on the other side. Essentially, it allows for communication between the two hemispheres of the brain.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Pituitary Gland</strong>: It is a pea-sized structure that's located at the base of the brain, right below the hypothalamus.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Often referred to as the \"master gland,\" the pituitary gland secretes hormones that control several other endocrine glands. It has an anterior and posterior portion, each releasing specific hormones. These hormones regulate various physiological processes, including growth, reproductive cycles, and stress response.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Cerebellum</strong>: Located at the ventral part of the brain, below the occipital lobes and posterior to the brainstem.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The cerebellum is primarily responsible for coordination and fine-tuning of motor movements. It also plays roles in posture and balance, and there is increasing evidence that it's involved in cognitive functions and emotion regulation.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hypothalamus is situated at the base of the brain, just below the thalamus and right above the pituitary gland. This plays a crucial role in many important functions, including releasing hormones, regulating body temperature, maintaining daily physiological cycles, controlling appetite, managing of sexual behavior, and responding to the feeling of being full (eating).</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-10.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50091,
      "choices": [
        {
          "id": 200364,
          "text": "<p><span style=\"font-size:16px;\">HBsAg, IgM anti-HBc, Anti-HCV, Anti HEV</span></p>"
        },
        {
          "id": 200365,
          "text": "<p><span style=\"font-size:16px;\">Anti-HAV, HBsAg, IgM anti-HBc, Anti-HCV</span></p>"
        },
        {
          "id": 200366,
          "text": "<p><span style=\"font-size:16px;\">HBsAg, IgM anti-HBc, Anti-HDV, Anti-HEV, Anti-HCV</span></p>"
        },
        {
          "id": 200367,
          "text": "<p><span style=\"font-size:16px;\">Anti-HAV, IgM anti-HBc, Anti-HCV, Anti-HEV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 40-year-old male chronic smoker presents to the AIIMS OPD with fever, fatigue, yellow-colored urine, and RUQ pain. For the past few days, he has developed an aversion to eating food. On examination icterus was present. What investigations would you advise to rule out acute viral hepatitis? (AIIMS MAY 2018)</span></p><p><br><span style=\"font-size:16px;\">Liver function test results are given below:</span></p><p> </p><ul><li><span style=\"font-size:16px;\">Total Bilirubin 18.5</span></li><li><span style=\"font-size:16px;\">Direct Bilirubin 10.5   </span></li><li><span style=\"font-size:16px;\">SGOT/AST 723</span></li><li><span style=\"font-size:16px;\">SGPT/ALT 812</span></li></ul>",
      "unique_key": "Q6566010",
      "question_audio": null,
      "question_video": null,
      "map_id": 34953688,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Anti-HAV, HBsAg, IgM anti-HBc, Anti-HCV</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Above history is suggestive of acute viral hepatitis with ALT>AST and elevated >10X times. With resolution of symptoms jaundice gradually increases and spontaneously improves.</span></p><p> </p><p><span style=\"font-size:16px;\">Common causes of AST, ALT > 10X are Viral Hepatitis (B, A, C-rare, E-In pregnancy/Post-transplant), Toxins, Shock liver, Fulminant Wilsons.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. </strong>Anti-HEV testing routinely not employed</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. </strong>Hepatitis D usually causes severe disease when B+D coinfection occurs.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. </strong>HbsAg is first test of hep B infection W/IgM HbC suggest FLARE, window period, acute infection.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">In cases of suspected acute viral hepatitis with significant liver enzyme elevation and icterus, it's essential to conduct a thorough serological evaluation to determine the specific type of hepatitis virus involved. This allows for targeted management and appropriate precautions to prevent transmission.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Reference: Harrison/gastroenterology/Viral Hepatitis/Chap 339</strong></span></p>",
      "correct_choice_id": 200365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50092,
      "choices": [
        {
          "id": 200368,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital glaucoma</span></p>"
        },
        {
          "id": 200369,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Retinoblastoma</span></p>"
        },
        {
          "id": 200370,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Congenital hereditary endothelial dystrophy</span></p>"
        },
        {
          "id": 200371,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Megalocornea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The child in the picture has large corneas, photophobia, and lacrimation. What is the likely diagnosis? (</span>AIIMS May 2018)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture6_xZp1Uzt.jpg\" alt=\"\" width=\"400\" height=\"166\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture6_xZp1Uzt.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1856346",
      "question_audio": null,
      "question_video": null,
      "map_id": 34952741,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Congenital glaucoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture8_uXBfm5X.jpg\" alt=\"\" width=\"700\" height=\"264\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The clinical history of inability to open eyes in light (photophobia), excessive watering, and hazy cornea, along with the image suggests a diagnosis of congenital glaucoma.</span></li><li><span style=\"font-size:12.0pt;\">Primary congenital glaucoma is abnormally high intraocular pressure due to a developmental anomaly of the anterior chamber angle.</span></li><li><span style=\"font-size:12.0pt;\">Classification:</span><ol><li><span style=\"font-size:12.0pt;\"><strong>True congenital glaucoma:</strong> IOP raised at birth.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Infantile glaucoma:</strong> Disease manifests before 3 years of age.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Juvenile glaucoma:</strong> IOP rises between 3-16 years of age.</span></li></ol></li><li><span style=\"font-size:12.0pt;\">CYP1B1 gene is implicated in the pathogenesis.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-153026.png\" alt=\"\" width=\"500\" height=\"476\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Diagnostic features:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Corneal haze</strong> due to diffuse edema from elevated IOP</span></li><li><span style=\"font-size:12.0pt;\"><strong>Buphthalmos</strong> from stretching before the age of 3 years</span></li><li><span style=\"font-size:12.0pt;\"><strong>Haab striae </strong>and <strong>corneal</strong> <strong>scarring</strong> can occur.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Evaluation:</span><ul><li><span style=\"font-size:12.0pt;\">IOP measurement</span></li><li><span style=\"font-size:12.0pt;\">Corneal diameter measurement</span></li><li><span style=\"font-size:12.0pt;\">Gonioscopy</span></li><li><span style=\"font-size:12.0pt;\">Ophthalmoscopy</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Management </span><ul><li><span style=\"font-size:12.0pt;\">Surgical with goniotomy or trabeculotomy</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Goniotomy</strong>: to remove obstructed tissue in the eye's drainage system.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Trabeculotomy</strong>: creates a drainage opening in the eye's trabecular meshwork.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">If unsuccessful: trabeculectomy, tube shunt implantation, and ciliary body ablative procedures are performed.</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Trabeculectomy</strong>: creates a new drainage channel for aqueous humor.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tube shunt implantation</strong>: involves placing a small tube in the eye to drain excess fluid.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ciliary body ablative procedures</strong>: destroy the ciliary body to reduce the production of aqueous humor.</span></li></ul></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Retinoblastoma:</strong> A cancer that would show more than simple enlargement of the corneas, typically presenting with a white pupillary reflex (leukocoria).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congenital hereditary endothelial dystrophy:</strong> Primarily affects the endothelium of the cornea, not associated with the enlargement of the corneas or elevated IOP.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Megalocornea:</strong> A non-glaucomatous condition where the corneas are enlarged but without other symptoms like photophobia or increased IOP.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Congenital glaucoma is characterized by symptoms like enlarged corneas, photophobia, and excessive lacrimation due to elevated intraocular pressure from developmental anomalies in the anterior chamber angle. Early diagnosis and management are crucial to prevent permanent vision loss.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture8_uXBfm5X.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200368,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50093,
      "choices": [
        {
          "id": 200372,
          "text": "<p><span style=\"font-size:12.0pt;\">Upper GI endocscopy</span></p>"
        },
        {
          "id": 200373,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrograffin follow-through</span></p>"
        },
        {
          "id": 200374,
          "text": "<p><span style=\"font-size:12.0pt;\">USG abdomen</span></p>"
        },
        {
          "id": 200375,
          "text": "<p><span style=\"font-size:12.0pt;\">Explorative laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-day-old neonate presented with recurrent bilious vomiting. An X-ray erect abdomen is shown below. What is the next best step in managing this condition? (AIIMS MAY 2018)</span></p><p> </p><p><span style=\"color:black;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-87_OM36NsA.jpg\" alt=\"\" width=\"284\" height=\"309\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-87_OM36NsA.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9180063",
      "question_audio": null,
      "question_video": null,
      "map_id": 34289045,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gastrograffin follow-through</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical history along with the radiograph showing the triple bubble sign implies a diagnosis of jejunal atresia. A contrast study should be the next best investigation to exclude other large bowel anomalies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">A Gastrograffin follow-through is a radiological procedure that involves the administration of contrast material (Gastrograffin) followed by a series of X-rays to visualize the gastrointestinal tract. An alternate investigation would be CT with contrast (not given in options). In cases of recurrent bilious vomiting, it is a valuable diagnostic tool to assess for intestinal obstruction, such as malrotation or other anatomical abnormalities. It helps determine if there are any blockages or abnormalities in the intestines that may be causing the vomiting.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Upper GI endoscopy</strong>: Performing an endoscopy is generally not the first-line investigation for a neonate with recurrent bilious vomiting where an obstructive GI pathology is likely.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C. USG abdomen</strong>: An ultrasound (USG) of the abdomen can provide useful information in some cases, but it may not be the most appropriate initial investigation for recurrent bilious vomiting when there is a need to evaluate the entire gastrointestinal tract.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Explorative laparotomy</strong>: Explorative laparotomy, which involves surgery to explore the abdominal cavity, is a more invasive option and is typically considered when other diagnostic methods have failed to provide a clear diagnosis or when there is a strong suspicion of a surgical emergency. It is not the first-line choice in this scenario.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Small bowel atresia’s present with intestinal obstruction soon after birth.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Bilious vomiting is the dominant feature in jejunal atresia</span></li><li><span style=\"font-size:12.0pt;\">Abdominal distension is more prominent with ileal atresia.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">A small amount of pale meconium may be passed despite the atresia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Plain abdominal radiographs show a variable number of dilated loops of bowel and fluid levels according to the level of obstruction</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In most cases of jejunal/ileal atresia, the distal end of the dilated proximal small bowel is resected and a primary end-to-end anastomosis is performed. If the proximal bowel is extremely dilated, it may need to be tapered to the distal bowel before anastomosis.</span></p>",
      "correct_choice_id": 200373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50094,
      "choices": [
        {
          "id": 200376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vancomycin</span></span></span></span></p>"
        },
        {
          "id": 200377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ceftriaxone</span></span></span></span></p>"
        },
        {
          "id": 200378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Azithromycin</span></span></span></span></p>"
        },
        {
          "id": 200379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Streptomycin</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following drugs is commonly used for treating community-acquired pneumonia in OPD? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q9036794",
      "question_audio": null,
      "question_video": null,
      "map_id": 34461793,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Azithromycin</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Decision for OPD vs Admission for CAP is <strong>assessed by CURB-65, PSI score</strong>. </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">For patients with risk factors (CKD, non-ambulator, Recent ABx, hospitalization last 3 months), macrolide + Beta-lactam /Respiratory FQ preferred. </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vancomycin given only if CA-MRSA is considered.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Suspicion for MRSA:</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"> </p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Necrotizing/Cavitary pneumonia</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Pleural based nodules</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">3. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Post viral pneumonia</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Treatment failure (Sx, hypoxemia, MODS @ 72 hours post admission)</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">5. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IVDU</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ceftriaxone is given for IP treatment and administered I.V.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option D. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Streptomycin is not used in management of CAP.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Azithromycin is a commonly used antibiotic for the outpatient treatment of community-acquired pneumonia due to its effectiveness against a wide range of respiratory pathogens and its patient-friendly dosing schedule.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reference - Harrison/Respiratory /Pneumonia/Chapter 126</span></span></strong></p>",
      "correct_choice_id": 200378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50095,
      "choices": [
        {
          "id": 200380,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">tRNA of Alanine</span></span></span></p>"
        },
        {
          "id": 200381,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">U6 SnRNA</span></span></span></p>"
        },
        {
          "id": 200382,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">mRNA for Histone</span></span></span></p>"
        },
        {
          "id": 200383,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SiRNA</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following does not require 5' capping? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q8327896",
      "question_audio": null,
      "question_video": null,
      "map_id": 34400217,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) tRNA of Alanine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5’ capping - Eukaryotic mRNAs are all ‘capped’ at the 5′ terminus by 7-methyl guanosine triphosphate. An unusual 5’ to 5′ triphosphate bridge is seen. This <strong>happens inside the nucleus</strong>. <strong>The cap is useful in recognition of mRNA by the translating machinery and in prevention of degradation by exonucleases. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Poly-A Tailing at 3′ End - </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The 3’ terminus is polyadenylated in the nucleoplasm. This</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">poly-A tail may be <strong>20 to 250 nucleotides long</strong>. This <strong>tail protects mRNA from attack by 3′ exonuclease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Note: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">tRNA do not require capping at 5’ end.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. U6 SnRNA:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Function:</span></strong><span style=\"font-size:12.0pt\"> U6 snRNA is part of the spliceosome complex involved in RNA splicing.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification:</span></strong><span style=\"font-size:12.0pt\"> U6 snRNA is not typically capped with 7-methyl guanosine but may undergo other modifications.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. mRNA for Histone:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Function:</span></strong><span style=\"font-size:12.0pt\"> Histone mRNAs are unique in that they typically do not have poly-A tails but do require 5' capping.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification:</span></strong><span style=\"font-size:12.0pt\"> Despite lacking poly-A tails, histone mRNAs still undergo 5' capping.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. SiRNA (Small interfering RNA):</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Function:</span></strong><span style=\"font-size:12.0pt\"> SiRNAs are involved in the RNA interference pathway, leading to the degradation of target mRNAs.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification:</span></strong><span style=\"font-size:12.0pt\"> SiRNAs are typically not capped at the 5' end as they are processed from longer double-stranded RNA precursors.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">tRNA, including tRNA for alanine, does not require 5' capping. This modification is specific to mRNAs and some snRNAs, playing a critical role in mRNA stability and translation.</span></span></span></p>",
      "correct_choice_id": 200380,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50096,
      "choices": [
        {
          "id": 200384,
          "text": "<p><span style=\"font-size:12.0pt;\">To magnify the specimen image</span></p>"
        },
        {
          "id": 200385,
          "text": "<p><span style=\"font-size:12.0pt;\">To hold and support the specimen slide</span></p>"
        },
        {
          "id": 200386,
          "text": "<p><span style=\"font-size:12.0pt;\">To regulate the amount of light reaching the specimen</span></p>"
        },
        {
          "id": 200387,
          "text": "<p><span style=\"font-size:12.0pt;\">To adjust the focus and clarity of the image</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the primary function of the condenser in a compound microscope? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p>",
      "unique_key": "Q2084642",
      "question_audio": null,
      "question_video": null,
      "map_id": 34354428,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) To regulate the amount of light reaching the specimen</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The condenser in a compound microscope is a crucial component located within or below the stage (sub-stage). Its primary function is to gather and concentrate light from the microscope's illuminator and direct it into a light cone that focuses on the specimen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Condenser Function:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Light Regulation:</strong> The condenser focuses and concentrates the light onto the specimen to ensure optimal illumination, which is critical for viewing the specimen clearly.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Improving Image Quality:</strong> By regulating and directing the light precisely, the condenser enhances the contrast and clarity of the image.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. To magnify the specimen image:</strong> Magnification is achieved by the objective lenses and eyepiece, not by the condenser.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. To hold and support the specimen slide:</strong> The stage is the part of the microscope that holds and supports the specimen slide, not the condenser.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. To adjust the focus and clarity of the image:</strong> Focus adjustment is achieved using the coarse and fine adjustment knobs, not the condenser.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Parts of Microscope</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-115338.png\" alt=\"\" width=\"600\" height=\"405\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-115442.png\" alt=\"\" width=\"1000\" height=\"383\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-115338.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50097,
      "choices": [
        {
          "id": 200388,
          "text": "<p><span style=\"font-size:12.0pt;\">Medial Longitudinal Fasciculus</span></p>"
        },
        {
          "id": 200389,
          "text": "<p><span style=\"font-size:12.0pt;\">6th Nerve nucleus</span></p>"
        },
        {
          "id": 200390,
          "text": "<p><span style=\"font-size:12.0pt;\">Pontine paramedian reticular formation</span></p>"
        },
        {
          "id": 200391,
          "text": "<p><span style=\"font-size:12.0pt;\">A & C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the site of lesion in internuclear ophthalmoplegia?</span></p>",
      "unique_key": "Q5148533",
      "question_audio": null,
      "question_video": null,
      "map_id": 34109390,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Medial Longitudinal Fasciculus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Medial longitudinal fasciculus (MLF): pair of tracts that interconnect CN VI and CN III nuclei. Internuclear ophthalmoplegia (INO) occurs due to a lesion in the medial longitudinal fasciculus (MLF), which is responsible for coordinating horizontal eye movements. The command for left gaze originates from the right cerebral cortex and travels to the left paramedian pontine reticular formation (PPRF). From there, an output goes to the left VI nerve nucleus, which supplies the left lateral rectus muscle, causing abduction. Another output from the left PPRF goes to the right III nerve nucleus via the right MLF, causing the right eye to adduct.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">If there is a lesion in the right MLF, it leads to the failure of adduction of the right eye. However, the left eye abducts normally. This is the classic presentation of INO.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture10_PoSvVid.jpg\" alt=\"\" width=\"700\" height=\"739\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 6th Nerve nucleus:</strong> A lesion here would result in an inability to abduct the eye on the same side, not INO.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pontine paramedian reticular formation (PPRF):</strong> A lesion here would typically affect both the initiation of gaze to the ipsilateral side and horizontal gaze coordination, leading to symptoms different from typical INO.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The classic presentation of internuclear ophthalmoplegia involves a failure of adduction in the affected eye due to a lesion in the medial longitudinal fasciculus. Recognizing this pathway and its role in horizontal eye movement coordination is crucial for diagnosing and understanding the clinical manifestations of INO.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture10_PoSvVid.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200388,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50098,
      "choices": [
        {
          "id": 200392,
          "text": "<p><span style=\"font-size:12.0pt;\">5 cm</span></p>"
        },
        {
          "id": 200393,
          "text": "<p><span style=\"font-size:12.0pt;\">6 cm</span></p>"
        },
        {
          "id": 200394,
          "text": "<p><span style=\"font-size:12.0pt;\">5.5 cm</span></p>"
        },
        {
          "id": 200395,
          "text": "<p><span style=\"font-size:12.0pt;\">6.5 cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Size cut off for operating an abdominal aortic aneurysm is greater than? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q8595530",
      "question_audio": null,
      "question_video": null,
      "map_id": 34389821,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 5.5 cm</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">(5.5) The threshold for surgical repair of an AAA is commonly set at 5.5 cm in diameter. This means that when the AAA reaches or exceeds 5.5 cm in size, surgical intervention is usually recommended to prevent the risk of rupture.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">AAA refers to an enlargement or ballooning of the abdominal aorta. It can be a potentially life-threatening condition if it ruptures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The size of the AAA is a crucial factor in determining the need for surgical intervention. The risk of rupture increases significantly as the size of the aneurysm grows.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">An asymptomatic abdominal aortic aneurysm in an otherwise fit patient is considered for repair if >55 mm in diameter (measured by ultrasonography). The annual incidence of rupture rises from 1% or less in aneurysms that are <55 mm in diameter to a significant level of nearly 25%, in those that are 70 mm in diameter.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">As open elective surgery (transabdominal) carries a 5% mortality rate, the balance is in favor of elective operation once the maximum diameter is >55 mm.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">6 monthly follow-up ultrasonographic surveillance is indicated for asymptomatic aneurysms <55 mm in diameter.</span></p>",
      "correct_choice_id": 200394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50099,
      "choices": [
        {
          "id": 200396,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphocyte</span></p>"
        },
        {
          "id": 200397,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibroblast</span></p>"
        },
        {
          "id": 200398,
          "text": "<p><span style=\"font-size:12.0pt;\">Macrophage</span></p>"
        },
        {
          "id": 200399,
          "text": "<p><span style=\"font-size:12.0pt;\">Mast Cell</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Toluidine blue staining is used in the Identification of which of the following cells? </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q5527466",
      "question_audio": null,
      "question_video": null,
      "map_id": 34298873,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mast Cell</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Toluidine blue is the special stain for mast cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Toluidine blue (also known as tolonium chloride) is an acidophilic metachromatic dye that selectively stains acidic tissue components (sulfates, carboxylates, and phosphate radicals). <strong>Toluidine blue (TB. has an affinity for nucleic acids, and therefore binds to nuclear material of tissues with a high DNA and RNA content.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">It also intensely stains some substances leading to a change in color. This effect known as metachromasia.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Orthochromatic Staining</strong> - structures stained blue (Lymphocytes)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Metachromatic Staining</strong> - structures stained dark purple from polymeric aggregates formed when binding to high concentrations of polyanions (Mast cells)</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Toluidine blue is often used to identify mast cells by virtue of heparin</strong> (which is very polyanionic. found in their secretion granules.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/960.jpg\" alt=\"\" width=\"677\" height=\"303\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Application of Toluidine Blue</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Connective tissue mucins, especially acid mucins. The tissue stains purple to red, while the background is stained blue.</span></li><li><span style=\"font-size:12.0pt;\">Mast cell granules stain purple in color due to the presence of heparin and histamine.</span></li><li><span style=\"font-size:12.0pt;\">Amyloid stain blue but under polarized light they give a bright red birefringence.</span></li><li><span style=\"font-size:12.0pt;\">Endocrine cell granules are stained purple to red.</span></li><li><span style=\"font-size:12.0pt;\">Sulfatides stain red brown or yellow. Only lipids that are sufficiently acidic to induce a metachromatic shift are stained.</span></li><li><span style=\"font-size:12.0pt;\">Corynebacterium diphtheria contains granules with polymerized inorganic polyphosphate, which stains red violet color.</span></li><li><span style=\"font-size:12.0pt;\">Helicobacter stains dark blue against a variably blue background.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lymphocyte</strong>: Lymphocytes can be stained with toluidine blue, but they show orthochromatic staining (blue), not the metachromasia that is characteristic of mast cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fibroblast</strong>: Fibroblasts are not specifically identified by toluidine blue staining.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Macrophage</strong>: While macrophages can be stained with various dyes, they do not exhibit the metachromasia seen in mast cells with toluidine blue.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Toluidine blue </strong>is primarily used to identify <strong>mast cells</strong> due to their characteristic <strong>metachromatic staining</strong> caused by the heparin in their granules.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/960.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50100,
      "choices": [
        {
          "id": 200400,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle meningeal artery - Anterior cranial fossa</span></p>"
        },
        {
          "id": 200401,
          "text": "<p><span style=\"font-size:12.0pt;\">Accessory meningeal branch of maxillary artery - Middle cranial fossa</span></p>"
        },
        {
          "id": 200402,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningeal branch of internal carotid artery - Posterior cranial fossa</span></p>"
        },
        {
          "id": 200403,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningeal branch of anterior and posterior ethmoid artery - Anterior cranial fossa</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following arteries does not supply the corresponding region of the dura mater? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q2577413",
      "question_audio": null,
      "question_video": null,
      "map_id": 34745597,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Meningeal branch of internal carotid artery - Posterior cranial fossa</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This is the incorrect pairing. The meningeal branch of the internal carotid artery doesn't primarily supply the dura mater of the posterior cranial fossa. The dura mater of the posterior cranial fossa is mainly supplied by branches from the vertebral arteries, such as the posterior meningeal artery.</span></li><li><span style=\"font-size:12.0pt;\">The meningeal branches of Internal Carotid artery supply the anterior cranial fossa </span><br> </li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Middle meningeal artery - Anterior cranial fossa</strong>: The middle meningeal artery is a branch of the maxillary artery. It is the most significant arterial supply to the dura mater. After entering the skull through the foramen spinosum, it typically divides into anterior and posterior branches. The anterior branch of the middle meningeal artery supplies the dura mater overlying the anterior cranial fossa.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Accessory meningeal branch of the maxillary artery - Middle cranial fossa</strong>: The accessory meningeal artery is a smaller branch that originates from the maxillary artery. It enters the middle cranial fossa through the foramen ovale. This artery supplies the dura of the middle cranial fossa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Meningeal branch of anterior and posterior ethmoid artery - Anterior cranial fossa</strong>: The anterior and posterior ethmoidal arteries arise from the ophthalmic artery (a branch of the internal carotid artery). These arteries have meningeal branches that supply the dura mater in the anterior cranial fossa, specifically the region overlying the ethmoid bone and the frontal bone's adjacent parts.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Summary of Blood supply to Dura</span></p><ol><li><span style=\"font-size:12.0pt;\">Anterior cranial fossa</span><ol><li><span style=\"font-size:12.0pt;\">By ethmoidal artery which is the branch of opthalmic artery which in tern is the branch of Internal carotid artery </span></li><li><span style=\"font-size:12.0pt;\">Middle meningeal artery which is the branch of maxillary artery which in tern is the branch of external carotid artery</span></li></ol></li><li><span style=\"font-size:12.0pt;\">Middle cranial fossa</span><ol><li><span style=\"font-size:12.0pt;\">Accessory meningeal artery which is the branch of maxillary artery which in tern is the branch of external carotid artery</span></li></ol></li><li><span style=\"font-size:12.0pt;\">Posterior Cranial fossa</span><ol><li><span style=\"font-size:12.0pt;\">Meningeal branches from the branches of the vertebral artery.</span><br> </li></ol></li></ol><ul><li><span style=\"font-size:12.0pt;\">The internal carotid artery (ICA) meningeal branch supply blood to the anterior cranial fossa.</span></li><li><span style=\"font-size:12.0pt;\">The dura mater is supplied by meningeal arteries, which run along the inner periosteum (endosteum) of the skull and supply the following regions.</span></li></ul>",
      "correct_choice_id": 200402,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50101,
      "choices": [
        {
          "id": 200404,
          "text": "<p><span style=\"font-size:12.0pt;\">Nausea</span></p>"
        },
        {
          "id": 200405,
          "text": "<p><span style=\"font-size:12.0pt;\">Vivid dreams</span></p>"
        },
        {
          "id": 200406,
          "text": "<p><span style=\"font-size:12.0pt;\">Anorgasmia</span></p>"
        },
        {
          "id": 200407,
          "text": "<p><span style=\"font-size:12.0pt;\">Sialorrhea</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient was prescribed escitalopram. Which of the following adverse effect is the least likely?</span></p>",
      "unique_key": "Q3917001",
      "question_audio": null,
      "question_video": null,
      "map_id": 34075116,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Sialorrhea</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Escitalopram is a selective serotonin reuptake inhibitor (SSRI). </span></p><p> </p><p><span style=\"font-size:12.0pt;\">Sialorrhea is not typically associated with SSRIs. They are more likely to cause dry mouth. Sialorrhea is a common side effect of clozapine</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nausea:</strong> Nausea is a common side effect of SSRIs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vivid dreams: </strong>Vivid dreams can occasionally be reported but are not the most common side effect.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anorgasmia: </strong>Anorgasmia or other sexual side effects are also commonly associated with SSRIs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Side effects of SSRIs include:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Most common: Nausea</span></li><li><span style=\"font-size:12.0pt;\">Most common long-term side effects: Sexual dysfunction including delayed orgasm, poor erection and low libido.</span></li><li><span style=\"font-size:12.0pt;\">CNS side effects- Paradoxical anxiety, sedation, vivid dreams, sweating, seizures, EPSE etc.</span></li><li><span style=\"font-size:12.0pt;\">QTc prolongation</span></li><li><span style=\"font-size:12.0pt;\">Weight gain</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 3156-3158</strong></span></p>",
      "correct_choice_id": 200407,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50102,
      "choices": [
        {
          "id": 200408,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase enzyme defect</span></p>"
        },
        {
          "id": 200409,
          "text": "<p><span style=\"font-size:12.0pt;\">White patch of hair due to tryptophan deficiency</span></p>"
        },
        {
          "id": 200410,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylacetate positive in urine</span></p>"
        },
        {
          "id": 200411,
          "text": "<p><span style=\"font-size:12.0pt;\">Mental retardation is present</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An infant presented to the OPD with a history of vomiting and poor feeding. Musty odor is present in the baby's sweat and urine. Guthrie test was done and it was found to be positive. All are true regarding this disease except? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q6572854",
      "question_audio": null,
      "question_video": null,
      "map_id": 34471417,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) White patch of hair due to tryptophan deficiency</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical history is suggesting a most probable diagnosis of <strong>phenylketonuria (PKU</strong>)</span></p><p><span style=\"font-size:12.0pt;\"><strong>Deficiency of phenylalanine hydroxylase</strong> is the cause for this disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Biochemical Abnormalities:</strong></span></p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Phenylalanine cannot be converted to tyrosine. So, phenylalanine accumulates. Phenylalanine level in blood is elevated.</span></li><li><span style=\"font-size:12.0pt;\">So alternate minor pathways are opened. Phenylketone (phenylpyruvate), phenyllactate and phenylacetate are excreted in urine.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Characteristic clinical findings in Phenylketonuria:</strong></span></p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">The classical PKU child is <strong>mentally retarded</strong> with an IQ of 50.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Agitation, hyperactivity, tremors and</strong> <strong>convulsions</strong> are often manifested. This may be because phenylalanine interferes with neurotransmitter synthesis.</span></li><li><span style=\"font-size:12.0pt;\">The child often has <strong>hypopigmentation</strong>, <strong>explained by the inhibition of tyrosinase</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Phenyl acetic acid in sweat may lead to <strong>mousy body odor.</strong></span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Laboratory Diagnosis:</strong></span></p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Blood phenylalanine:</strong> <strong>Normal level is 1 mg/dL</strong>. In PKU, the level is <strong>>20 mg/dL</strong>. This may be demonstrated by chromatography. <strong>Tandem mass spectroscopy is the most reliable test</strong>; but is costly.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Guthrie test</strong> <strong>is a rapid screening test</strong> - Certain strains of Bacillus subtilis need phenylalanine as an essential growth factor. Bacteria cannot grow in a medium devoid of phenylalanine. Bacterial growth is proportional to the phenylalanine content in the patient’s blood.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ferric chloride test</strong>: Urine of the patient contains phenylketones about 500–3000 mg/day. This could be detected by adding a drop of ferric chloride to the urine. A transient blue-green color is a positive test. But this is a less reliable test.</span></li><li><span style=\"font-size:12.0pt;\">DNA probes are now available to diagnose the defects in phenylalanine hydroxylase and dihydrobiopterin reductase.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span></p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Early detection is very important</strong>. About 5 units of IQ are lost for each 10-week delay in starting the treatment.</span></li><li><span style=\"font-size:12.0pt;\">The treatment is to provide a <strong>diet containing low phenylalanine</strong> (10–20 mg/kg body weight per day)</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Phenylalanine hydroxylase enzyme defect: True:</strong> This is the primary defect in PKU, leading to elevated phenylalanine levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Phenylacetate positive in urine: True:</strong> Phenylacetate, a metabolite of phenylalanine, is found in the urine of patients with PKU.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mental retardation is present: True:</strong> Without early treatment, children with PKU often suffer from severe mental retardation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">PKU is characterized by a deficiency in phenylalanine hydroxylase, leading to elevated phenylalanine levels and its metabolites, which cause neurological symptoms, hypopigmentation, and a musty odor. Early detection and dietary management are crucial for preventing severe mental retardation.</span></p>",
      "correct_choice_id": 200409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50103,
      "choices": [
        {
          "id": 200412,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">i-4, ii-3, iii-2, iv-1</span></p>"
        },
        {
          "id": 200413,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">i-3, ii-4, iii-2, iv-1</span></p>"
        },
        {
          "id": 200414,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">i-3, ii-1, iii-4, iv-2</span></p>"
        },
        {
          "id": 200415,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">i-3, ii-4, iii-1, iv-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following: (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/20/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_262_page_9.jpg\" alt=\"\" width=\"400\" height=\"492\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/20/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_262_page_9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1886696",
      "question_audio": null,
      "question_video": null,
      "map_id": 34245114,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D. i-3, ii-4, iii-1, iv-2 </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>i. Mummification - Image 3.</strong> It is a method of embalming the dead body. It occurs in the absence of moisture in the air and continuous action of dry or warmed air.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>ii. Adipocere - Image 4.</strong> It forms under warm and humid weather due to hydrolysis of lipids.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>iii. Marbling - Image 1.</strong> In marbling, blood vessels are visible on the skin as greenish-black streaks and eventually results in skin discoloration ranging from green to black, due to the formation of sulphmethemoglobin, which starts in 24 hours and becomes prominent in 36-48 hours.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>iv. Postmortem lividity - Image 2. </strong>Livor mortis, also known as postmortem hypostasis or postmortem lividity, is a passive process of blood accumulating within the blood vessels in the dependent parts of the body as a result of gravity, causing a discoloration of the skin that varies from pink to dark purplish.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Mummification:</strong> Occurs in dry or warm environments, preserving the body by desiccation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Adipocere:</strong> Forms in warm, humid conditions through the hydrolysis of lipids, leading to a waxy transformation of body fat.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Marbling:</strong> Blood vessels become visible as greenish-black streaks due to sulphmethemoglobin formation, appearing within 24 hours and becoming prominent by 36-48 hours.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Postmortem Lividity:</strong> Blood accumulates in dependent body parts due to gravity, causing discoloration from pink to dark purple.</span></li></ul>",
      "correct_choice_id": 200415,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50104,
      "choices": [
        {
          "id": 200416,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spurious drug</span></span></span></p>"
        },
        {
          "id": 200417,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adulterated drug</span></span></span></p>"
        },
        {
          "id": 200418,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unethical drug</span></span></span></p>"
        },
        {
          "id": 200419,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Misbranded drug</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The manufacturer of a drug company labels a drug as having 500 mg paracetamol. On quantitative analysis of the drug, it actually contained only 200 mg of paracetamol. What is this type of drug called? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q7893288",
      "question_audio": null,
      "question_video": null,
      "map_id": 34359701,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Misbranded drug</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug stating that 500mg of paracetamol is present in each tablet, but contains only 200mg is a misbranded drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A misbranded drug will not produce the effect due to reasons like lesser dose, different molecules in it etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Spurious drugs:</strong> are drugs with improper labelling, labeling from a fictitious company, with improper storage guidelines, or even partly or wholly substituted by another drug or substance.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Adulterated drugs:</strong> are drugs with unwanted substance, for example iron in Paracetamol.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. unethical drug: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The term unethical drug is not used. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A drug that is labeled as containing a certain amount of an active ingredient but actually contains a different amount is considered misbranded. Misbranded drugs can lead to ineffective treatment and potential harm due to incorrect dosing.</span></span></span></p>",
      "correct_choice_id": 200419,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50105,
      "choices": [
        {
          "id": 200420,
          "text": "<p><span style=\"font-size:12.0pt;\">There is enzymatic digestion of cellular contents</span></p>"
        },
        {
          "id": 200421,
          "text": "<p><span style=\"font-size:12.0pt;\">Karyolysis is present</span></p>"
        },
        {
          "id": 200422,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma membrane remains intact</span></p>"
        },
        {
          "id": 200423,
          "text": "<p><span style=\"font-size:12.0pt;\">It is associated with adjacent inflammation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a true statement about apoptosis? </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q2397484",
      "question_audio": null,
      "question_video": null,
      "map_id": 34391947,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Plasma membrane remains intact </strong></span><span style=\"font-size:11pt;\"> </span></p><p> </p><p><span style=\"font-size:12.0pt;\">The plasma membrane remains intact in apoptosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Apoptosis literally means falling-off in Greek. It is a pathway of programmed cell death.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Apoptotic cells break up into fragments called apoptotic bodies. These apoptotic bodies have intact plasma membrane but altered structures. Hence, they are subjected to phagocytosis without eliciting inflammation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Key Features of Apoptosis:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Cell shrinkage: The cell becomes smaller in size.</span></li><li><span style=\"font-size:12.0pt;\">Chromatin condensation and nuclear fragmentation (called pyknosis and karyorrhexis).</span></li><li><span style=\"font-size:12.0pt;\">Formation of apoptotic bodies: The cell fragments into small, membrane-bound vesicles.</span></li><li><span style=\"font-size:12.0pt;\">Phagocytosis without inflammation: Apoptotic bodies are recognized and engulfed by macrophages or nearby cells.</span></li><li><span style=\"font-size:12.0pt;\">Plasma membrane remains intact during the entire process, preventing leakage of contents and avoiding inflammation.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Necrosis is an unprogrammed form of cell death that includes:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Enzymatic digestion</span></li><li><span style=\"font-size:12.0pt;\">Adjacent inflammation</span></li><li><span style=\"font-size:12.0pt;\">Karyolysis</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/974.jpg\" alt=\"\" width=\"500\" height=\"364\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. There is enzymatic digestion of cellular contents</strong>: This occurs in necrosis, not apoptosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Karyolysis is present</strong>: Karyolysis is a feature of necrosis, not apoptosis. In apoptosis, the nucleus fragments in an orderly manner.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is associated with adjacent inflammation</strong>: Inflammation is characteristic of necrosis due to the release of cellular contents, but apoptosis avoids this through the containment of cell contents within intact membranes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-125200.png\" alt=\"\" width=\"1000\" height=\"387\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8th edition pg 59</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/974.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50106,
      "choices": [
        {
          "id": 200424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Right atrial contraction</span></span></span></span></p>"
        },
        {
          "id": 200425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Closure of tricuspid valve</span></span></span></span></p>"
        },
        {
          "id": 200426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Onset of ventricular systole</span></span></span></span></p>"
        },
        {
          "id": 200427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Maximal atrial filling</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">'a' wave in JVP corresponds to? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q8743830",
      "question_audio": null,
      "question_video": null,
      "map_id": 34746390,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Right atrial contraction</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The 'a' wave in the jugular venous pulse (JVP) represents right atrial contraction. This occurs towards the end of ventricular diastole and reflects the pressure increase within the right atrium as it contracts to push blood into the right ventricle just before the tricuspid valve closes.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Closure of tricuspid valve: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incorrect, this would not be specifically represented by an 'a' wave; instead, it typically follows the 'a' wave and leads into the 'c' wave associated with right ventricular contraction.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Onset of ventricular systole: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incorrect, ventricular systole corresponds to the 'c' wave and the 'x' descent on JVP.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Maximal atrial filling: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incorrect, maximal atrial filling occurs towards the end of the 'v' wave and into the 'y' descent, which corresponds to passive ventricular filling when the tricuspid valve is open.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture56.jpg\" style=\"height:517px; width:1000px\" /></span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Harrison/Cardiology/Basics of CVS/Chap 239</span></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture56.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50107,
      "choices": [
        {
          "id": 200428,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary active transport</span></span></span></p>"
        },
        {
          "id": 200429,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary active transport</span></span></span></p>"
        },
        {
          "id": 200430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Facilitated diffusion</span></span></span></p>"
        },
        {
          "id": 200431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Any of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The mechanism by which glucose is absorbed in the intestine is? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q8166643",
      "question_audio": null,
      "question_video": null,
      "map_id": 34808472,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Secondary active transport</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose enters the lumen of the small intestine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium ions (Na+) are present in the lumen of the intestine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium-Glucose Co-Transporter 1 (SGLT1) on the luminal membrane of enterocytes facilitates glucose absorption:</span></span></span>\r\n\t<ol style=\"list-style-type:lower-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SGLT1 binds to both glucose and sodium ions.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium ions move down their electrochemical gradient into the enterocyte, providing energy for transport.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose molecules are co-transported with sodium ions into the enterocyte.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose enters the cytoplasm of the enterocyte.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inside the enterocyte, glucose can be used for energy or transported across the basolateral membrane.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose Transporter 2 (GLUT2) on the basolateral membrane of enterocytes facilitates glucose transport out of the cell:</span></span></span>\r\n\t<ol style=\"list-style-type:lower-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">GLUT2 allows glucose to move down its concentration gradient.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose diffuses across the basolateral membrane into the bloodstream.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Glucose is carried away by the bloodstream to various tissues and organs for utilization.</span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-152428.png\" style=\"height:425px; width:500px\" /></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Primary active transport: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Involves direct use of ATP for the movement of substances against their concentration gradient and does not apply to glucose absorption in the intestine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Facilitated diffusion: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Passive movement of molecules along their concentration gradient through a membrane protein, applies to the exit of glucose at the basolateral side but not to its uptake at the luminal side.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Any of the above: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Not applicable as the specific mechanism for glucose absorption is secondary active transport.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glucose is absorbed in the intestine through secondary active transport utilizing the Sodium-Glucose Co-Transporter 1 (SGLT1), which couples the energetically favorable transport of sodium with the transport of glucose against its gradient into enterocytes.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-152428.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200429,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50108,
      "choices": [
        {
          "id": 200432,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichophyton</span></p>"
        },
        {
          "id": 200433,
          "text": "<p><span style=\"font-size:12.0pt;\">Microsporum</span></p>"
        },
        {
          "id": 200434,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspergillus</span></p>"
        },
        {
          "id": 200435,
          "text": "<p><span style=\"font-size:12.0pt;\">Epidermophyton</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following will not commonly present as shown in the image below?(AIIMS MAY 2018)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture1_bkii7yU.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture1_bkii7yU.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1671684",
      "question_audio": null,
      "question_video": null,
      "map_id": 34013524,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Aspergillus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows a <strong>dermatophytic infection in the groin region called as Tinea cruris</strong>. <strong>Aspergillus</strong> species are <strong>not dermatophytes</strong> & are not associated with tinea infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This genus of fungi is not commonly involved in tinea infections. Aspergillus species are known to cause various diseases, primarily in the <strong>respiratory system</strong>, such as <strong>allergic bronchopulmonary aspergillosis</strong>, <strong>aspergillom</strong>a, and <strong>invasive aspergillosis</strong>. They are <strong>not </strong>usually responsible for <strong>superficial skin </strong>infections like the one shown in the image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Annular </strong>lesions are <strong>ring shaped</strong> with <strong>central clearing</strong> i.e., only the <strong>edges are active</strong> & appear <strong>raised</strong>, or in different color. It is present in <strong>granuloma annulare and tinea (Dermatophytic</strong> infection).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture2_HyT1gmF.jpg\" alt=\"\" width=\"250\" height=\"323\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture3_CejtCjC.jpg\" alt=\"\" width=\"733\" height=\"403\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Dermatophytes include 3 genera:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">﻿﻿﻿<strong>Trichophyton species infect skin, hair and nails</strong>. E.g., T. rubrum, T. mentagrophytes, T. tonsurans, T. schoenleinii, T. violaceum, etc.</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿﻿<strong>Microsporum</strong> contains M. gypseum, M. canis, and M. nanum. <strong>These infect only hair and skin (not nails).</strong></span></li><li><span style=\"font-size:12.0pt;\">﻿﻿﻿<strong>Floccosum </strong>is the only species in the genus Epidermophyton, it <strong>infects only skin and nails (not hair).</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Dermatophytes </strong>infect and survive <strong>only</strong> in the <strong>dead keratin</strong> layers of skin (<strong>stratum corneum</strong>), hair and nails as they are Keratinophilic.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture4_i2iKIuX.jpg\" alt=\"\" width=\"700\" height=\"335\"></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/14/screenshot-2024-06-14-124415.png\" alt=\"\" width=\"1000\" height=\"776\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Trichophyton:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong> Trichophyton species are among the most common dermatophytes associated with Tinea cruris. They infect skin, hair, and nails and are known for their role in various forms of tinea, including Tinea cruris.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Why it could present as shown:</strong> Trichophyton often causes ring-shaped lesions with a clear center and scaly borders, matching the typical presentation of Tinea cruris.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Microsporum:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong> While Microsporum primarily infects the hair and skin and is less commonly associated with Tinea cruris compared to Trichophyton, it can still cause dermatophytic infections of the groin.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Why it could present as shown:</strong> Microsporum can cause similar clinical manifestations as Trichophyton in Tinea infections, including red, itchy, and ring-shaped rashes.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Epidermophyton:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong> Epidermophyton floccosum specifically targets the skin and nails and is a known causative agent of Tinea cruris. This fungus does not infect the hair, differentiating it from some other dermatophytes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Why it could present as shown:</strong> Similar to other dermatophytes, Epidermophyton can cause the classic ring-shaped lesions of Tinea cruris with involvement of the groin area.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Aspergillus species </strong>do <strong>not</strong> typically cause <strong>superficial skin </strong>infections such as tinea cruris; instead, they are more associated with <strong>respiratory</strong> system conditions. <strong>Trichophyton, Microsporum, and Epidermophyton </strong>are genera of fungi that commonly cause <strong>dermatophytosis</strong> like the tinea infections seen in the presented image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition volume I Chapter 4. Page no 4.11, 4.13</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Rook's Textbook of Dermatology - Volume II-9th Edition Chapter 32 Page no 32.18-20</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Ananthanarayan and Paniker's Textbook of Microbiology 9th edition Page no 599</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture2_HyT1gmF.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200434,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50109,
      "choices": [
        {
          "id": 200436,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phosphocreatine</span></span></span></p>"
        },
        {
          "id": 200437,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aerobic glycolysis</span></span></span></p>"
        },
        {
          "id": 200438,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oxidation of Fatty acids</span></span></span></p>"
        },
        {
          "id": 200439,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In a 100-m dash, most of the energy consumed by skeletal muscles to replenish ATP is derived from? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q3133333",
      "question_audio": null,
      "question_video": null,
      "map_id": 34092513,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Phosphocreatine</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phosphocreatine (also called creatine phosphate) is another chemical compound that has a high-energy phosphate bond. The combined amounts of cell ATP and cell phosphocreatine are called the phosphagen energy system. These together can provide maximal muscle power for 8 to 10 seconds, almost enough for the 100-meter run.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thus, the energy from the phosphagen system is used for maximal short bursts of muscle power.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-154947.png\" style=\"height:140px; width:1000px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Aerobic glycolysis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This process occurs in the mitochondria and is used for longer-duration, lower-intensity exercise. It involves the oxidation of glucose to produce ATP, but it is too slow to meet the immediate energy demands of a 100-meter dash.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Oxidation of Fatty acids: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a slower process involving the breakdown of fatty acids in the mitochondria to produce ATP. It primarily supports prolonged, steady-state activities rather than short bursts of high-intensity exercise.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. None of the above: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect, as phosphocreatine is the primary source of rapid ATP replenishment during short, high-intensity activities like a 100-meter dash.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">During a 100-meter dash, the primary source of energy for rapidly replenishing ATP in skeletal muscles is the phosphagen system, utilizing phosphocreatine for short bursts of maximal muscle power lasting approximately 8 to 10 seconds.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-154947.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200436,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50110,
      "choices": [
        {
          "id": 200440,
          "text": "<p><span style=\"font-size:12.0pt;\">9 minutes</span></p>"
        },
        {
          "id": 200441,
          "text": "<p><span style=\"font-size:12.0pt;\">4.5 minutes</span></p>"
        },
        {
          "id": 200442,
          "text": "<p><span style=\"font-size:12.0pt;\">27 minutes</span></p>"
        },
        {
          "id": 200443,
          "text": "<p><span style=\"font-size:12.0pt;\">13.5 minutes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a reaction, the substrate is available in a concentration that is 1000 times the Km value of the enzyme. After 9 minutes of reaction, 1% of substrate is converted to product (12 microgram/ml). If the concentration of the enzyme is changed to 1/3 and concentration of substrate is doubled, what is the time taken to convert the substrate into the same amount of product that i.e., 12 microgram/ml? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p>",
      "unique_key": "Q6071028",
      "question_audio": null,
      "question_video": null,
      "map_id": 34581704,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 27 minutes</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The time taken for the formation of the same amount of product is 27 minutes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">When the substrate concentration is much greater than the Km value, the rate of the reaction is independent of the substrate concentration i.e., it <strong>follows zero-order kinetics</strong>. In this reaction, the substrate concentration is 1000 times the Km value therefore it follows zero-order kinetics. So, <strong>doubling the substrate concentration does not change the velocity of the reaction.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The rate of the reaction is directly proportional to the concentration of the enzyme. As the enzyme concentration becomes 1/3<sup>rd</sup>, the velocity of the reaction also becomes 1/3<sup>rd</sup>.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Therefore, the time taken for the formation of the same amount of product will become tripled. That is, 9 × 3 = 27 minutes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In zero-order kinetics, the reaction rate is independent of substrate concentration but directly proportional to enzyme concentration. Reducing the enzyme concentration to 1/3 increases the time taken to produce the same amount of product by a factor of 3.</span></p>",
      "correct_choice_id": 200442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50111,
      "choices": [
        {
          "id": 200444,
          "text": "<p><span style=\"font-size:12.0pt;\">Most of the grafts are multi-visceral grafts.</span></p>"
        },
        {
          "id": 200445,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not widely used due to vigorous rejection reactions.</span></p>"
        },
        {
          "id": 200446,
          "text": "<p><span style=\"font-size:12.0pt;\">The most dangerous complication is sepsis.</span></p>"
        },
        {
          "id": 200447,
          "text": "<p><span style=\"font-size:12.0pt;\">The most common indication is the ischemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the incorrect statement about intestinal transplantation: (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3595811",
      "question_audio": null,
      "question_video": null,
      "map_id": 34435465,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Most of the grafts are multi-visceral grafts</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This statement is <strong>incorrect.</strong> While multi-visceral transplantation, which includes the intestine along with other abdominal organs like the liver and pancreas, can occur, it is not the most common type of intestinal transplantation. Isolated intestinal transplantation, where only the intestine is transplanted, is more common.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is not widely used due to vigorous rejection reactions</strong>: This statement is <strong>correct.</strong> Intestinal transplantation is not as widely performed as other organ transplants like kidney or liver transplantation because the intestine is known to trigger vigorous rejection reactions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The most dangerous complication is sepsis</strong>: This statement is <strong>correct</strong>. Sepsis is indeed a significant and life-threatening complication associated with intestinal transplantation. The immunosuppressive medications used to prevent rejection can increase the risk of infections, including sepsis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The most common indication is ischemia. (Correct)</strong>: Ischemia is one of the common indications for intestinal transplantation. It is often used when patients have suffered from ischemic bowel disease and other treatments have been ineffective.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Multi-visceral grafts are rarely used in intestinal transplantation. The most common intestinal graft is small bowel graft, with or without the colon or a combined liver and small bowel graft.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">All the other statements are correct.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Small bowel transplantation is the final treatment option when the outcome of reconstruction and lengthening procedures are unsatisfactory.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The small bowel transplant is highly immunogenic as it contains a large amount of gut-associated lymphoid tissue, donor dendritic cells, and macrophages. Acute rejection has been reported in 56-75% of patients, with small bowel transplant limiting the overall survival to only one-third of recipients.</span></p>",
      "correct_choice_id": 200444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50112,
      "choices": [
        {
          "id": 200448,
          "text": "<p><span style=\"font-size:12.0pt;\">ETEC</span></p>"
        },
        {
          "id": 200449,
          "text": "<p><span style=\"font-size:12.0pt;\">EIEC</span></p>"
        },
        {
          "id": 200450,
          "text": "<p><span style=\"font-size:12.0pt;\">ЕРЕС</span></p>"
        },
        {
          "id": 200451,
          "text": "<p><span style=\"font-size:12.0pt;\">EHEC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism shown below, which causes effacement and attachment of intestinal cells? (INICET MAY 2018)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-246.jpg\" alt=\"\" width=\"274\" height=\"184\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-246.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4192221",
      "question_audio": null,
      "question_video": null,
      "map_id": 34550167,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) EPEC</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Attachment and effacement lesions </u>on intestinal cells are caused by enteropathogenic Escherichia coli (EPEC).</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">EPEC adheres to the mucosal cells of the small bowel and causes loss of microvilli (effacement). This leads to the formation of filamentous actin pedestals or cuplike structures and occasionally may cause entry of the EPEC into the mucosal cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Pathogenicity requires the presence of two important factors:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Bundle-forming pilus</strong> encoded by plasmid containing EPEC adherence factor (EAF).</span></li><li><span style=\"font-size:12.0pt;\">Chromosomal locus of enterocyte effacement <strong>(LEE)</strong> pathogenicity island</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ETEC:</strong> ETEC is known for causing watery diarrhea via enterotoxins but does not cause the attachment and effacement lesions seen with EPEC.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. EIEC:</strong> EIEC causes invasive disease and dysentery by invading and destroying epithelial cells, but it does not cause attachment and effacement lesions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. EHEC:</strong> EHEC causes hemorrhagic colitis and can lead to hemolytic-uremic syndrome through the production of Shiga toxin, but it does not cause the effacement and attachment of intestinal cells as EPEC does.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-122710.png\" alt=\"\" width=\"1000\" height=\"736\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-122710.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50113,
      "choices": [
        {
          "id": 200452,
          "text": "<p><span style=\"font-size:12.0pt;\">Brain infarct</span></p>"
        },
        {
          "id": 200453,
          "text": "<p><span style=\"font-size:12.0pt;\">Brainstem injury</span></p>"
        },
        {
          "id": 200454,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic demyelination syndrome</span></p>"
        },
        {
          "id": 200455,
          "text": "<p><span style=\"font-size:12.0pt;\">Rare cause of hypernatremia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year gentleman was referred from outside hospital to AIIMS ER after he developed sudden onset quadriparesis. In hospital patient was treated with 3%NaCl, Oral tolvaptan. Initial metabolic panel revealed Na: 115 mEq/L, K: 2.8 mEq/L, Cl: 85 mEq/L with normal TSH, CBC, RFT, LFT.  What is the most likely cause for this patient's condition?  (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4141505",
      "question_audio": null,
      "question_video": null,
      "map_id": 34677008,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Osmotic demyelination syndrome</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Previously called central pontine myelinolysis. It occurs due to rapid correction of Chronic Hyponatremia (>8 mg/dL).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Timing: </strong>2-6 days after rapid correction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Rx:</strong> Irreversible. Desmopressin clamp if overcorrection in q6h Na values.  </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. In Hyponatremia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture53_qnfCv6M.jpg\" alt=\"\" width=\"500\" height=\"453\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. On sudden correction:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture54_956T8fI.jpg\" alt=\"\" width=\"500\" height=\"252\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Risk factors:</strong></span></p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Serum sodium ≤ 105 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Concurrent hypokalemia</span></li><li><span style=\"font-size:12.0pt;\">Chronic excess alcohol intake</span></li><li><span style=\"font-size:12.0pt;\">Acute or chronic hepatic disease</span></li><li><span style=\"font-size:12.0pt;\">Malnourishment</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Brain infarct: </strong>Not directly suggested by the rapid onset of symptoms following electrolyte correction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Brainstem injury: </strong>Could be considered but is less likely without trauma or vascular insult history.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rare cause of hypernatremia: </strong>Not applicable as the condition involves the rapid correction of hyponatremia, not hypernatremia itself.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Rapid correction of chronic hyponatremia should be avoided to prevent the severe neurological complications associated with osmotic demyelination syndrome. Control and monitoring of serum sodium levels are crucial during treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Electrolytes/Chap 53</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture53_qnfCv6M.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50114,
      "choices": [
        {
          "id": 200456,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 200457,
          "text": "<p><span style=\"font-size:12.0pt;\">Merkel Cell Carcinoma</span></p>"
        },
        {
          "id": 200458,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal Cell Carcinoma</span></p>"
        },
        {
          "id": 200459,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cancer that least commonly spreads by lymphatic route is: </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q5779507",
      "question_audio": null,
      "question_video": null,
      "map_id": 34940606,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Basal Cell Carcinoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Basal cell carcinoma is a locally aggressive tumor that rarely spreads by the lymphatic route.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Mutations in sonic hedgehog pathway</strong> are associated with it.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Grossly, the most common pattern is a <strong>nodulo-ulcerative basal cell carcinoma</strong> in which a slow-growing small nodule undergoes <strong>central ulceration with pearly, rolled margins</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/963.jpg\" alt=\"\" width=\"400\" height=\"264\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The occasional presence of melanin in this variant of nodular BCC (pigmented BCC. may lead to confusion with melanoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It occurs exclusively on hairy skin, the most common location (90%) being the face, usually above a line from the lobe of the ear to the corner of the mouth. <strong>The most common site is the inner canthus of the eye.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/964.jpg\" alt=\"\" width=\"400\" height=\"400\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Basal cell carcinoma does not show lymphatic or hematogenous metastasis. It is primarily locally invasive</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Squamous cell carcinoma</strong>: Squamous cell carcinoma often spreads via the lymphatic system, particularly when occurring in the skin or mucous membranes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Merkel Cell Carcinoma</strong>: This is a rare and aggressive form of skin cancer that frequently metastasizes via the lymphatic system.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Malignant melanoma</strong>: Melanoma is known for its high metastatic potential, often spreading through both lymphatic and hematogenous routes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Basal cell carcinoma </strong>is primarily a <strong>locally invasive tumor</strong> that <strong>rarely spreads</strong> via the lymphatic or hematogenous routes, distinguishing it from other more aggressive skin cancers.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/963.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50115,
      "choices": [
        {
          "id": 200460,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased schistocytes</span></p>"
        },
        {
          "id": 200461,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased PT</span></p>"
        },
        {
          "id": 200462,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased fibrinogen</span></p>"
        },
        {
          "id": 200463,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased FDPs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is wrong about DIC? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3855506",
      "question_audio": null,
      "question_video": null,
      "map_id": 34453251,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Increased fibrinogen</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Disseminated Intravascular Coagulation (DIC) is a complex condition characterized by systemic activation of blood clotting, which results in the generation and deposition of fibrin, leading to microvascular thrombi in various organs and contributing to multiple organ dysfunction syndrome. As a part of this process, there is widespread consumption of clotting factors and platelets, which leads to a paradoxical increase in bleeding risk.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Increased fibrinogen </strong>is incorrect because in DIC, fibrinogen is typically decreased, not increased. This decrease is due to its consumption during the formation of fibrin clots throughout the body.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. </strong>30% of patients w/DIC may have schistocytes on PS.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. </strong>Consumption of clotting factors leads to ↑PT, aPTT. Presence of normal PT, aPTT w/schistocytes hints towards possibility of MAHA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. </strong>FDP are elevated due to activation of coagulation cascade.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In DIC, one typically sees a constellation of laboratory findings including decreased fibrinogen, increased PT and aPTT, elevated FDPs, and the presence of schistocytes on peripheral blood smear. These changes reflect both the excessive activation of the coagulation cascade and the secondary activation of fibrinolytic pathways, leading to the consumption of clotting factors and secondary bleeding complications.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hematology/Coagulation disorders</strong></span></p>",
      "correct_choice_id": 200462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50116,
      "choices": [
        {
          "id": 200464,
          "text": "<p><span style=\"font-size:12.0pt;\">Heat stress</span></p>"
        },
        {
          "id": 200465,
          "text": "<p><span style=\"font-size:12.0pt;\">Voyeurism</span></p>"
        },
        {
          "id": 200466,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothermia</span></p>"
        },
        {
          "id": 200467,
          "text": "<p><span style=\"font-size:12.0pt;\">LSD overdose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Paradoxical undressing is seen in? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4377115",
      "question_audio": null,
      "question_video": null,
      "map_id": 34550878,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Hypothermia</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Paradoxical undressing is seen in hypothermia victims.</span></li><li><span style=\"font-size:12.0pt;\">The victims, despite low environmental temperatures, paradoxically remove their clothes due to a sudden feeling of warmth.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Heat stress: </strong>Heat stress leads to symptoms such as heat cramps, heat exhaustion, and heat stroke, characterized by elevated body temperature, dehydration, and sometimes loss of consciousness. It does not cause paradoxical undressing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Voyeurism: </strong>Voyeurism is a psychiatric condition where an individual derives sexual pleasure from observing unsuspecting people who are naked, undressing, or engaging in sexual activities. It is unrelated to hypothermia or paradoxical undressing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. LSD overdose: </strong>LSD overdose can cause hallucinations, altered mental status, and sensory distortions. While individuals may engage in bizarre behaviors, paradoxical undressing is not a recognized symptom of LSD overdose.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Paradoxical undressing occurs in hypothermia victims who, despite experiencing extremely low temperatures, remove their clothing due to a sudden and misleading sensation of warmth.</span></p>",
      "correct_choice_id": 200466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50117,
      "choices": [
        {
          "id": 200468,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthenospermia</span></p>"
        },
        {
          "id": 200469,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligospermia</span></p>"
        },
        {
          "id": 200470,
          "text": "<p><span style=\"font-size:12.0pt;\">Epididymis obstruction</span></p>"
        },
        {
          "id": 200471,
          "text": "<p><span style=\"font-size:12.0pt;\">Undescended testes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Infertility in Kartagener's syndrome is due to which of the following? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q6859934",
      "question_audio": null,
      "question_video": null,
      "map_id": 34983332,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Asthenospermia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Asthenospermia (Immotile sperm [Greek sthenos = strength]</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Kartagener result from <strong>loss of function of axonemal dynein that impairs sperm motility</strong>. Respiratory Ciliary dysmotility leads to bronchiectasis and recurrent infections. Association of situs inversus is noted.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Oligospermia: </strong>Incorrect because while sperm count can be affected in some genetic or hormonal disorders, in Kartagener's syndrome, the sperm count is typically normal; the issue lies in their motility.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Epididymis obstruction: </strong>Incorrect as this is not a feature of Kartagener’s syndrome. While structural anomalies in the reproductive tract can lead to such issues, Kartagener’s syndrome specifically affects the motility of sperm due to ciliary dysfunction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Undescended testes: </strong>Incorrect as undescended testes are not associated with Kartagener’s syndrome, which primarily affects ciliary function and not the anatomical position of the testes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br> </p><p><span style=\"font-size:12.0pt;\">Infertility in Kartagener's syndrome is primarily due to asthenospermia, which is caused by the immobility of sperm. This immotility results from the genetic defect affecting the dynein arm of sperm flagella, similar to the defect affecting cilia in the respiratory tract, leading to the classic symptoms of the syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Pulmonology/Bronchiectasis/Chapter 290</strong></span></p>",
      "correct_choice_id": 200468,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50118,
      "choices": [
        {
          "id": 200472,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 24 hours after starting antibiotics</span></p>"
        },
        {
          "id": 200473,
          "text": "<p><span style=\"font-size:12.0pt;\">Till cultures become negative</span></p>"
        },
        {
          "id": 200474,
          "text": "<p><span style=\"font-size:12.0pt;\">Till antibiotic course is complete</span></p>"
        },
        {
          "id": 200475,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 12 hours after admission</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How long should a child be isolated after being diagnosed with bacterial meningitis to prevent further transmission? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2813740",
      "question_audio": null,
      "question_video": null,
      "map_id": 34548542,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Till 24 hours after starting antibiotics</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The recommended duration for isolation in cases of bacterial meningitis is <strong>until 24 hours after the initiation of effective antibiotic therapy</strong>. This is crucial for preventing the spread of infections caused by organisms such as <strong>Neisseria meningitidis</strong> and <strong>Haemophilus influenzae type b (Hib)</strong>. After 24 hours of effective treatment, the risk of transmission significantly decreases, allowing the patient to be removed from isolation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Guidelines for prophylaxis:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Standard precautions </strong>should be implemented for all patients admitted with meningitis.</span></li><li><span style=\"font-size:12.0pt;\">Patients with <strong>Neisseria meningitidis</strong> and <strong>Hib meningitis</strong> should be placed on <strong>droplet precautions</strong> until they have received 24 hours of effective antibiotic therapy.</span></li><li><span style=\"font-size:12.0pt;\">Patients with these infections should be placed in <strong>private rooms</strong> during this isolation period.</span></li><li><span style=\"font-size:12.0pt;\">Hospital personnel should wear a <strong>face mask</strong> when within 3 feet (1 meter) of the patient.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Till cultures become negative: </strong>This is not a practical or recommended criterion for lifting isolation because cultures can take several days to become negative, and the patient is not typically contagious after 24 hours of effective treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Till antibiotic course is complete: </strong>The full course of antibiotics may last 7-14 days, during which time isolation is not necessary after the first 24 hours of effective treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Till 12 hours after admission: </strong>This is incorrect as it does not meet the standard infection control guidelines. The 24-hour mark after starting effective antibiotics is the critical time point for lifting isolation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Children with bacterial meningitis caused by Neisseria meningitidis or Haemophilus influenzae should be isolated for 24 hours after starting effective antibiotic therapy to prevent transmission.</span></p>",
      "correct_choice_id": 200472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50119,
      "choices": [
        {
          "id": 200476,
          "text": "<p><span style=\"font-size:12pt;\">Pituitary dysfunction</span></p>"
        },
        {
          "id": 200477,
          "text": "<p><span style=\"font-size:12pt;\">Ovarian dysfunction</span></p>"
        },
        {
          "id": 200478,
          "text": "<p><span style=\"font-size:12pt;\">First pregnancy</span></p>"
        },
        {
          "id": 200479,
          "text": "<p><span style=\"font-size:12pt;\">Uterine synechiae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A young female has history of a induced abortion at 11 weeks. She has had amenorrhea since then. Her FSH now is 6 mlU/ml. Which of the following can be a cause for her amenorrhea? (INICET MAY 2018)</span></p>",
      "unique_key": "Q7395842",
      "question_audio": null,
      "question_video": null,
      "map_id": 34011632,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Uterine synechiae</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a spontaneous abortion and subsequent dilation and curettage (D&C) is typically due to intrauterine adhesions, also known as Asherman syndrome.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Uterine Synechiae (Asherman Syndrome):</strong> This condition involves the formation of scar tissue within the uterine cavity, leading to amenorrhea or menstrual abnormalities. It commonly occurs after uterine surgeries like D&C.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Diagnosis:</strong> Hysteroscopy is the gold standard for diagnosing Asherman syndrome.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment:</strong> Hysteroscopic adhesiolysis is the treatment to remove the adhesions and restore normal uterine cavity function.</span></li></ul></li></ul><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Pituitary dysfunction:</strong> This would typically be associated with abnormal levels of pituitary hormones, including FSH. The normal FSH level (6 mIU/ml) suggests that pituitary function is intact.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Ovarian dysfunction:</strong> This condition would generally present with elevated or depressed levels of FSH and other ovarian hormones. The normal FSH level suggests that ovarian function is likely normal.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. First pregnancy:</strong> In pregnancy, FSH levels are very low (<0.1 mIU/ml). The FSH level of 6 mIU/ml makes this an unlikely cause.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a history of spontaneous abortion and D&C is usually due to intrauterine adhesions (Asherman syndrome), diagnosed by hysteroscopy and treated with hysteroscopic adhesiolysis.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 459, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50120,
      "choices": [
        {
          "id": 200480,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of soft tissue planes is the earliest X-ray change of infection</span></p>"
        },
        {
          "id": 200481,
          "text": "<p><span style=\"font-size:12.0pt;\">Glass pieces can be seen as radiopaque in X-ray images</span></p>"
        },
        {
          "id": 200482,
          "text": "<p><span style=\"font-size:12.0pt;\">Cartilage is not visualized on X-ray.</span></p>"
        },
        {
          "id": 200483,
          "text": "<p><span style=\"font-size:12.0pt;\">Live bone is more radio-opaque than dead bone on X- Ray</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements are false regarding X Rays? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4973900",
      "question_audio": null,
      "question_video": null,
      "map_id": 34195487,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Live bone is more radio-opaque than dead bone on X- Ray images.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">On X-ray imaging, dead bones are whiter (more radio-opaque) than live bone due to absence of bone resorption activity as vascular demineralization is lost. This is known as sequestrum.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Loss of soft tissue planes is the earliest X-ray change of infection:</strong> This statement is true. The loss of definition of soft tissue planes due to swelling or fluid accumulation is often the earliest radiographic sign of infection, typically appearing within 24-48 hours after disease onset.</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Glass pieces can be seen as radiopaque on X-ray images:</strong> This is true. Glass, especially if it contains lead, shows up as radiopaque on X-rays, making it visible.</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Cartilage is not visualized on X-ray:</strong> This is true. Cartilage itself does not appear on X-rays because it does not absorb X-rays well; the space where cartilage is located appears radiolucent, which is often perceived as joint space.</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\"><br><span style=\"font-size:12.0pt;\">On X-ray imaging, dead bone appears more radio-opaque than live bone due to the lack of resorption activity. Understanding these differences is crucial for correctly interpreting radiologic findings related to bone vitality and infection.</span></p>",
      "correct_choice_id": 200483,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50121,
      "choices": [
        {
          "id": 200484,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension band wiring</span></p>"
        },
        {
          "id": 200485,
          "text": "<p><span style=\"font-size:12.0pt;\">Compression plating</span></p>"
        },
        {
          "id": 200486,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal fixation</span></p>"
        },
        {
          "id": 200487,
          "text": "<p><span style=\"font-size:12.0pt;\">K-wire fixation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An athlete suffers a fracture as shown in the knee X-ray below. How is this fracture managed? (AIIMS MAY 2018)</span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110859.JPG\" alt=\"\" width=\"250\" height=\"421\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110859.JPG\" alt=\"Question Image\"></p>",
      "unique_key": "Q2174613",
      "question_audio": null,
      "question_video": null,
      "map_id": 34513492,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tension band wiring</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>PATELLA FRACTURE TREATMENT</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The image displays a displaced patellar fracture, and the treatment of choice is <strong>Tension Band Wiring</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tension Band Wiring (TBW)</strong> is a surgical method to secure the bones in place which are subjected to tension forces.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Wires</strong> and <strong>Screws</strong> or <strong>Pins</strong> are used to create this tension band effect.</span></li><li><span style=\"font-size:12.0pt;\">In <strong>two-part fracture of Patella</strong>, the <strong>pull of Quadriceps</strong> on the proximal fragment keeps them apart.</span></li><li><span style=\"font-size:12.0pt;\">In the operation, first the fractured <strong>fragments are reduced, fixed with TBW</strong> and then the <strong>extensor retinacula are repaired</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>TBW converts distractive forces into compressive forces.</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110958.JPG\" alt=\"\" width=\"500\" height=\"313\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>In case if there is comminuted fracture where accurate reduction is not possible, patellectomy is done.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Tension band wiring is done using: </strong></span><ul><li><span style=\"font-size:12.0pt;\">Cancellous screws for fracture of Olecranon process</span></li><li><span style=\"font-size:12.0pt;\">K-wires and stainless steel wires for fracture of Patella</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Tension band wiring is the gold standard treatment for the two-part patella fracture.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110958.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50122,
      "choices": [
        {
          "id": 200488,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoelectric focusing</span></p>"
        },
        {
          "id": 200489,
          "text": "<p><span style=\"font-size:12.0pt;\">Affinity chromatography</span></p>"
        },
        {
          "id": 200490,
          "text": "<p><span style=\"font-size:12.0pt;\">Ion exchange chromatography</span></p>"
        },
        {
          "id": 200491,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrophoresis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The best method to measure HbA<sub>1c</sub> is? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p>",
      "unique_key": "Q6602566",
      "question_audio": null,
      "question_video": null,
      "map_id": 34812048,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ion exchange chromatography</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Glycated hemoglobin (GHB), reported as hemoglobin A1c (HbA<sub>1c</sub>), is a biochemical marker that is used routinely in the management of individuals with diabetes mellitus to monitor long-term glycemic control and assess the risk of developing complications.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The fraction of hemoglobin glycated, normally about 5%, is proportionate to blood</span></p><p><span style=\"font-size:12.0pt;\">glucose concentration. Since the half-life of an erythrocyte is typically 60 days, the level of glycated hemoglobin (HbA<sub>1c</sub>) reflects the mean blood glucose concentration over the preceding 6–8 weeks.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Four basic types of methods are used most commonly to measure HbA<sub>1c</sub>: immunoassay, ion-exchange high-performance liquid chromatography (HPLC), boronate affinity HPLC, and enzymatic assays.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ion-exchange HPLC </strong>separates Hb species based on charge differences between HbA<sub>1c</sub> and other hemoglobins. It is considered as a<strong> gold standard for HbA<sub>1c</sub> analysis</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Isoelectric focusing:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Separates proteins based on their isoelectric points.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Limitation:</strong> Not commonly used for HbA1c measurement due to complexity and lower specificity for glycated hemoglobin.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Affinity chromatography:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Uses specific binding interactions to separate molecules.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Limitation:</strong> While effective in some contexts, it is not the most common method for routine HbA1c measurement.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Electrophoresis:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Separates proteins based on their size and charge under an electric field.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Limitation:</strong> Not as specific or reliable for HbA1c measurement compared to ion-exchange HPLC.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Ion-exchange chromatography is considered the gold standard for measuring HbA1c due to its high accuracy and ability to separate HbA1c from other hemoglobin variants based on charge differences.</span></p>",
      "correct_choice_id": 200490,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50123,
      "choices": [
        {
          "id": 200492,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum potassium</span></p>"
        },
        {
          "id": 200493,
          "text": "<p><span style=\"font-size:12.0pt;\">СВС</span></p>"
        },
        {
          "id": 200494,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum chloride</span></p>"
        },
        {
          "id": 200495,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum calcium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">After the delivery of an infant of a diabetic mother, the blood glucose of the Infant was 60 mg/dl. Which other investigation would you do? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4832661",
      "question_audio": null,
      "question_video": null,
      "map_id": 34550349,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Serum calcium</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In infants born to diabetic mothers, it is essential to assess the serum calcium level to rule out hypocalcemia. Infants of diabetic mothers are predisposed to conditions like hypoglycemia, hypocalcemia, and hypomagnesemia.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hypocalcemia </strong>is defined as a total serum calcium level below 8 mg/dL in term infants and below 7 mg/dL in preterm infants. This condition often occurs due to lower levels of parathyroid hormone (PTH) in infants of diabetic mothers. In utero, the higher levels of maternal serum ionized calcium may suppress the fetal parathyroid glands, leading to hypocalcemia after birth. If untreated, hypocalcemia can result in neurological symptoms, including seizures, headaches, and neurological deficits.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum potassium</strong>: Serum potassium is not directly related to hypoglycemia in infants of diabetic mothers. The primary concern in this scenario is hypocalcemia rather than potassium imbalance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CBC</strong>: While a complete blood count (CBC) can provide useful information, it is not specifically related to the metabolic risks associated with infants of diabetic mothers. Serum calcium is a more appropriate investigation in this context.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serum chloride</strong>: Serum chloride levels do not have a direct connection with hypoglycemia or the other metabolic issues typically seen in infants of diabetic mothers. Therefore, it is not the most relevant test in this scenario.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In infants of diabetic mothers, it is crucial to monitor serum calcium levels alongside blood glucose to detect and manage hypocalcemia, which can have significant neurological implications if untreated.</span></p>",
      "correct_choice_id": 200495,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50124,
      "choices": [
        {
          "id": 200496,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Septic shock</span></span></span></span></p>"
        },
        {
          "id": 200497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cardiogenic shock</span></span></span></span></p>"
        },
        {
          "id": 200498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypoglycemia</span></span></span></span></p>"
        },
        {
          "id": 200499,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Myxedema coma</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A middle-aged woman with a history of constipation, dry skin and menorrhagia presents to the ER with altered sensorium, non-pitting edema, hypothermia, bradycardia, and hypotension. What is the most likely diagnosis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q6199920",
      "question_audio": null,
      "question_video": null,
      "map_id": 34739086,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Myxedema coma</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Myxedema coma is part of myxedema crisis which can be considered as “<strong><em>Decompensated Hypothyroidism”,</em></strong><em> </em>where, organ dysfunctions occur compared to hypothyroidism (functioning is fairly preserved). </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is characterized by: </span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypothermia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypotension</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypoventilation</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Altered Mental Status (including coma /Hypersomnolence)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hyponatremia (Euvolemic similar to SIADH)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypoglycemia</span></span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Adrenal insufficiency may co-exist. Hence, treated with IV steroids + IV levothyroxine/Nasogastric LT4. </span></span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\"> </p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Steroid given to prevent precipitation of adrenal crisis as well.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Often precipitated by infection or major cardiopulmonary or neurologic illness. Rarely precipitated by severe cold climate exposure.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">No obvious source, fever suggestive of septic shock given in the question.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">No cardiac symptoms, elevated JVP, cardiac risk factors.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dry-skin, hypotension, hypothermia, menorrhagia as presentation of Hypoglycemia is unlikely.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In cases where a patient presents with hypothermia, bradycardia, hypotension, and altered mental status, especially in conjunction with a history suggestive of hypothyroidism, myxedema coma should be considered a critical diagnosis. Immediate and aggressive thyroid hormone replacement therapy is essential for survival.</span></span></span></span></p>",
      "correct_choice_id": 200499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50125,
      "choices": [
        {
          "id": 200500,
          "text": "<p><span style=\"font-size:12.0pt;\">Uveitis</span></p>"
        },
        {
          "id": 200501,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Retinitis pigmentosa</span></p>"
        },
        {
          "id": 200502,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Keratitis</span></p>"
        },
        {
          "id": 200503,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Glaucoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old girl is admitted for evaluation for recurrent seizures. She has a large port-wine stain on her face as shown below. The MRI of the head shows a leptomeningeal angioma. What is the most common ocular manifestation of the underlying condition?</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture7_xw827Wj.jpg\" alt=\"\" width=\"300\" height=\"280\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture7_xw827Wj.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2364525",
      "question_audio": null,
      "question_video": null,
      "map_id": 34167429,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Glaucoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Glaucoma is the most common ocular manifestation of Sturge-Weber syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Sturge-Weber syndrome (SWS)</strong> is a rare congenital vascular disorder characterized by facial capillary malformation (port-wine stain) and associated capillary-venous malformations affecting the brain and eye.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Mechanisms of glaucoma.</strong> The two main theories regarding the mechanism of glaucoma in eyes with SWS are developmental anomaly of the anterior chamber angle and elevated episcleral venous pressure, each of which leads to aqueous outflow restriction leading to rise in IOP. </span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-152605.png\" alt=\"\" width=\"1000\" height=\"296\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Uveitis:</strong> This is inflammation of the uvea and not a typical manifestation of SWS.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Retinitis pigmentosa:</strong> This is a group of genetic disorders that affect the retina's ability to respond to light, not commonly associated with SWS.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Keratitis:</strong> Inflammation or infection of the cornea, not linked to SWS.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In patients with Sturge-Weber syndrome, particularly those presenting with facial port-wine stains and neurological symptoms, glaucoma is a critical ocular manifestation to consider. Regular ophthalmic evaluations are essential due to the high incidence of glaucoma in these patients, focusing on managing elevated IOP to prevent vision loss.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-152605.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50126,
      "choices": [
        {
          "id": 200504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH</span></span></span></p>"
        },
        {
          "id": 200505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin</span></span></span></p>"
        },
        {
          "id": 200506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin</span></span></span></p>"
        },
        {
          "id": 200507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GH</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following hormones play a permissive role in the attainment of puberty? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q1358989",
      "question_audio": null,
      "question_video": null,
      "map_id": 34808159,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Leptin</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The hormone that plays a permissive role in the attainment of puberty is leptin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin is a peptide hormone released from adipocytes</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin plays an important role in controlling the adipose tissue and food intake. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Actions of leptin:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acts on hypothalamus and inhibits the feeding center, resulting in stoppage of food intake</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stimulates the metabolic reactions involved in utilization of fat stored in adipose tissue for energy. Thus, the circulating leptin level informs the brain about the energy storage and the necessity to regulate metabolic reactions, food intake and body weight</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated leptin levels might have a permissive effect on the pubertal process and pubertal growth.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. GnRH: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as GnRH directly stimulates the secretion of LH and FSH, which are critical for puberty but not considered permissive.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Insulin: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While it plays a supportive role in general growth and development, it is not specifically permissive for the onset of puberty.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. GH: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Growth hormone is vital for growth and development during puberty but does not have a direct permissive role in the initiation of puberty.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin serves a permissive role in puberty, indicating to the hypothalamus that sufficient energy reserves are available for the safe progression of reproductive development. This hormone essentially \"permits\" the initiation of puberty when energy conditions are met.</span></span></span></p>",
      "correct_choice_id": 200505,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50127,
      "choices": [
        {
          "id": 200508,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Metabolic acidosis with respiratory compensation</span></span></span></span></p>"
        },
        {
          "id": 200509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Respiratory acidosis with metabolic compensation</span></span></span></span></p>"
        },
        {
          "id": 200510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Respiratory alkalosis with metabolic compensation</span></span></span></span></p>"
        },
        {
          "id": 200511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Metabolic alkalosis with respiratory compensation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The arterial blood gas findings of a patient are pH = 7.32, pCO2 = 50, HCO3- = 29. What is the diagnosis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q2496876",
      "question_audio": null,
      "question_video": null,
      "map_id": 34391608,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Respiratory acidosis with metabolic compensation</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The patient's arterial blood gas (ABG) results indicate:</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">pH = 7.12 (<7.4 = acidemic/acidosis) → Metabolic vs respiratory (pCO2 > 40= Respiratory drive is towards acidosis while metabolic [HCO3-] is towards alkalosis) → Respiratory acidosis with metabolic compensation (Every 10 ↑ pCO2 = ↑4 HCO3- = Chronic).</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">These findings are characteristic of <strong><span style=\"font-family:\"Calibri\",sans-serif\">respiratory acidosis with metabolic compensation</span></strong>. In respiratory acidosis, the body compensates by increasing renal reabsorption of bicarbonate to buffer the excess hydrogen ions resulting from elevated CO2 levels, which shifts the pH back towards normal. This compensation is a slower process and suggests a chronic respiratory condition.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In cases where ABG shows a low pH and high pCO2 with compensatory high bicarbonate, the diagnosis is typically respiratory acidosis with metabolic compensation. This is indicative of a chronic condition where the body adjusts bicarbonate levels to buffer the increased acidity due to CO2 retention.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reference - Harrison/Acid-Base Disturbances</span></span></strong></span></span></p>",
      "correct_choice_id": 200509,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50128,
      "choices": [
        {
          "id": 200512,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondria</span></p>"
        },
        {
          "id": 200513,
          "text": "<p><span style=\"font-size:12.0pt;\">Golgi bodies</span></p>"
        },
        {
          "id": 200514,
          "text": "<p><span style=\"font-size:12.0pt;\">Secretory vesicles</span></p>"
        },
        {
          "id": 200515,
          "text": "<p><span style=\"font-size:12.0pt;\">Ribosomes</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The structure marked with the asterisk in the electron micrograph indicates? (AIIMS 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture1_DROcD2q.jpg\" alt=\"\" width=\"300\" height=\"305\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture1_DROcD2q.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4477644",
      "question_audio": null,
      "question_video": null,
      "map_id": 34273470,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Secretory vesicles</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Presynaptic secretory vesicles are indicated by the asterisk in the electron micrograph. The structure with the arrowhead represents postsynaptic density.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Neurons produce secretory vesicles, which are involved in electrochemical signalling in the brain and neuromuscular junctions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Synapse - electron microscopy</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/26/whatsapp-image-2023-06-12-at-1901216.jpg\" alt=\"\" width=\"400\" height=\"375\"></p><p> </p><p><span style=\"font-size:12.0pt;\">On electron microscopy:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mitochondria</strong>- On an electron microscope, mitochondria appear as round or elliptical bodies 0.5-2.0 micron long, with an outer and inner mitochondrial membrane, cristae, and mitochondrial matrix.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-3.jpg\" alt=\"\" width=\"490\" height=\"549\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B.  Golgi bodies</strong> (or Golgi apparatus) appear as stacks of flattened membranous cisternae surrounded by clusters of vesicles.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-4.jpg\" alt=\"\" width=\"500\" height=\"162\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ribosomes</strong> may be attached to the membrane of the rough endoplasmic reticulum (as shown in the image below), or else, they may exist as monosomes or as a chain of granular structures called polyribosomes associated with mRNA</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-5.jpg\" alt=\"\" width=\"636\" height=\"325\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Secretory vesicles are essential for neurotransmission at synapses, and play the critical role in neuronal communication.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/26/whatsapp-image-2023-06-12-at-1901216.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200514,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50129,
      "choices": [
        {
          "id": 200516,
          "text": "<p><span style=\"font-size:12.0pt;\">14 to 15 years</span></p>"
        },
        {
          "id": 200517,
          "text": "<p><span style=\"font-size:12.0pt;\">16 to 17 years</span></p>"
        },
        {
          "id": 200518,
          "text": "<p><span style=\"font-size:12.0pt;\">18 to 19 years</span></p>"
        },
        {
          "id": 200519,
          "text": "<p><span style=\"font-size:12.0pt;\">21 to 22 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A girl was allegedly kidnapped by a man. In court, she states that she is a major and is married to the man. X-ray images of her elbow, wrist, and pelvis are given. What is the approximate age of the girl?</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150344.jpg\" width=\"1231\" height=\"449\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150344.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7236183",
      "question_audio": null,
      "question_video": null,
      "map_id": 34031932,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 21 to 22 years</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The most approximate age of this girl is <strong>21-22 years</strong>. This conclusion is based on the X-ray findings of her bone centers:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The <strong>elbow joint centers</strong> (lower end of the humerus, upper end of the radius, and olecranon) are fused, indicating that the age is more than 16 years.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>wrist joint centers</strong> (lower end of the ulna and radius) are also fused, indicating the age is more than 19 years.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>hip bone centers</strong> (head of the femur, greater and lesser trochanter, ischial tuberosity) are fused, which typically occurs at or after 21 years.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Thus, based on the fusion of the ischial tuberosity and other bone centers, the girl’s age is estimated to be approximately 21 to 22 years, making her legally an adult.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Bone fusion patterns are critical in age estimation. Complete fusion of the wrist, elbow, and pelvic joints typically indicates an age of over 21 years, which is crucial in legal cases determining whether an individual is a minor or an adult.</span></p>",
      "correct_choice_id": 200519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50130,
      "choices": [
        {
          "id": 200520,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetazolamide</span></p>"
        },
        {
          "id": 200521,
          "text": "<p><span style=\"font-size:12.0pt;\">Labyrinthectomy</span></p>"
        },
        {
          "id": 200522,
          "text": "<p><span style=\"font-size:12.0pt;\">Vestibular neurectomy</span></p>"
        },
        {
          "id": 200523,
          "text": "<p><span style=\"font-size:12.0pt;\">Intratympanic gentamicin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the definitive approach for managing uncontrollable vertigo caused by Meniere's disease?(</span>AIIMS May 2018)</p>",
      "unique_key": "Q6686361",
      "question_audio": null,
      "question_video": null,
      "map_id": 34020065,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Labyrinthectomy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Definitive treatment of intractable vertigo due to Meniere’s disease is labyrinthectomy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The step-up management of Meniere’s disease is</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Dietary changes – low salt and caffeine free diet</span></li><li><span style=\"font-size:12.0pt;\">First-line medical treatment to prevent recurrence of vertigo may include <strong>betahistine dihydrochloride </strong>16 mg thrice daily and/or diuretics. Betahistine has a limited side effect profile while diuretics can cause electrolyte disturbances, potentially interacting with patient-specific drugs and conditions.</span></li><li><span style=\"font-size:12.0pt;\">Salvage treatment in case of medical treatment failure may include repetitive <strong>intratympanic injections of dexamethasone</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>In refractory cases </strong>after intratympanic injection of dexamethasone, <strong>intratympanic injection of gentamicin</strong> (as-needed) can be offered (recommendation grade A). This treatment is based on the vestibulotoxic effect of gentamicin and aims to destroy vestibular hair cell function (therefore also called partial chemo labyrinthectomy).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Surgical destruction (Labyrinthectomy, Vestibular nerve section): </strong>Labyrinthectomy totally destroys cochlear and vestibular function and are thus used only when cochlear function is not serviceable and when conservative treatments fail. It has shown the highest rate of vertigo control (>95%), and is considered as the single definitive treatment.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acetazolamide: </strong>This medication is not typically used as a definitive treatment for Meniere's disease. It may be used in some cases for its diuretic effect to manage symptoms, but it does not address the root causes or provide long-term control of vertigo.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vestibular neurectomy: </strong>This surgical procedure involves severing the vestibular nerve to alleviate vertigo while preserving hearing. It is considered for patients where hearing preservation is a priority, but it is not as definitive as labyrinthectomy for completely eliminating vertigo.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intratympanic gentamicin: </strong>This treatment involves injecting gentamicin, a vestibulotoxic antibiotic, into the middle ear to chemically ablate vestibular function. It is used as a salvage treatment for vertigo control in Meniere's disease when other medical treatments fail. However, it is not considered as definitive as labyrinthectomy due to its potential for hearing loss and the need for repeated treatments in some cases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For patients with Meniere's disease who have debilitating vertigo and no serviceable hearing in the affected ear, labyrinthectomy offers a definitive solution with a very high success rate in eliminating vertigo. This surgical option is reserved for severe cases where other less invasive treatments have been exhausted.</span></p>",
      "correct_choice_id": 200521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50131,
      "choices": [
        {
          "id": 200524,
          "text": "<p><span style=\"font-size:12.0pt;\">Presbyopia</span></p>"
        },
        {
          "id": 200525,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Aphakia</span></p>"
        },
        {
          "id": 200526,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Pediatric pseudophakia</span></p>"
        },
        {
          "id": 200527,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Hypermetropia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The spectacles shown in the image are not used for the management of which of the following? (</span>AIIMS May 2018)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_flbmEsJ.jpg\" alt=\"\" width=\"400\" height=\"142\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_flbmEsJ.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8466460",
      "question_audio": null,
      "question_video": null,
      "map_id": 34360480,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypermetropia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows a bifocal spectacle that is made of lenses with two different optical powers (upper half for distant vision and lower half for near vision). Hypermetropia, or farsightedness, primarily affects near vision, necessitating correction that provides a uniform optical adjustment across the entire lens surface to assist with close vision tasks, rather than segmented correction like in bifocals.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Bifocal spectacles are typically used for treating following conditions:</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-152331.png\" alt=\"\" width=\"1000\" height=\"234\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Bifocal spectacles are not typically used for treating hypermetropia, which generally requires a uniform optical correction across the entire lens to aid in near tasks. Bifocals are instead beneficial in conditions requiring simultaneous correction for near and far vision, such as presbyopia, or specific needs following surgical interventions like in aphakia and pediatric pseudophakia.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-152331.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200527,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50132,
      "choices": [
        {
          "id": 200528,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI Abdomen</span></p>"
        },
        {
          "id": 200529,
          "text": "<p><span style=\"font-size:12.0pt;\">USG Abdomen</span></p>"
        },
        {
          "id": 200530,
          "text": "<p><span style=\"font-size:12.0pt;\">СЕСТ</span></p>"
        },
        {
          "id": 200531,
          "text": "<p><span style=\"font-size:12.0pt;\">Exploratory laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-month-old child was brought with complaints of umbilical discharge. Abdominal examination was otherwise normal except for the below finding. The next step of management is: (AIIMS MAY 2018)</span></p><p> </p><p><span style=\"font-size:11.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-89_3BO2aHs.jpg\" alt=\"\" width=\"300\" height=\"232\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-89_3BO2aHs.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4175559",
      "question_audio": null,
      "question_video": null,
      "map_id": 34870630,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) USG Abdomen</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image is that of a congenital umbilical anomaly with an apparent discharging sinus. The given clinical scenario is suggestive of embryonal umbilical anomalies such as patent urachus, urachal cyst, and vitelline cyst (resulting from the persistence of omphalomesenteric duct). The next best step in the management of this case is USG abdomen to diagnose if the anomaly is cystic, fibrous, or of fistula.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Ultrasonography (USG) of the abdomen is a safe and non-invasive imaging technique commonly used to evaluate abdominal conditions in pediatric patients. It is particularly useful for assessing the umbilical region and identifying any abnormalities that may be causing the umbilical discharge. USG provides real-time imaging and can help in diagnosing conditions such as umbilical granulomas, urachal abnormalities, or other underlying issues.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>MRI Abdomen</strong>: MRI (Magnetic Resonance Imaging) of the abdomen is a valuable diagnostic tool for various abdominal conditions. However, in the case of a 3-month-old child with umbilical discharge, an ultrasound (USG) is typically the initial imaging modality of choice. MRI is generally reserved for more complex or specific cases.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>СЕСТ</strong>: CECT may be done after USG if further information was desired.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Exploratory laparotomy</strong>: Performing an exploratory laparotomy as the initial step in a 3-month-old child with umbilical discharge and an otherwise normal abdominal examination would be overly aggressive and not indicated.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Omphalomesenteric duct abnormalities:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Vitello intestinal duct or omphalomesenteric duct is the connection between yolk sac and the midgut during embryonic life, which eventually gets obliterated.</span></li><li><span style=\"font-size:12.0pt;\">The persistence of the vitellointestinal duct can lead to various abnormalities according to the part of the duct that is persistent.</span></li><li><span style=\"font-size:12.0pt;\">Persistence of the proximal intestinal end of the duct leads to Meckel's diverticula.</span></li><li><span style=\"font-size:12.0pt;\">Persistence of the distal end near umbilicus leads to umbilical sinus, likely to be the case here.</span></li><li><span style=\"font-size:12.0pt;\">Fully patent vitellointestinal duct can lead to enterocutaneous fistula.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/whatsapp-image-2024-09-09-at-60623-pm.jpeg\" alt=\"\" width=\"600\" height=\"160\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/whatsapp-image-2024-09-09-at-60623-pm.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200529,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50133,
      "choices": [
        {
          "id": 200532,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior uveitis</span></p>"
        },
        {
          "id": 200533,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjunctivitis</span></p>"
        },
        {
          "id": 200534,
          "text": "<p><span style=\"font-size:12.0pt;\">Fungal corneal ulcer</span></p>"
        },
        {
          "id": 200535,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal laceration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man presented to the OPD with complaints of pain, photophobia and redness of the right eye since 2 days. He gave a history of injury by a leaf, to the same eye, 5 days back. What is the likely diagnosis?(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2509540",
      "question_audio": null,
      "question_video": null,
      "map_id": 34419804,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Fungal corneal ulcer</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical situation suggests that it is a fungal corneal ulcer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fungal corneal ulcer is usually caused by trauma with vegetative or organic matter or injury by animal tail.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">A very characteristic feature of fungal corneal ulcer is that the <strong>Signs are much more than Symptoms</strong>.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-150712.png\" alt=\"\" width=\"1000\" height=\"521\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anterior uveitis:</strong> This involves inflammation of the middle layer of the eye, which can cause pain and redness but does not involve the specific corneal changes seen in fungal ulcers.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Conjunctivitis:</strong> An inflammation or infection of the outer membrane of the eyeball and the inner eyelid, typically causing redness and discharge, not the specific features of a corneal ulcer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Corneal laceration:</strong> While also a result of trauma, lacerations would generally present immediately post-injury with sharp, distinct cuts, rather than developing signs of infection such as those described.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A fungal corneal ulcer should be considered when a patient presents with eye symptoms following trauma involving vegetative or organic material. Key diagnostic features include a greyish-white ulcer with feathery margins, potentially accompanied by a hypopyon, and absence of corneal vascularization.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-150712.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200534,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50134,
      "choices": [
        {
          "id": 200536,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryoglobulinemic vasculitis</span></p>"
        },
        {
          "id": 200537,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyarteritis nodosa</span></p>"
        },
        {
          "id": 200538,
          "text": "<p><span style=\"font-size:12.0pt;\">EGPA</span></p>"
        },
        {
          "id": 200539,
          "text": "<p><span style=\"font-size:12.0pt;\">Giant cell arteritis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A triad of skin lesions, asymmetric mononeuritis multiplex and eosinophilia is seen in which of the following conditions? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4779600",
      "question_audio": null,
      "question_video": null,
      "map_id": 34004776,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) EGPA</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is characterized by a combination of <strong>asthma, eosinophilia, and vasculitis </strong>affecting multiple organ systems.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical triad of skin lesions (such as purpura or nodules), asymmetric mononeuritis multiplex (manifesting as numbness, pain, or muscle weakness typically in the limbs), and eosinophilia is highly suggestive of this condition. EGPA is a type of ANCA-associated vasculitis but differs from others in its prominent eosinophilic involvement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cryoglobulinemic vasculitis: </strong>Typically associated with hepatitis C infection and features immune complexes in the blood that precipitate in the cold. It commonly presents with palpable purpura, joint pains, and kidney involvement but not typically with eosinophilia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polyarteritis nodosa (PAN): </strong>A medium vessel vasculitis that may present with similar features including neuropathy and skin lesions but does not typically include eosinophilia as a prominent feature.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Giant cell arteritis (GCA): </strong>Primarily affects large vessels, particularly the temporal arteries, and presents with symptoms such as headache, jaw claudication, and potential blindness. It does not feature the triad of skin lesions, mononeuritis multiplex, and eosinophilia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">EGPA is a distinctive form of vasculitis marked by asthma, eosinophilia, and a systemic vasculitis involving skin and nerves among other systems. Its recognition is crucial due to the need for early and aggressive treatment to prevent significant morbidity and mortality.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture55.jpg\" alt=\"\" width=\"1000\" height=\"554\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Vasculitis/Chap 363</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture55.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200538,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50135,
      "choices": [
        {
          "id": 200540,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vicarious liability</span></span></span></p>"
        },
        {
          "id": 200541,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Doctrine of negligent choice</span></span></span></p>"
        },
        {
          "id": 200542,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Contributory negligence</span></span></span></p>"
        },
        {
          "id": 200543,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borrowed servant doctrine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A surgeon lends his assistant to a physician; the new employer is responsible for his actions by? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q9341827",
      "question_audio": null,
      "question_video": null,
      "map_id": 34242340,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D. Borrowed servant doctrine </strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The borrowed servant rule is a legal doctrine in which an employer is held liable for the actions of a temporary employee. When an employee is being borrowed, the lending employer temporarily surrenders control over this worker and the borrowing employer temporarily assumes control.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Vicarious liability: </span></strong><span style=\"font-size:12.0pt\">Incorrect. Vicarious liability is a legal principle where an employer is held responsible for the actions of their employees while they are performing their job duties. However, it does not specifically address situations involving borrowed employees.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Doctrine of negligent choice: </span></strong><span style=\"font-size:12.0pt\">Incorrect. The doctrine of negligent choice involves holding someone liable for choosing an incompetent or unfit person to perform a task. This doctrine is not directly relevant to the situation described.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Contributory negligence: </span></strong><span style=\"font-size:12.0pt\">Incorrect. Contributory negligence refers to a situation where the injured party has, through their own negligence, contributed to the harm they suffered. It does not apply to the responsibility of an employer for the actions of a borrowed employee.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The borrowed servant doctrine holds that the borrowing employer assumes liability for the actions of an employee borrowed from another employer during the period of borrowing. This ensures that the temporary employer is responsible for supervising and controlling the borrowed employee.</span></span></span></p>",
      "correct_choice_id": 200543,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50136,
      "choices": [
        {
          "id": 200544,
          "text": "<p><span style=\"font-size:12.0pt;\">Mouth-nose</span></p>"
        },
        {
          "id": 200545,
          "text": "<p><span style=\"font-size:12.0pt;\">Nose-mouth</span></p>"
        },
        {
          "id": 200546,
          "text": "<p><span style=\"font-size:12.0pt;\">Mouth-nose-oesophagus</span></p>"
        },
        {
          "id": 200547,
          "text": "<p><span style=\"font-size:12.0pt;\">Trachea-nose-mouth</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the correct order of suctioning during neonatal resuscitation? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2999779",
      "question_audio": null,
      "question_video": null,
      "map_id": 34892991,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mouth-nose</strong></span></p><p><br><span style=\"font-size:12.0pt;\">During neonatal resuscitation, suctioning is performed to clear the airway of the newborn to ensure effective breathing. The correct order for suctioning is <strong>mouth first, followed by the nose</strong>. This order is crucial because suctioning the nose first could cause the newborn to gasp and potentially aspirate any fluids or secretions present in the mouth.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Technical Details:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The suction catheter typically used is 12 or 14 French, and the suction pressure is maintained between 80-100 mmHg.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tracheal suctioning</strong> has become obsolete and is no longer routinely performed unless specifically indicated.</span></li><li><span style=\"font-size:12.0pt;\">Suctioning of the esophagus and stomach is avoided as it can stimulate the vagal nerve, leading to apnea and/or bradycardia.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nose-mouth: </strong>This is incorrect as suctioning the nose first increases the risk of aspiration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mouth-nose-oesophagus: </strong>Suctioning the esophagus is not part of the standard procedure and can cause complications such as vagal stimulation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Trachea-nose-mouth: </strong>Tracheal suctioning is obsolete and not recommended in modern neonatal resuscitation protocols.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">During neonatal resuscitation, the mouth should be suctioned before the nose to minimize the risk of aspiration and ensure a clear airway for effective ventilation.</span></p>",
      "correct_choice_id": 200544,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50137,
      "choices": [
        {
          "id": 200548,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">37 weeks</span></span></span></p>"
        },
        {
          "id": 200549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">39 weeks</span></span></span></p>"
        },
        {
          "id": 200550,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">38 weeks</span></span></span></p>"
        },
        {
          "id": 200551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">40 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A pregnant woman has gestational diabetes mellitus (GDM) and her blood glucose levels are well controlled on insulin. What will be the appropriate gestational age for her delivery? </span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q7195656",
      "question_audio": null,
      "question_video": null,
      "map_id": 34060144,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 39 weeks</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The appropriate timing of delivery in a pregnant woman with gestational diabetes mellitus (GDM) whose blood glucose levels are well controlled on insulin is at or after 39 weeks of gestation. This recommendation is based on the following considerations:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Lung Maturity:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> GDM pregnancies are associated with a delay in fetal lung maturity. Routine delivery before 39 weeks is generally not recommended to avoid respiratory complications in the newborn.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Induction of Labor:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> If the patient with well-controlled GDM has not delivered spontaneously by 39 weeks, induction of labor should be scheduled at or after 39 weeks to minimize the risks associated with GDM and to ensure fetal maturity.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other important points in GDM:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Avoid Past Dates:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Delivery should not be delayed beyond the expected due date to prevent complications.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Anticipate Shoulder Dystocia:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> There is an increased risk of shoulder dystocia in infants of mothers with GDM.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Prophylactic Cesarean Section (LSCS):</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Considered if the estimated fetal weight is greater than 4.5 kg to avoid complications during vaginal delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In a pregnant woman with well-controlled gestational diabetes mellitus (GDM) on insulin, the appropriate gestational age for delivery is at or after 39 weeks to ensure fetal lung maturity and reduce the risk of complications.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: </span></strong><a href=\"https://nhm.gov.in/images/pdf/programmes/maternal-health/guidelines/National_Guidelines_for_Diagnosis_&_Management_of_Gestational_Diabetes_Mellitus.pdf\" style=\"color:blue; text-decoration:underline\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">https://nhm.gov.in/images/pdf/programmes/maternal-health/guidelines/National_Guidelines_for_Diagnosis_&_Management_of_Gestational_Diabetes_Mellitus.pdf</span></strong></a></span></span></p>",
      "correct_choice_id": 200549,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50138,
      "choices": [
        {
          "id": 200552,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoriasis vulgaris</span></p>"
        },
        {
          "id": 200553,
          "text": "<p><span style=\"font-size:12.0pt;\">Leishmaniasis</span></p>"
        },
        {
          "id": 200554,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycosis fungoides</span></p>"
        },
        {
          "id": 200555,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The histopathology picture below is suggestive of? (</span>AIIMS May 2018)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13496.jpg\" alt=\"\" width=\"300\" height=\"217\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13496.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8427612",
      "question_audio": null,
      "question_video": null,
      "map_id": 34854866,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Pemphigus vulgaris</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given slide shows a <strong>row of tombstones' appearance</strong>, which is classically seen in Pemphigus vulgaris.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The production of <strong>antibodies, specifically those against Desmoglein 3</strong>, is seen in Pemphigus vulgaris. Desmoglein 1 antibodies are also occasionally associated. Usually, the antibodies are <strong>IgG antibodies</strong>. The skin and mucosa's <strong>basal and suprabasal</strong> layers contain the majority of <strong>Desmoglein 3</strong>. <strong>Hemidesmosomes </strong>help in connecting <strong>basal layer </strong>to underlying <strong>dermo-epidermal junction</strong>, in <strong>pemphigus vulgaris</strong> there are <strong>no antibodies</strong> against <strong>Hemidesmosomes</strong>, so the basal layer remains attached to the underlying dermo-epidermal junction giving the classical <strong>Row of tombstones appearance</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patients, therefore, present with <strong>flaccid bullae over the skin</strong> and due to Desmoglein 3 involvement, mucosal involvement can also be seen. <strong>Oral mucosa is commonly affected</strong>. Other areas where ulceration can be seen are conjunctiva, nasopharynx, larynx, etc.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cutaneous lesions are more common over the scalp, face, neck, upper chest, and back.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Biopsy: </strong>The basal layer remains adherent to the basement membrane and gives the resemblance to a <strong>row of tombstones.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13497.jpg\" alt=\"\" width=\"500\" height=\"178\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">IMAGE of row of tombstones appearance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Psoriasis vulgaris:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This is an <strong>autoimmune</strong> disease characterized by <strong>hyperproliferation of keratinocytes</strong> leading to thickened, <strong>scaly plaques</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Histologically, it shows <strong>parakeratosis</strong> (<strong>retention of nuclei </strong>in the stratum c<strong>orneum</strong>), elongation of <strong>rete ridges</strong>, and a <strong>neutrophilic </strong>infiltrate (<strong>Munro's </strong>microabscesses) as shown in the image below.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture8999.jpg\" alt=\"\" width=\"500\" height=\"223\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The tombstone appearance is not a feature of psoriasis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Leishmaniasis:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It's a <strong>parasitic</strong> infection caused by the <strong>Leishmania</strong> species.</span></li><li><span style=\"font-size:12.0pt;\">Histologically, it is characterized by <strong>macrophages</strong> containing the <strong>parasite</strong> <strong>(Leishman-Donovan bodies</strong>) in the <strong>dermis </strong>as shown in the image below.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture966.jpg\" alt=\"\" width=\"300\" height=\"298\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The tombstone appearance is not seen in leishmaniasis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycosis fungoides:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This is a type of <strong>cutaneous T-cell lymphoma</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Histologically, there is an <strong>atypical lymphocytic </strong>infiltrate in the epidermis <strong>(epidermotropism</strong>), and the formation of <strong>Pautrier's microabscesses </strong>(collections of l<strong>ymphocytes</strong> in the epidermis) as shown in the image below.</span></li></ul><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture10555.jpg\" alt=\"\" width=\"500\" height=\"284\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It does <strong>not</strong> exhibit a <strong>tombstone appearance</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The histopathology image suggests <strong>Pemphigus vulgaris</strong>, which is characterized by <strong>intraepidermal blistering</strong> due to <strong>acantholysis</strong>, or <strong>separation of keratinocytes</strong>, as a result of <strong>autoantibody</strong> attack on <strong>desmosomal proteins.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition Chapter 50 Page no 50.1-50.8</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13497.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200555,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50139,
      "choices": [
        {
          "id": 200556,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Red bin</span></p>"
        },
        {
          "id": 200557,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Yellow bin</span></p>"
        },
        {
          "id": 200558,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Blue bin</span></p>"
        },
        {
          "id": 200559,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Black bin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to the current biomedical waste management guidelines, which colored bin should be used </span><span style=\"color:black;font-size:12.0pt;\">for the disposal of blood bag? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9628727",
      "question_audio": null,
      "question_video": null,
      "map_id": 34086849,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Yellow bin </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Yellow Bin:</strong> Used for human and animal anatomical waste, soiled waste, expired or discarded medicines, chemical waste, and clinical lab waste.</span></li><li><span style=\"font-size:12.0pt;\">This includes items such as body parts, blood bags, and items contaminated with body fluids.</span></li><li><span style=\"font-size:12.0pt;\">The disposal methods typically involve incineration, plasma pyrolysis, deep burial, or chemical treatment.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/category222.jpg\" alt=\"\" width=\"800\" height=\"1080\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/category222.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50140,
      "choices": [
        {
          "id": 200560,
          "text": "<p><span style=\"font-size:12.0pt;\">1-5 days</span></p>"
        },
        {
          "id": 200561,
          "text": "<p><span style=\"font-size:12.0pt;\">7-10 days</span></p>"
        },
        {
          "id": 200562,
          "text": "<p><span style=\"font-size:12.0pt;\">10-30 days</span></p>"
        },
        {
          "id": 200563,
          "text": "<p><span style=\"font-size:12.0pt;\">30-60 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the incubation period of lymphogranuloma venereum? (INICET MAY 2018)</span></p>",
      "unique_key": "Q3995894",
      "question_audio": null,
      "question_video": null,
      "map_id": 34742292,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 10-30 days</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The incubation period of Lymphogranuloma venereum ranges from 10-30 days.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The causative agent is Chlamydia trachomatis, serovars <strong>L1, L2, L3</strong>. Chlamydia is a ubiquitous ovoid or obligate intracellular bacteria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Lymphogranuloma venereum <strong>primarily affects the lymphatic system</strong>. Chlamydia trachomatis serovars extend from the primary infection site to the regional lymph nodes and cause a lymphoproliferative reaction, facilitated by binding of Chlamydia trachomatis to the epithelial cells. Binding occurs via heparin sulfate receptors.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The basis for a definitive diagnosis of LGV is on serology tests (complement fixation or micro-immunofluorescence) or identification of Chlamydia trachomatis in genital, rectal and lymph node specimens (by culture, nucleic acid amplification test or direct immunofluorescence).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The incubation period of lymphogranuloma venereum (LGV) is 10-30 days. It is caused by Chlamydia trachomatis serovars L1, L2, and L3, and primarily affects the lymphatic system. Diagnosis is based on serological tests or identification of the bacteria in clinical specimens through various methods.</span></p>",
      "correct_choice_id": 200562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50141,
      "choices": [
        {
          "id": 200564,
          "text": "<p><span style=\"font-size:12.0pt;\">Inner plexiform layer</span></p>"
        },
        {
          "id": 200565,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿External limiting layer</span></p>"
        },
        {
          "id": 200566,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Internal limiting layer</span></p>"
        },
        {
          "id": 200567,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Outer plexiform layer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the marked layer of the retina: (</span>AIIMS May 2018)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/untitled-1rrr_tkipPsE.jpg\" alt=\"\" width=\"400\" height=\"380\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/untitled-1rrr_tkipPsE.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9294622",
      "question_audio": null,
      "question_video": null,
      "map_id": 34203169,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Inner plexiform layer</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The inner plexiform layer is marked in the above histological image of the retina.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-124946.jpg\" alt=\"\" width=\"700\" height=\"543\"></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-152115.png\" alt=\"\" width=\"1000\" height=\"606\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The inner plexiform layer of the retina is a crucial site for synaptic activity among various retinal cells, playing a key role in the preprocessing of visual information before it is sent to the brain. Recognizing this layer and understanding its function are important for comprehending the overall neural circuitry of the retina.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-124946.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50142,
      "choices": [
        {
          "id": 200568,
          "text": "<p><span style=\"font-size:12pt;\">Immediate termination</span></p>"
        },
        {
          "id": 200569,
          "text": "<p><span style=\"font-size:12pt;\">Give surfactant and wait till 36 weeks</span></p>"
        },
        {
          "id": 200570,
          "text": "<p><span style=\"font-size:12pt;\">Do Doppler everyday to check for reversion</span></p>"
        },
        {
          "id": 200571,
          "text": "<p><span style=\"font-size:12pt;\">Terminate after 37 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management? </span>(INICET MAY 2018)</p>",
      "unique_key": "Q6940379",
      "question_audio": null,
      "question_video": null,
      "map_id": 34616467,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Immediate termination</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The scenario described indicates fetal compromise, specifically with the findings of oligohydramnios (AFI = 5) and absent end-diastolic flow in the umbilical artery Doppler. These are signs of severe placental insufficiency and fetal distress.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Absent or Reversed End-Diastolic Flow:</strong> This is a critical finding on Doppler ultrasound indicating severe fetal compromise. The absence of end-diastolic flow in the umbilical artery suggests that the fetus is not receiving adequate blood flow, leading to an increased risk of hypoxia and stillbirth.</span></li><li><span style=\"font-size:12pt;\"><strong>Management:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Immediate Termination:</strong> For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Give surfactant and wait till 36 weeks:</strong> This is not appropriate because the immediate risk to the fetus requires prompt delivery.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Do Doppler everyday to check for reversion:</strong> Continuous monitoring is insufficient in this scenario as the condition indicates severe fetal distress requiring urgent intervention.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Terminate after 37 weeks:</strong> Waiting until 37 weeks is not appropriate due to the immediate risk of fetal compromise.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In cases of severe fetal compromise indicated by absent or reversed end-diastolic flow in the umbilical artery Doppler, especially beyond 34 weeks of gestation, immediate termination of the pregnancy is warranted to prevent fetal hypoxia and potential stillbirth.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2141, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200568,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50143,
      "choices": [
        {
          "id": 200572,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Burst forming units</span></span></span></p>"
        },
        {
          "id": 200573,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colony forming units</span></span></span></p>"
        },
        {
          "id": 200574,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Late erythroblast stage</span></span></span></p>"
        },
        {
          "id": 200575,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normoblast stage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The earliest stage at which erythropoietin is effective in red blood cell formation? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q4674548",
      "question_audio": null,
      "question_video": null,
      "map_id": 34226311,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Burst forming units</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythropoietin (EPO) primarily acts on early erythroid progenitor cells, particularly the Burst Forming Unit-Erythroid (BFU-E). The BFU-E is among the earliest erythroid progenitor cells and requires EPO to proliferate and differentiate into more mature forms of red blood cell precursors.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mechanism of Action:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BFU-E: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Burst Forming Unit-Erythroid is sensitive to erythropoietin and under its influence can proliferate and differentiate, giving rise to Colony Forming Unit-Erythroid (CFU-E).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CFU-E: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This stage follows BFU-E and leads to the development of more differentiated erythroid cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of EPO: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EPO binds to specific receptors on the surface of erythroid progenitor cells, initiating a cascade of intracellular events that promote cell survival, proliferation, and differentiation.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Colony forming units: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a later stage than BFU-E and is also influenced by EPO but not the earliest.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Late erythroblast stage: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EPO's influence diminishes as cells mature to this stage.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Normoblast stage: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a more mature stage of erythroid development where EPO has minimal effect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Erythropoietin is most effective at the burst forming unit stage of red blood cell development, where it stimulates the proliferation and differentiation of these early progenitor cells into more mature red blood cells.</span></span></p>",
      "correct_choice_id": 200572,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50144,
      "choices": [
        {
          "id": 200576,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">6 to 7 months</span></p>"
        },
        {
          "id": 200577,
          "text": "<p><span style=\"font-size:12.0pt;\">4 to 5 months</span></p>"
        },
        {
          "id": 200578,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">7 to 8 months</span></p>"
        },
        {
          "id": 200579,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Term</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the gestational age of the fetus if the Crown Rump Length is 21 cm, length of lower limb is 10 cm, gestational age of the fetus will be: (AIIMS May 2018)</span></p>",
      "unique_key": "Q6301700",
      "question_audio": null,
      "question_video": null,
      "map_id": 34217001,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. 6 to 7 months</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Crown rump length + length of lower limb = crown heel length</span></p><p> </p><p><span style=\"font-size:12.0pt;\">According to the <strong>Rule of Haase</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Age in months = Square root of crown-heel length (when the crown-heel length is 25 cm or less/ first 5 months).</span></li><li><span style=\"font-size:12.0pt;\">Age in months = crown-heel length divided by 5 (when the crown-heel length is more than 25 cm/ last 5 months).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Here, crown heel length = Crown rump + lower limb length = 31 cm.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hence, gestational age = 31 / 5 = 6-7 months.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Rule of Haase can be used to estimate gestational age from fetal measurements. For a crown-heel length greater than 25 cm, the gestational age is calculated by dividing the crown-heel length by 5.</span></p>",
      "correct_choice_id": 200576,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50145,
      "choices": [
        {
          "id": 200580,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Laparoscopic tubal ligation</span></span></span></p>"
        },
        {
          "id": 200581,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Copper-T</span></span></span></p>"
        },
        {
          "id": 200582,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Implanon</span></span></span></p>"
        },
        {
          "id": 200583,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">LNG-IUD</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is an irreversible method of contraception? </span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q3250585",
      "question_audio": null,
      "question_video": null,
      "map_id": 34111428,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Laparoscopic tubal ligation</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Contraceptive methods can be classified into temporary (reversible) and permanent (irreversible) methods.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Permanent Methods (Irreversible):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Laparoscopic Tubal Ligation:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is a surgical procedure where the fallopian tubes are cut, tied, or sealed to prevent pregnancy permanently. It is considered an irreversible method of contraception as it is intended to be a permanent solution for women who do not wish to have more children.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Temporary Methods (Reversible):</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Copper-T (Intrauterine Device - IUD):</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> A long-term but reversible method that can be removed when pregnancy is desired.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Implanon (Subdermal Contraceptive Implant):</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> A long-term reversible method that can be removed to restore fertility.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">LNG-IUD (Levonorgestrel Intrauterine Device):</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Another long-term reversible method that can be removed when pregnancy is desired.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Laparoscopic tubal ligation is a permanent (irreversible) method of contraception.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 611, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 200580,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50146,
      "choices": [
        {
          "id": 200584,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Age and serum cholesterol level</span></p>"
        },
        {
          "id": 200585,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Heart rate and body mass index</span></p>"
        },
        {
          "id": 200586,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sex and type of cancer</span></p>"
        },
        {
          "id": 200587,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Weight of a patient before and after a treatment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are working on a research project and need to determine the appropriate usage of the Chi-square test. </span><span style=\"color:black;font-size:12.0pt;\">Which of the following sets of data would be most appropriate for utilizing the Chi-square test? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9059589",
      "question_audio": null,
      "question_video": null,
      "map_id": 34893030,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Sex and type of cancer</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">The chi-square test is a nonparametric statistical method used to evaluate the significance of an association between two categorical variables.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Within the provided choices, the only pair of categorical variables (qualitative data) is sex and type of cancer. Therefore, this is the correct answer.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/222.jpg\" alt=\"\" width=\"900\" height=\"484\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/222.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200586,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50147,
      "choices": [
        {
          "id": 200588,
          "text": "<p><span style=\"font-size:12.0pt;\">Ganciclovir resistance is due to mutation in UL97 phosphotransferase gene</span></p>"
        },
        {
          "id": 200589,
          "text": "<p><span style=\"font-size:12.0pt;\">CMV can be cultured in vitro in any mammalian cell</span></p>"
        },
        {
          "id": 200590,
          "text": "<p><span style=\"font-size:12.0pt;\">Commonest manifestation of CMV associated disease is watery diarrhea</span></p><p> </p>"
        },
        {
          "id": 200591,
          "text": "<p><span style=\"font-size:12.0pt;\">UL54 mutated CMV strains do not show cross resistance to Foscarnet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the correct statement regarding CMV? (INICET MAY 2018)</span></p>",
      "unique_key": "Q8492472",
      "question_audio": null,
      "question_video": null,
      "map_id": 34796596,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Ganciclovir resistance is due to mutation in UL97 phosphotransferase gene</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Resistance to ganciclovir </strong>(GCV) most commonly occurs <strong>due to mutations in the UL97 phosphotransferase gene.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Viral UL97 kinase and UL54 DNA polymerase gene mutations are well-documented mechanisms of resistance to current antivirals. The UL97 kinase normally phosphorylates serine and threonine residues of various cellular and viral proteins, and is required for efficient CMV replication. This kinase also effects the initial phosphorylation of GCV that is required for antiviral activity, and UL97 mutations that impair this phosphorylation are the preferred mechanism of GCV resistance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>UL54 mutations can confer resistance to all current drugs</strong> and may emerge after prolonged GCV therapy to increase the level of resistance conferred by a pre-existing UL97 mutation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B: </strong>Human <strong>CMV replicates in vitro only in human fibroblasts</strong>, although the virus is often isolated from epithelial cells of the host.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>: CMV infection is <strong>mostly subclinical</strong>. In immunocompromised individuals, CMV can cause various manifestations, including retinitis, colitis, esophagitis, pneumonitis, and encephalitis, but watery diarrhea is not the most common manifestation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D: </strong>UL54 mutations can confer resistance to ganciclovir, cidofovir, and foscamet. These mutations affect the viral DNA polymerase, leading to cross-resistance to multiple antiviral drugs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">CMV is ganciclovir resistance is due to mutation in the UL97 phosphotransferase gene. This gene is responsible for the initial phosphorylation of ganciclovir, and mutations here can prevent the drug's activation, leading to resistance. Human CMV replicates in vitro only in human fibroblasts, and UL54 mutations can confer cross-resistance to multiple antiviral drugs, including foscarnet. CMV infections are mostly subclinical, and the common manifestations in immunocompromised patients are not typically watery diarrhea.</span></p>",
      "correct_choice_id": 200588,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50148,
      "choices": [
        {
          "id": 200592,
          "text": "<p><span style=\"font-size:12.0pt;\">Extradural Hemorrhage</span></p>"
        },
        {
          "id": 200593,
          "text": "<p><span style=\"font-size:12.0pt;\">Subdural Hemorrhage</span></p>"
        },
        {
          "id": 200594,
          "text": "<p><span style=\"font-size:12.0pt;\">Subarachnoid Hemorrhage</span></p>"
        },
        {
          "id": 200595,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraventricular Hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presented with a history of road traffic accident. The axial CT image of the child is shown below. What is the likely diagnosis? (AIIMS MAY 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-126_PNCl6dR.jpg\" alt=\"\" width=\"700\" height=\"772\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-126_PNCl6dR.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3165696",
      "question_audio": null,
      "question_video": null,
      "map_id": 34351237,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Extradural hemorrhage</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:10.5pt;\">The CT image shows a right-sided hyperdense area indicative of an acute extradural hemorrhage (EDH). Extradural hemorrhages typically result from high-energy trauma, such as a road traffic accident, and are often arterial in origin, frequently involving the middle meningeal artery (MMA). The classic biconvex or \"lens-shaped\" appearance, as observed, does not cross sutures but may cross the midline, distinguishing it from other types of hemorrhages.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Right sided hyperdense acute EDH is shown in the NCCT</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-127.jpg\" alt=\"\" width=\"400\" height=\"586\"></strong></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Subdural Hemorrhage:</strong> Typically presents with a crescentic or \"banana-shaped\" appearance, crosses sutures, and involves bridging veins, usually from lower energy trauma or trivial injuries, which is not compatible with the findings on this CT.</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Subarachnoid Hemorrhage:</strong> Involves bleeding into the subarachnoid space, generally producing a diffuse or layered appearance in the CT, which is not evident here.</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Intraventricular Hemorrhage:</strong> Results in blood within the ventricular system, showing up as hyperdense within the ventricles, not applicable to this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-102918.png\" alt=\"\" width=\"877\" height=\"396\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-127.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50149,
      "choices": [
        {
          "id": 200596,
          "text": "<p><span style=\"font-size:12pt;\">S3</span></p>"
        },
        {
          "id": 200597,
          "text": "<p><span style=\"font-size:12pt;\">S4</span></p>"
        },
        {
          "id": 200598,
          "text": "<p><span style=\"font-size:12pt;\">Fixed splitting of S2</span></p>"
        },
        {
          "id": 200599,
          "text": "<p><span style=\"font-size:12pt;\">Pericardial knock</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following heart sounds would be normal in pregnancy? </span>(INICET MAY 2018)</p>",
      "unique_key": "Q4446262",
      "question_audio": null,
      "question_video": null,
      "map_id": 34465129,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) S3</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">During pregnancy, the cardiovascular system undergoes significant changes to accommodate the increased blood volume and cardiac output required to support both the mother and the developing fetus. One of the normal physiological changes includes the presence of the S3 heart sound.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>S3 Heart Sound:</strong> The S3 sound, also known as the ventricular gallop, is due to rapid diastolic filling of the ventricles. It is commonly heard in pregnant women due to the increased blood volume and cardiac output.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other heart sounds mentioned are not typically considered normal in pregnancy</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. S4 Heart Sound:</strong> The S4 sound, or atrial gallop, is generally associated with pathological conditions such as left ventricular hypertrophy or myocardial ischemia. It is rare in pregnancy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Fixed Splitting of S2:</strong> Fixed splitting of the second heart sound is usually indicative of an atrial septal defect (ASD) and is not normal in pregnancy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Pericardial Knock:</strong> This is a sound heard in cases of constrictive pericarditis and is not a normal finding in pregnancy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The S3 heart sound is considered normal during pregnancy due to the increased blood volume and rapid diastolic filling of the ventricles.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 178, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50150,
      "choices": [
        {
          "id": 200600,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary spastic quadriplegia</span></p>"
        },
        {
          "id": 200601,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute combined degeneration</span></p>"
        },
        {
          "id": 200602,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuromyelitis optica</span></p>"
        },
        {
          "id": 200603,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old female patient presents with 6/60 visual acuity in one eye and 6/18 in the other eye. She has recurrent episodes of diminution of vision which recovers on treatment with steroids. She also has a history of transverse myelitis. What is the most probable diagnosis?</span></p>",
      "unique_key": "Q1626132",
      "question_audio": null,
      "question_video": null,
      "map_id": 34056010,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Neuromyelitis optica</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The most probable diagnosis is neuromyelitis optica (NMO).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">NMO is a demyelinating autoimmune disease that primarily affects the optic nerves and spinal cord. Patients with NMO can present with recurrent episodes of optic neuritis, which can result in decreased visual acuity, as well as myelitis, which can cause weakness, sensory loss, and bladder dysfunction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patient's history of recurrent episodes of diminution of vision that recovers on treatment with steroids is consistent with optic neuritis, which is a common presenting feature of NMO. The history of transverse myelitis also supports a diagnosis of NMO, as myelitis is a common feature of the disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Management of acute attacks:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">High-dose glucocorticoids</span></li><li><span style=\"font-size:12.0pt;\">Plasma exchange.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Drugs used for prophylaxis against relapses:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Mycophenolate mofetil</span></li><li><span style=\"font-size:12.0pt;\">Rituximab</span></li><li><span style=\"font-size:12.0pt;\">Glucocorticoids</span></li><li><span style=\"font-size:12.0pt;\">Azathioprine.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hereditary spastic quadriplegia:</strong> This is a genetic disorder affecting motor functions and does not involve optic neuritis or transverse myelitis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Subacute combined degeneration:</strong> Typically associated with vitamin B12 deficiency affecting the spinal cord, but not specifically linked with optic neuritis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Multiple sclerosis (MS):</strong> While MS can present with symptoms similar to NMO, including optic neuritis and spinal cord involvement, the pattern of attacks and the severity of symptoms in the context of transverse myelitis point more specifically to NMO, especially considering the distinct pathophysiology and antibody profiles (e.g., anti-aquaporin-4 antibodies).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Neuromyelitis optica should be considered in patients presenting with recurrent optic neuritis and transverse myelitis, especially when there is a good response to steroid treatment. Distinguishing NMO from multiple sclerosis is crucial, as treatment and prognosis differ significantly between these conditions.</span></p>",
      "correct_choice_id": 200602,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50151,
      "choices": [
        {
          "id": 200604,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral compartment</span></p>"
        },
        {
          "id": 200605,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior superficial compartment</span></p>"
        },
        {
          "id": 200606,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior deep compartment</span></p>"
        },
        {
          "id": 200607,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior compartment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Neurovascular bundle is absent in which compartment of the leg? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p>",
      "unique_key": "Q6629421",
      "question_audio": null,
      "question_video": null,
      "map_id": 34737158,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Posterior superficial compartment</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">There is no neurovascular bundle in the leg's posterior superficial compartment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The transverse intermuscular septum divides the posterior compartment of the leg into deep and superficial compartments.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The gastrocnemius, plantaris, and soles muscles are found in the posterior superficial compartment.</span></p><p>    </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-7.jpg\" alt=\"\" width=\"600\" height=\"323\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Neurovascular components in various compartments of leg are as follows:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Anterior compartment: Anterior tibial artery and Deep fibular/peroneal nerve</span></li><li><span style=\"font-size:12.0pt;\">Posterior deep compartment: Tibial nerve and posterior tibial vessels in the deep plane.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Lateral Compartment</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Muscles</strong>: This compartment primarily contains the peroneus longus and peroneus brevis (fibularis longus and fibularis brevis in newer nomenclature).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neurovascular Bundle</strong>: These muscles are innervated by the superficial fibular (peroneal) nerve. The blood supply comes from branches of the anterior tibial and fibular (peroneal) arteries.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Posterior Deep Compartment</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Muscles</strong>: This compartment contains the popliteus, flexor digitorum longus, flexor hallucis longus, and tibialis posterior.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neurovascular Bundle</strong>: These muscles are innervated by the tibial nerve. The blood supply primarily comes from the posterior tibial artery.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Anterior Compartment</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Muscles</strong>: This compartment houses the tibialis anterior, extensor hallucis longus, extensor digitorum longus, and fibularis (peroneus) tertius.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neurovascular Bundle</strong>: These muscles are innervated by the deep fibular (peroneal) nerve. The anterior tibial artery supplies blood to this compartment.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Posterior Superficial Compartment</strong> has the gastrocnemius, soleus, and plantaris muscles. These muscles are innervated by the tibial nerve. However, this compartment does not have a specific named artery or vein running through it, as the main vessels (the posterior tibial and fibular arteries and their accompanying veins) are located deep in the leg, closer to the bones. Instead, the vascular supply to these muscles comes from branching vessels that penetrate the compartment.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-7.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200605,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50152,
      "choices": [
        {
          "id": 200608,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior olivary nucleus</span></p>"
        },
        {
          "id": 200609,
          "text": "<p><span style=\"font-size:12.0pt;\">Raphe nucleus</span></p>"
        },
        {
          "id": 200610,
          "text": "<p><span style=\"font-size:12.0pt;\">Vestibular nucleus</span></p>"
        },
        {
          "id": 200611,
          "text": "<p><span style=\"font-size:12.0pt;\">Locus coeruleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following fibres reach the Purkinje cell directly?</span></p>",
      "unique_key": "Q9257229",
      "question_audio": null,
      "question_video": null,
      "map_id": 34274609,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Inferior olivary nucleus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The fibres of inferior olivary nucleus (climbing fibres) reach the purkinje cell directly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The inferior olivary nucleus is a key part of the cerebellar circuitry and is responsible for providing input to the Purkinje cells via the climbing fibers. These fibers make direct synaptic connections with Purkinje cells and are involved in the modulation of motor learning, control, and coordination. The inferior olivary nucleus receives a wide range of inputs from other areas of the brain, including the spinal cord and sensory systems, and is thought to play an important role in the integration of sensory and motor information during movement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Excitatory and inhibitory fibres –</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-154222_fNgzyCp.png\" alt=\"\" width=\"500\" height=\"455\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Raphe nucleus: </strong>Primarily associated with serotonin production, influencing many brain functions including mood and sleep, but does not directly connect to Purkinje cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vestibular nucleus: </strong>Sends information to the cerebellum about head position and movement via mossy fibers, not directly to Purkinje cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Locus coeruleus: </strong>Provides widespread noradrenergic projections that influence arousal and attentiveness, not directly targeting Purkinje cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Climbing fibers from the inferior olivary nucleus directly synapse onto Purkinje cells in the cerebellum, playing a pivotal role in motor control and learning processes.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-154222_fNgzyCp.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50153,
      "choices": [
        {
          "id": 200612,
          "text": "<p><span style=\"font-size:12.0pt;\">It should be started within 4 hours of receiving it from the blood bank.</span></p>"
        },
        {
          "id": 200613,
          "text": "<p><span style=\"font-size:12.0pt;\">It should be completed within 4 hours of receiving from the blood bank.</span></p>"
        },
        {
          "id": 200614,
          "text": "<p><span style=\"font-size:12.0pt;\">No such time restraint and can be done anytime.</span></p>"
        },
        {
          "id": 200615,
          "text": "<p><span style=\"font-size:12.0pt;\">It should be completed within 6 hours of receiving from the blood bank.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is correct regarding transfusion of the blood received from blood bank? </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q9690224",
      "question_audio": null,
      "question_video": null,
      "map_id": 34793910,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) It should be completed within 4 hours of receiving from the blood bank.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Blood received from blood bank should be completely transfused within 4 hours of receiving.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Principles of blood administration:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">All blood products should be given through an appropriate blood administration set containing a filter.</span></li><li><span style=\"font-size:12.0pt;\">A careful aseptic technique should be practiced at all times.</span></li><li><span style=\"font-size:12.0pt;\">Vital signs should be documented before and after transfusion and as clinically required. For the first 15 minutes after the infusion has begun, the patient should be kept under close observation to detect any signs of a serious transfusion reaction. If none is observed, the infusion rate may be increased.</span></li><li><span style=\"font-size:12.0pt;\">One unit of red cells is often given in 1 to 4 hours, depending on the amount to be transfused and on the patient's cardiovascular status. <strong>Infusion of a unit for longer than 4 hours is not recommended, as there is a risk of bacterial proliferation because the opened unit is at room temperature.</strong></span></li><li><span style=\"font-size:12.0pt;\">No other solution and no medication should be added to or infused through the same tubing as a blood product.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ringer's lactate or other solutions containing calcium must never be added to a blood product because the calcium present leads to coagulation</strong>.</span></li><li><span style=\"font-size:12.0pt;\">After the transfusion has been completed, the transfusion tag or record should become part of the patient's chart.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It should be started within 4 hours of receiving it from the blood bank</strong>: This option is incorrect as the emphasis is on completing the transfusion within 4 hours, not just starting it.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. No such time restraint and can be done anytime</strong>: This is incorrect, as there is a specific time frame to prevent bacterial proliferation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It should be completed within 6 hours of receiving from the blood bank</strong>: This option is incorrect; the recommended maximum time for completion is 4 hours.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Blood transfusions must be completed within 4 hours of receiving the blood from the blood bank</strong> to minimize the risk of bacterial proliferation and ensure patient safety.</span></p>",
      "correct_choice_id": 200613,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50154,
      "choices": [
        {
          "id": 200616,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Type II error is small and we can accept the findings of the study</span></p>"
        },
        {
          "id": 200617,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The probability of false negative conclusion that operation A is better than B is 4%</span></p>"
        },
        {
          "id": 200618,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The power of the study to detect the difference between operation A and B is 96%</span></p>"
        },
        {
          "id": 200619,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The probability of a false positive conclusion that operation A is better than B is 4%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a journal club discussion on a randomized controlled trial comparing two surgical techniques for direct inguinal hernia, the reported p-value is 0.04. What is the most accurate interpretation of this p-value? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q8558701",
      "question_audio": null,
      "question_video": null,
      "map_id": 34341092,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) The probability of a false positive conclusion that operation A is better than B is 4%</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">With a calculated p-value of 0.04, we can deduce that there is a 4% chance of arriving at a false positive conclusion, suggesting that operation A is superior to operation B.</span></li><li><span style=\"color:black;font-size:12.0pt;\">In this context, the p-value of 0.04 attains statistical significance by conventional standards.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Consequently, we have grounds to reject the null hypothesis and accept the alternative hypothesis, indicating that operation A outperforms operation B.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">A p-value of 0.04 suggests that there is a statistically significant difference, at the 5% significance level, between the surgical techniques being compared, assuming the risk of a false positive conclusion is acceptable at 4%.</span></li></ul>",
      "correct_choice_id": 200619,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50155,
      "choices": [
        {
          "id": 200620,
          "text": "<p><span style=\"font-size:12.0pt;\">Candida albicans</span></p>"
        },
        {
          "id": 200621,
          "text": "<p><span style=\"font-size:12.0pt;\">Candida glabrata</span></p>"
        },
        {
          "id": 200622,
          "text": "<p><span style=\"font-size:12.0pt;\">Candida parapsilosis</span></p>"
        },
        {
          "id": 200623,
          "text": "<p><span style=\"font-size:12.0pt;\">Candida tropicalis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following test is positive for identification of: (INICET MAY 2018)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-244.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-244.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4524702",
      "question_audio": null,
      "question_video": null,
      "map_id": 34491530,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Candida albicans</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows the germ tube test used for identifying Candida albicans.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Germ tube test is a screening test for the presumptive identification of Candida albicans. Candida dubliniensis can also form germ tubes and Candida tropicalis can produce pseudohyphae that closely resemble germ tubes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Germ tube formation was first reported by Reynolds and Braude and hence the germ tube test is also known as <strong>Reynolds-Braude phenomenon</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Buds and pseudo-hyphae can be distinguished from germ tubes by the constricted attachment at the point of origin. Germ tubes don’t show constriction at the point of origin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Candida albicans and Candida dubliniensis produce short, slender, tube-like structures called germ tubes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The formation of germ tubes is associated with increased synthesis of protein and ribonucleic acid. Various media like fetal bovine serum may be used as a substitute for human pooled serum.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-245.jpg\" alt=\"\" width=\"400\" height=\"239\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Candida glabrata:</strong> Candida glabrata does not produce germ tubes. It forms small, round yeast cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Candida parapsilosis:</strong> Candida parapsilosis does not produce germ tubes. It forms pseudohyphae and yeast cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Candida tropicalis:</strong> Candida tropicalis can produce pseudohyphae that resemble germ tubes, but they show constriction at the point of origin. This is a distinguishing feature from the true germ tubes of Candida albicans.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The germ tube test is used for the presumptive identification of Candida albicans. It detects the formation of germ tubes, which are characteristic of Candida albicans and Candida dubliniensis but not other Candida species. Germ tubes are short, slender, tube-like structures without constriction at their point of origin, differentiating them from pseudohyphae.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-245.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50156,
      "choices": [
        {
          "id": 200624,
          "text": "<p><span style=\"font-size:12.0pt;\">Scaphoid</span></p>"
        },
        {
          "id": 200625,
          "text": "<p><span style=\"font-size:12.0pt;\">Triquetrum</span></p>"
        },
        {
          "id": 200626,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal end of radius</span></p>"
        },
        {
          "id": 200627,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal end of ulna</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following take part in the formation of the wrist joint, except: (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4080704",
      "question_audio": null,
      "question_video": null,
      "map_id": 34243231,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Distal end of ulna</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The distal end of the ulna does not directly participate in the wrist joint. Instead, it articulates with the triangular fibrocartilage complex (TFCC). The TFCC acts as a cushion and allows for the smooth rotation of the radius over the ulna during forearm pronation and supination. Due to this articulation with the TFCC and not with the carpal bones, the distal end of the ulna does not form the wrist joint.  .</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Scaphoid</strong>: The scaphoid is one of the eight carpal bones in the wrist and is situated on the radial side of the carpus. It articulates proximally with the radius and participates in the formation of the wrist joint.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Triquetrum</strong>: The triquetrum is another one of the carpal bones. It is located on the ulnar side of the carpus. Like the scaphoid, the triquetrum also articulates with the distal end of the radius, contributing to the wrist joint's structure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Distal end of radius</strong>: The wrist joint is primarily formed by the articulation between the distal end of the radius and the proximal row of carpal bones, specifically the scaphoid, lunate, and triquetrum. Thus, the distal end of the radius plays a crucial role in the formation and function of the wrist joint.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The radiocarpal joint, also known as the wrist joint, is a synovial, biaxial, and ellipsoid joint created by the articulation of:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Triangular fibrocartilage articular disc</span></li><li><span style=\"font-size:12.0pt;\">The scaphoids, lunates, and triquetrum</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Just the scaphoid and lunate are in contact with the radius and articular disc when the wrist is in its neutral position; the triquetrum does not come into contact with the disc until the wrist joint is fully adducted.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-162551.JPG\" alt=\"\" width=\"500\" height=\"301\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-162551.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50157,
      "choices": [
        {
          "id": 200628,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">10%</span></span></span></p>"
        },
        {
          "id": 200629,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">100%</span></span></span></p>"
        },
        {
          "id": 200630,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">50%</span></span></span></p>"
        },
        {
          "id": 200631,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Variable</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the bioavailability of a drug administered intravenously?</span></span></p>",
      "unique_key": "Q7829620",
      "question_audio": null,
      "question_video": null,
      "map_id": 34529139,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. 100%</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bioavailability of an administered drug is the fraction of that drug that reaches unchanged into systemic circulation. It depends upon 2 factors:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absorption of the drug from the site of application</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">First pass metabolism</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The bioavailability of a drug administered intravenously (I.V) is 100% because it is neither subjected to the first-pass metabolism as in oral route nor does it depend on local factors that affect absorption as in subcutaneous, intramuscular, or transdermal. In IV route, the drug is directly delivered to the systemic circulation and hence has the maximum availability for action at the intended site.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The bioavailability of a drug administered intravenously is 100% because the drug is directly delivered into the systemic circulation without any loss due to absorption barriers or first-pass metabolism.</span></span></span></p>",
      "correct_choice_id": 200629,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50158,
      "choices": [
        {
          "id": 200632,
          "text": "<p><span style=\"font-size:12.0pt;\">Remove with bronchoscopy</span></p>"
        },
        {
          "id": 200633,
          "text": "<p><span style=\"font-size:12.0pt;\">Remove endoscopically</span></p>"
        },
        {
          "id": 200634,
          "text": "<p><span style=\"font-size:12.0pt;\">Reassure and to check whether passed in stools</span></p>"
        },
        {
          "id": 200635,
          "text": "<p><span style=\"font-size:12.0pt;\">Induce vomiting</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with history of acute dysphagia. CXR is shown below. What is the next best step? (AIIMS 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-124.jpg\" alt=\"\" width=\"652\" height=\"441\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-124.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7884042",
      "question_audio": null,
      "question_video": null,
      "map_id": 34311148,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Remove endoscopically</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given CXR shows a foreign body in the esophagus which is likely to be a button battery as seen by the double margins.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-125.jpg\" alt=\"\" width=\"400\" height=\"346\"></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">In profile/ en face: Foreign body is in the esophagus</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The next step should be to endoscopically removing those batteries as they lead to tissue necrosis by liquefactive necrosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patient’s oral intake should be prohibited until the location of the foreign body is confirmed. Never induce vomiting in these patients as it can again lodge back in the esophagus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Remove with bronchoscopy:</strong> Bronchoscopy is not suitable as the foreign body is located in the esophagus, not the airways.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Reassure and check whether passed in stools:</strong> This approach is inappropriate due to the urgent risk of tissue damage from the battery; immediate removal is necessary.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Induce vomiting:</strong> Inducing vomiting is contraindicated as it can cause further esophageal injury or lead to re-lodgement of the battery in the esophagus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In cases of suspected ingestion of button batteries as seen on CXR, urgent endoscopic removal is critical to prevent tissue damage and potential complications. Vomiting should never be induced in these situations as it can exacerbate the problem.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-125.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50159,
      "choices": [
        {
          "id": 200636,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Strength of muscle contraction</span></span></span></p>"
        },
        {
          "id": 200637,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intensity of stimulus</span></span></span></p>"
        },
        {
          "id": 200638,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amplitude of action potential</span></span></span></p>"
        },
        {
          "id": 200639,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Duration of stimulus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weber-Fechner law relates magnitude of sensation to? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q2507878",
      "question_audio": null,
      "question_video": null,
      "map_id": 34964352,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Intensity of stimulus</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Weber-Fechner law is a psychophysical law that describes the relationship between the magnitude of a physical stimulus and the perceived intensity of the resulting sensation. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">According to this law, the perceived magnitude of a sensory stimulus is proportional to the logarithm of the stimulus intensity. In other words, as the intensity of the stimulus increases, the change needed to produce a noticeable difference in sensation also increases, and this relationship is logarithmic rather than linear.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-150236.png\" style=\"height:418px; width:600px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The law was first formulated by the German scientists Ernst Heinrich Weber and Gustav Theodor Fechner in the mid-19th century and has since been applied to a wide range of sensory modalities, including vision, hearing, and touch.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Strength of muscle contraction: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is unrelated to the Weber-Fechner law, which does not concern muscle contraction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Amplitude of action potential: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While action potentials are critical for neural transmission, the Weber-Fechner law specifically relates to the perception of stimulus intensity, not the electrical properties of neurons.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Duration of stimulus: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The duration of a stimulus affects perception in different ways but is not the focus of the Weber-Fechner law.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Weber-Fechner law illustrates the logarithmic relationship between the actual intensity of a stimulus and the perceived intensity, emphasizing that the human sensory system scales the perception of stimulus magnitude logarithmically rather than linearly.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additional information </span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Laws in Physiology:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Doctrine of specific nerve energies states that the nature of perception is defined by the pathway over which the sensory information is carried. Hence, the origin of the sensation is not important. </span></span></span></li>\r\n\t<li><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Law of projection</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> - Regardless of stimulation point for a particular sensory pathway (along its course to cortex), conscious sensation produced is referred to the location of receptor.</span></span></li>\r\n</ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-150236.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200637,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50160,
      "choices": [
        {
          "id": 200640,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis virus</span></p>"
        },
        {
          "id": 200641,
          "text": "<p><span style=\"font-size:12.0pt;\">Influenza virus</span></p>"
        },
        {
          "id": 200642,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV</span></p>"
        },
        {
          "id": 200643,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organisms is represented by the given form of replication? (INICET MAY 2018)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-12.jpg\" alt=\"\" width=\"700\" height=\"489\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-12.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5541750",
      "question_audio": null,
      "question_video": null,
      "map_id": 34018995,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Influenza virus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image shows the replication of influenza virus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Stages of replication:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Replication of influenza A viruses in the lung epithelium.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Binding of haemagglutinin (HA</strong>), expressed on the surface of the influenza virion, <strong>with sialic acid</strong> <strong>residues</strong> linked to cell surface glycans induces binding and fusion of the virion with the plasma membrane of the target cell.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The virus then enters the cell via endocytosis or micropinocytosis and is trafficked to the lysosome where acidification activates the proton selective matrix protein-2 viral channel (M2), inducing membrane fusion and dissociation of the viral ribonucleoprotein (RNP) core, which is then <strong>transported to the nucleus where viral RNA replication occurs</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Progeny viral RNP cores are generated in the cytosol and, with the viral surface proteins, HA and neuraminidase (NA), and other viral proteins, are concentrated in and near lipid rafts at the plasma membrane.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Budding of these plasma membrane regions forms complete viral progeny, which is linked to the plasma membrane by HA/sialic acid interactions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cleavage of sialic acid residues by neuraminidase releases the viral progeny so they are then free to infect other cells, which can be prevented by NA inhibitors.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hepatitis virus:</strong> Hepatitis viruses have different replication mechanisms and do not exhibit the specific stages shown in the image for influenza virus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HIV:</strong> HIV is a retrovirus that integrates its RNA into the host DNA using reverse transcriptase, followed by integration into the host genome, which is not depicted in the given image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Herpes virus:</strong> Herpes viruses have a different replication mechanism involving DNA replication within the nucleus and the formation of nucleocapsids in the nucleus, not shown in the given image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The replication cycle depicted in the image is characteristic of the influenza virus, involving binding of hemagglutinin (HA) to sialic acid residues, endocytosis, acidification within lysosomes, RNA replication in the nucleus, assembly at the plasma membrane, and release mediated by neuraminidase.</span></p>",
      "correct_choice_id": 200641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50161,
      "choices": [
        {
          "id": 200644,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroids</span></p>"
        },
        {
          "id": 200645,
          "text": "<p><span style=\"font-size:12.0pt;\">Isotretinoin</span></p>"
        },
        {
          "id": 200646,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 200647,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetracycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the case of a patient presenting with multiple nodulocystic lesions on the face, which drug is considered the preferred choice for treatment?(</span>AIIMS May 2018)</p>",
      "unique_key": "Q2699501",
      "question_audio": null,
      "question_video": null,
      "map_id": 34088310,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Isotretinoin</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is a case of <strong>nodular acne.</strong> It comes under <strong>grade IV/severe acne</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Oral isotretinoin</strong>, an oral <strong>retinoid</strong> is indicated for the treatment of <strong>severe acne (nodular, acne conglobata & recalcitrant acne.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Recalcitrant acne </strong>is <strong>poorly responsive</strong> acne, with <strong>less than 50% improvement</strong> after 6 months of therapy with <strong>combined oral & topical antibiotics</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">ACNE VULGARIS:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Most common form of acne.</span></li><li><span style=\"font-size:12.0pt;\">Most characteristic lesion - Comedones.</span></li><li><span style=\"font-size:12.0pt;\">Most severe form of acne vulgaris - Grade IV / Nodulocystic Acne.</span></li><li><span style=\"font-size:12.0pt;\">Most severe form of acne - Acne conglobata.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Comedones </strong>(are considered as <strong>special lesions</strong>) are the <strong>specific lesions</strong> of acne vulgaris</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Acne </strong>is a <strong>chronic inflammatory</strong> disease of the <strong>pilosebaceous unit</strong>. Comedonal lesions are the <strong>Earliest lesions</strong> of acne. They represent the keratin plugs of the pilosebaceous duct.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">When the <strong>keratin plug</strong> is <strong>inside</strong> the follicle, it is called a <strong>closed</strong> comedone or <strong>whitehead</strong> .</span></p><p> </p><p><span style=\"font-size:12.0pt;\">When the <strong>keratin plug</strong> is <strong>exposed</strong> to the environment, it gets <strong>oxidised</strong> by the air & turns <strong>black</strong> which is known as <strong>open comedone (blackhead)</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Stages of acne</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture65555.jpg\" alt=\"\" width=\"500\" height=\"612\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">According to <strong>Global alliance algorithm</strong> for acne, <strong>Oral isotretinoin</strong> is indicated for the treatment of severe acne.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Global alliance algorithm for acne treatment</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Image: global alliance algorithm for improving outcomes in acne</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Global alliance algorithm for acne treatment:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13493.jpg\" alt=\"\" width=\"700\" height=\"137\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13494.jpg\" alt=\"\" width=\"700\" height=\"353\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">BPO= Benzoyl peroxide.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. </strong>Steroids particularly <strong>corticosteroids</strong>, can reduce inflammation and are sometimes used to treat severe <strong>inflammatory</strong> conditions. However, <strong>systemic</strong> corticosteroids are generally not a first-line treatment for nodulocystic acne because of their potential side effects, including <strong>exacerbating acne</strong> upon <strong>withdrawal.</strong> <strong>Intralesional</strong> corticosteroids can be used for <strong>large, painful</strong> nodules but are not the primary treatment for widespread nodulocystic acne.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Erythromycin: </strong>It<strong> </strong>is an antibiotic that can be used to treat acne due to its <strong>antibacteria</strong>l effects against <strong>Cutibacterium acnes</strong> (formerly <strong>Propionibacterium acnes)</strong>, the bacteria partly responsible for acne. However, it is not as effective as isotretinoin for severe nodulocystic acne and is generally used for less severe forms or when other treatments are contraindicated.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tetracycline:</strong> It is another class of antibiotics used in the treatment of acne. While tetracyclines can be effective for <strong>inflammatory</strong> acne, they are typically less effective than isotretinoin for severe nodulocystic acne and are not the preferred treatment in such cases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>::</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Isotretinoin </strong>is the preferred treatment for <strong>severe nodulocystic</strong> acne due to its comprehensive action on <strong>reducing sebum</strong> production, decreasing <strong>inflammation</strong>, and <strong>normalizing keratinization</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Volume 3 Chapter 90 page no 90.7 & 90.37</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture65555.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200645,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50162,
      "choices": [
        {
          "id": 200648,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Swabs should be taken immediately after moistening with sterile water</span></p>"
        },
        {
          "id": 200649,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">It is most commonly caused by incisors and canines</span></p>"
        },
        {
          "id": 200650,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Photograph is taken with two scales at right angle to one another in the vertical plane</span></p>"
        },
        {
          "id": 200651,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">3D imaging is possible in the given condition</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A mentally challenged person bites his brother on the hand during a physical fight. All of the following statements are true about the given condition except? (</span>AIIMS May 2018)</p><p> </p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/image-7.jpg\" alt=\"\" width=\"400\" height=\"214\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/image-7.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6898686",
      "question_audio": null,
      "question_video": null,
      "map_id": 34760094,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Photograph is taken with two scales at right angle to one another in the vertical plane</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct method for photographing bite marks is to use two scales placed at right angles to each other in the horizontal plane. This positioning ensures that the dimensions and orientation of the bite mark are accurately recorded for forensic analysis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Swabs should be taken immediately after moistening with sterile water: </strong>Correct. Swabbing the bite mark is essential for collecting DNA evidence, which can be critical in identifying the biter.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is most commonly caused by incisors and canines: </strong>Correct. Bite marks are typically made by the front teeth, especially the incisors and canines, which are used to grasp and tear.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 3D imaging is possible in the given condition: </strong>Correct. 3D imaging can be used to analyze bite marks more accurately, providing detailed information about the depth and pattern of the bite.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In a human bite mark:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Swabs should be taken immediately after moistening with sterile water</span></li><li><span style=\"font-size:12.0pt;\">It is most commonly caused by front teeth - incisors and canines</span></li><li><span style=\"font-size:12.0pt;\">Photograph is taken with two scales at right angle to one another in the <strong>HORIZONTAL plane</strong></span></li><li><span style=\"font-size:12.0pt;\">3D imaging is a valuable tool for analysis</span></li></ul>",
      "correct_choice_id": 200650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50163,
      "choices": [
        {
          "id": 200652,
          "text": "<p><span style=\"font-size:12.0pt;\">Monophasic</span></p>"
        },
        {
          "id": 200653,
          "text": "<p><span style=\"font-size:12.0pt;\">Biphasic</span></p>"
        },
        {
          "id": 200654,
          "text": "<p><span style=\"font-size:12.0pt;\">Triphasic</span></p>"
        },
        {
          "id": 200655,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent flow</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The normal Doppler waveform of the venous blood flow is: (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5372627",
      "question_audio": null,
      "question_video": null,
      "map_id": 34829087,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Monophasic</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The normal Doppler waveform for venous blood flow is monophasic. This refers to the uniform, steady, and continuous flow pattern typically observed in veins, unlike the varying phases seen in arterial blood flow. Monophasic waveforms indicate a lack of cardiac modulation and resistance, which is characteristic of venous structures that carry blood under lower pressure and with less force than arteries.</span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-104938.png\" alt=\"\" width=\"626\" height=\"282\"></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Biphasic:</strong> Generally observed in visceral arteries, biphasic waveforms show two distinct directional phases in the blood flow, reflecting the resistance encountered by the blood as it moves through these arteries.</span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-104951.png\" alt=\"\" width=\"617\" height=\"255\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Triphasic:</strong> This waveform is characteristic of extremity arteries and includes three phases—forward flow, brief reverse flow, and forward flow again, which correspond to the cardiac cycle's effects on arterial blood movement.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-105005.png\" alt=\"\" width=\"621\" height=\"255\"></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Absent flow:</strong> This is not a normal finding and indicates a blockage or absence of blood flow, which requires further investigation.</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>Doppler waveforms </strong>refer to the morphology of pulsatile blood flow velocity tracings on </span><a href=\"https://radiopaedia.org/articles/spectral-doppler-ultrasound?lang=us\"><span style=\"background-color:white;color:black;font-size:12.0pt;\"><u>spectral Doppler ultrasound</u></span></a><span style=\"background-color:white;color:black;font-size:12.0pt;\">. </span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"color:#0d0d0d;font-size:12.0pt;\">In Doppler ultrasound, the normal venous waveform is monophasic, indicating a steady flow without the complex fluctuations seen in arterial blood flow.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-104938.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200652,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50164,
      "choices": [
        {
          "id": 200656,
          "text": "<p><span style=\"font-size:12.0pt;\">Colle’s fracture</span></p>"
        },
        {
          "id": 200657,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral epicondyle fracture</span></p>"
        },
        {
          "id": 200658,
          "text": "<p><span style=\"font-size:12.0pt;\">Medial epicondyle fracture</span></p>"
        },
        {
          "id": 200659,
          "text": "<p><span style=\"font-size:12.0pt;\">Supracondylar fracture</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 9-year-old child presents to your clinic with the following deformity of the right arm. Which is the most likely fracture leading to such a defect? (AIIMS MAY 2019)</span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-617.jpg\" alt=\"\" width=\"200\" height=\"208\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-617.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7448093",
      "question_audio": null,
      "question_video": null,
      "map_id": 34057673,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:windowtext;font-size:16px;\"><strong>Ans. D) Supracondylar fracture</strong></span></p><p> </p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>SUPRACONDYLAR FRACTURE OF THE HUMERUS</strong></span></p><p style=\"margin-left:0cm;\"> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is one of the most serious fractures in childhood as it is often associated with complications. </span></li><li><span style=\"font-size:16px;\">Most common elbow fractures – 50-70%</span></li><li><span style=\"font-size:16px;\"><strong>Mechanism:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">The fracture is caused by a fall on an out-stretched hand. </span></li><li><span style=\"font-size:16px;\">As the hand strikes the ground, the elbow is forced into hyperextension resulting in fracture of the humerus above the condyles. </span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Pathoanatomy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">The fracture line extends transversely through the distal metaphysis of humerus just above the condyles. </span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Types:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">A supracondylar fracture may be of extension or flexion type, depending upon the displacement of the distal fragment. </span></li><li><span style=\"font-size:16px;\">The extension type is the commoner (98%) of the two. </span></li><li><span style=\"font-size:16px;\">In this, the distal fragment is extended (tilted backwards) in relation to the proximal fragment. </span></li><li><span style=\"font-size:16px;\">In the flexion type, the distal fragment is flexed (tilted forwards) in relation to the proximal fragment. </span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Treatment:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Closed reduction and cast</span></li><li><span style=\"font-size:16px;\">If conservative management fails or if fracture is displaced, closed reduction and K-wire fixation is done.</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Complications:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Malunion – most common </span></li><li><span style=\"font-size:16px;\">Posteromedial displacement develops cubitus varus/gunstock deformity</span></li><li><span style=\"font-size:16px;\"><strong>Nerve injury:</strong> Anterior interosseous nerve most commonly injured followed by median, radial and ulnar nerves – transient neuropraxia occurs </span></li><li><span style=\"font-size:16px;\"><strong>Vessel injury:</strong> Brachial artery </span></li><li><span style=\"font-size:16px;\">Volkmann’s ischemia and compartment syndrome </span></li><li><span style=\"font-size:16px;\">Elbow stiffness </span></li><li><span style=\"font-size:16px;\">Myositis ossificans </span></li></ul></li></ul><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Colle’s fracture</strong>. Colles fracture is <strong>fracture of lower end of radius at its corti-cocancellous junction </strong>mostly occurring in post-menopausal osteoporotic elderly women; as a result of fall on outstretched hand, with wrist in extension. It is one of the <strong>most common fractures in elderly. </strong>It is commonly associated with<strong> dinner fork deformity. </strong>It is treated successfully with a<strong> hand-shaking cast. Finger stiffness </strong>is the most common complication<strong>. Malunion </strong>is the 2<sup>nd</sup> most common complication, leading to dinner fork deformity<strong>. </strong>Colle’s fracture is the commonest cause of<strong> sudeck’s dystrophy </strong>in the upper limb<strong>. </strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture33_lMz4cLB.jpg\" alt=\"\" width=\"250\" height=\"315\"></strong></span></p><p> </p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option B. Lateral epicondyle fracture</strong>. Lateral humeral condyle fractures are the second most commonly encountered elbow fractures after supracondylar fractures in the pediatric age group. These fractures are intra-articular and are prone to displacement owing to the attachment of the forearm extensor muscles on the lateral condyle. Due to this, they can produce various complications, including elbow deformity, if not appropriately managed. Displaced fractures are at a higher risk of non-union. Malunion, cubitus varus, avascular necrosis, and post-operative infection are recognized complications following surgery. </span><span style=\"background-color:white;color:black;font-size:16px;\">The most common mechanism is a fall on the outstretched hand with the elbow in extension and the forearm in supination.</span><span style=\"font-size:16px;\"> </span><span style=\"background-color:white;color:black;font-size:16px;\">Fractures with <2mm displacement can have conservative treatment. The indications of surgery are fracture displacement >2 mm and articular surface incongruency. Closed reduction and percutaneous fixation are options.</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture34_rnYjhVA.jpg\" alt=\"\" width=\"250\" height=\"250\"></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Medial epicondyle fracture</strong>. </span><span style=\"background-color:white;color:black;font-size:16px;\">A medial epicondyle fracture is an avulsion injury of the attachment of the common flexors of the forearm. The injury is usually extra-articular but can be sometimes associated with an elbow dislocation. </span><span style=\"font-size:16px;\">Medial epicondyle fractures are common and account for 10% of all elbow fractures in children. They occur between the ages of 7-15 years. They are usually a result from an avulsion injury caused by a valgus stress at the elbow and contraction of the flexor muscles. <strong>Potential complications include medial elbow instability and nonunion.</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture35_MBYr1Tu.jpg\" alt=\"\" width=\"250\" height=\"249\"></span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The given image shows a gunstock deformity i.e., cubitus varus deformity of the elbow after malunion of the supracondylar fracture of the humerus. </span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture33_lMz4cLB.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200659,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50165,
      "choices": [
        {
          "id": 200660,
          "text": "<p><span style=\"font-size:12.0pt;\">90 mmHg</span></p>"
        },
        {
          "id": 200661,
          "text": "<p><span style=\"font-size:12.0pt;\">60 mmHg</span></p>"
        },
        {
          "id": 200662,
          "text": "<p><span style=\"font-size:12.0pt;\">30 mmHg</span></p>"
        },
        {
          "id": 200663,
          "text": "<p><span style=\"font-size:12.0pt;\">15 mmHg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Calculate the net filtration pressure across the GFM for a patient with the data given below? (</span>AIIMS May 2018)</p><p> </p><p><span style=\"font-size:12.0pt;\">Glomerular ultrafiltration coefficient = 6</span></p><p><span style=\"font-size:12.0pt;\">Glomerular hydrostatic pressure =45</span></p><p><span style=\"font-size:12.0pt;\">Glomerular capillary oncotic pressure =20</span></p><p><span style=\"font-size:12.0pt;\">Bowman's capsule hydrostatic pressure =10</span></p><p><span style=\"font-size:12.0pt;\">Bowman's capsule oncotic pressure =0</span></p>",
      "unique_key": "Q7819167",
      "question_audio": null,
      "question_video": null,
      "map_id": 34026755,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 15 mmHg</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Four primary forces that determine whether fluid will move out of the blood into the interstitial fluid or in the opposite direction. These forces are:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">The <strong>capillary pressure (Pc), </strong>which tends to force fluid outward through the capillary membrane.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>interstitial fluid pressure (Pif), </strong>which tends to force fluid inward through the capillary membrane when Pif is positive but outward when Pif is negative.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>capillary plasma colloid osmotic pressure</strong> <strong>(Pp)</strong>, which tends to cause osmosis of fluid inward through the capillary membrane.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>interstitial fluid colloid osmotic pressure</strong> <strong>(Cif), </strong>which tends to cause osmosis of fluid outward through the capillary membrane.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">If the sum of these forces, the net filtration pressure, is positive, there will be a net fluid filtration across the capillaries. If the sum of the Starling forces is negative, there will be a net fluid absorption from the interstitial spaces into the capillaries.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The net filtration pressure (NFP) is calculated as:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">NFP = Pc - Pif - Pp + Cif</span></p><p><br><span style=\"font-size:12.0pt;\">Where Pc – Capillary pressure, Pif is Interstitial fluid pressure, Pp is plasma colloid osmotic pressure, Cif is interstitial colloid osmotic pressure</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Therefore, Net filtration pressure = 45 – 10 – 20 + 0 = 15mmHg</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">The net filtration pressure (NFP) in the glomerulus, essential for kidney filtration, is calculated based on the differences between hydrostatic and oncotic pressures inside and outside the glomerular capillaries. In this scenario, an NFP of 15 mmHg favors the formation of urine by pushing fluid out of blood vessels into the Bowman's capsule.</span></p>",
      "correct_choice_id": 200663,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50166,
      "choices": [
        {
          "id": 200664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Artemether plus lumefantrine</span></span></span></span></p>"
        },
        {
          "id": 200665,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Artesunate plus Sulfadoxine plus pyrimethamine</span></span></span></span></p>"
        },
        {
          "id": 200666,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Chloroquine</span></span></span></span></p>"
        },
        {
          "id": 200667,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Mefloquine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:black\">A 28-year-old man from west Garo Hill district of Meghalaya presents to the Civil Hospital with intermittent fever, chills, and malaise. Laboratory findings confirm the diagnosis of P. falciparum malaria. The region is known for its Multidrug- resistant strains of P. falciparum. Which of the following antimalarial regimens is considered the most appropriate first-line treatment for P. falciparum malaria in areas with multidrug-resistant strains? (AIIMS MAY 2018)</span></span></span></p>",
      "unique_key": "Q7354950",
      "question_audio": null,
      "question_video": null,
      "map_id": 34973891,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A) Artemether plus lumefantrine</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The Drug of choice treatment for Plasmodium falciparum infection in North Eastern states is artemether + lumefantrine</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">ARTEMISINS - ARTESUNATE AND ARTEMETHER</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Fastest acting anti-malarial</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Effective against MDR parasites</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Short acting</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">C/I in 1st trimester</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> Artemisinin Combination Therapy [ACT]</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Artemisin + Long acting drug</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">DOC for chloroquine resistant malaria Combinations</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Artemether + Lumefantrine: DOC in North Eastern States</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Artesunate + Sulfadoxine-Pyrimethamine: DOC for rest of India</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The dose of artesunate is 200 mg OD for 3 days whereas sulfadoxine (1500 mg) and pyrimethamine (75 mg) should be taken on day 1 only)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For P. falciparum malaria in regions with known drug resistance, artemether plus lumefantrine is the most effective first-line treatment, ensuring rapid and sustained clearance of the malaria parasite.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50167,
      "choices": [
        {
          "id": 200668,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule M drugs</span></p>"
        },
        {
          "id": 200669,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule H drugs</span></p>"
        },
        {
          "id": 200670,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule J drugs</span></p>"
        },
        {
          "id": 200671,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule X drugs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs should be sold only on prescription from a registered medical practitioner? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q7674677",
      "question_audio": null,
      "question_video": null,
      "map_id": 34998735,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Schedule H drugs</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Under the \"Drugs and Cosmetics Act,\" certain schedules classify drugs based on various criteria, including the need for prescription, potential for abuse, and manufacturing practices.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H drugs</strong>: These drugs can only be sold with a prescription from a registered medical practitioner. They are labeled with \"Rx\" written in black color to indicate that they should be dispensed only on prescription.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Schedule M drugs</strong>: These pertain to Good Manufacturing Practices (GMP) for pharmaceuticals and do not indicate a requirement for prescription-based sale.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Schedule J drugs</strong>: This schedule lists diseases and ailments for which a drug may not claim to prevent or cure. It does not pertain to prescription requirements.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Schedule X drugs</strong>: These are psychotropic substances with a high potential for abuse and must be sold with a valid prescription. While Schedule X drugs also require a prescription, the question specifically asks about drugs that should be sold only on prescription from a registered medical practitioner, making Schedule H drugs the correct answer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The important schedules under the “Drugs and Cosmetics Act” are:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H</strong> – The drugs that can be sold only by prescription where Rx is written in black color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule H1</strong> – for antibiotics where Rx is written in red color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule G</strong> – Drugs that need labelling as “Dangerous to use except under medical supervision.”</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule X</strong> – Psychotropic drugs that have a high abuse liability and are to be sold with a valid prescription only.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule P drug</strong> – describes the life period of drugs in months (unless otherwise specified) between the date of manufacture and date of expiry.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule M</strong> – GMP or Good Manufacturing Practices.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule J </strong>- List of diseases and ailments which a drug may not claim to prevent or cure</span></li></ul>",
      "correct_choice_id": 200669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50168,
      "choices": [
        {
          "id": 200672,
          "text": "<p><span style=\"font-size:12.0pt;\">TCA cycle</span></p>"
        },
        {
          "id": 200673,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycolytic pathway</span></p>"
        },
        {
          "id": 200674,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxidative phosphorylation</span></p>"
        },
        {
          "id": 200675,
          "text": "<p><span style=\"font-size:12.0pt;\">ETC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Fluoroacetate is a component of pesticides. Which of the following metabolic pathways is inhibited by this compound? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q7522882",
      "question_audio": null,
      "question_video": null,
      "map_id": 34293692,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) TCA cycle</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Sodium fluoroacetate, is usually<strong> used as a rodenticide</strong>. It is highly toxic towards humans and other mammals through <strong>inhibition of the enzyme aconitase in the tricarboxylic acid cycle (metabolic uncoupler)</strong>, caused by 'lethal synthesis' of an isomer of <strong>fluorocitrate</strong> (FC). FA is found in a range of plant species and their ingestion can cause the death of ruminant animals.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Inhibition of the TCA Cycle by Fluoroacetate:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Aconitase:</strong> Converts citrate to aconitate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate is metabolized to fluorocitrate, which inhibits aconitase, leading to the accumulation of citrate and disruption of the TCA cycle.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glycolytic pathway:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Converts glucose to pyruvate, generating ATP.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate does not affect glycolysis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Oxidative phosphorylation:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Produces ATP through the electron transport chain and ATP synthase.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate does not directly inhibit oxidative phosphorylation.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. ETC (Electron Transport Chain):</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Transfers electrons from NADH and FADH2 to oxygen, generating ATP.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate does not directly inhibit the electron transport chain.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Inhibitors of TCA Cycle</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-122100.jpg\" alt=\"\" width=\"1000\" height=\"219\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-122100.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50169,
      "choices": [
        {
          "id": 200676,
          "text": "<p><span style=\"font-size:12.0pt;\">Low control and skilled movements</span></p>"
        },
        {
          "id": 200677,
          "text": "<p><span style=\"font-size:12.0pt;\">More muscle fibres are present</span></p>"
        },
        {
          "id": 200678,
          "text": "<p><span style=\"font-size:12.0pt;\">Precision of movements</span></p>"
        },
        {
          "id": 200679,
          "text": "<p><span style=\"font-size:12.0pt;\">Intensity of perception</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the motor homunculus, which of the following has maximum representation? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q9281665",
      "question_audio": null,
      "question_video": null,
      "map_id": 34336972,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Precision of movements</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Precision of movements has maximum representation in the motor homunculus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In the sensory homunculus, the relative sizes of the cortical areas is proportional to the use of the part, the number of specialized sensory receptors and precision required by respective peripheral area of the body.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Some body parts like lips are represented by large areas in the somatic cortex followed by the face and thumb while the trunk and lower part of the body are represented by relatively small areas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Low control and skilled movements: </strong>Incorrect, as areas requiring low control do not have extensive cortical representation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. More muscle fibres are present: </strong>Incorrect, as the size of representation in the motor homunculus is not based on the number of muscle fibers, but rather on the precision and complexity of movements.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intensity of perception: Incorrect</strong>, as intensity of perception is related to sensory input and the sensory homunculus, not the motor homunculus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The motor homunculus has maximum representation for body parts requiring precision of movements, reflecting the complexity and intricacy needed for fine motor control.</span></p>",
      "correct_choice_id": 200678,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50170,
      "choices": [
        {
          "id": 200680,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondria</span></p>"
        },
        {
          "id": 200681,
          "text": "<p><span style=\"font-size:12.0pt;\">Lysosome</span></p>"
        },
        {
          "id": 200682,
          "text": "<p><span style=\"font-size:12.0pt;\">Golgi bodies</span></p>"
        },
        {
          "id": 200683,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoplasmic reticulum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organelles is absent in the area of the cardiac muscle marked:  </span><br>(<span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2018)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-153718.png\" alt=\"\" width=\"600\" height=\"342\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-153718.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q4307562",
      "question_audio": null,
      "question_video": null,
      "map_id": 34700837,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Lysosome</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Lysosomes are not typically concentrated in the marked perinuclear area of cardiac muscle cells. Instead, lysosomes are distributed throughout the cytoplasm of the cell. This means that they are present in the cell but do not show a significant concentration or structure in the indicated area of cardiac muscle fibers.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In cardiac muscle cells, mitochondria are abundant due to the high-energy demand for contraction, and endoplasmic reticulum (sarcoplasmic reticulum) and Golgi bodies are usually present in the perinuclear area for synthesis and modification of proteins and other important molecules.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mitochondria</strong>: Mitochondria are highly abundant in cardiac muscle cells, particularly near areas that need significant energy. The heart has a high demand for ATP due to its continuous contractions, and mitochondria are essential for this energy supply.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Golgi bodies</strong>: Golgi bodies are present in cardiac muscle cells, often localized around the perinuclear area. They are important for modifying, packaging, and sorting proteins, which are needed in various cellular functions, including those in muscle contraction and maintenance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Endoplasmic reticulum (ER)</strong>: The endoplasmic reticulum (or sarcoplasmic reticulum in muscle cells) is crucial for calcium storage and release, which is essential for muscle contraction. It is indeed present in cardiac muscle cells and has a significant role in the regulation of contraction and relaxation cycles.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Lysosomes are widely distributed throughout the cytoplasm of cells,</span></p><p> </p><ol><li><span style=\"color:black;font-size:12.0pt;\">Lysosomes are membrane-bound organelles </span></li><li><span style=\"color:black;font-size:12.0pt;\">The enzymes within lysosomes are responsible for breaking down various cellular waste materials, such as proteins, lipids, carbohydrates, and even organelles.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Lysosomes play a crucial role in cellular homeostasis by recycling and eliminating unwanted or damaged cellular components through a process known as autophagy.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The acidic environment within lysosomes (pH around 4.5-5) is necessary for the optimal activity of the digestive enzymes.</span></li></ol><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Lysosomal storage disorders, such as Tay-Sachs disease and Gaucher's disease, occur when there is a malfunction or deficiency of enzymes within lysosomes, leading to the accumulation of undigested materials and subsequent cellular dysfunction.</span></p>",
      "correct_choice_id": 200681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50171,
      "choices": [
        {
          "id": 200684,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 200685,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension pneumothorax</span></p>"
        },
        {
          "id": 200686,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardial effusion</span></p>"
        },
        {
          "id": 200687,
          "text": "<p><span style=\"font-size:12.0pt;\">Massive hemothorax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female victim of RTA presents to the ER. On examination, GCS is 15/15, heart rate = 110/min, BP = 90/60 mmHg, and there is elevated JVP. The right chest is tympanic on percussion with decreased breath sounds on auscultation. The left chest appears normal. But the patient is dyspneic and ecchymosis is noted over the chest wall. The abdomen is soft. The probable diagnosis is: (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q6992168",
      "question_audio": null,
      "question_video": null,
      "map_id": 34287975,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tension Pneumothorax</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of hemodynamic instability, tympanic note (hyper-resonant) on percussion, and decreased breath sounds on the affected side is suggestive of tension pneumothorax.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Tension pneumothorax occurs when air accumulates in the pleural space and cannot escape, leading to increased pressure in the chest cavity. This condition can compress the lungs and the great vessels in the chest, causing respiratory distress, hypotension, elevated JVP, and decreased breath sounds on auscultation. Tympanic percussion note over the right chest is consistent with air in the pleural space. Ecchymosis (bruising) over the chest wall can result from trauma and rib fractures associated with tension pneumothorax.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Cardiac tamponade</strong>: Cardiac tamponade typically presents with symptoms such as hypotension, muffled heart sounds, and distended neck veins (Jugular Venous Pressure - JVP). While elevated JVP is mentioned in the scenario, the other symptoms associated with cardiac tamponade, such as muffled heart sounds and hypotension, are not present.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Pericardial effusion</strong>: Pericardial effusion involves the accumulation of fluid around the heart. While it can cause elevated JVP, it typically presents with other cardiac symptoms, such as muffled heart sounds and chest pain. The scenario does not mention these cardiac-specific symptoms.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Massive hemothorax</strong>: Massive hemothorax refers to a significant accumulation of blood in the pleural space. It can cause decreased breath sounds, but it is not typically associated with a tympanic percussion note or elevated JVP unless there is concurrent tension pneumothorax.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A tension pneumothorax develops when there is a tear is either in the parietal or visceral pleura. This tear acts as a one-way valve i.e., air enters from the lung or chest wall through it during inspiration but has no way to escape during expiration. This ultimately causes collapse of the affected lung.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>It is characterized by:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Chest pain</span></li><li><span style=\"font-size:12.0pt;\">Tachypnoea, and acute dyspnea</span></li><li><span style=\"font-size:12.0pt;\">Sudden onset hemodynamic compromise (tachycardia, hypotension, low O2 saturation, loss of consciousness)</span></li><li><span style=\"font-size:12.0pt;\">Neck vein distention</span></li><li><span style=\"font-size:12.0pt;\">Tracheal deviation away from the side of injury</span></li><li><span style=\"font-size:12.0pt;\">Decreased chest movements on the affected side</span></li><li><span style=\"font-size:12.0pt;\">Hyper-resonance on percussion on the affected side</span></li><li><span style=\"font-size:12.0pt;\">Absence or decreased breath sounds on the affected side</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Tension pneumothorax is a clinical diagnosis, and treatment must never be delayed waiting for radiological confirmation. Management includes:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Immediate management: </strong>Needle decompression or needle thoracostomy i.e. insertion of a wide-bore needle in the 5th ICS anterior to the midaxillary line. In the pediatric age group, the needle thoracostomy location is at the 2nd ICS midclavicular line.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Definitive management: </strong>Tube thoracostomy or chest tube insertion in the 5th ICS in the triangle of safety.</span></li></ul>",
      "correct_choice_id": 200685,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50172,
      "choices": [
        {
          "id": 200688,
          "text": "<p><span style=\"font-size:12.0pt;\">Mamillary body</span></p>"
        },
        {
          "id": 200689,
          "text": "<p><span style=\"font-size:12.0pt;\">Hippocampus</span></p>"
        },
        {
          "id": 200690,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalamus</span></p>"
        },
        {
          "id": 200691,
          "text": "<p><span style=\"font-size:12.0pt;\">Amygdala</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The structure marked with the black arrow in the given picture arises from the ……… (</span>AIIMS May 2018)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-14.jpg\" alt=\"\" width=\"300\" height=\"217\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-14.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1187512",
      "question_audio": null,
      "question_video": null,
      "map_id": 34891870,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Hippocampus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is a coronal section of the brain and the marked structure is the fornix. It arises from the hippocampus and ends in the mammillary body of the hypothalamus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Hippocampus </strong>is located in the medial temporal lobe of the brain.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The hippocampus is critical for the formation and retrieval of memories, particularly episodic memories. It's also involved in spatial navigation. Damage or atrophy of the hippocampus can result in difficulties forming new memories. Conditions like Alzheimer's disease often exhibit significant hippocampal atrophy.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mamillary body</strong>: Part of the diencephalon, present at the base of the brain, posterior to the pituitary gland.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The mammillary bodies are primarily associated with memory processing. They receive projections from the hippocampus via the fornix and send projections to the anterior nucleus of the thalamus. They're particularly involved in the recall of past memories and are thought to play a role in spatial memory. Damage to the mammillary bodies, often due to thiamine (vitamin B1) deficiency as seen in Wernicke-Korsakoff syndrome, can lead to memory deficits.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Thalamus: </strong>Positioned centrally in the brain, the thalamus is a large mass of gray matter deep within the brain. It is part of the diencephalon.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Often referred to as the \"relay station\" of the brain, the thalamus receives sensory and motor signals and relays them to the cerebral cortex. It's involved in consciousness, sleep, and alertness. Thalamic strokes or lesions can lead to sensory deficits, altered consciousness, and movement disorders.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Amygdala</strong>: Located in the anterior portion of the temporal lobe, deep within the brain.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The amygdala plays a pivotal role in processing emotions, particularly fear and pleasure. It helps determine which memories are stored and where they are stored based on emotional significance. Dysfunction of the amygdala can lead to various emotional and behavioral abnormalities. It's also implicated in conditions such as anxiety disorders and post-traumatic stress disorder (PTSD).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Coronal Section of Brain</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-15.jpg\" alt=\"\" width=\"500\" height=\"254\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-15.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50173,
      "choices": [
        {
          "id": 200692,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 20, 23, 35, 42, 52</span></p>"
        },
        {
          "id": 200693,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 19, 23, 33, 45, 58</span></p>"
        },
        {
          "id": 200694,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 32, 34, 45, 52, 58</span></p>"
        },
        {
          "id": 200695,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against which of the following serotypes? </span>(INICET MAY 2018)</p>",
      "unique_key": "Q7439604",
      "question_audio": null,
      "question_video": null,
      "map_id": 34692450,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 6, 11, 16, 18, 31, 33, 45, 52, 58</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">HPV Vaccines available are:</span></p><p> </p><ol><li><span style=\"font-size:12pt;\">Cervarix (Bivalent): 16, 18</span></li><li><span style=\"font-size:12pt;\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></li><li><span style=\"font-size:12pt;\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18,31,33,45,52,58.</span></li><li><span style=\"font-size:12pt;\">Cervavac (India’s indigenous HPV vaccine): Quadrivalent: 6,11,16,18</span></li></ol><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against serotypes <strong>6, 11, 16, 18, 31, 33, 45, 52, 58.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule</u></strong></span></a></p>",
      "correct_choice_id": 200695,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50174,
      "choices": [
        {
          "id": 200696,
          "text": "<p><span style=\"font-size:12.0pt;\">Supranuclear</span></p>"
        },
        {
          "id": 200697,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal</span></p>"
        },
        {
          "id": 200698,
          "text": "<p><span style=\"font-size:12.0pt;\">Adjacent to nucleus</span></p>"
        },
        {
          "id": 200699,
          "text": "<p><span style=\"font-size:12.0pt;\">Apical</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the usual position of the Golgi apparatus in serous acinar cells? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q7319130",
      "question_audio": null,
      "question_video": null,
      "map_id": 34441763,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Supranuclear</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Golgi complex is located in supranuclear cytoplasm in serous acinar cells. Serous acinar cells are generally found in pancreas and the submandibular salivary glands.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In serous acinar cells, the Golgi complex is involved in the modification and packaging of secretory proteins into vesicles that can be transported to the apical surface of the cell for release into the ducts or glands. The supranuclear location of the Golgi complex in these cells allows for efficient transport of these vesicles to the apical surface for secretion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In contrast, other organelles such as the nucleus, mitochondria, and rough endoplasmic reticulum are typically located in the basal or perinuclear regions of the cell.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Basal:</strong> Incorrect, as the basal region is typically where the nucleus and other organelles like mitochondria are located.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adjacent to nucleus:</strong> Incorrect, while the Golgi apparatus is near the nucleus, it is specifically located above the nucleus in the supranuclear position in serous acinar cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Apical: </strong>Incorrect, as the Golgi apparatus itself is not located in the apical region, though it directs secretory vesicles to this area.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In serous acinar cells, the Golgi apparatus is typically located in the supranuclear region, facilitating the modification and transport of secretory proteins for efficient secretion into the glandular ducts.</span></p>",
      "correct_choice_id": 200696,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50175,
      "choices": [
        {
          "id": 200700,
          "text": "<p><span style=\"font-size:12.0pt;\">Third part of duodenum is compressed</span></p>"
        },
        {
          "id": 200701,
          "text": "<p><span style=\"font-size:12.0pt;\">Angle between MA and aorta is more than 70 degrees</span></p>"
        },
        {
          "id": 200702,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgical management is by Duodenojejunostomy</span></p>"
        },
        {
          "id": 200703,
          "text": "<p><span style=\"font-size:12.0pt;\">Also known as Wilkie's Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is incorrect about superior mesenteric artery syndrome? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q6296996",
      "question_audio": null,
      "question_video": null,
      "map_id": 34347030,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Angle between MA and aorta is more than 70 degrees</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In superior mesenteric artery (SMA) syndrome, the aortomesenteric angle is reduced to less than 25 degrees, which normally is between 38-65 degrees.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>This statement is incorrect. </strong>In SMAS, the angle between the SMA and aorta is typically <strong>less</strong> than 20 to 25 degrees, not more than 70 degrees. The narrowing of this angle contributes to the compression of the duodenum.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Third part of duodenum is compressed</strong>: This statement is correct. Superior Mesenteric Artery Syndrome involves the compression of the third part of the duodenum by the SMA and the aorta.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Surgical management is by Duodenojejunostomy</strong>: This statement is correct. One of the surgical treatments for SMAS is Duodenojejunostomy, which involves creating an opening between the duodenum and the jejunum to bypass the compressed area.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Also known as Wilkie's Syndrome</strong>: This statement is correct. Superior Mesenteric Artery Syndrome is also known as Wilkie's Syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">SMA syndrome, also called Wilkie's syndrome, is characterized by an obstruction of the third part of the duodenum by the SMA due to compression against fixed retroperitoneal structures. Symptoms include episodic epigastric pain associated with vomiting.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/whatsapp-image-2024-09-09-at-60550-pm.jpeg\" alt=\"\" width=\"300\" height=\"179\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/whatsapp-image-2024-09-09-at-60554-pm.jpeg\" alt=\"\" width=\"300\" height=\"188\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SMA syndrome is associated with:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Rapid growth during childhood</span></li><li><span style=\"font-size:12.0pt;\">Profound weight loss</span></li><li><span style=\"font-size:12.0pt;\">Abdominal surgery</span></li><li><span style=\"font-size:12.0pt;\">Inflammatory diseases of the GIT</span></li><li><span style=\"font-size:12.0pt;\">Immobilization in a cast that increases lordosis and accentuates the angle of the SMA with the aorta</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Abdominal CT angiography is the investigation of choice.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Treatment involves measures to promote weight gain like NJ feeds, which will lead to widening to aortomesenteric angle (due to deposition of fat). If it fails, then a duodeno-jejunal bypass is done.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/whatsapp-image-2024-09-09-at-60550-pm.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200701,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50176,
      "choices": [
        {
          "id": 200704,
          "text": "<p><span style=\"font-size:12.0pt;\">Clearance</span></p>"
        },
        {
          "id": 200705,
          "text": "<p><span style=\"font-size:12.0pt;\">Volume of distribution</span></p>"
        },
        {
          "id": 200706,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma half life</span></p>"
        },
        {
          "id": 200707,
          "text": "<p><span style=\"font-size:12.0pt;\">Bioavailability</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The loading dose of a drug is governed primarily by? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9235599",
      "question_audio": null,
      "question_video": null,
      "map_id": 34402637,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Volume of distribution</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Loading dose = Volume of Distribution * Target plasma concentration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Loading dose is the high initial dose of the drug that is initially given to cover the distribution so that the desired action can take place. In other words, when the time to reach a steady-state is long, it may be desirable to administer a loading dose that promptly raises the concentration of drug in plasma to the target concentration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Clearance</strong>: Clearance is a measure of the body's efficiency in eliminating the drug but does not determine the loading dose. It is more relevant to the maintenance dose.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Plasma half-life</strong>: The half-life of a drug determines how long it stays in the body but is not directly used to calculate the loading dose.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Bioavailability</strong>: Bioavailability refers to the fraction of the administered dose that reaches the systemic circulation. While important for understanding the effective dose, it does not govern the calculation of the loading dose.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The loading dose of a drug is primarily governed by its volume of distribution, which helps achieve the desired plasma concentration quickly, especially when the drug has a long half-life.</span></p>",
      "correct_choice_id": 200705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50177,
      "choices": [
        {
          "id": 200708,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">14 to 15 years</span></p>"
        },
        {
          "id": 200709,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">16 to 17 years</span></p>"
        },
        {
          "id": 200710,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">18 to 19 years</span></p>"
        },
        {
          "id": 200711,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">> 21 years</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A girl runs away from home with her boyfriend and they get married. In court, she says that she is a major and is married to the boy. Identify the approximate age of the girl from the Xray picture of her pelvis? (</span>AIIMS May 2018)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/image-5.jpg\" alt=\"\" width=\"300\" height=\"276\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/image-5.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7624372",
      "question_audio": null,
      "question_video": null,
      "map_id": 34667212,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. > 21 years</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ischial tuberosity in the X ray is fused, hence the age is > 21 years</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Some students can get confused and are not able to distinguish whether ischial tuberosity has fused or not yet appeared. It is not possible that ischial tuberosity has not yet appeared because the upper end of femur (head, greater trochanter, lesser trochanter) has fused with shaft which occurs between 17- 19 years, whereas ischial tuberosity appears earlier at 16 years.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Femur</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Upper end of Femur</strong> is composed of three centres:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Head – 1 yr (A)             </span></li><li><span style=\"font-size:12.0pt;\">Greater Trochanter- 4 yr (A)</span></li><li><span style=\"font-size:12.0pt;\">Lesser trochanter – 14 yr (A)          </span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">These three centres fuse with shaft at 17- 19 yrs of age</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Pelvis</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-122720_94pJySN.png\" alt=\"\" width=\"1000\" height=\"611\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-122720_94pJySN.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200711,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50178,
      "choices": [
        {
          "id": 200712,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Safety</span></p>"
        },
        {
          "id": 200713,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Efficacy</span></p>"
        },
        {
          "id": 200714,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dose range</span></p>"
        },
        {
          "id": 200715,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pharmacoeconomics</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A pharmaceutical company is in the early stages of developing a new antihypertensive medication. They are planning to conduct several phases of clinical trials to assess different aspects of the drug. As part of this process, the research team is set to embark on Phase 1 of the trial. In the context of clinical trial phases, what is the primary objective of this initial phase? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q9688384",
      "question_audio": null,
      "question_video": null,
      "map_id": 34251804,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Safety </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Phase 1 of clinical trials is critically important as it marks the first introduction of a new drug into human subjects.</span></li><li><span style=\"font-size:12.0pt;\">The primary focus during this phase is to evaluate the safety of the drug.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Key elements assessed in Phase 1 include:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Safety & Non-toxicity</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Maximum Tolerated Dose (MTD</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/phase-i_page_1.jpg\" alt=\"\" width=\"787\" height=\"1679\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/phase-i_page_1.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200712,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50179,
      "choices": [
        {
          "id": 200716,
          "text": "<p><span style=\"font-size:12.0pt;\">Colon</span></p>"
        },
        {
          "id": 200717,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast</span></p>"
        },
        {
          "id": 200718,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostate</span></p>"
        },
        {
          "id": 200719,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following given cancers rarely metastasize to the liver? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2884130",
      "question_audio": null,
      "question_video": null,
      "map_id": 34069762,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Prostate</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Prostate Cancers rarely metastasize to the liver.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Prostate cancer tends to metastasize to bones via periprostatic venous plexus (Bateson) rather than the liver. Bone metastases are a hallmark of advanced prostate cancer. </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>A.</strong> <strong>Colon</strong>: Colon cancer commonly metastasizes to the liver. The liver is one of the most common sites of metastasis for colon cancer, and it frequently spreads to the liver through the bloodstream.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B.</strong> <strong>Breast</strong>: Breast cancer can metastasize to various organs, including the liver. Liver metastases in breast cancer are not uncommon, and the liver is considered a potential site of spread for breast cancer cells.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>Melanoma</strong>: Melanoma is known for its propensity to metastasize to various organs, including the liver. Liver metastases are common in advanced melanoma cases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The most common malignant tumors of the liver are metastasis. The liver is a common site of metastases from gastrointestinal tumors because of dissemination via the portal venous system. The most relevant such metastatic tumor of the liver to the surgeon is colorectal cancer because of the well-documented potential for long-term survival after its complete resection.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The more frequent primary sites include carcinomas of the colon, pancreas, lung, and breast in adults, and neuroblastoma, Wilms tumor, and rhabdomyosarcoma in pediatric patients. Although the origin of the tumor is often known when metastases are biopsied, carcinomas of the pancreas, stomach, and lung are particularly notorious for being occult primary neoplasms.</span></p>",
      "correct_choice_id": 200718,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50180,
      "choices": [
        {
          "id": 200720,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloramphenicol, doxycycline</span></p>"
        },
        {
          "id": 200721,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline, doxycycline</span></p>"
        },
        {
          "id": 200722,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline, azithromycin</span></p>"
        },
        {
          "id": 200723,
          "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin, doxycycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the drug of choice for scrub typhus during pregnancy and otherwise respectively? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q9524844",
      "question_audio": null,
      "question_video": null,
      "map_id": 34056898,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Azithromycin, doxycycline</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The DOC for scrub typhus is Doxycycline, but it cannot be used during pregnancy as it can lead to bone growth abnormality in the newborn. So, in that case, to treat Scrub Typhus in Pregnancy, we use Azithromycin.</span></p><p> </p><h3><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></h3><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Chloramphenicol, doxycycline</strong>: Chloramphenicol is not the first-line treatment for scrub typhus, and doxycycline is indeed used for non-pregnant individuals, but this pair does not cover the correct alternatives during pregnancy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Doxycycline, doxycycline</strong>: This option does not address the contraindication of doxycycline during pregnancy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Doxycycline, azithromycin</strong>: This reverses the correct pair; azithromycin is used during pregnancy, not doxycycline.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The drug of choice for treating scrub typhus in pregnant women is azithromycin, while doxycycline is used for non-pregnant individuals.</span></p>",
      "correct_choice_id": 200723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50181,
      "choices": [
        {
          "id": 200724,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Safety</span></span></span></p>"
        },
        {
          "id": 200725,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Efficacy</span></span></span></p>"
        },
        {
          "id": 200726,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Potency</span></span></span></p>"
        },
        {
          "id": 200727,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Toxicity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therapeutic index is used for assessing which of the following factors? (AIIMS MAY 2018)</span></span></span></p>",
      "unique_key": "Q6223958",
      "question_audio": null,
      "question_video": null,
      "map_id": 34887720,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Safety</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therapeutic Index tells us about the margin of safety for a drug. It is calculated as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therapeutic index = TD50/ED50</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• TD50 (Median toxic dose) = Dose at which there were toxic effects at 50% of the subjects</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• ED50 (Median effect dose) = Dose required to produce a therapeutic effect in 50% of the individuals.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Efficacy</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Efficacy refers to the maximum effect a drug can produce, regardless of dose. The therapeutic index does not measure this.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Potency</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Potency is the amount of drug needed to produce a given effect. It is not assessed by the therapeutic index.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Toxicity</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While toxicity is a component of the therapeutic index (TD50), the index itself is used to measure the safety margin rather than toxicity alone.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The therapeutic index is used to assess the safety of a drug, indicating the margin between effective and toxic doses. A higher therapeutic index means a drug is safer, with a lower risk of adverse effects at therapeutic doses.</span></span></span></p>",
      "correct_choice_id": 200724,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50182,
      "choices": [
        {
          "id": 200728,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bleomycin</span></span></span></p>"
        },
        {
          "id": 200729,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Doxorubicin</span></span></span></p>"
        },
        {
          "id": 200730,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vincristine</span></span></span></p>"
        },
        {
          "id": 200731,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Minocycline</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following drugs can cause flagellated pigmentation of skin? (</span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q4939196",
      "question_audio": null,
      "question_video": null,
      "map_id": 34104466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Bleomycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bleomycin is the chemotherapeutic drug that is known to cause flagellated hyperpigmentation in the skin. Another side effect of Bleomycin is pulmonary fibrosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Doxorubicin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This chemotherapeutic agent is known for causing cardiotoxicity and myelosuppression, but it does not typically cause flagellated pigmentation of the skin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Vincristine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This drug is associated with neurotoxicity, particularly peripheral neuropathy, but it does not cause flagellated hyperpigmentation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Minocycline</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This antibiotic can cause skin pigmentation, but it is not typically flagellated. The pigmentation with minocycline tends to be more diffuse and can affect the skin, nails, and other tissues.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Bleomycin is known to cause flagellated hyperpigmentation of the skin as a unique side effect. It can also cause pulmonary fibrosis, making it important to monitor patients for respiratory symptoms during treatment.</span></span></span></p>",
      "correct_choice_id": 200728,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50183,
      "choices": [
        {
          "id": 200732,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unfractionated Heparin</span></span></span></p>"
        },
        {
          "id": 200733,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Warfarin</span></span></span></p>"
        },
        {
          "id": 200734,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low molecular weight heparin</span></span></span></p>"
        },
        {
          "id": 200735,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dabigatran</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which is the anticoagulant of choice for the management of cancer-associated thromboembolism? (AIIMS MAY 2018)</span></span></span></p>",
      "unique_key": "Q1680493",
      "question_audio": null,
      "question_video": null,
      "map_id": 34283384,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Low molecular weight heparin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMWH is the anticoagulant of choice for the treatment of Cancer associated thromboembolism. It has a long half-life, higher bioavailability and does not require anticoagulant monitoring.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Unfractionated Heparin</span></strong><span style=\"font-size:12.0pt\">: While effective, it requires continuous intravenous infusion and frequent monitoring of activated partial thromboplastin time (aPTT), making it less convenient for long-term management.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Warfarin</span></strong><span style=\"font-size:12.0pt\">: Warfarin requires regular monitoring of the international normalized ratio (INR) to maintain therapeutic levels, which can be challenging in cancer patients due to potential drug interactions and varying dietary intake.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Dabigatran</span></strong><span style=\"font-size:12.0pt\">: Dabigatran is an oral direct thrombin inhibitor. Although effective, it is not the first choice for cancer-associated thromboembolism due to limited evidence compared to LMWH and potential for drug interactions and gastrointestinal side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Low molecular weight heparin (LMWH) is the preferred anticoagulant for managing cancer-associated thromboembolism due to its long half-life, higher bioavailability, and the convenience of not requiring routine anticoagulant monitoring.</span></span></span></p>",
      "correct_choice_id": 200734,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50184,
      "choices": [
        {
          "id": 200736,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Edaravone</span></span></span></p>"
        },
        {
          "id": 200737,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Piracetam</span></span></span></p>"
        },
        {
          "id": 200738,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dabrafenib</span></span></span></p>"
        },
        {
          "id": 200739,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trametinib</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following new drugs has been approved for the treatment of amyotrophic lateral sclerosis? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q4615964",
      "question_audio": null,
      "question_video": null,
      "map_id": 34980518,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Edaravone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Edaravone is an FDA approved drug used in the treatment of Amyotrophic Lateral Sclerosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It has free radical scavenging properties that may reduce oxidative stress although the exact mechanism of action is unknown. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Piracetam</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Piracetam is used off-label for cognitive enhancement and the treatment of myoclonus. It is not approved for the treatment of ALS.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Dabrafenib</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Dabrafenib is a targeted therapy used for the treatment of BRAF V600E mutation-positive melanoma. It is not used for ALS.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Trametinib</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Trametinib is also used for the treatment of BRAF V600E mutation-positive melanoma. It is not indicated for ALS.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Edaravone is the new drug approved for the treatment of amyotrophic lateral sclerosis (ALS), primarily due to its free radical scavenging properties that may help reduce oxidative stress, a factor involved in the disease's progression.</span></span></span></p>",
      "correct_choice_id": 200736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50185,
      "choices": [
        {
          "id": 200740,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine</span></span></span></p>"
        },
        {
          "id": 200741,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine</span></span></span></p>"
        },
        {
          "id": 200742,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoclopramide</span></span></span></p>"
        },
        {
          "id": 200743,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Domperidone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient presented to the casualty with signs of dehydration due to severe vomiting.<strong> </strong>The intern gave the patient a parenteral medication, following which the patient developed grimacing and abnormal posturing. What could have been the inciting drug for this reaction? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q9363484",
      "question_audio": null,
      "question_video": null,
      "map_id": 34655724,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Metoclopramide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoclopramide is an anti-emetic that acts by blocking the D2 receptors. It can cross the blood brain barrier and can lead to Dopaminergic blockade in the various parts of the brain leading to Acute dystonia, drowsiness, abnormal posturing, Parkinsonism etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Domperidone is also a D2 Receptor blocker, but cannot cross the BBB, therefore it does not produce such side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Atropine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Atropine is an anticholinergic drug that does not typically cause extrapyramidal side effects. It is used to reduce salivation and bronchial secretions and to treat bradycardia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Ranitidine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Ranitidine is an H2 receptor antagonist used to reduce stomach acid production. It does not have significant central nervous system effects or cause extrapyramidal symptoms.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Domperidone</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Domperidone is also a dopamine D2 receptor blocker used as an anti-emetic. However, it does not cross the blood-brain barrier effectively and therefore does not typically cause central nervous system side effects like metoclopramide.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Metoclopramide, an anti-emetic that blocks D2 receptors and crosses the blood-brain barrier, can cause extrapyramidal side effects such as acute dystonia, drowsiness, abnormal posturing, and Parkinsonism-like symptoms.</span></span></span></p>",
      "correct_choice_id": 200742,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50186,
      "choices": [
        {
          "id": 200744,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tmax</span></span></span></p>"
        },
        {
          "id": 200745,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cmax</span></span></span></p>"
        },
        {
          "id": 200746,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T1/2</span></span></span></p>"
        },
        {
          "id": 200747,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Area under the curve</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following parameters is used to assess the extent of drug absorption in a plasma concentration vs. time graph? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q3296345",
      "question_audio": null,
      "question_video": null,
      "map_id": 34075137,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Area under the curve</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the Concentration-time curve for a given drug, the area under the curve (AUC) tells us about the bioavailability of the drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The bioavailability of a given drug is defined as the fraction of the given dose that reaches the systemic circulation. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It depends on 2 factors:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.Absorption of the drug (More the extent of absorption of the drug, greater is the bioavailability)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2.First pass metabolism of the drug (More the first pass metabolism of a drug, lesser is its bioavailability).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">So, in other words, the AUC tells us about the extent of absorption of the drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Tmax</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The time to reach the maximum concentration (Cmax) in plasma. It indicates the rate of absorption but not the extent of absorption.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Cmax</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The maximum concentration of the drug in plasma. It provides information on the peak level achieved but does not reflect the overall extent of absorption.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">T1/2</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The half-life of the drug, which is the time it takes for the plasma concentration to reduce by half. This parameter is related to the duration of action and elimination of the drug, not the extent of absorption.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Area Under the Curve (AUC) in a plasma concentration vs. time graph is used to assess the extent of drug absorption, reflecting the bioavailability of the drug in the systemic circulation.</span></span></span></p>",
      "correct_choice_id": 200747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50187,
      "choices": [
        {
          "id": 200748,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sublingual</span></span></span></p>"
        },
        {
          "id": 200749,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral</span></span></span></p>"
        },
        {
          "id": 200750,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intravenous</span></span></span></p>"
        },
        {
          "id": 200751,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transdermal</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following routes of administration will not bypass hepatic first-pass metabolism? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q8084691",
      "question_audio": null,
      "question_video": null,
      "map_id": 34741945,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Oral</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatic first-pass metabolism refers to the process where the concentration of a drug is greatly reduced before it reaches the systemic circulation. This occurs primarily when drugs are metabolized in the liver after being absorbed. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a drug is taken orally, it is absorbed through the gastrointestinal tract and then passes through the liver before reaching systemic circulation. This route is subject to significant hepatic first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sublingual</span></strong><span style=\"font-size:12.0pt\">: This route involves placing a drug under the tongue, where it is absorbed directly into the bloodstream through the tissues beneath the tongue. It bypasses the liver initially, thus avoiding hepatic first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Intravenous (IV)</span></strong><span style=\"font-size:12.0pt\">: Intravenous administration delivers a drug directly into the bloodstream, completely bypassing the liver initially. Therefore, it does not undergo first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transdermal</span></strong><span style=\"font-size:12.0pt\">: Transdermal administration involves applying a drug through the skin (e.g., via a patch). The drug is absorbed directly into systemic circulation, bypassing the liver initially and thus avoiding first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note: </span></strong><span style=\"font-size:12.0pt\">Please read the question carefully, which does not bypass means which undergoes first pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The route of administration that does not bypass hepatic first-pass metabolism is Oral. This is because drugs taken orally are absorbed from the gastrointestinal tract and then pass through the liver where they may be metabolically altered before reaching the systemic circulation.</span></span></span></p>",
      "correct_choice_id": 200749,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50188,
      "choices": [
        {
          "id": 200752,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombin</span></span></span></p>"
        },
        {
          "id": 200753,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plasmin</span></span></span></p>"
        },
        {
          "id": 200754,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antithrombin-III</span></span></span></p>"
        },
        {
          "id": 200755,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombomodulin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">For the action of heparin as an anticoagulant, availability of which of the following chemical substances is mandatory? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q9264115",
      "question_audio": null,
      "question_video": null,
      "map_id": 34628925,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Antithrombin-III</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heparin acts indirectly by activating Antithrombin-III. The heparin-antithrombin III then binds to the clotting factors of the intrinsic pathway (10, 2, 9 ,11 and 12) and inactivates them. The anticoagulation action is exerted mainly by the inhibition of factor 10 as well as thrombin or factor 2. Therefore Antithrombin-Ill is mandatory for the action of heparin as an anticoagulant. Reduced antithrombin levels can lead to resistance.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In true heparin resistance, there is an actual blunting of heparin's anticoagulant effect. This occurs due to:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low ATIII levels (most common cause)</span></span></span></li>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased heparin-binding plasma proteins (acute phase reactants)</span></span></span></li>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased heparin clearance (e.g., due to splenomegaly in liver disease)</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low ATIII levels could be due to decreased synthesis (hereditary, hepatic failure), increased consumption (DIC, MAHA, or in a bypass circuit) or increased loss (nephrotic syndrome).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The dose of heparin has to be increased to achieve therapeutic aPTT. Severe antithrombin deficiency may require antithrombin concentrate as well.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Thrombin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Thrombin is a target of the heparin-antithrombin III complex, not a necessary cofactor for heparin's action.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Plasmin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Plasmin is involved in fibrinolysis (the breakdown of clots) and is not directly related to the anticoagulant action of heparin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Thrombomodulin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Thrombomodulin is a receptor that binds thrombin and is involved in the activation of protein C, which has anticoagulant properties. However, it is not directly required for the action of heparin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The availability of antithrombin-III is mandatory for the anticoagulant action of heparin, as it forms a complex with heparin to inactivate key enzymes in the coagulation cascade.</span></span></span></p>",
      "correct_choice_id": 200754,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50189,
      "choices": [
        {
          "id": 200756,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.8</span></span></span></p>"
        },
        {
          "id": 200757,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">10</span></span></span></p>"
        },
        {
          "id": 200758,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">14</span></span></span></p>"
        },
        {
          "id": 200759,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">18</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug solution containing 500 mg/5 ml of the drug is given to you. You are provided with a 2 ml syringe (having 10 divisions for each mI). How many divisions of the 2 m syringe need to be administered to deliver 180 mg of the drug to a patient? (</span></span></span>AIIMS May 2018)</p>",
      "unique_key": "Q8762373",
      "question_audio": null,
      "question_video": null,
      "map_id": 34873281,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 18</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">500 mg of the drug is present in 5ml of the solution.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, 180 mg will be present in (5/500) *180 = 1.8ml</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the syringe provided, 1ml = 10 divisions,</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore 1.8ml = 18 divisions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To deliver 180 mg of the drug using the provided 2 ml syringe with 10 divisions per ml, you need to fill the syringe to 18 divisions.</span></span></span></p>",
      "correct_choice_id": 200759,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50190,
      "choices": [
        {
          "id": 200760,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarinic</span></span></span></p>"
        },
        {
          "id": 200761,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nicotinic</span></span></span></p>"
        },
        {
          "id": 200762,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GABA-A</span></span></span></p>"
        },
        {
          "id": 200763,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is an example of a GPCR? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q6921356",
      "question_audio": null,
      "question_video": null,
      "map_id": 34494084,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Muscarinic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarinic receptors are G-protein-coupled receptors. Out of them, M1 and M3 act through Gq pathway and via the IP3/DAG pathway, whereas M2 and M4 act via Gi protein, that inhibits adenylyl cyclase leading to a decrease in the levels of cAMP.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Nicotinic</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Nicotinic receptors are ionotropic receptors, which means they are ion channel receptors and not GPCRs. They allow the passage of ions across the cell membrane when activated.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">GABA-A</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: GABA-A receptors are also ionotropic receptors that function as chloride ion channels. They are not GPCRs.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Insulin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The insulin receptor is a receptor tyrosine kinase (RTK), not a GPCR. It initiates a cascade of intracellular signaling upon binding insulin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Muscarinic receptors are G-protein-coupled receptors (GPCRs) that play a role in various physiological processes through different G-protein signaling pathways.</span></span></span></p>",
      "correct_choice_id": 200760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50191,
      "choices": [
        {
          "id": 200764,
          "text": "<p><span style=\"font-size:12.0pt;\">Call a vascular surgeon</span></p>"
        },
        {
          "id": 200765,
          "text": "<p><span style=\"font-size:12.0pt;\">Place generalized sutures in the area of bleeding</span></p>"
        },
        {
          "id": 200766,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevate the endopelvic fascia by inserting fingers in the vagina</span></p>"
        },
        {
          "id": 200767,
          "text": "<p><span style=\"font-size:12.0pt;\">Insert a surgical drain to monitor further bleeding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">A 45-year-old female undergoes a Burch colposuspension for stress urinary incontinence. During the procedure, there is significant bleeding in the space of Retzius, and the source of bleeding cannot be clearly visualized. What is the most appropriate next step in the management?</span></p>",
      "unique_key": "Q2747046",
      "question_audio": null,
      "question_video": null,
      "map_id": 34265297,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Elevate the endopelvic fascia by inserting fingers in the vagina</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Elevating the <strong>endopelvic fascia by inserting fingers in the vagina</strong> helps to identify the bleeding vessels by putting tension on the tissues, making it easier to visualize and grasp the bleeders, thus controlling the hemorrhage during Burch colposuspension.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Call a vascular surgeon</strong>: In most cases of intraoperative bleeding in the space of Retzius, initial management is performed by the surgical team rather than calling a vascular surgeon unless the bleeding is extensive and cannot be controlled by routine methods.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Place generalized sutures in the area of bleeding</strong>: Applying generalized sutures without clear visualization may inadvertently damage other important structures, such as vessels or nerves, and does not guarantee control of the actual bleeding site.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Insert a surgical drain to monitor further bleeding</strong>: While inserting a surgical drain is useful for postoperative monitoring, it is not a solution for active bleeding during surgery. The first goal is to achieve hemostasis before the placement of a drain.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">During pelvic surgeries, if significant bleeding occurs in the <strong>space of Retzius</strong> and visualization is difficult, <strong>lifting the endopelvic fascia by placing fingers in the vagina</strong> can facilitate hemostasis.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>Burch colposuspension</strong> procedure aims to correct stress urinary incontinence by suspending the bladder neck.</span></li><li><span style=\"font-size:12.0pt;\">Proper intraoperative management of bleeding can prevent complications, and it is essential to stabilize the patient before additional interventions.</span></li></ul>",
      "correct_choice_id": 200766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50192,
      "choices": [
        {
          "id": 200768,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        },
        {
          "id": 200769,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal atrial tachycardia</span></p>"
        },
        {
          "id": 200770,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation</span></p>"
        },
        {
          "id": 200771,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial tachycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">A 50-year-old man was brought to the emergency department in an unconscious state. He had a fever for the past two days and is a known case of severe COPD. His ECG is given below. What is the most likely diagnosis?</span></p><p> </p><p><span style=\"font-size:11.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150136.jpg\" width=\"741\" height=\"396\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150136.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1249678",
      "question_audio": null,
      "question_video": null,
      "map_id": 34070230,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Multifocal atrial tachycardia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Multifocal atrial tachycardia (MAT) is a type of supraventricular tachycardia that occurs due to multiple abnormal electrical foci within the atria. It is characterized by the presence of at least three different P-wave morphologies on an ECG, as seen in this case. This condition often arises in patients with chronic pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), especially during an acute illness like a fever or infection. The patient’s history of severe COPD and the ECG findings of varying P-wave morphologies are consistent with MAT.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20165832.jpg\" width=\"963\" height=\"534\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ventricular tachycardia:</strong> This condition presents with broad, wide QRS complexes and regular rhythm, which is not consistent with the ECG findings in this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atrial fibrillation:</strong> Atrial fibrillation is another type of supraventricular tachycardia, but it is characterized by the absence of distinct P waves and irregular RR intervals. In this case, distinct P waves of different morphologies are present, ruling out atrial fibrillation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Atrial tachycardia:</strong> Atrial tachycardia is a type of supraventricular tachycardia but typically arises from a single focus, leading to uniform P-wave morphologies. This is not consistent with the presence of multiple P-wave morphologies seen in MAT.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Multifocal atrial tachycardia (MAT) is commonly seen in patients with chronic pulmonary diseases and is characterized by irregular RR intervals and at least three distinct P-wave morphologies on an ECG. Recognizing these ECG features is essential for accurate diagnosis.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20165832.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200769,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50193,
      "choices": [
        {
          "id": 200772,
          "text": "<p><span style=\"font-size:12.0pt;\">Malleus</span></p>"
        },
        {
          "id": 200773,
          "text": "<p><span style=\"font-size:12.0pt;\">Incus</span></p>"
        },
        {
          "id": 200774,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior Semicircular Canal</span></p>"
        },
        {
          "id": 200775,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral Semicircular Canal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the marked structure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150234.jpg\" width=\"785\" height=\"580\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150234.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9792737",
      "question_audio": null,
      "question_video": null,
      "map_id": 34346099,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Incus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image provided is from a mastoidectomy, a procedure where the middle ear structures are often visualized. The <strong>incus</strong> is one of the three ossicles of the middle ear and is located between the malleus and the stapes. It has a distinctive structure with both a short process and a long process. The long process of the incus articulates with the head of the stapes, facilitating the transmission of sound vibrations from the eardrum to the inner ear. The arrow in the image points to the incus, which confirms the diagnosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Malleus:</strong> The malleus is another middle ear ossicle, but it articulates with the tympanic membrane and the incus. The image, however, shows the incus, not the malleus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Posterior Semicircular Canal:</strong> The posterior semicircular canal is part of the inner ear and is involved in balance, but it is not the structure indicated in the image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lateral Semicircular Canal:</strong> Similar to the posterior semicircular canal, the lateral semicircular canal is also part of the inner ear and plays a role in detecting head rotation, but it is not visible in this image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The <strong>incus</strong> is one of the three ossicles in the middle ear and plays a crucial role in sound transmission by articulating with the malleus and stapes.</span></p>",
      "correct_choice_id": 200773,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50194,
      "choices": [
        {
          "id": 200776,
          "text": "<p><span style=\"font-size:12.0pt;\">RBC 20-22°C, Platelet 2-6°C, FFP -30°C</span></p>"
        },
        {
          "id": 200777,
          "text": "<p><span style=\"font-size:12.0pt;\">RBC 2-6°C, Platelet 20-22°C, FFP -30°C</span></p>"
        },
        {
          "id": 200778,
          "text": "<p><span style=\"font-size:12.0pt;\">RBC -30°C, FFP 2-6°C, Platelet 20-22°C</span></p>"
        },
        {
          "id": 200779,
          "text": "<p><span style=\"font-size:12.0pt;\">RBC 20-22°C, FFP below -30°C, Platelet 2-6°C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">Choose the correct option regarding the storage temperatures of blood components.</span></p>",
      "unique_key": "Q6409696",
      "question_audio": null,
      "question_video": null,
      "map_id": 34817707,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) RBC 2-6°C, Platelet 20-22°C, FFP -30°C</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct storage temperatures for various blood components are essential to ensure the viability and safety of transfusions:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Red Blood Cells (RBCs):</strong> Stored at 2-6°C to preserve their integrity and function for up to 42 days in CPD (Citrate-Phosphate-Dextrose) solution. This temperature range prevents hemolysis and preserves red cell function.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Platelets:</strong> Stored at 20-22°C with continuous gentle agitation to prevent clumping. This temperature ensures the platelets remain viable for up to 5-7 days.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fresh Frozen Plasma (FFP):</strong> Stored at -30°C or lower, which maintains the activity of clotting factors. FFP can be stored for up to 1 year at this temperature.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Recommended storage temperatures:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150328.jpg\" width=\"833\" height=\"321\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150328.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50195,
      "choices": [
        {
          "id": 200780,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 200781,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoriatic arthritis</span></p>"
        },
        {
          "id": 200782,
          "text": "<p><span style=\"font-size:12.0pt;\">Seronegative arthritis</span></p>"
        },
        {
          "id": 200783,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoarthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">The most common form of arthritis is: </span></p>",
      "unique_key": "Q4536615",
      "question_audio": null,
      "question_video": null,
      "map_id": 34061743,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Osteoarthritis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Osteoarthritis (OA) is the most common form of arthritis, especially affecting individuals older than 75 years, with up to 80% experiencing it. OA is a degenerative joint disease characterized by the breakdown of cartilage, which leads to pain, stiffness, and reduced mobility in affected joints. It primarily affects weight-bearing joints such as the hips, knees, and spine, but can also involve the hands. Unlike inflammatory arthritis, it is not systemic, and joint involvement tends to be limited to specific areas rather than widespread.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rheumatoid arthritis:</strong> This is an autoimmune inflammatory arthritis, but it is less common than osteoarthritis. It tends to affect smaller joints like the hands and wrists.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Psoriatic arthritis:</strong> This is a type of inflammatory arthritis associated with psoriasis, and it is far less common compared to osteoarthritis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Seronegative arthritis:</strong> This is a group of inflammatory joint diseases that do not have rheumatoid factor, including ankylosing spondylitis, but it is also much less common than osteoarthritis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Osteoarthritis is the most prevalent form of arthritis, primarily affecting older adults. It involves the degeneration of joint cartilage, particularly in weight-bearing joints, and differs from inflammatory forms of arthritis like rheumatoid arthritis.</span></p>",
      "correct_choice_id": 200783,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50196,
      "choices": [
        {
          "id": 200784,
          "text": "<p><span style=\"font-size:12.0pt;\">Conduct a thorough examination</span></p>"
        },
        {
          "id": 200785,
          "text": "<p><span style=\"font-size:12.0pt;\">Seek a social worker’s help</span></p>"
        },
        {
          "id": 200786,
          "text": "<p><span style=\"font-size:12.0pt;\">Inform higher authorities immediately</span></p>"
        },
        {
          "id": 200787,
          "text": "<p><span style=\"font-size:12.0pt;\">Inform your colleagues</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">A 14-year-old girl presents to the emergency room with a fractured forearm and says she tripped and fell. On examination, you notice multiple cigarette burns on her forearm. What will you do next?</span></p>",
      "unique_key": "Q5193565",
      "question_audio": null,
      "question_video": null,
      "map_id": 34921761,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Conduct a thorough examination</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In cases of suspected child abuse, the first and most important step is to conduct a thorough physical examination to assess the extent of any injuries and identify any additional signs of abuse. Noticing multiple cigarette burns on the child’s forearm raises strong suspicion of physical abuse, and documenting all findings accurately is critical. After the physical examination, it is essential to follow up with a psychiatric evaluation and ensure the child's safety. In cases of confirmed or suspected abuse, further steps will include informing child protective services or relevant authorities.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Seek a social worker’s help:</strong> While involving a social worker is important, it is not the immediate next step. The priority should be a thorough physical examination to assess the injuries.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Inform higher authorities immediately:</strong> Reporting to authorities is necessary, but only after conducting a detailed examination and collecting the necessary evidence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inform your colleagues:</strong> Although consulting colleagues might be helpful, the first step is a thorough examination to gather crucial details for further action.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">When encountering a suspected case of child abuse, the first step should be a comprehensive physical examination to document and evaluate the injuries, followed by appropriate reporting and interventions to ensure the child's safety.</span></p>",
      "correct_choice_id": 200784,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50197,
      "choices": [
        {
          "id": 200788,
          "text": "<p><span style=\"font-size:12.0pt;\">c, b, a, d</span></p>"
        },
        {
          "id": 200789,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, d</span></p>"
        },
        {
          "id": 200790,
          "text": "<p><span style=\"font-size:12.0pt;\">a, c, b, d</span></p>"
        },
        {
          "id": 200791,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c, a, d</span></p>"
        }
      ],
      "text": "<p>Arrange the sequence of steps in leukocyte migration: </p><p> </p><p><span style=\"font-size:12.0pt;\">a. Stable adhesion</span><br><span style=\"font-size:12.0pt;\">b. Integration activation by chemokine</span><br><span style=\"font-size:12.0pt;\">c. Rolling</span><br><span style=\"font-size:12.0pt;\">d. Migration through endothelium</span></p>",
      "unique_key": "Q3689167",
      "question_audio": null,
      "question_video": null,
      "map_id": 34610678,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) c, b, a, d</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Leukocyte migration from the bloodstream to the tissue during inflammation is a multi-step process:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Rolling (c)</strong>: Leukocytes first \"roll\" along the endothelium. This process is mediated by selectins, which interact with glycoproteins on the leukocyte surface. Rolling allows leukocytes to slow down and move along the vessel wall.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Activation by chemokines (b)</strong>: Chemokines activate integrins on leukocytes, increasing their affinity for adhesion molecules on the endothelial surface.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stable adhesion (a)</strong>: Once integrins are activated, leukocytes firmly adhere to the endothelium through integrin-mediated binding.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Migration through endothelium (d)</strong>: Finally, leukocytes migrate across the endothelial barrier into the tissue through a process called diapedesis, following a chemotactic gradient to the site of inflammation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150410.jpg\" width=\"1251\" height=\"615\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Leukocyte migration involves rolling, chemokine-mediated integrin activation, stable adhesion, and migration across the endothelium, a crucial sequence in the immune response during inflammation.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150410.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200788,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50198,
      "choices": [
        {
          "id": 200792,
          "text": "<p><span style=\"font-size:12.0pt;\">Scleroderma</span></p>"
        },
        {
          "id": 200793,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematosus</span></p>"
        },
        {
          "id": 200794,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 200795,
          "text": "<p><span style=\"font-size:12.0pt;\">Sjogren's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">Anti-nuclear antibodies are required for the diagnosis of which of the following?</span></p>",
      "unique_key": "Q2969858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34858843,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Systemic lupus erythematosus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anti-nuclear antibodies (ANAs) are autoantibodies that bind to cellular nuclear contents. They are present in over 95% of patients with Systemic Lupus Erythematosus (SLE), making them a crucial marker for its diagnosis. A positive ANA test with a titer of at least 1:80 is an essential criterion for diagnosing SLE. According to the 2019 EULAR/ACR Classification Criteria for SLE, a positive ANA test must be met alongside a set of additive criteria across 7 clinical and 3 immunologic domains. When these criteria achieve a total score of more than 10 points, SLE can be diagnosed. ANAs are recognized as the most sensitive antibodies for SLE diagnosis, although they lack specificity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Additionally, specific antibodies such as Anti-Smith and Anti-dsDNA antibodies offer higher specificity for SLE, with Anti-Smith being the most specific, followed closely by Anti-dsDNA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Scleroderma</strong>:  Scleroderma, also known as systemic sclerosis, is characterized by antibodies specific to anti-topoisomerase I (Scl-70) and anti-centromere antibodies, which are highly specific for systemic sclerosis. ANA may be positive in some cases of scleroderma, but it is not a criterion for diagnosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rheumatoid arthritis</strong>: Rheumatoid arthritis (RA) is primarily associated with rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. ANAs may occasionally be present in RA patients, but they are not diagnostic criteria for RA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sjogren's syndrome</strong>: In Sjogren's syndrome, the specific autoantibodies are Anti-Ro and Anti-La. While ANAs may also be positive in Sjogren's syndrome, they are not a diagnostic criterion for this condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anti-nuclear antibodies (ANAs) are a required diagnostic criterion for Systemic Lupus Erythematosus (SLE) and are present in over 95% of SLE patients.</span></p>",
      "correct_choice_id": 200793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50199,
      "choices": [
        {
          "id": 200796,
          "text": "<p><span style=\"font-size:12.0pt;\">Celiac disease</span></p>"
        },
        {
          "id": 200797,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulcerative colitis</span></p>"
        },
        {
          "id": 200798,
          "text": "<p><span style=\"font-size:12.0pt;\">Intestinal lymphangiectasia</span></p>"
        },
        {
          "id": 200799,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatic insufficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">A patient presented with chronic diarrhea and steatorrhea. D-xylose test was normal and the Schilling test was abnormal. A duodenal biopsy was normal. What is the most likely diagnosis? </span></p>",
      "unique_key": "Q9673712",
      "question_audio": null,
      "question_video": null,
      "map_id": 34202550,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Pancreatic insufficiency</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The presentation of chronic diarrhea and steatorrhea indicates a malabsorption syndrome. Key diagnostic tests include the D-xylose test, duodenal biopsy, and Schilling test to help identify the underlying pathology. In this case:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Normal D-xylose test</strong> – This suggests an intact small intestinal mucosa, as D-xylose is a monosaccharide absorbed directly by the intestinal lining without requiring digestive enzymes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Normal duodenal biopsy</strong> – This finding further excludes small intestinal conditions like celiac disease or intestinal lymphangiectasia, which typically show abnormalities on biopsy.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Abnormal Schilling test</strong> – An abnormal Schilling test indicates impaired absorption of vitamin B12. Pancreatic enzymes are required to release vitamin B12 from its bound form, facilitating its absorption. In pancreatic insufficiency, a lack of these enzymes leads to an abnormal Schilling test, which may normalize after pancreatic enzyme supplementation.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Pancreatic insufficiency, often associated with chronic pancreatitis, causes a deficiency in pancreatic enzymes, which are crucial for the digestion and absorption of nutrients, particularly fats. This deficiency leads to steatorrhea and an abnormal Schilling test, aligning with the clinical findings.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Celiac disease</strong>:  In celiac disease, the D-xylose test would typically be decreased, and duodenal biopsy would show abnormal findings such as villous atrophy, crypt hyperplasia, and epithelial cell damage. This makes celiac disease an unlikely diagnosis here.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ulcerative colitis</strong>:  Ulcerative colitis affects the colon and does not typically lead to fat malabsorption or steatorrhea, as fat absorption occurs in the small intestine. Additionally, it does not affect the Schilling or D-xylose tests.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Intestinal lymphangiectasia</strong> : This condition involves abnormal lymphatic function, leading to malabsorption, but it would show an abnormal duodenal biopsy with findings such as dilated lymphatics and clubbed villi. The normal biopsy here rules out this diagnosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150601.jpg\" width=\"1258\" height=\"575\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150601.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200799,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}